id	sid	tid	token	lemma	pos
cuesj-1122	1	1	tx_1	tx_1	PROPN
cuesj-1122	1	2	~	~	X
cuesj-1122	1	3	abs	ab	NOUN
cuesj-1122	1	4	:	:	PUNCT
cuesj-1122	1	5	at	at	ADP
cuesj-1122	1	6	/	/	SYM
cuesj-1122	1	7	add	add	VERB
cuesj-1122	1	8	:	:	PUNCT
cuesj-1122	1	9	tx_2	tx_2	PROPN
cuesj-1122	1	10	~	~	NOUN
cuesj-1122	1	11	abs	ab	NOUN
cuesj-1122	1	12	:	:	PUNCT
cuesj-1122	1	13	at	at	ADP
cuesj-1122	1	14	46	46	NUM
cuesj-1122	1	15	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1122	1	16	cuesj	cuesj	NOUN
cuesj-1122	1	17	2024	2024	NUM
cuesj-1122	1	18	,	,	PUNCT
cuesj-1122	1	19	8	8	NUM
cuesj-1122	1	20	(	(	PUNCT
cuesj-1122	1	21	1	1	NUM
cuesj-1122	1	22	):	):	PUNCT
cuesj-1122	1	23	46	46	NUM
cuesj-1122	1	24	-	-	SYM
cuesj-1122	1	25	57	57	NUM
cuesj-1122	1	26	research	research	NOUN
cuesj-1122	1	27	article	article	NOUN
cuesj-1122	1	28	comparison	comparison	NOUN
cuesj-1122	1	29	of	of	ADP
cuesj-1122	1	30	biochemical	biochemical	ADJ
cuesj-1122	1	31	parameters	parameter	NOUN
cuesj-1122	1	32	in	in	ADP
cuesj-1122	1	33	vaccinated	vaccinated	ADJ
cuesj-1122	1	34	and	and	CCONJ
cuesj-1122	1	35	non	non	ADJ
cuesj-1122	1	36	-	-	ADJ
cuesj-1122	1	37	vaccinated	vaccinated	ADJ
cuesj-1122	1	38	sars	sar	NOUN
cuesj-1122	1	39	-	-	PUNCT
cuesj-1122	1	40	cov-2	cov-2	NOUN
cuesj-1122	1	41	patients	patient	NOUN
cuesj-1122	1	42	in	in	ADP
cuesj-1122	1	43	erbil	erbil	PROPN
cuesj-1122	1	44	-	-	PUNCT
cuesj-1122	1	45	city	city	NOUN
cuesj-1122	1	46	hardi	hardi	PROPN
cuesj-1122	1	47	s.	s.	PROPN
cuesj-1122	1	48	ahmed1	ahmed1	PROPN
cuesj-1122	1	49	,	,	PUNCT
cuesj-1122	2	1	nadir	nadir	NOUN
cuesj-1122	2	2	m.	m.	NOUN
cuesj-1122	2	3	q.	q.	PROPN
cuesj-1122	2	4	nanakali1,2	nanakali1,2	PROPN
cuesj-1122	2	5	,	,	PUNCT
cuesj-1122	2	6	khabat	khabat	PROPN
cuesj-1122	2	7	a.	a.	NOUN
cuesj-1122	2	8	ali1	ali1	PROPN
cuesj-1122	2	9	1department	1department	NUM
cuesj-1122	2	10	of	of	ADP
cuesj-1122	2	11	biology	biology	NOUN
cuesj-1122	2	12	,	,	PUNCT
cuesj-1122	2	13	salahaddin	salahaddin	VERB
cuesj-1122	2	14	university	university	NOUN
cuesj-1122	2	15	,	,	PUNCT
cuesj-1122	2	16	kurdistan	kurdistan	PROPN
cuesj-1122	2	17	region	region	NOUN
cuesj-1122	2	18	,	,	PUNCT
cuesj-1122	2	19	iraq	iraq	PROPN
cuesj-1122	2	20	,	,	PUNCT
cuesj-1122	2	21	2department	2department	NUM
cuesj-1122	2	22	of	of	ADP
cuesj-1122	2	23	biomedical	biomedical	ADJ
cuesj-1122	2	24	sciences	science	NOUN
cuesj-1122	2	25	,	,	PUNCT
cuesj-1122	2	26	cihan	cihan	VERB
cuesj-1122	2	27	university	university	NOUN
cuesj-1122	2	28	-	-	PUNCT
cuesj-1122	2	29	erbil	erbil	PROPN
cuesj-1122	2	30	,	,	PUNCT
cuesj-1122	2	31	kurdistan	kurdistan	ADJ
cuesj-1122	2	32	region	region	NOUN
cuesj-1122	2	33	,	,	PUNCT
cuesj-1122	2	34	iraq	iraq	PROPN
cuesj-1122	2	35	abstract	abstract	PROPN
cuesj-1122	2	36	covid-19	covid-19	PROPN
cuesj-1122	2	37	is	be	AUX
cuesj-1122	2	38	one	one	NUM
cuesj-1122	2	39	of	of	ADP
cuesj-1122	2	40	the	the	DET
cuesj-1122	2	41	major	major	ADJ
cuesj-1122	2	42	pandemic	pandemic	ADJ
cuesj-1122	2	43	diseases	disease	NOUN
cuesj-1122	2	44	caused	cause	VERB
cuesj-1122	2	45	by	by	ADP
cuesj-1122	2	46	sars	sar	NOUN
cuesj-1122	2	47	-	-	PUNCT
cuesj-1122	2	48	cov-2	cov-2	NOUN
cuesj-1122	2	49	.	.	PUNCT
cuesj-1122	3	1	vaccination	vaccination	NOUN
cuesj-1122	3	2	is	be	AUX
cuesj-1122	3	3	one	one	NUM
cuesj-1122	3	4	of	of	ADP
cuesj-1122	3	5	the	the	DET
cuesj-1122	3	6	methods	method	NOUN
cuesj-1122	3	7	used	use	VERB
cuesj-1122	3	8	that	that	PRON
cuesj-1122	3	9	reduce	reduce	VERB
cuesj-1122	3	10	the	the	DET
cuesj-1122	3	11	spread	spread	NOUN
cuesj-1122	3	12	of	of	ADP
cuesj-1122	3	13	an	an	DET
cuesj-1122	3	14	infectious	infectious	ADJ
cuesj-1122	3	15	disease	disease	NOUN
cuesj-1122	3	16	.	.	PUNCT
cuesj-1122	4	1	consequently	consequently	ADV
cuesj-1122	4	2	,	,	PUNCT
cuesj-1122	4	3	we	we	PRON
cuesj-1122	4	4	aimed	aim	VERB
cuesj-1122	4	5	to	to	PART
cuesj-1122	4	6	measure	measure	VERB
cuesj-1122	4	7	liver	liver	NOUN
cuesj-1122	4	8	parameters	parameter	NOUN
cuesj-1122	4	9	(	(	PUNCT
cuesj-1122	4	10	alanine	alanine	NOUN
cuesj-1122	4	11	transaminase	transaminase	NOUN
cuesj-1122	4	12	(	(	PUNCT
cuesj-1122	4	13	alt	alt	PROPN
cuesj-1122	4	14	)	)	PUNCT
cuesj-1122	4	15	,	,	PUNCT
cuesj-1122	4	16	aspartate	aspartate	NOUN
cuesj-1122	4	17	transaminase	transaminase	NOUN
cuesj-1122	4	18	(	(	PUNCT
cuesj-1122	4	19	ast	ast	NOUN
cuesj-1122	4	20	)	)	PUNCT
cuesj-1122	4	21	,	,	PUNCT
cuesj-1122	4	22	alkaline	alkaline	NOUN
cuesj-1122	4	23	phosphatase	phosphatase	NOUN
cuesj-1122	4	24	(	(	PUNCT
cuesj-1122	4	25	alp	alp	PROPN
cuesj-1122	4	26	)	)	PUNCT
cuesj-1122	4	27	,	,	PUNCT
cuesj-1122	4	28	total	total	ADJ
cuesj-1122	4	29	serum	serum	NOUN
cuesj-1122	4	30	bilirubin	bilirubin	NOUN
cuesj-1122	4	31	(	(	PUNCT
cuesj-1122	4	32	tsb	tsb	NOUN
cuesj-1122	4	33	)	)	PUNCT
cuesj-1122	4	34	,	,	PUNCT
cuesj-1122	4	35	and	and	CCONJ
cuesj-1122	4	36	lactate	lactate	NOUN
cuesj-1122	4	37	dehydrogenase	dehydrogenase	NOUN
cuesj-1122	4	38	(	(	PUNCT
cuesj-1122	4	39	ldh	ldh	NOUN
cuesj-1122	4	40	)	)	PUNCT
cuesj-1122	4	41	and	and	CCONJ
cuesj-1122	4	42	albumin	albumin	NOUN
cuesj-1122	4	43	)	)	PUNCT
cuesj-1122	4	44	,	,	PUNCT
cuesj-1122	4	45	as	as	ADV
cuesj-1122	4	46	well	well	ADV
cuesj-1122	4	47	as	as	ADP
cuesj-1122	4	48	bone	bone	NOUN
cuesj-1122	4	49	markers	marker	NOUN
cuesj-1122	4	50	(	(	PUNCT
cuesj-1122	4	51	calcium	calcium	NOUN
cuesj-1122	4	52	,	,	PUNCT
cuesj-1122	4	53	phosphorous	phosphorous	ADJ
cuesj-1122	4	54	,	,	PUNCT
cuesj-1122	4	55	parathyroid	parathyroid	ADJ
cuesj-1122	4	56	hormone	hormone	NOUN
cuesj-1122	4	57	(	(	PUNCT
cuesj-1122	4	58	pth	pth	NOUN
cuesj-1122	4	59	)	)	PUNCT
cuesj-1122	4	60	with	with	ADP
cuesj-1122	4	61	thyroid	thyroid	NOUN
cuesj-1122	4	62	stimulating	stimulate	VERB
cuesj-1122	4	63	hormone	hormone	NOUN
cuesj-1122	4	64	(	(	PUNCT
cuesj-1122	4	65	tsh	tsh	NOUN
cuesj-1122	4	66	)	)	PUNCT
cuesj-1122	4	67	as	as	ADP
cuesj-1122	4	68	marker	marker	NOUN
cuesj-1122	4	69	for	for	ADP
cuesj-1122	4	70	the	the	DET
cuesj-1122	4	71	severity	severity	NOUN
cuesj-1122	4	72	of	of	ADP
cuesj-1122	4	73	the	the	DET
cuesj-1122	4	74	disease	disease	NOUN
cuesj-1122	4	75	in	in	ADP
cuesj-1122	4	76	non	non	ADJ
cuesj-1122	4	77	-	-	ADJ
cuesj-1122	4	78	vaccinated	vaccinated	ADJ
cuesj-1122	4	79	and	and	CCONJ
cuesj-1122	4	80	vaccinated	vaccinated	ADJ
cuesj-1122	4	81	sars	sar	NOUN
cuesj-1122	4	82	-	-	PUNCT
cuesj-1122	4	83	cov-2	cov-2	NOUN
cuesj-1122	4	84	 	 	SPACE
cuesj-1122	4	85	patients	patient	NOUN
cuesj-1122	4	86	.	.	PUNCT
cuesj-1122	5	1	between	between	ADP
cuesj-1122	5	2	november	november	PROPN
cuesj-1122	5	3	2021	2021	NUM
cuesj-1122	5	4	and	and	CCONJ
cuesj-1122	5	5	may	may	AUX
cuesj-1122	5	6	2022	2022	NUM
cuesj-1122	5	7	,	,	PUNCT
cuesj-1122	5	8	130	130	NUM
cuesj-1122	5	9	 	 	SPACE
cuesj-1122	5	10	samples	sample	NOUN
cuesj-1122	5	11	of	of	ADP
cuesj-1122	5	12	both	both	DET
cuesj-1122	5	13	genders	gender	NOUN
cuesj-1122	5	14	(	(	PUNCT
cuesj-1122	5	15	healthy	healthy	ADJ
cuesj-1122	5	16	and	and	CCONJ
cuesj-1122	5	17	infected	infect	VERB
cuesj-1122	5	18	with	with	ADP
cuesj-1122	5	19	covid-19	covid-19	PROPN
cuesj-1122	5	20	)	)	PUNCT
cuesj-1122	5	21	were	be	AUX
cuesj-1122	5	22	obtained	obtain	VERB
cuesj-1122	5	23	and	and	CCONJ
cuesj-1122	5	24	divided	divide	VERB
cuesj-1122	5	25	into	into	ADP
cuesj-1122	5	26	three	three	NUM
cuesj-1122	5	27	groups	group	NOUN
cuesj-1122	5	28	:	:	PUNCT
cuesj-1122	5	29	healthy	healthy	ADJ
cuesj-1122	5	30	individuals	individual	NOUN
cuesj-1122	5	31	(	(	PUNCT
cuesj-1122	5	32	50	50	NUM
cuesj-1122	5	33	)	)	PUNCT
cuesj-1122	5	34	,	,	PUNCT
cuesj-1122	5	35	vaccinated	vaccinate	VERB
cuesj-1122	5	36	(	(	PUNCT
cuesj-1122	5	37	30	30	NUM
cuesj-1122	5	38	)	)	PUNCT
cuesj-1122	5	39	and	and	CCONJ
cuesj-1122	5	40	non	non	ADJ
cuesj-1122	5	41	-	-	ADJ
cuesj-1122	5	42	vaccinated	vaccinated	ADJ
cuesj-1122	5	43	(	(	PUNCT
cuesj-1122	5	44	50	50	NUM
cuesj-1122	5	45	)	)	PUNCT
cuesj-1122	5	46	group	group	NOUN
cuesj-1122	5	47	”	"	PUNCT
cuesj-1122	5	48	(	(	PUNCT
cuesj-1122	5	49	ages	age	NOUN
cuesj-1122	5	50	;	;	PUNCT
cuesj-1122	5	51	20–65	20–65	NUM
cuesj-1122	5	52	)	)	PUNCT
cuesj-1122	5	53	.	.	PUNCT
cuesj-1122	6	1	the	the	DET
cuesj-1122	6	2	findings	finding	NOUN
cuesj-1122	6	3	of	of	ADP
cuesj-1122	6	4	the	the	DET
cuesj-1122	6	5	current	current	ADJ
cuesj-1122	6	6	study	study	NOUN
cuesj-1122	6	7	showed	show	VERB
cuesj-1122	6	8	that	that	SCONJ
cuesj-1122	6	9	alt	alt	ADJ
cuesj-1122	6	10	,	,	PUNCT
cuesj-1122	6	11	alp	alp	PROPN
cuesj-1122	6	12	,	,	PUNCT
cuesj-1122	6	13	and	and	CCONJ
cuesj-1122	6	14	ldh	ldh	PROPN
cuesj-1122	6	15	significantly	significantly	ADV
cuesj-1122	6	16	elevated	elevate	VERB
cuesj-1122	6	17	(	(	PUNCT
cuesj-1122	6	18	p	p	X
cuesj-1122	6	19	<	<	X
cuesj-1122	6	20	0.01	0.01	NUM
cuesj-1122	6	21	)	)	PUNCT
cuesj-1122	6	22	,	,	PUNCT
cuesj-1122	6	23	and	and	CCONJ
cuesj-1122	6	24	despite	despite	SCONJ
cuesj-1122	6	25	comparing	compare	VERB
cuesj-1122	6	26	patients	patient	NOUN
cuesj-1122	6	27	who	who	PRON
cuesj-1122	6	28	were	be	AUX
cuesj-1122	6	29	not	not	PART
cuesj-1122	6	30	vaccinated	vaccinate	VERB
cuesj-1122	6	31	to	to	ADP
cuesj-1122	6	32	those	those	PRON
cuesj-1122	6	33	who	who	PRON
cuesj-1122	6	34	were	be	AUX
cuesj-1122	6	35	,	,	PUNCT
cuesj-1122	6	36	albumin	albumin	PROPN
cuesj-1122	6	37	considerably	considerably	ADV
cuesj-1122	6	38	dropped	drop	VERB
cuesj-1122	6	39	.	.	PUNCT
cuesj-1122	7	1	moreover	moreover	ADV
cuesj-1122	7	2	,	,	PUNCT
cuesj-1122	7	3	ast	ast	PROPN
cuesj-1122	7	4	and	and	CCONJ
cuesj-1122	7	5	tsb	tsb	PROPN
cuesj-1122	7	6	moderately	moderately	ADV
cuesj-1122	7	7	elevated	elevate	VERB
cuesj-1122	7	8	in	in	ADP
cuesj-1122	7	9	unvaccinated	unvaccinated	ADJ
cuesj-1122	7	10	group	group	NOUN
cuesj-1122	7	11	in	in	ADP
cuesj-1122	7	12	comparison	comparison	NOUN
cuesj-1122	7	13	to	to	ADP
cuesj-1122	7	14	unvaccinated	unvaccinated	ADJ
cuesj-1122	7	15	patients	patient	NOUN
cuesj-1122	7	16	.	.	PUNCT
cuesj-1122	8	1	calcium	calcium	NOUN
cuesj-1122	8	2	and	and	CCONJ
cuesj-1122	8	3	phosphorous	phosphorous	ADJ
cuesj-1122	8	4	slightly	slightly	ADV
cuesj-1122	8	5	decreased	decrease	VERB
cuesj-1122	8	6	in	in	ADP
cuesj-1122	8	7	non	non	ADJ
cuesj-1122	8	8	-	-	ADJ
cuesj-1122	8	9	vaccinated	vaccinated	ADJ
cuesj-1122	8	10	and	and	CCONJ
cuesj-1122	8	11	vaccinated	vaccinated	ADJ
cuesj-1122	8	12	patients	patient	NOUN
cuesj-1122	8	13	as	as	SCONJ
cuesj-1122	8	14	compare	compare	VERB
cuesj-1122	8	15	to	to	ADP
cuesj-1122	8	16	control	control	NOUN
cuesj-1122	8	17	.	.	PUNCT
cuesj-1122	9	1	whereas	whereas	SCONJ
cuesj-1122	9	2	pth	pth	NOUN
cuesj-1122	9	3	and	and	CCONJ
cuesj-1122	9	4	tsh	tsh	NOUN
cuesj-1122	9	5	significantly	significantly	ADV
cuesj-1122	9	6	less	less	ADV
cuesj-1122	9	7	in	in	ADP
cuesj-1122	9	8	both	both	CCONJ
cuesj-1122	9	9	patient	patient	ADJ
cuesj-1122	9	10	groups	group	NOUN
cuesj-1122	9	11	than	than	ADP
cuesj-1122	9	12	in	in	ADP
cuesj-1122	9	13	control	control	NOUN
cuesj-1122	9	14	.	.	PUNCT
cuesj-1122	10	1	“	"	PUNCT
cuesj-1122	10	2	the	the	DET
cuesj-1122	10	3	optimal	optimal	ADJ
cuesj-1122	10	4	cutoff	cutoff	NOUN
cuesj-1122	10	5	values	value	NOUN
cuesj-1122	10	6	for	for	ADP
cuesj-1122	10	7	parameters	parameter	NOUN
cuesj-1122	10	8	were	be	AUX
cuesj-1122	10	9	determined	determine	VERB
cuesj-1122	10	10	by	by	ADP
cuesj-1122	10	11	roc	roc	PROPN
cuesj-1122	10	12	curve	curve	NOUN
cuesj-1122	10	13	analysis	analysis	NOUN
cuesj-1122	10	14	.	.	PUNCT
cuesj-1122	11	1	in	in	ADP
cuesj-1122	11	2	conclusion	conclusion	NOUN
cuesj-1122	11	3	,	,	PUNCT
cuesj-1122	11	4	vaccine	vaccine	NOUN
cuesj-1122	11	5	plays	play	VERB
cuesj-1122	11	6	a	a	DET
cuesj-1122	11	7	major	major	ADJ
cuesj-1122	11	8	role	role	NOUN
cuesj-1122	11	9	in	in	ADP
cuesj-1122	11	10	minimizing	minimize	VERB
cuesj-1122	11	11	liver	liver	NOUN
cuesj-1122	11	12	biomarkers	biomarker	NOUN
cuesj-1122	11	13	in	in	ADP
cuesj-1122	11	14	covid-19	covid-19	PROPN
cuesj-1122	11	15	 	 	SPACE
cuesj-1122	11	16	patients	patient	NOUN
cuesj-1122	11	17	.	.	PUNCT
cuesj-1122	12	1	moreover	moreover	ADV
cuesj-1122	12	2	,	,	PUNCT
cuesj-1122	12	3	low	low	ADJ
cuesj-1122	12	4	concentrations	concentration	NOUN
cuesj-1122	12	5	of	of	ADP
cuesj-1122	12	6	bone	bone	NOUN
cuesj-1122	12	7	markers	marker	NOUN
cuesj-1122	12	8	were	be	AUX
cuesj-1122	12	9	associated	associate	VERB
cuesj-1122	12	10	with	with	ADP
cuesj-1122	12	11	both	both	CCONJ
cuesj-1122	12	12	vaccinated	vaccinate	VERB
cuesj-1122	12	13	and	and	CCONJ
cuesj-1122	12	14	nonvaccinated	nonvaccinate	VERB
cuesj-1122	12	15	covid-19	covid-19	PROPN
cuesj-1122	12	16	 	 	SPACE
cuesj-1122	12	17	patients	patient	NOUN
cuesj-1122	12	18	.	.	PUNCT
cuesj-1122	13	1	therefore	therefore	ADV
cuesj-1122	13	2	,	,	PUNCT
cuesj-1122	13	3	the	the	DET
cuesj-1122	13	4	bone	bone	NOUN
cuesj-1122	13	5	health	health	NOUN
cuesj-1122	13	6	status	status	NOUN
cuesj-1122	13	7	of	of	ADP
cuesj-1122	13	8	covid-19	covid-19	PROPN
cuesj-1122	13	9	 	 	SPACE
cuesj-1122	13	10	patients	patient	NOUN
cuesj-1122	13	11	and	and	CCONJ
cuesj-1122	13	12	liver	liver	NOUN
cuesj-1122	13	13	markers	marker	NOUN
cuesj-1122	13	14	are	be	AUX
cuesj-1122	13	15	helpful	helpful	ADJ
cuesj-1122	13	16	for	for	ADP
cuesj-1122	13	17	the	the	DET
cuesj-1122	13	18	diagnosis	diagnosis	NOUN
cuesj-1122	13	19	and	and	CCONJ
cuesj-1122	13	20	monitoring	monitoring	NOUN
cuesj-1122	13	21	of	of	ADP
cuesj-1122	13	22	disease	disease	NOUN
cuesj-1122	13	23	severity	severity	NOUN
cuesj-1122	13	24	in	in	ADP
cuesj-1122	13	25	covid‐19	covid‐19	PROPN
cuesj-1122	13	26	 	 	SPACE
cuesj-1122	13	27	patient	patient	NOUN
cuesj-1122	13	28	.	.	PUNCT
cuesj-1122	14	1	keywords	keyword	NOUN
cuesj-1122	14	2	:	:	PUNCT
cuesj-1122	14	3	vaccine	vaccine	NOUN
cuesj-1122	14	4	,	,	PUNCT
cuesj-1122	14	5	bone	bone	NOUN
cuesj-1122	14	6	markers	marker	NOUN
cuesj-1122	14	7	,	,	PUNCT
cuesj-1122	14	8	liver	liver	NOUN
cuesj-1122	14	9	enzymes	enzyme	NOUN
cuesj-1122	14	10	,	,	PUNCT
cuesj-1122	14	11	biochemical	biochemical	ADJ
cuesj-1122	14	12	,	,	PUNCT
cuesj-1122	14	13	sars	sar	NOUN
cuesj-1122	14	14	-	-	PUNCT
cuesj-1122	14	15	cov-2	cov-2	PART
cuesj-1122	14	16	introduction	introduction	NOUN
cuesj-1122	14	17	coronavirus	coronavirus	NOUN
cuesj-1122	14	18	disease	disease	NOUN
cuesj-1122	14	19	2019	2019	NUM
cuesj-1122	14	20	(	(	PUNCT
cuesj-1122	14	21	covid-19	covid-19	PROPN
cuesj-1122	14	22	)	)	PUNCT
cuesj-1122	14	23	is	be	AUX
cuesj-1122	14	24	an	an	DET
cuesj-1122	14	25	extremely	extremely	ADV
cuesj-1122	14	26	infectious	infectious	ADJ
cuesj-1122	14	27	and	and	CCONJ
cuesj-1122	14	28	pathogenic	pathogenic	ADJ
cuesj-1122	14	29	infectious	infectious	ADJ
cuesj-1122	14	30	disease	disease	NOUN
cuesj-1122	14	31	carried	carry	VERB
cuesj-1122	14	32	on	on	ADP
cuesj-1122	14	33	by	by	ADP
cuesj-1122	14	34	the	the	DET
cuesj-1122	14	35	recently	recently	ADV
cuesj-1122	14	36	identified	identify	VERB
cuesj-1122	14	37	severe	severe	ADJ
cuesj-1122	14	38	acute	acute	ADJ
cuesj-1122	14	39	respiratory	respiratory	ADJ
cuesj-1122	14	40	syndrome	syndrome	NOUN
cuesj-1122	14	41	coronavirus	coronavirus	NOUN
cuesj-1122	14	42	2	2	NUM
cuesj-1122	14	43	(	(	PUNCT
cuesj-1122	14	44	sars	sar	NOUN
cuesj-1122	14	45	-	-	PUNCT
cuesj-1122	14	46	cov-2	cov-2	NOUN
cuesj-1122	14	47	)	)	PUNCT
cuesj-1122	14	48	.	.	PUNCT
cuesj-1122	15	1	in	in	ADP
cuesj-1122	15	2	march	march	PROPN
cuesj-1122	15	3	2020	2020	NUM
cuesj-1122	15	4	,	,	PUNCT
cuesj-1122	15	5	the	the	DET
cuesj-1122	15	6	world	world	PROPN
cuesj-1122	15	7	health	health	NOUN
cuesj-1122	15	8	organization	organization	NOUN
cuesj-1122	15	9	(	(	PUNCT
cuesj-1122	15	10	who	who	PRON
cuesj-1122	15	11	)	)	PUNCT
cuesj-1122	15	12	classified	classify	VERB
cuesj-1122	15	13	the	the	DET
cuesj-1122	15	14	covid-19	covid-19	PROPN
cuesj-1122	15	15	outbreak	outbreak	NOUN
cuesj-1122	15	16	as	as	ADP
cuesj-1122	15	17	a	a	DET
cuesj-1122	15	18	pandemic	pandemic	ADJ
cuesj-1122	15	19	disease.[1	disease.[1	NOUN
cuesj-1122	15	20	]	]	PUNCT
cuesj-1122	15	21	“	"	PUNCT
cuesj-1122	15	22	one	one	NUM
cuesj-1122	15	23	of	of	ADP
cuesj-1122	15	24	the	the	DET
cuesj-1122	15	25	biggest	big	ADJ
cuesj-1122	15	26	rna	rna	NOUN
cuesj-1122	15	27	viruses	virus	NOUN
cuesj-1122	15	28	,	,	PUNCT
cuesj-1122	15	29	with	with	ADP
cuesj-1122	15	30	a	a	DET
cuesj-1122	15	31	genomic	genomic	ADJ
cuesj-1122	15	32	size	size	NOUN
cuesj-1122	15	33	of	of	ADP
cuesj-1122	15	34	27–32	27–32	NUM
cuesj-1122	15	35	kb	kb	PROPN
cuesj-1122	15	36	,	,	PUNCT
cuesj-1122	15	37	is	be	AUX
cuesj-1122	15	38	the	the	DET
cuesj-1122	15	39	coronavirus	coronavirus	NOUN
cuesj-1122	15	40	.	.	PUNCT
cuesj-1122	16	1	sars	sar	NOUN
cuesj-1122	16	2	-	-	PUNCT
cuesj-1122	16	3	cov-2	cov-2	NOUN
cuesj-1122	16	4	infects	infect	VERB
cuesj-1122	16	5	cells	cell	NOUN
cuesj-1122	16	6	through	through	ADP
cuesj-1122	16	7	binding	bind	VERB
cuesj-1122	16	8	to	to	ADP
cuesj-1122	16	9	ace2	ace2	PROPN
cuesj-1122	16	10	,	,	PUNCT
cuesj-1122	16	11	a	a	DET
cuesj-1122	16	12	cellsurface	cellsurface	NOUN
cuesj-1122	16	13	receptor	receptor	NOUN
cuesj-1122	16	14	found	find	VERB
cuesj-1122	16	15	in	in	ADP
cuesj-1122	16	16	the	the	DET
cuesj-1122	16	17	kidney	kidney	NOUN
cuesj-1122	16	18	,	,	PUNCT
cuesj-1122	16	19	blood	blood	NOUN
cuesj-1122	16	20	vessels	vessel	NOUN
cuesj-1122	16	21	,	,	PUNCT
cuesj-1122	16	22	heart	heart	NOUN
cuesj-1122	16	23	,	,	PUNCT
cuesj-1122	16	24	and	and	CCONJ
cuesj-1122	16	25	crucially	crucially	ADV
cuesj-1122	16	26	in	in	ADP
cuesj-1122	16	27	alveolar	alveolar	ADJ
cuesj-1122	16	28	epithelial	epithelial	ADJ
cuesj-1122	16	29	type	type	NOUN
cuesj-1122	16	30	ii	ii	NOUN
cuesj-1122	16	31	cells	cell	NOUN
cuesj-1122	16	32	(	(	PUNCT
cuesj-1122	16	33	at2	at2	PROPN
cuesj-1122	16	34	)	)	PUNCT
cuesj-1122	16	35	which	which	PRON
cuesj-1122	16	36	line	line	VERB
cuesj-1122	16	37	the	the	DET
cuesj-1122	16	38	lungs”.[2	lungs”.[2	PROPN
cuesj-1122	16	39	]	]	X
cuesj-1122	16	40	the	the	DET
cuesj-1122	16	41	clinical	clinical	ADJ
cuesj-1122	16	42	manifestations	manifestation	NOUN
cuesj-1122	16	43	of	of	ADP
cuesj-1122	16	44	covid-19	covid-19	PROPN
cuesj-1122	16	45	vary	vary	VERB
cuesj-1122	16	46	from	from	ADP
cuesj-1122	16	47	mild	mild	ADJ
cuesj-1122	16	48	to	to	ADP
cuesj-1122	16	49	severe	severe	ADJ
cuesj-1122	16	50	difficulty	difficulty	NOUN
cuesj-1122	16	51	breathing	breathe	VERB
cuesj-1122	16	52	,	,	PUNCT
cuesj-1122	16	53	exhibiting	exhibit	VERB
cuesj-1122	16	54	symptoms	symptom	NOUN
cuesj-1122	16	55	such	such	ADJ
cuesj-1122	16	56	as	as	ADP
cuesj-1122	16	57	fever	fever	NOUN
cuesj-1122	16	58	,	,	PUNCT
cuesj-1122	16	59	exhaustion	exhaustion	NOUN
cuesj-1122	16	60	,	,	PUNCT
cuesj-1122	16	61	taste	taste	NOUN
cuesj-1122	16	62	and	and	CCONJ
cuesj-1122	16	63	smell	smell	NOUN
cuesj-1122	16	64	loss	loss	NOUN
cuesj-1122	16	65	,	,	PUNCT
cuesj-1122	16	66	coughing	coughing	NOUN
cuesj-1122	16	67	,	,	PUNCT
cuesj-1122	16	68	nose	nose	NOUN
cuesj-1122	16	69	congestion	congestion	NOUN
cuesj-1122	16	70	,	,	PUNCT
cuesj-1122	16	71	dyspnea	dyspnea	NOUN
cuesj-1122	16	72	,	,	PUNCT
cuesj-1122	16	73	and	and	CCONJ
cuesj-1122	16	74	so	so	ADV
cuesj-1122	16	75	on.[3	on.[3	NOUN
cuesj-1122	16	76	]	]	PUNCT
cuesj-1122	16	77	droplets	droplet	NOUN
cuesj-1122	16	78	from	from	ADP
cuesj-1122	16	79	the	the	DET
cuesj-1122	16	80	respiratory	respiratory	ADJ
cuesj-1122	16	81	system	system	NOUN
cuesj-1122	16	82	are	be	AUX
cuesj-1122	16	83	the	the	DET
cuesj-1122	16	84	main	main	ADJ
cuesj-1122	16	85	method	method	NOUN
cuesj-1122	16	86	of	of	ADP
cuesj-1122	16	87	transmission	transmission	NOUN
cuesj-1122	16	88	;	;	PUNCT
cuesj-1122	16	89	sars	sar	NOUN
cuesj-1122	16	90	-	-	PUNCT
cuesj-1122	16	91	cov-2	cov-2	NUM
cuesj-1122	16	92	can	can	AUX
cuesj-1122	16	93	always	always	ADV
cuesj-1122	16	94	spread	spread	VERB
cuesj-1122	16	95	through	through	ADP
cuesj-1122	16	96	the	the	DET
cuesj-1122	16	97	air	air	NOUN
cuesj-1122	16	98	if	if	SCONJ
cuesj-1122	16	99	an	an	DET
cuesj-1122	16	100	uninfected	uninfected	ADJ
cuesj-1122	16	101	individual	individual	NOUN
cuesj-1122	16	102	comes	come	VERB
cuesj-1122	16	103	into	into	ADP
cuesj-1122	16	104	contact	contact	NOUN
cuesj-1122	16	105	with	with	ADP
cuesj-1122	16	106	an	an	DET
cuesj-1122	16	107	infected	infected	ADJ
cuesj-1122	16	108	or	or	CCONJ
cuesj-1122	16	109	any	any	PRON
cuesj-1122	16	110	of	of	ADP
cuesj-1122	16	111	his	his	PRON
cuesj-1122	16	112	possessions	possession	NOUN
cuesj-1122	16	113	,	,	PUNCT
cuesj-1122	16	114	such	such	ADJ
cuesj-1122	16	115	as	as	ADP
cuesj-1122	16	116	clothing	clothing	NOUN
cuesj-1122	16	117	or	or	CCONJ
cuesj-1122	16	118	doorknobs.[4,2	doorknobs.[4,2	NOUN
cuesj-1122	16	119	]	]	X
cuesj-1122	16	120	vaccination	vaccination	NOUN
cuesj-1122	16	121	can	can	AUX
cuesj-1122	16	122	be	be	AUX
cuesj-1122	16	123	used	use	VERB
cuesj-1122	16	124	to	to	PART
cuesj-1122	16	125	control	control	VERB
cuesj-1122	16	126	the	the	DET
cuesj-1122	16	127	pandemic	pandemic	NOUN
cuesj-1122	16	128	of	of	ADP
cuesj-1122	16	129	sars	sar	NOUN
cuesj-1122	16	130	-	-	PUNCT
cuesj-1122	16	131	cov-2	cov-2	NOUN
cuesj-1122	16	132	.	.	PUNCT
cuesj-1122	17	1	the	the	DET
cuesj-1122	17	2	risk	risk	NOUN
cuesj-1122	17	3	of	of	ADP
cuesj-1122	17	4	developing	develop	VERB
cuesj-1122	17	5	severe	severe	ADJ
cuesj-1122	17	6	illnesses	illness	NOUN
cuesj-1122	17	7	,	,	PUNCT
cuesj-1122	17	8	requiring	require	VERB
cuesj-1122	17	9	hospitalization	hospitalization	NOUN
cuesj-1122	17	10	,	,	PUNCT
cuesj-1122	17	11	and	and	CCONJ
cuesj-1122	17	12	dying	die	VERB
cuesj-1122	17	13	from	from	ADP
cuesj-1122	17	14	covid-19	covid-19	PROPN
cuesj-1122	17	15	is	be	AUX
cuesj-1122	17	16	decreased	decrease	VERB
cuesj-1122	17	17	with	with	ADP
cuesj-1122	17	18	covid-19	covid-19	PROPN
cuesj-1122	17	19	vaccines	vaccine	NOUN
cuesj-1122	17	20	in	in	ADP
cuesj-1122	17	21	a	a	DET
cuesj-1122	17	22	safe	safe	ADJ
cuesj-1122	17	23	and	and	CCONJ
cuesj-1122	17	24	efficient	efficient	ADJ
cuesj-1122	17	25	manner.[5	manner.[5	NOUN
cuesj-1122	17	26	]	]	X
cuesj-1122	17	27	unprecedented	unprecedented	ADJ
cuesj-1122	17	28	international	international	ADJ
cuesj-1122	17	29	attempts	attempt	NOUN
cuesj-1122	17	30	to	to	PART
cuesj-1122	17	31	create	create	VERB
cuesj-1122	17	32	vaccines	vaccine	NOUN
cuesj-1122	17	33	to	to	PART
cuesj-1122	17	34	stave	stave	VERB
cuesj-1122	17	35	off	off	ADP
cuesj-1122	17	36	infection	infection	NOUN
cuesj-1122	17	37	and	and	CCONJ
cuesj-1122	17	38	serious	serious	ADJ
cuesj-1122	17	39	illness	illness	NOUN
cuesj-1122	17	40	,	,	PUNCT
cuesj-1122	17	41	reverse	reverse	VERB
cuesj-1122	17	42	the	the	DET
cuesj-1122	17	43	pandemic	pandemic	NOUN
cuesj-1122	17	44	’s	’s	PART
cuesj-1122	17	45	course	course	NOUN
cuesj-1122	17	46	,	,	PUNCT
cuesj-1122	17	47	and	and	CCONJ
cuesj-1122	17	48	lessen	lessen	VERB
cuesj-1122	17	49	the	the	DET
cuesj-1122	17	50	terrible	terrible	ADJ
cuesj-1122	17	51	economic	economic	ADJ
cuesj-1122	17	52	and	and	CCONJ
cuesj-1122	17	53	societal	societal	ADJ
cuesj-1122	17	54	effects	effect	NOUN
cuesj-1122	17	55	of	of	ADP
cuesj-1122	17	56	sars	sar	NOUN
cuesj-1122	17	57	-	-	PUNCT
cuesj-1122	17	58	cov-2	cov-2	PART
cuesj-1122	17	59	were	be	AUX
cuesj-1122	17	60	rapidly	rapidly	ADV
cuesj-1122	17	61	initiated	initiate	VERB
cuesj-1122	17	62	in	in	ADP
cuesj-1122	17	63	the	the	DET
cuesj-1122	17	64	wake	wake	NOUN
cuesj-1122	17	65	of	of	ADP
cuesj-1122	17	66	the	the	DET
cuesj-1122	17	67	global	global	ADJ
cuesj-1122	17	68	sars	sar	NOUN
cuesj-1122	17	69	-	-	PUNCT
cuesj-1122	17	70	cov-2	cov-2	NOUN
cuesj-1122	17	71	epidemic	epidemic	NOUN
cuesj-1122	17	72	and	and	CCONJ
cuesj-1122	17	73	the	the	DET
cuesj-1122	17	74	discovery	discovery	NOUN
cuesj-1122	17	75	of	of	ADP
cuesj-1122	17	76	it.[6	it.[6	PROPN
cuesj-1122	17	77	]	]	PUNCT
cuesj-1122	17	78	the	the	DET
cuesj-1122	17	79	fda	fda	PROPN
cuesj-1122	17	80	approved	approve	VERB
cuesj-1122	17	81	a	a	DET
cuesj-1122	17	82	widespread	widespread	ADJ
cuesj-1122	17	83	immunization	immunization	NOUN
cuesj-1122	17	84	program	program	NOUN
cuesj-1122	17	85	to	to	PART
cuesj-1122	17	86	stop	stop	VERB
cuesj-1122	17	87	the	the	DET
cuesj-1122	17	88	spread	spread	NOUN
cuesj-1122	17	89	of	of	ADP
cuesj-1122	17	90	sars	sar	NOUN
cuesj-1122	17	91	-	-	PUNCT
cuesj-1122	17	92	cov-2	cov-2	PUNCT
cuesj-1122	17	93	and	and	CCONJ
cuesj-1122	17	94	lessen	lessen	VERB
cuesj-1122	17	95	the	the	DET
cuesj-1122	17	96	severity	severity	NOUN
cuesj-1122	17	97	of	of	ADP
cuesj-1122	17	98	the	the	DET
cuesj-1122	17	99	disease	disease	NOUN
cuesj-1122	17	100	in	in	ADP
cuesj-1122	17	101	infected	infected	ADJ
cuesj-1122	17	102	individuals	individual	NOUN
cuesj-1122	17	103	.	.	PUNCT
cuesj-1122	18	1	two	two	NUM
cuesj-1122	18	2	authorized	authorize	VERB
cuesj-1122	18	3	vaccines	vaccine	NOUN
cuesj-1122	18	4	based	base	VERB
cuesj-1122	18	5	on	on	ADP
cuesj-1122	18	6	messenger	messenger	PROPN
cuesj-1122	18	7	rna	rna	PROPN
cuesj-1122	18	8	(	(	PUNCT
cuesj-1122	18	9	mrna	mrna	PROPN
cuesj-1122	18	10	)	)	PUNCT
cuesj-1122	18	11	are	be	AUX
cuesj-1122	18	12	mrna-1273	mrna-1273	ADJ
cuesj-1122	18	13	(	(	PUNCT
cuesj-1122	18	14	moderna	moderna	PROPN
cuesj-1122	18	15	therapeutics	therapeutics	PROPN
cuesj-1122	18	16	inc	inc	PROPN
cuesj-1122	18	17	.	.	PUNCT
cuesj-1122	18	18	)	)	PUNCT
cuesj-1122	19	1	and	and	CCONJ
cuesj-1122	19	2	bnt162b2	bnt162b2	NOUN
cuesj-1122	19	3	(	(	PUNCT
cuesj-1122	19	4	pfizer	pfizer	PROPN
cuesj-1122	19	5	inc	inc	PROPN
cuesj-1122	19	6	/	/	SYM
cuesj-1122	19	7	biontech	biontech	NOUN
cuesj-1122	19	8	corresponding	correspond	VERB
cuesj-1122	19	9	author	author	NOUN
cuesj-1122	19	10	:	:	PUNCT
cuesj-1122	19	11	hardi	hardi	PROPN
cuesj-1122	19	12	s.	s.	PROPN
cuesj-1122	19	13	ahmed	ahmed	PROPN
cuesj-1122	19	14	,	,	PUNCT
cuesj-1122	19	15	department	department	NOUN
cuesj-1122	19	16	of	of	ADP
cuesj-1122	19	17	biology	biology	NOUN
cuesj-1122	19	18	,	,	PUNCT
cuesj-1122	19	19	salahaddin	salahaddin	VERB
cuesj-1122	19	20	university	university	NOUN
cuesj-1122	19	21	,	,	PUNCT
cuesj-1122	19	22	kurdistan	kurdistan	PROPN
cuesj-1122	19	23	region	region	NOUN
cuesj-1122	19	24	,	,	PUNCT
cuesj-1122	19	25	iraq	iraq	PROPN
cuesj-1122	19	26	e	e	PROPN
cuesj-1122	19	27	-	-	NOUN
cuesj-1122	19	28	mail	mail	NOUN
cuesj-1122	19	29	:	:	PUNCT
cuesj-1122	19	30	hardi.shukur@cihanuniversity.edu.iq	hardi.shukur@cihanuniversity.edu.iq	NOUN
cuesj-1122	19	31	received	receive	VERB
cuesj-1122	19	32	:	:	PUNCT
cuesj-1122	19	33	march	march	PROPN
cuesj-1122	19	34	03	03	NUM
cuesj-1122	19	35	,	,	PUNCT
cuesj-1122	19	36	2024	2024	NUM
cuesj-1122	19	37	accepted	accept	VERB
cuesj-1122	19	38	:	:	PUNCT
cuesj-1122	19	39	may	may	AUX
cuesj-1122	19	40	23	23	NUM
cuesj-1122	19	41	,	,	PUNCT
cuesj-1122	19	42	2024	2024	NUM
cuesj-1122	19	43	published	publish	VERB
cuesj-1122	19	44	:	:	PUNCT
cuesj-1122	19	45	june	june	PROPN
cuesj-1122	19	46	20	20	NUM
cuesj-1122	19	47	,	,	PUNCT
cuesj-1122	19	48	2024	2024	NUM
cuesj-1122	19	49	doi:10.24086	doi:10.24086	X
cuesj-1122	19	50	/	/	SYM
cuesj-1122	19	51	cuesj.v8n1y2024.pp46	cuesj.v8n1y2024.pp46	NUM
cuesj-1122	19	52	-	-	SYM
cuesj-1122	19	53	57	57	NUM
cuesj-1122	19	54	copyright	copyright	NOUN
cuesj-1122	19	55	©	©	PROPN
cuesj-1122	19	56	2024	2024	NUM
cuesj-1122	19	57	hardi	hardi	PROPN
cuesj-1122	19	58	s.	s.	PROPN
cuesj-1122	19	59	ahmed	ahmed	PROPN
cuesj-1122	19	60	,	,	PUNCT
cuesj-1122	19	61	nadir	nadir	NOUN
cuesj-1122	19	62	m.	m.	NOUN
cuesj-1122	19	63	q.	q.	PROPN
cuesj-1122	19	64	nanakali	nanakali	PROPN
cuesj-1122	19	65	,	,	PUNCT
cuesj-1122	19	66	khabat	khabat	PROPN
cuesj-1122	19	67	a.	a.	PROPN
cuesj-1122	19	68	ali	ali	PROPN
cuesj-1122	19	69	.	.	PUNCT
cuesj-1122	20	1	this	this	PRON
cuesj-1122	20	2	is	be	AUX
cuesj-1122	20	3	an	an	DET
cuesj-1122	20	4	open	open	ADJ
cuesj-1122	20	5	-	-	PUNCT
cuesj-1122	20	6	access	access	NOUN
cuesj-1122	20	7	article	article	NOUN
cuesj-1122	20	8	distributed	distribute	VERB
cuesj-1122	20	9	under	under	ADP
cuesj-1122	20	10	the	the	DET
cuesj-1122	20	11	creative	creative	ADJ
cuesj-1122	20	12	commons	common	NOUN
cuesj-1122	20	13	attribution	attribution	NOUN
cuesj-1122	20	14	license	license	NOUN
cuesj-1122	20	15	.	.	PUNCT
cuesj-1122	21	1	cihan	cihan	VERB
cuesj-1122	21	2	university	university	NOUN
cuesj-1122	21	3	-	-	PUNCT
cuesj-1122	21	4	erbil	erbil	PROPN
cuesj-1122	21	5	scientific	scientific	ADJ
cuesj-1122	21	6	journal	journal	NOUN
cuesj-1122	21	7	(	(	PUNCT
cuesj-1122	21	8	cuesj	cuesj	PROPN
cuesj-1122	21	9	)	)	PUNCT
cuesj-1122	21	10	ahmed	ahmed	PROPN
cuesj-1122	21	11	,	,	PUNCT
cuesj-1122	21	12	et	et	PROPN
cuesj-1122	21	13	al	al	PROPN
cuesj-1122	21	14	.	.	PUNCT
cuesj-1122	21	15	:	:	PUNCT
cuesj-1122	22	1	comparison	comparison	NOUN
cuesj-1122	22	2	of	of	ADP
cuesj-1122	22	3	biochemical	biochemical	ADJ
cuesj-1122	22	4	parameters	parameter	NOUN
cuesj-1122	22	5	in	in	ADP
cuesj-1122	22	6	vaccinated	vaccinated	ADJ
cuesj-1122	22	7	47	47	NUM
cuesj-1122	22	8	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1122	22	9	cuesj	cuesj	NOUN
cuesj-1122	22	10	2024	2024	NUM
cuesj-1122	22	11	,	,	PUNCT
cuesj-1122	22	12	8	8	NUM
cuesj-1122	22	13	(	(	PUNCT
cuesj-1122	22	14	1	1	NUM
cuesj-1122	22	15	):	):	PUNCT
cuesj-1122	22	16	46	46	NUM
cuesj-1122	22	17	-	-	SYM
cuesj-1122	22	18	57	57	NUM
cuesj-1122	22	19	se).[7	se).[7	NOUN
cuesj-1122	22	20	]	]	PUNCT
cuesj-1122	22	21	the	the	DET
cuesj-1122	22	22	vaccination	vaccination	NOUN
cuesj-1122	22	23	demonstrated	demonstrate	VERB
cuesj-1122	22	24	great	great	ADJ
cuesj-1122	22	25	efficiency	efficiency	NOUN
cuesj-1122	22	26	against	against	ADP
cuesj-1122	22	27	numerous	numerous	ADJ
cuesj-1122	22	28	fresh	fresh	ADJ
cuesj-1122	22	29	forms	form	NOUN
cuesj-1122	22	30	and	and	CCONJ
cuesj-1122	22	31	provided	provide	VERB
cuesj-1122	22	32	protection	protection	NOUN
cuesj-1122	22	33	against	against	ADP
cuesj-1122	22	34	reinfection	reinfection	NOUN
cuesj-1122	22	35	.	.	PUNCT
cuesj-1122	23	1	with	with	ADP
cuesj-1122	23	2	the	the	DET
cuesj-1122	23	3	help	help	NOUN
cuesj-1122	23	4	of	of	ADP
cuesj-1122	23	5	immunization	immunization	NOUN
cuesj-1122	23	6	programs	program	NOUN
cuesj-1122	23	7	,	,	PUNCT
cuesj-1122	23	8	hope	hope	NOUN
cuesj-1122	23	9	was	be	AUX
cuesj-1122	23	10	raised	raise	VERB
cuesj-1122	23	11	for	for	ADP
cuesj-1122	23	12	lowering	lower	VERB
cuesj-1122	23	13	the	the	DET
cuesj-1122	23	14	incidence	incidence	NOUN
cuesj-1122	23	15	of	of	ADP
cuesj-1122	23	16	coronavirus	coronavirus	NOUN
cuesj-1122	23	17	sickness	sickness	NOUN
cuesj-1122	23	18	.	.	PUNCT
cuesj-1122	24	1	the	the	DET
cuesj-1122	24	2	benefits	benefit	NOUN
cuesj-1122	24	3	of	of	ADP
cuesj-1122	24	4	covid-19	covid-19	PROPN
cuesj-1122	24	5	vaccination	vaccination	NOUN
cuesj-1122	24	6	must	must	AUX
cuesj-1122	24	7	be	be	AUX
cuesj-1122	24	8	understood	understand	VERB
cuesj-1122	24	9	in	in	ADP
cuesj-1122	24	10	the	the	DET
cuesj-1122	24	11	context	context	NOUN
cuesj-1122	24	12	of	of	ADP
cuesj-1122	24	13	sickness	sickness	NOUN
cuesj-1122	24	14	attenuation	attenuation	NOUN
cuesj-1122	24	15	.	.	PUNCT
cuesj-1122	25	1	to	to	PART
cuesj-1122	25	2	do	do	VERB
cuesj-1122	25	3	this	this	PRON
cuesj-1122	25	4	,	,	PUNCT
cuesj-1122	25	5	research	research	NOUN
cuesj-1122	25	6	should	should	AUX
cuesj-1122	25	7	be	be	AUX
cuesj-1122	25	8	done	do	VERB
cuesj-1122	25	9	to	to	PART
cuesj-1122	25	10	see	see	VERB
cuesj-1122	25	11	if	if	SCONJ
cuesj-1122	25	12	those	those	PRON
cuesj-1122	25	13	who	who	PRON
cuesj-1122	25	14	get	get	VERB
cuesj-1122	25	15	covid-19	covid-19	PROPN
cuesj-1122	25	16	despite	despite	SCONJ
cuesj-1122	25	17	immunization	immunization	NOUN
cuesj-1122	25	18	have	have	VERB
cuesj-1122	25	19	fewer	few	ADJ
cuesj-1122	25	20	symptoms	symptom	NOUN
cuesj-1122	25	21	than	than	ADP
cuesj-1122	25	22	those	those	PRON
cuesj-1122	25	23	who	who	PRON
cuesj-1122	25	24	are	be	AUX
cuesj-1122	25	25	unvaccinated.[8	unvaccinated.[8	NOUN
cuesj-1122	25	26	]	]	X
cuesj-1122	25	27	a	a	DET
cuesj-1122	25	28	systematic	systematic	ADJ
cuesj-1122	25	29	review	review	NOUN
cuesj-1122	25	30	by	by	ADP
cuesj-1122	25	31	fatima	fatima	PROPN
cuesj-1122	25	32	et	et	PROPN
cuesj-1122	25	33	al.[9	al.[9	PROPN
cuesj-1122	25	34	]	]	PUNCT
cuesj-1122	25	35	of	of	ADP
cuesj-1122	25	36	51	51	NUM
cuesj-1122	25	37	research	research	NOUN
cuesj-1122	25	38	from	from	ADP
cuesj-1122	25	39	14	14	NUM
cuesj-1122	25	40	different	different	ADJ
cuesj-1122	25	41	countries	country	NOUN
cuesj-1122	25	42	found	find	VERB
cuesj-1122	25	43	that	that	SCONJ
cuesj-1122	25	44	vaccinations	vaccination	NOUN
cuesj-1122	25	45	were	be	AUX
cuesj-1122	25	46	effective	effective	ADJ
cuesj-1122	25	47	against	against	ADP
cuesj-1122	25	48	89.1	89.1	NUM
cuesj-1122	25	49	%	%	NOUN
cuesj-1122	25	50	,	,	PUNCT
cuesj-1122	25	51	97.2	97.2	NUM
cuesj-1122	25	52	%	%	NOUN
cuesj-1122	25	53	,	,	PUNCT
cuesj-1122	25	54	97.4	97.4	NUM
cuesj-1122	25	55	%	%	NOUN
cuesj-1122	25	56	,	,	PUNCT
cuesj-1122	25	57	and	and	CCONJ
cuesj-1122	25	58	99	99	NUM
cuesj-1122	25	59	%	%	NOUN
cuesj-1122	25	60	of	of	ADP
cuesj-1122	25	61	illnesses	illness	NOUN
cuesj-1122	25	62	,	,	PUNCT
cuesj-1122	25	63	hospitalizations	hospitalization	NOUN
cuesj-1122	25	64	,	,	PUNCT
cuesj-1122	25	65	and	and	CCONJ
cuesj-1122	25	66	icu	icu	PROPN
cuesj-1122	25	67	admissions	admission	NOUN
cuesj-1122	25	68	,	,	PUNCT
cuesj-1122	25	69	respectively	respectively	ADV
cuesj-1122	25	70	.	.	PUNCT
cuesj-1122	26	1	for	for	ADP
cuesj-1122	26	2	evaluation	evaluation	NOUN
cuesj-1122	26	3	,	,	PUNCT
cuesj-1122	26	4	clinical	clinical	ADJ
cuesj-1122	26	5	care	care	NOUN
cuesj-1122	26	6	,	,	PUNCT
cuesj-1122	26	7	and	and	CCONJ
cuesj-1122	26	8	the	the	DET
cuesj-1122	26	9	prevention	prevention	NOUN
cuesj-1122	26	10	of	of	ADP
cuesj-1122	26	11	severe	severe	ADJ
cuesj-1122	26	12	consequences	consequence	NOUN
cuesj-1122	26	13	,	,	PUNCT
cuesj-1122	26	14	efficient	efficient	ADJ
cuesj-1122	26	15	biomarkers	biomarker	NOUN
cuesj-1122	26	16	would	would	AUX
cuesj-1122	26	17	be	be	AUX
cuesj-1122	26	18	helpful.[10	helpful.[10	NOUN
cuesj-1122	26	19	]	]	PUNCT
cuesj-1122	26	20	a	a	DET
cuesj-1122	26	21	significant	significant	ADJ
cuesj-1122	26	22	predictor	predictor	NOUN
cuesj-1122	26	23	of	of	ADP
cuesj-1122	26	24	covid-19	covid-19	PROPN
cuesj-1122	26	25	patient	patient	ADJ
cuesj-1122	26	26	death	death	NOUN
cuesj-1122	26	27	has	have	AUX
cuesj-1122	26	28	also	also	ADV
cuesj-1122	26	29	been	be	AUX
cuesj-1122	26	30	found	find	VERB
cuesj-1122	26	31	to	to	PART
cuesj-1122	26	32	be	be	AUX
cuesj-1122	26	33	liver	liver	NOUN
cuesj-1122	26	34	function	function	NOUN
cuesj-1122	26	35	.	.	PUNCT
cuesj-1122	27	1	according	accord	VERB
cuesj-1122	27	2	to	to	ADP
cuesj-1122	27	3	a	a	DET
cuesj-1122	27	4	research	research	NOUN
cuesj-1122	27	5	report	report	NOUN
cuesj-1122	27	6	,	,	PUNCT
cuesj-1122	27	7	the	the	DET
cuesj-1122	27	8	virus	virus	NOUN
cuesj-1122	27	9	may	may	AUX
cuesj-1122	27	10	directly	directly	ADV
cuesj-1122	27	11	attach	attach	VERB
cuesj-1122	27	12	to	to	ADP
cuesj-1122	27	13	cholangiocytes	cholangiocyte	NOUN
cuesj-1122	27	14	that	that	PRON
cuesj-1122	27	15	are	be	AUX
cuesj-1122	27	16	ace2positive	ace2positive	ADJ
cuesj-1122	27	17	,	,	PUNCT
cuesj-1122	27	18	and	and	CCONJ
cuesj-1122	27	19	as	as	ADP
cuesj-1122	27	20	a	a	DET
cuesj-1122	27	21	result	result	NOUN
cuesj-1122	27	22	,	,	PUNCT
cuesj-1122	27	23	covid-19	covid-19	PROPN
cuesj-1122	27	24	patients	patient	NOUN
cuesj-1122	27	25	’	'	PUNCT
cuesj-1122	27	26	liver	liver	NOUN
cuesj-1122	27	27	problems	problem	NOUN
cuesj-1122	27	28	might	might	AUX
cuesj-1122	27	29	be	be	AUX
cuesj-1122	27	30	caused	cause	VERB
cuesj-1122	27	31	by	by	ADP
cuesj-1122	27	32	cholangiocyte	cholangiocyte	NOUN
cuesj-1122	27	33	malfunction.[11	malfunction.[11	PROPN
cuesj-1122	27	34	]	]	PUNCT
cuesj-1122	27	35	early	early	ADV
cuesj-1122	27	36	in	in	ADP
cuesj-1122	27	37	the	the	DET
cuesj-1122	27	38	pandemic	pandemic	ADJ
cuesj-1122	27	39	’s	’s	PART
cuesj-1122	27	40	development	development	NOUN
cuesj-1122	27	41	,	,	PUNCT
cuesj-1122	27	42	liver	liver	NOUN
cuesj-1122	27	43	involvement	involvement	NOUN
cuesj-1122	27	44	determined	determine	VERB
cuesj-1122	27	45	by	by	ADP
cuesj-1122	27	46	abnormal	abnormal	ADJ
cuesj-1122	27	47	liver	liver	NOUN
cuesj-1122	27	48	parameters	parameter	NOUN
cuesj-1122	27	49	in	in	ADP
cuesj-1122	27	50	infected	infected	ADJ
cuesj-1122	27	51	individuals	individual	NOUN
cuesj-1122	27	52	was	be	AUX
cuesj-1122	27	53	regarded	regard	VERB
cuesj-1122	27	54	as	as	ADP
cuesj-1122	27	55	one	one	NUM
cuesj-1122	27	56	of	of	ADP
cuesj-1122	27	57	the	the	DET
cuesj-1122	27	58	clinical	clinical	ADJ
cuesj-1122	27	59	symptoms	symptom	NOUN
cuesj-1122	27	60	.	.	PUNCT
cuesj-1122	28	1	major	major	ADJ
cuesj-1122	28	2	liver	liver	NOUN
cuesj-1122	28	3	damage	damage	NOUN
cuesj-1122	28	4	is	be	AUX
cuesj-1122	28	5	rare	rare	ADJ
cuesj-1122	28	6	.	.	PUNCT
cuesj-1122	29	1	sars	sar	NOUN
cuesj-1122	29	2	-	-	PUNCT
cuesj-1122	29	3	cov-2	cov-2	NUM
cuesj-1122	29	4	could	could	AUX
cuesj-1122	29	5	impact	impact	VERB
cuesj-1122	29	6	the	the	DET
cuesj-1122	29	7	liver	liver	NOUN
cuesj-1122	29	8	directly	directly	ADV
cuesj-1122	29	9	or	or	CCONJ
cuesj-1122	29	10	indirectly	indirectly	ADV
cuesj-1122	29	11	.	.	PUNCT
cuesj-1122	30	1	liver	liver	NOUN
cuesj-1122	30	2	abnormalities	abnormality	NOUN
cuesj-1122	30	3	can	can	AUX
cuesj-1122	30	4	result	result	VERB
cuesj-1122	30	5	from	from	ADP
cuesj-1122	30	6	a	a	DET
cuesj-1122	30	7	variety	variety	NOUN
cuesj-1122	30	8	of	of	ADP
cuesj-1122	30	9	pathogenic	pathogenic	ADJ
cuesj-1122	30	10	mechanisms	mechanism	NOUN
cuesj-1122	30	11	,	,	PUNCT
cuesj-1122	30	12	including	include	VERB
cuesj-1122	30	13	immune	immune	NOUN
cuesj-1122	30	14	-	-	PUNCT
cuesj-1122	30	15	mediated	mediate	VERB
cuesj-1122	30	16	injury	injury	NOUN
cuesj-1122	30	17	brought	bring	VERB
cuesj-1122	30	18	on	on	ADP
cuesj-1122	30	19	by	by	ADP
cuesj-1122	30	20	the	the	DET
cuesj-1122	30	21	intense	intense	ADJ
cuesj-1122	30	22	inflammatory	inflammatory	ADJ
cuesj-1122	30	23	response	response	NOUN
cuesj-1122	30	24	,	,	PUNCT
cuesj-1122	30	25	direct	direct	ADJ
cuesj-1122	30	26	cytotoxicity	cytotoxicity	NOUN
cuesj-1122	30	27	brought	bring	VERB
cuesj-1122	30	28	on	on	ADP
cuesj-1122	30	29	by	by	ADP
cuesj-1122	30	30	viral	viral	ADJ
cuesj-1122	30	31	replication	replication	NOUN
cuesj-1122	30	32	in	in	ADP
cuesj-1122	30	33	the	the	DET
cuesj-1122	30	34	hepatocytes	hepatocyte	NOUN
cuesj-1122	30	35	,	,	PUNCT
cuesj-1122	30	36	anoxia	anoxia	PROPN
cuesj-1122	30	37	brought	bring	VERB
cuesj-1122	30	38	on	on	ADP
cuesj-1122	30	39	by	by	ADP
cuesj-1122	30	40	covid-19	covid-19	PROPN
cuesj-1122	30	41	-	-	PUNCT
cuesj-1122	30	42	related	relate	VERB
cuesj-1122	30	43	respiratory	respiratory	ADJ
cuesj-1122	30	44	failure	failure	NOUN
cuesj-1122	30	45	,	,	PUNCT
cuesj-1122	30	46	pharmacological	pharmacological	ADJ
cuesj-1122	30	47	liver	liver	NOUN
cuesj-1122	30	48	damage	damage	NOUN
cuesj-1122	30	49	primarily	primarily	ADV
cuesj-1122	30	50	caused	cause	VERB
cuesj-1122	30	51	by	by	ADP
cuesj-1122	30	52	hepatotoxic	hepatotoxic	ADJ
cuesj-1122	30	53	antivirals	antiviral	NOUN
cuesj-1122	30	54	,	,	PUNCT
cuesj-1122	30	55	reactivation	reactivation	NOUN
cuesj-1122	30	56	of	of	ADP
cuesj-1122	30	57	pre	pre	ADJ
cuesj-1122	30	58	-	-	ADJ
cuesj-1122	30	59	existing	existing	ADJ
cuesj-1122	30	60	liver	liver	NOUN
cuesj-1122	30	61	disease	disease	NOUN
cuesj-1122	30	62	,	,	PUNCT
cuesj-1122	30	63	and	and	CCONJ
cuesj-1122	30	64	vascular	vascular	ADJ
cuesj-1122	30	65	injury	injury	NOUN
cuesj-1122	30	66	brought	bring	VERB
cuesj-1122	30	67	on	on	ADP
cuesj-1122	30	68	by	by	ADP
cuesj-1122	30	69	hypercoagulation.[12	hypercoagulation.[12	PROPN
cuesj-1122	30	70	]	]	PUNCT
cuesj-1122	30	71	according	accord	VERB
cuesj-1122	30	72	to	to	ADP
cuesj-1122	30	73	the	the	DET
cuesj-1122	30	74	research	research	NOUN
cuesj-1122	30	75	that	that	PRON
cuesj-1122	30	76	is	be	AUX
cuesj-1122	30	77	now	now	ADV
cuesj-1122	30	78	available	available	ADJ
cuesj-1122	30	79	on	on	ADP
cuesj-1122	30	80	covid-19	covid-19	PROPN
cuesj-1122	30	81	,	,	PUNCT
cuesj-1122	30	82	patients	patient	NOUN
cuesj-1122	30	83	who	who	PRON
cuesj-1122	30	84	are	be	AUX
cuesj-1122	30	85	male	male	ADJ
cuesj-1122	30	86	,	,	PUNCT
cuesj-1122	30	87	fat	fat	ADJ
cuesj-1122	30	88	,	,	PUNCT
cuesj-1122	30	89	and	and	CCONJ
cuesj-1122	30	90	elderly	elderly	ADJ
cuesj-1122	30	91	are	be	AUX
cuesj-1122	30	92	more	more	ADV
cuesj-1122	30	93	likely	likely	ADJ
cuesj-1122	30	94	to	to	PART
cuesj-1122	30	95	suffer	suffer	VERB
cuesj-1122	30	96	liver	liver	NOUN
cuesj-1122	30	97	dysfunction	dysfunction	NOUN
cuesj-1122	30	98	.	.	PUNCT
cuesj-1122	31	1	liver	liver	NOUN
cuesj-1122	31	2	injury	injury	NOUN
cuesj-1122	31	3	is	be	AUX
cuesj-1122	31	4	caused	cause	VERB
cuesj-1122	31	5	by	by	ADP
cuesj-1122	31	6	multiple	multiple	ADJ
cuesj-1122	31	7	causes	cause	NOUN
cuesj-1122	31	8	,	,	PUNCT
cuesj-1122	31	9	such	such	ADJ
cuesj-1122	31	10	as	as	ADP
cuesj-1122	31	11	a	a	DET
cuesj-1122	31	12	direct	direct	ADJ
cuesj-1122	31	13	cytopathic	cytopathic	ADJ
cuesj-1122	31	14	effect	effect	NOUN
cuesj-1122	31	15	,	,	PUNCT
cuesj-1122	31	16	a	a	DET
cuesj-1122	31	17	strong	strong	ADJ
cuesj-1122	31	18	inflammatory	inflammatory	ADJ
cuesj-1122	31	19	response	response	NOUN
cuesj-1122	31	20	,	,	PUNCT
cuesj-1122	31	21	the	the	DET
cuesj-1122	31	22	unique	unique	ADJ
cuesj-1122	31	23	effects	effect	NOUN
cuesj-1122	31	24	of	of	ADP
cuesj-1122	31	25	treatment	treatment	NOUN
cuesj-1122	31	26	regimens	regimen	NOUN
cuesj-1122	31	27	,	,	PUNCT
cuesj-1122	31	28	and	and	CCONJ
cuesj-1122	31	29	cytokine	cytokine	VERB
cuesj-1122	31	30	storm.[13	storm.[13	PROPN
cuesj-1122	31	31	]	]	PUNCT
cuesj-1122	31	32	based	base	VERB
cuesj-1122	31	33	on	on	ADP
cuesj-1122	31	34	additional	additional	ADJ
cuesj-1122	31	35	studies	study	NOUN
cuesj-1122	31	36	,	,	PUNCT
cuesj-1122	31	37	covid-19	covid-19	PROPN
cuesj-1122	31	38	frequently	frequently	ADV
cuesj-1122	31	39	manifests	manifest	VERB
cuesj-1122	31	40	as	as	ADP
cuesj-1122	31	41	liver	liver	NOUN
cuesj-1122	31	42	disease	disease	NOUN
cuesj-1122	31	43	,	,	PUNCT
cuesj-1122	31	44	which	which	PRON
cuesj-1122	31	45	is	be	AUX
cuesj-1122	31	46	connected	connect	VERB
cuesj-1122	31	47	to	to	ADP
cuesj-1122	31	48	a	a	DET
cuesj-1122	31	49	higher	high	ADJ
cuesj-1122	31	50	mortality	mortality	NOUN
cuesj-1122	31	51	rate.[14	rate.[14	PROPN
cuesj-1122	31	52	]	]	PUNCT
cuesj-1122	31	53	“	"	PUNCT
cuesj-1122	31	54	patients	patient	NOUN
cuesj-1122	31	55	with	with	ADP
cuesj-1122	31	56	covid-19	covid-19	PROPN
cuesj-1122	31	57	have	have	AUX
cuesj-1122	31	58	been	be	AUX
cuesj-1122	31	59	found	find	VERB
cuesj-1122	31	60	to	to	PART
cuesj-1122	31	61	frequently	frequently	ADV
cuesj-1122	31	62	have	have	VERB
cuesj-1122	31	63	increased	increase	VERB
cuesj-1122	31	64	levels	level	NOUN
cuesj-1122	31	65	of	of	ADP
cuesj-1122	31	66	the	the	DET
cuesj-1122	31	67	serum	serum	NOUN
cuesj-1122	31	68	enzymes	enzyme	NOUN
cuesj-1122	31	69	aspartate	aspartate	NOUN
cuesj-1122	31	70	aminotransferase	aminotransferase	NOUN
cuesj-1122	31	71	(	(	PUNCT
cuesj-1122	31	72	ast	ast	PROPN
cuesj-1122	31	73	)	)	PUNCT
cuesj-1122	31	74	,	,	PUNCT
cuesj-1122	31	75	alanine	alanine	NOUN
cuesj-1122	31	76	aminotransferase	aminotransferase	PROPN
cuesj-1122	31	77	(	(	PUNCT
cuesj-1122	31	78	alt	alt	PROPN
cuesj-1122	31	79	)	)	PUNCT
cuesj-1122	31	80	,	,	PUNCT
cuesj-1122	31	81	alkaline	alkaline	NOUN
cuesj-1122	31	82	phosphatase	phosphatase	NOUN
cuesj-1122	31	83	(	(	PUNCT
cuesj-1122	31	84	alp	alp	PROPN
cuesj-1122	31	85	)	)	PUNCT
cuesj-1122	31	86	,	,	PUNCT
cuesj-1122	31	87	lactate	lactate	NOUN
cuesj-1122	31	88	dehydrogenase	dehydrogenase	NOUN
cuesj-1122	31	89	(	(	PUNCT
cuesj-1122	31	90	ldh	ldh	NOUN
cuesj-1122	31	91	)	)	PUNCT
cuesj-1122	31	92	,	,	PUNCT
cuesj-1122	31	93	total	total	ADJ
cuesj-1122	31	94	bilirubin	bilirubin	NOUN
cuesj-1122	31	95	(	(	PUNCT
cuesj-1122	31	96	tbil	tbil	NOUN
cuesj-1122	31	97	)	)	PUNCT
cuesj-1122	31	98	,	,	PUNCT
cuesj-1122	31	99	and	and	CCONJ
cuesj-1122	31	100	gamma	gamma	NOUN
cuesj-1122	31	101	-	-	PUNCT
cuesj-1122	31	102	glutamyl	glutamyl	VERB
cuesj-1122	31	103	transpeptidase	transpeptidase	NOUN
cuesj-1122	31	104	(	(	PUNCT
cuesj-1122	31	105	ggt	ggt	NOUN
cuesj-1122	31	106	)	)	PUNCT
cuesj-1122	31	107	”	"	PUNCT
cuesj-1122	31	108	,	,	PUNCT
cuesj-1122	31	109	along	along	ADP
cuesj-1122	31	110	with	with	ADP
cuesj-1122	31	111	decreased	decrease	VERB
cuesj-1122	31	112	levels	level	NOUN
cuesj-1122	31	113	of	of	ADP
cuesj-1122	31	114	albumin	albumin	NOUN
cuesj-1122	31	115	(	(	PUNCT
cuesj-1122	31	116	alb).[15,16	alb).[15,16	ADJ
cuesj-1122	31	117	]	]	X
cuesj-1122	31	118	hence	hence	ADV
cuesj-1122	31	119	,	,	PUNCT
cuesj-1122	31	120	these	these	DET
cuesj-1122	31	121	parameters	parameter	NOUN
cuesj-1122	31	122	can	can	AUX
cuesj-1122	31	123	be	be	AUX
cuesj-1122	31	124	useful	useful	ADJ
cuesj-1122	31	125	marker	marker	NOUN
cuesj-1122	31	126	to	to	PART
cuesj-1122	31	127	evaluate	evaluate	VERB
cuesj-1122	31	128	liver	liver	NOUN
cuesj-1122	31	129	functions	function	NOUN
cuesj-1122	31	130	in	in	ADP
cuesj-1122	31	131	patient	patient	ADJ
cuesj-1122	31	132	groups	group	NOUN
cuesj-1122	31	133	.	.	PUNCT
cuesj-1122	32	1	reduced	reduce	VERB
cuesj-1122	32	2	bone	bone	NOUN
cuesj-1122	32	3	mineral	mineral	NOUN
cuesj-1122	32	4	density	density	NOUN
cuesj-1122	32	5	and	and	CCONJ
cuesj-1122	32	6	other	other	ADJ
cuesj-1122	32	7	musculoskeletal	musculoskeletal	ADJ
cuesj-1122	32	8	symptoms	symptom	NOUN
cuesj-1122	32	9	have	have	AUX
cuesj-1122	32	10	been	be	AUX
cuesj-1122	32	11	linked	link	VERB
cuesj-1122	32	12	to	to	ADP
cuesj-1122	32	13	sars	sar	NOUN
cuesj-1122	32	14	-	-	PUNCT
cuesj-1122	32	15	cov-2	cov-2	PART
cuesj-1122	32	16	infection	infection	NOUN
cuesj-1122	32	17	.	.	PUNCT
cuesj-1122	33	1	these	these	DET
cuesj-1122	33	2	symptoms	symptom	NOUN
cuesj-1122	33	3	could	could	AUX
cuesj-1122	33	4	be	be	AUX
cuesj-1122	33	5	brought	bring	VERB
cuesj-1122	33	6	on	on	ADP
cuesj-1122	33	7	by	by	ADP
cuesj-1122	33	8	a	a	DET
cuesj-1122	33	9	number	number	NOUN
cuesj-1122	33	10	of	of	ADP
cuesj-1122	33	11	disease	disease	NOUN
cuesj-1122	33	12	-	-	PUNCT
cuesj-1122	33	13	related	relate	VERB
cuesj-1122	33	14	variables	variable	NOUN
cuesj-1122	33	15	,	,	PUNCT
cuesj-1122	33	16	including	include	VERB
cuesj-1122	33	17	medication	medication	NOUN
cuesj-1122	33	18	,	,	PUNCT
cuesj-1122	33	19	mobility	mobility	NOUN
cuesj-1122	33	20	restrictions	restriction	NOUN
cuesj-1122	33	21	,	,	PUNCT
cuesj-1122	33	22	or	or	CCONJ
cuesj-1122	33	23	diet.[17	diet.[17	PROPN
cuesj-1122	33	24	]	]	PUNCT
cuesj-1122	33	25	to	to	PART
cuesj-1122	33	26	infect	infect	VERB
cuesj-1122	33	27	host	host	NOUN
cuesj-1122	33	28	cells	cell	NOUN
cuesj-1122	33	29	,	,	PUNCT
cuesj-1122	34	1	sarscov-2	sarscov-2	NUM
cuesj-1122	34	2	interacts	interact	VERB
cuesj-1122	34	3	with	with	ADP
cuesj-1122	34	4	ace2	ace2	NOUN
cuesj-1122	34	5	receptors	receptor	NOUN
cuesj-1122	34	6	that	that	PRON
cuesj-1122	34	7	exist	exist	VERB
cuesj-1122	34	8	on	on	ADP
cuesj-1122	34	9	cell	cell	NOUN
cuesj-1122	34	10	targets	target	NOUN
cuesj-1122	34	11	,	,	PUNCT
cuesj-1122	34	12	including	include	VERB
cuesj-1122	34	13	bone	bone	NOUN
cuesj-1122	34	14	cells.[18	cells.[18	PROPN
cuesj-1122	34	15	]	]	PUNCT
cuesj-1122	34	16	bone	bone	NOUN
cuesj-1122	34	17	fragility	fragility	NOUN
cuesj-1122	34	18	may	may	AUX
cuesj-1122	34	19	result	result	VERB
cuesj-1122	34	20	from	from	ADP
cuesj-1122	34	21	ace2	ace2	NOUN
cuesj-1122	34	22	downregulation	downregulation	NOUN
cuesj-1122	34	23	’s	’s	PART
cuesj-1122	34	24	impact	impact	NOUN
cuesj-1122	34	25	on	on	ADP
cuesj-1122	34	26	bone	bone	NOUN
cuesj-1122	34	27	homeostasis.[19	homeostasis.[19	NOUN
cuesj-1122	34	28	]	]	PUNCT
cuesj-1122	34	29	“	"	PUNCT
cuesj-1122	34	30	the	the	DET
cuesj-1122	34	31	balance	balance	NOUN
cuesj-1122	34	32	of	of	ADP
cuesj-1122	34	33	p	p	PROPN
cuesj-1122	34	34	and	and	CCONJ
cuesj-1122	34	35	ca	can	AUX
cuesj-1122	34	36	in	in	ADP
cuesj-1122	34	37	the	the	DET
cuesj-1122	34	38	body	body	NOUN
cuesj-1122	34	39	,	,	PUNCT
cuesj-1122	34	40	which	which	PRON
cuesj-1122	34	41	is	be	AUX
cuesj-1122	34	42	essential	essential	ADJ
cuesj-1122	34	43	for	for	ADP
cuesj-1122	34	44	many	many	ADJ
cuesj-1122	34	45	physiological	physiological	ADJ
cuesj-1122	34	46	functions	function	NOUN
cuesj-1122	34	47	,	,	PUNCT
cuesj-1122	34	48	including	include	VERB
cuesj-1122	34	49	bone	bone	NOUN
cuesj-1122	34	50	health	health	NOUN
cuesj-1122	34	51	,	,	PUNCT
cuesj-1122	34	52	muscular	muscular	ADJ
cuesj-1122	34	53	function	function	NOUN
cuesj-1122	34	54	,	,	PUNCT
cuesj-1122	34	55	nerve	nerve	NOUN
cuesj-1122	34	56	transmission	transmission	NOUN
cuesj-1122	34	57	,	,	PUNCT
cuesj-1122	34	58	and	and	CCONJ
cuesj-1122	34	59	cellular	cellular	ADJ
cuesj-1122	34	60	signaling	signaling	NOUN
cuesj-1122	34	61	,	,	PUNCT
cuesj-1122	34	62	is	be	AUX
cuesj-1122	34	63	maintained	maintain	VERB
cuesj-1122	34	64	by	by	ADP
cuesj-1122	34	65	phosphocalcium	phosphocalcium	ADJ
cuesj-1122	34	66	metabolism”.[20	metabolism”.[20	NOUN
cuesj-1122	34	67	]	]	PUNCT
cuesj-1122	34	68	another	another	DET
cuesj-1122	34	69	research	research	NOUN
cuesj-1122	34	70	investigation[21	investigation[21	NOUN
cuesj-1122	34	71	]	]	PUNCT
cuesj-1122	34	72	demonstrated	demonstrate	VERB
cuesj-1122	34	73	that	that	SCONJ
cuesj-1122	34	74	covid-19	covid-19	PROPN
cuesj-1122	34	75	and	and	CCONJ
cuesj-1122	34	76	its	its	PRON
cuesj-1122	34	77	therapy	therapy	NOUN
cuesj-1122	34	78	had	have	VERB
cuesj-1122	34	79	negative	negative	ADJ
cuesj-1122	34	80	impacts	impact	NOUN
cuesj-1122	34	81	on	on	ADP
cuesj-1122	34	82	covid-19	covid-19	PROPN
cuesj-1122	34	83	survivors	survivor	NOUN
cuesj-1122	34	84	’	'	PUNCT
cuesj-1122	34	85	bone	bone	NOUN
cuesj-1122	34	86	health	health	NOUN
cuesj-1122	34	87	.	.	PUNCT
cuesj-1122	35	1	these	these	DET
cuesj-1122	35	2	effects	effect	NOUN
cuesj-1122	35	3	tend	tend	VERB
cuesj-1122	35	4	to	to	PART
cuesj-1122	35	5	be	be	AUX
cuesj-1122	35	6	stronger	strong	ADJ
cuesj-1122	35	7	in	in	ADP
cuesj-1122	35	8	older	old	ADJ
cuesj-1122	35	9	and	and	CCONJ
cuesj-1122	35	10	weak	weak	ADJ
cuesj-1122	35	11	patients	patient	NOUN
cuesj-1122	35	12	,	,	PUNCT
cuesj-1122	35	13	thus	thus	ADV
cuesj-1122	35	14	it	it	PRON
cuesj-1122	35	15	is	be	AUX
cuesj-1122	35	16	important	important	ADJ
cuesj-1122	35	17	to	to	PART
cuesj-1122	35	18	regularly	regularly	ADV
cuesj-1122	35	19	monitor	monitor	VERB
cuesj-1122	35	20	their	their	PRON
cuesj-1122	35	21	risk	risk	NOUN
cuesj-1122	35	22	of	of	ADP
cuesj-1122	35	23	bone	bone	NOUN
cuesj-1122	35	24	loss	loss	NOUN
cuesj-1122	35	25	and	and	CCONJ
cuesj-1122	35	26	falls	fall	NOUN
cuesj-1122	35	27	.	.	PUNCT
cuesj-1122	36	1	furthermore,[22	furthermore,[22	NOUN
cuesj-1122	36	2	]	]	PUNCT
cuesj-1122	36	3	discovered	discover	VERB
cuesj-1122	36	4	that	that	SCONJ
cuesj-1122	36	5	greater	great	ADJ
cuesj-1122	36	6	phosphate	phosphate	ADJ
cuesj-1122	36	7	concentration	concentration	NOUN
cuesj-1122	36	8	might	might	AUX
cuesj-1122	36	9	be	be	AUX
cuesj-1122	36	10	related	relate	VERB
cuesj-1122	36	11	to	to	ADP
cuesj-1122	36	12	improved	improve	VERB
cuesj-1122	36	13	lung	lung	NOUN
cuesj-1122	36	14	ct	ct	NUM
cuesj-1122	36	15	imaging	imaging	NOUN
cuesj-1122	36	16	consequences	consequence	NOUN
cuesj-1122	36	17	in	in	ADP
cuesj-1122	36	18	sars	sar	NOUN
cuesj-1122	36	19	-	-	PUNCT
cuesj-1122	36	20	cov-2	cov-2	NOUN
cuesj-1122	36	21	,	,	PUNCT
cuesj-1122	36	22	whereas	whereas	SCONJ
cuesj-1122	36	23	hypophosphatemia	hypophosphatemia	NOUN
cuesj-1122	36	24	is	be	AUX
cuesj-1122	36	25	related	relate	VERB
cuesj-1122	36	26	to	to	ADP
cuesj-1122	36	27	serious	serious	ADJ
cuesj-1122	36	28	lung	lung	NOUN
cuesj-1122	36	29	damage	damage	NOUN
cuesj-1122	36	30	.	.	PUNCT
cuesj-1122	37	1	in	in	ADP
cuesj-1122	37	2	earlier	early	ADJ
cuesj-1122	37	3	research	research	NOUN
cuesj-1122	37	4	by	by	ADP
cuesj-1122	37	5	yang	yang	PROPN
cuesj-1122	37	6	et	et	PROPN
cuesj-1122	37	7	al	al	PROPN
cuesj-1122	37	8	.	.	PROPN
cuesj-1122	37	9	,[23	,[23	PROPN
cuesj-1122	37	10	]	]	PUNCT
cuesj-1122	37	11	hypophosphatemia	hypophosphatemia	NOUN
cuesj-1122	37	12	was	be	AUX
cuesj-1122	37	13	seen	see	VERB
cuesj-1122	37	14	in	in	ADP
cuesj-1122	37	15	patients	patient	NOUN
cuesj-1122	37	16	with	with	ADP
cuesj-1122	37	17	chronic	chronic	ADJ
cuesj-1122	37	18	obstructive	obstructive	ADJ
cuesj-1122	37	19	pulmonary	pulmonary	ADJ
cuesj-1122	37	20	disease	disease	NOUN
cuesj-1122	37	21	(	(	PUNCT
cuesj-1122	37	22	copd	copd	NOUN
cuesj-1122	37	23	)	)	PUNCT
cuesj-1122	37	24	and	and	CCONJ
cuesj-1122	37	25	acute	acute	ADJ
cuesj-1122	37	26	lung	lung	NOUN
cuesj-1122	37	27	failure	failure	NOUN
cuesj-1122	37	28	.	.	PUNCT
cuesj-1122	38	1	it	it	PRON
cuesj-1122	38	2	has	have	AUX
cuesj-1122	38	3	also	also	ADV
cuesj-1122	38	4	been	be	AUX
cuesj-1122	38	5	noted	note	VERB
cuesj-1122	38	6	that	that	SCONJ
cuesj-1122	38	7	the	the	DET
cuesj-1122	38	8	virus	virus	NOUN
cuesj-1122	38	9	-	-	PUNCT
cuesj-1122	38	10	induced	induce	VERB
cuesj-1122	38	11	illness	illness	NOUN
cuesj-1122	38	12	has	have	VERB
cuesj-1122	38	13	abnormal	abnormal	ADJ
cuesj-1122	38	14	serum	serum	NOUN
cuesj-1122	38	15	ca	ca	NOUN
cuesj-1122	38	16	concentration	concentration	NOUN
cuesj-1122	38	17	.	.	PUNCT
cuesj-1122	39	1	the	the	DET
cuesj-1122	39	2	parathyroid	parathyroid	ADJ
cuesj-1122	39	3	hormone	hormone	NOUN
cuesj-1122	39	4	produced	produce	VERB
cuesj-1122	39	5	by	by	ADP
cuesj-1122	39	6	parathyroid	parathyroid	ADJ
cuesj-1122	39	7	glands	gland	NOUN
cuesj-1122	39	8	,	,	PUNCT
cuesj-1122	39	9	is	be	AUX
cuesj-1122	39	10	vital	vital	ADJ
cuesj-1122	39	11	in	in	ADP
cuesj-1122	39	12	controlling	control	VERB
cuesj-1122	39	13	phosphorus	phosphorus	NOUN
cuesj-1122	39	14	and	and	CCONJ
cuesj-1122	39	15	calcium	calcium	NOUN
cuesj-1122	39	16	concentration	concentration	NOUN
cuesj-1122	39	17	in	in	ADP
cuesj-1122	39	18	bone	bone	NOUN
cuesj-1122	39	19	,	,	PUNCT
cuesj-1122	39	20	kidneys	kidney	NOUN
cuesj-1122	39	21	,	,	PUNCT
cuesj-1122	39	22	and	and	CCONJ
cuesj-1122	39	23	digestive	digestive	ADJ
cuesj-1122	39	24	system.[22	system.[22	NOUN
cuesj-1122	39	25	]	]	PUNCT
cuesj-1122	39	26	in	in	ADP
cuesj-1122	39	27	addition,[24	addition,[24	NOUN
cuesj-1122	39	28	]	]	PUNCT
cuesj-1122	39	29	investigated	investigate	VERB
cuesj-1122	39	30	that	that	SCONJ
cuesj-1122	39	31	covid-19	covid-19	PROPN
cuesj-1122	39	32	might	might	AUX
cuesj-1122	39	33	influence	influence	VERB
cuesj-1122	39	34	parathyroid	parathyroid	ADJ
cuesj-1122	39	35	gland	gland	NOUN
cuesj-1122	39	36	function	function	NOUN
cuesj-1122	39	37	in	in	ADP
cuesj-1122	39	38	a	a	DET
cuesj-1122	39	39	pair	pair	NOUN
cuesj-1122	39	40	of	of	ADP
cuesj-1122	39	41	manners	manner	NOUN
cuesj-1122	39	42	:	:	PUNCT
cuesj-1122	39	43	directly	directly	ADV
cuesj-1122	39	44	through	through	ADP
cuesj-1122	39	45	covid-19	covid-19	PROPN
cuesj-1122	39	46	infection	infection	NOUN
cuesj-1122	39	47	of	of	ADP
cuesj-1122	39	48	parathyroid	parathyroid	ADJ
cuesj-1122	39	49	glands	gland	NOUN
cuesj-1122	39	50	,	,	PUNCT
cuesj-1122	39	51	and	and	CCONJ
cuesj-1122	39	52	indirectly	indirectly	ADV
cuesj-1122	39	53	as	as	ADP
cuesj-1122	39	54	a	a	DET
cuesj-1122	39	55	result	result	NOUN
cuesj-1122	39	56	of	of	ADP
cuesj-1122	39	57	chronic	chronic	ADJ
cuesj-1122	39	58	respiratory	respiratory	ADJ
cuesj-1122	39	59	alkalosis	alkalosis	NOUN
cuesj-1122	39	60	and	and	CCONJ
cuesj-1122	39	61	lung	lung	NOUN
cuesj-1122	39	62	failure	failure	NOUN
cuesj-1122	39	63	,	,	PUNCT
cuesj-1122	39	64	it	it	PRON
cuesj-1122	39	65	could	could	AUX
cuesj-1122	39	66	be	be	AUX
cuesj-1122	39	67	interpreted	interpret	VERB
cuesj-1122	39	68	as	as	ADP
cuesj-1122	39	69	extra	extra	ADJ
cuesj-1122	39	70	explanations	explanation	NOUN
cuesj-1122	39	71	for	for	ADP
cuesj-1122	39	72	why	why	SCONJ
cuesj-1122	39	73	hypocalcemia	hypocalcemia	NOUN
cuesj-1122	39	74	is	be	AUX
cuesj-1122	39	75	common	common	ADJ
cuesj-1122	39	76	in	in	ADP
cuesj-1122	39	77	covid-19	covid-19	PROPN
cuesj-1122	39	78	individuals	individual	NOUN
cuesj-1122	39	79	.	.	PUNCT
cuesj-1122	40	1	the	the	DET
cuesj-1122	40	2	hormones	hormone	NOUN
cuesj-1122	40	3	thyroid	thyroid	VERB
cuesj-1122	40	4	stimulating	stimulate	VERB
cuesj-1122	40	5	hormone	hormone	NOUN
cuesj-1122	40	6	(	(	PUNCT
cuesj-1122	40	7	tsh	tsh	NOUN
cuesj-1122	40	8	)	)	PUNCT
cuesj-1122	40	9	,	,	PUNCT
cuesj-1122	40	10	free	free	ADJ
cuesj-1122	40	11	thyroxine	thyroxine	NOUN
cuesj-1122	40	12	(	(	PUNCT
cuesj-1122	40	13	ft4	ft4	NOUN
cuesj-1122	40	14	)	)	PUNCT
cuesj-1122	40	15	,	,	PUNCT
cuesj-1122	40	16	and	and	CCONJ
cuesj-1122	40	17	free	free	ADJ
cuesj-1122	40	18	triiodothyronine	triiodothyronine	NOUN
cuesj-1122	40	19	(	(	PUNCT
cuesj-1122	40	20	ft3	ft3	NOUN
cuesj-1122	40	21	)	)	PUNCT
cuesj-1122	40	22	control	control	NOUN
cuesj-1122	40	23	the	the	DET
cuesj-1122	40	24	hypothalamus	hypothalamus	NOUN
cuesj-1122	40	25	-	-	PUNCT
cuesj-1122	40	26	pituitary	pituitary	ADJ
cuesj-1122	40	27	-	-	PUNCT
cuesj-1122	40	28	thyroid	thyroid	NOUN
cuesj-1122	40	29	axis.[25	axis.[25	PROPN
cuesj-1122	40	30	]	]	PUNCT
cuesj-1122	40	31	medically	medically	ADV
cuesj-1122	40	32	,	,	PUNCT
cuesj-1122	40	33	covid-19	covid-19	PROPN
cuesj-1122	40	34	individuals	individual	NOUN
cuesj-1122	40	35	who	who	PRON
cuesj-1122	40	36	have	have	VERB
cuesj-1122	40	37	low	low	ADJ
cuesj-1122	40	38	tsh	tsh	NOUN
cuesj-1122	40	39	and	and	CCONJ
cuesj-1122	40	40	ft3	ft3	NOUN
cuesj-1122	40	41	concentration	concentration	NOUN
cuesj-1122	40	42	seem	seem	VERB
cuesj-1122	40	43	to	to	PART
cuesj-1122	40	44	have	have	VERB
cuesj-1122	40	45	a	a	DET
cuesj-1122	40	46	greater	great	ADJ
cuesj-1122	40	47	rate	rate	NOUN
cuesj-1122	40	48	of	of	ADP
cuesj-1122	40	49	mortality	mortality	NOUN
cuesj-1122	40	50	,	,	PUNCT
cuesj-1122	40	51	which	which	PRON
cuesj-1122	40	52	is	be	AUX
cuesj-1122	40	53	not	not	PART
cuesj-1122	40	54	exactly	exactly	ADV
cuesj-1122	40	55	in	in	ADP
cuesj-1122	40	56	line	line	NOUN
cuesj-1122	40	57	with	with	ADP
cuesj-1122	40	58	earlier	early	ADJ
cuesj-1122	40	59	investigations	investigation	NOUN
cuesj-1122	40	60	of	of	ADP
cuesj-1122	40	61	the	the	DET
cuesj-1122	40	62	non	non	ADJ
cuesj-1122	40	63	-	-	ADJ
cuesj-1122	40	64	thyroidal	thyroidal	ADJ
cuesj-1122	40	65	illness	illness	NOUN
cuesj-1122	40	66	syndrome	syndrome	NOUN
cuesj-1122	40	67	(	(	PUNCT
cuesj-1122	40	68	nti).[26	nti).[26	PROPN
cuesj-1122	40	69	]	]	PUNCT
cuesj-1122	40	70	also	also	ADV
cuesj-1122	40	71	,	,	PUNCT
cuesj-1122	40	72	zaidi	zaidi	PROPN
cuesj-1122	40	73	et	et	PROPN
cuesj-1122	40	74	al.[27	al.[27	PROPN
cuesj-1122	40	75	]	]	PUNCT
cuesj-1122	40	76	reported	report	VERB
cuesj-1122	40	77	that	that	SCONJ
cuesj-1122	40	78	lowered	lower	VERB
cuesj-1122	40	79	tsh	tsh	NOUN
cuesj-1122	40	80	signaling	signal	VERB
cuesj-1122	40	81	is	be	AUX
cuesj-1122	40	82	a	a	DET
cuesj-1122	40	83	factor	factor	NOUN
cuesj-1122	40	84	in	in	ADP
cuesj-1122	40	85	hyperthyroid	hyperthyroid	NOUN
cuesj-1122	40	86	osteoporosis	osteoporosis	NOUN
cuesj-1122	40	87	.	.	PUNCT
cuesj-1122	41	1	moreover	moreover	ADV
cuesj-1122	41	2	,	,	PUNCT
cuesj-1122	41	3	deng	deng	PROPN
cuesj-1122	41	4	et	et	PROPN
cuesj-1122	41	5	al.[28	al.[28	PROPN
cuesj-1122	41	6	]	]	PUNCT
cuesj-1122	41	7	indicated	indicate	VERB
cuesj-1122	41	8	that	that	SCONJ
cuesj-1122	41	9	through	through	ADP
cuesj-1122	41	10	controlling	control	VERB
cuesj-1122	41	11	osteoblast	osteoblast	ADJ
cuesj-1122	41	12	proliferation	proliferation	NOUN
cuesj-1122	41	13	and	and	CCONJ
cuesj-1122	41	14	differentiation	differentiation	NOUN
cuesj-1122	41	15	,	,	PUNCT
cuesj-1122	41	16	tsh	tsh	NOUN
cuesj-1122	41	17	lowers	lower	VERB
cuesj-1122	41	18	the	the	DET
cuesj-1122	41	19	incidence	incidence	NOUN
cuesj-1122	41	20	of	of	ADP
cuesj-1122	41	21	osteoporosis	osteoporosis	NOUN
cuesj-1122	41	22	.	.	PUNCT
cuesj-1122	42	1	in	in	ADP
cuesj-1122	42	2	addition	addition	NOUN
cuesj-1122	42	3	,	,	PUNCT
cuesj-1122	42	4	yanachkova	yanachkova	PROPN
cuesj-1122	42	5	et	et	PROPN
cuesj-1122	42	6	al.[29	al.[29	PROPN
cuesj-1122	42	7	]	]	PUNCT
cuesj-1122	42	8	made	make	VERB
cuesj-1122	42	9	the	the	DET
cuesj-1122	42	10	suggestion	suggestion	NOUN
cuesj-1122	42	11	that	that	SCONJ
cuesj-1122	42	12	covid-19	covid-19	PROPN
cuesj-1122	42	13	might	might	AUX
cuesj-1122	42	14	have	have	AUX
cuesj-1122	42	15	negative	negative	ADJ
cuesj-1122	42	16	long	long	ADJ
cuesj-1122	42	17	-	-	PUNCT
cuesj-1122	42	18	term	term	NOUN
cuesj-1122	42	19	effects	effect	NOUN
cuesj-1122	42	20	on	on	ADP
cuesj-1122	42	21	thyroid	thyroid	NOUN
cuesj-1122	42	22	function	function	NOUN
cuesj-1122	42	23	.	.	PUNCT
cuesj-1122	43	1	tft	tft	INTJ
cuesj-1122	43	2	should	should	AUX
cuesj-1122	43	3	therefore	therefore	ADV
cuesj-1122	43	4	be	be	AUX
cuesj-1122	43	5	included	include	VERB
cuesj-1122	43	6	in	in	ADP
cuesj-1122	43	7	the	the	DET
cuesj-1122	43	8	follow	follow	VERB
cuesj-1122	43	9	-	-	PUNCT
cuesj-1122	43	10	up	up	NOUN
cuesj-1122	43	11	algorithm	algorithm	NOUN
cuesj-1122	43	12	even	even	ADV
cuesj-1122	43	13	for	for	ADP
cuesj-1122	43	14	individuals	individual	NOUN
cuesj-1122	43	15	presenting	present	VERB
cuesj-1122	43	16	with	with	ADP
cuesj-1122	43	17	mild	mild	ADJ
cuesj-1122	43	18	-	-	PUNCT
cuesj-1122	43	19	to	to	ADP
cuesj-1122	43	20	-	-	PUNCT
cuesj-1122	43	21	moderate	moderate	ADJ
cuesj-1122	43	22	covid-19	covid-19	PROPN
cuesj-1122	43	23	.	.	PUNCT
cuesj-1122	44	1	these	these	DET
cuesj-1122	44	2	variables	variable	NOUN
cuesj-1122	44	3	which	which	PRON
cuesj-1122	44	4	are	be	AUX
cuesj-1122	44	5	thought	think	VERB
cuesj-1122	44	6	to	to	PART
cuesj-1122	44	7	be	be	AUX
cuesj-1122	44	8	covid-19	covid-19	PROPN
cuesj-1122	44	9	indicators	indicator	NOUN
cuesj-1122	44	10	will	will	AUX
cuesj-1122	44	11	help	help	VERB
cuesj-1122	44	12	with	with	ADP
cuesj-1122	44	13	patient	patient	ADJ
cuesj-1122	44	14	care	care	NOUN
cuesj-1122	44	15	and	and	CCONJ
cuesj-1122	44	16	epidemic	epidemic	NOUN
cuesj-1122	44	17	containment	containment	NOUN
cuesj-1122	44	18	.	.	PUNCT
cuesj-1122	45	1	the	the	DET
cuesj-1122	45	2	present	present	ADJ
cuesj-1122	45	3	study	study	NOUN
cuesj-1122	45	4	aimed	aim	VERB
cuesj-1122	45	5	to	to	PART
cuesj-1122	45	6	assess	assess	VERB
cuesj-1122	45	7	the	the	DET
cuesj-1122	45	8	value	value	NOUN
cuesj-1122	45	9	liver	liver	NOUN
cuesj-1122	45	10	parameters	parameter	NOUN
cuesj-1122	45	11	including	include	VERB
cuesj-1122	45	12	(	(	PUNCT
cuesj-1122	45	13	ast	ast	INTJ
cuesj-1122	45	14	,	,	PUNCT
cuesj-1122	45	15	alt	alt	ADJ
cuesj-1122	45	16	,	,	PUNCT
cuesj-1122	45	17	alp	alp	PROPN
cuesj-1122	45	18	,	,	PUNCT
cuesj-1122	45	19	ldh	ldh	PROPN
cuesj-1122	45	20	,	,	PUNCT
cuesj-1122	45	21	tsb	tsb	ADJ
cuesj-1122	45	22	,	,	PUNCT
cuesj-1122	45	23	and	and	CCONJ
cuesj-1122	45	24	albumin	albumin	NOUN
cuesj-1122	45	25	)	)	PUNCT
cuesj-1122	45	26	,	,	PUNCT
cuesj-1122	45	27	as	as	ADV
cuesj-1122	45	28	well	well	ADV
cuesj-1122	45	29	as	as	ADP
cuesj-1122	45	30	bone	bone	NOUN
cuesj-1122	45	31	markers	marker	NOUN
cuesj-1122	45	32	such	such	ADJ
cuesj-1122	45	33	as	as	ADP
cuesj-1122	45	34	(	(	PUNCT
cuesj-1122	45	35	ca	ca	NOUN
cuesj-1122	45	36	,	,	PUNCT
cuesj-1122	45	37	p	p	NOUN
cuesj-1122	45	38	,	,	PUNCT
cuesj-1122	45	39	pth	pth	NOUN
cuesj-1122	45	40	,	,	PUNCT
cuesj-1122	45	41	and	and	CCONJ
cuesj-1122	45	42	tsh	tsh	NOUN
cuesj-1122	45	43	)	)	PUNCT
cuesj-1122	45	44	to	to	PART
cuesj-1122	45	45	diagnosis	diagnosis	NOUN
cuesj-1122	45	46	and	and	CCONJ
cuesj-1122	45	47	severity	severity	NOUN
cuesj-1122	45	48	of	of	ADP
cuesj-1122	45	49	disease	disease	NOUN
cuesj-1122	45	50	in	in	ADP
cuesj-1122	45	51	non	non	ADJ
cuesj-1122	45	52	-	-	ADJ
cuesj-1122	45	53	vaccinated	vaccinated	ADJ
cuesj-1122	45	54	and	and	CCONJ
cuesj-1122	45	55	vaccinated	vaccinated	ADJ
cuesj-1122	45	56	sars	sar	NOUN
cuesj-1122	45	57	-	-	PUNCT
cuesj-1122	45	58	cov-2	cov-2	PART
cuesj-1122	45	59	patients	patient	NOUN
cuesj-1122	45	60	.	.	PUNCT
cuesj-1122	46	1	material	material	NOUN
cuesj-1122	46	2	and	and	CCONJ
cuesj-1122	46	3	methods	method	NOUN
cuesj-1122	46	4	participants	participant	NOUN
cuesj-1122	46	5	this	this	DET
cuesj-1122	46	6	study	study	NOUN
cuesj-1122	46	7	recruited	recruit	VERB
cuesj-1122	46	8	130	130	NUM
cuesj-1122	46	9	participants	participant	NOUN
cuesj-1122	46	10	in	in	ADP
cuesj-1122	46	11	total	total	NOUN
cuesj-1122	46	12	between	between	ADP
cuesj-1122	46	13	november	november	PROPN
cuesj-1122	46	14	2021	2021	NUM
cuesj-1122	46	15	and	and	CCONJ
cuesj-1122	46	16	may	may	PROPN
cuesj-1122	46	17	2022	2022	NUM
cuesj-1122	46	18	.	.	PUNCT
cuesj-1122	47	1	the	the	DET
cuesj-1122	47	2	patients	patient	NOUN
cuesj-1122	47	3	(	(	PUNCT
cuesj-1122	47	4	aged	age	VERB
cuesj-1122	47	5	from	from	ADP
cuesj-1122	47	6	20	20	NUM
cuesj-1122	47	7	to	to	PART
cuesj-1122	47	8	65	65	NUM
cuesj-1122	47	9	years	year	NOUN
cuesj-1122	47	10	)	)	PUNCT
cuesj-1122	47	11	diagnosed	diagnose	VERB
cuesj-1122	47	12	in	in	ADP
cuesj-1122	47	13	two	two	NUM
cuesj-1122	47	14	hospitals	hospital	NOUN
cuesj-1122	47	15	in	in	ADP
cuesj-1122	47	16	erbil	erbil	PROPN
cuesj-1122	47	17	city	city	PROPN
cuesj-1122	47	18	,	,	PUNCT
cuesj-1122	47	19	erbil	erbil	PROPN
cuesj-1122	47	20	emergency	emergency	NOUN
cuesj-1122	47	21	hospital	hospital	NOUN
cuesj-1122	47	22	,	,	PUNCT
cuesj-1122	47	23	and	and	CCONJ
cuesj-1122	47	24	lalav	lalav	ADJ
cuesj-1122	47	25	emergency	emergency	NOUN
cuesj-1122	47	26	that	that	PRON
cuesj-1122	47	27	were	be	AUX
cuesj-1122	47	28	confirmed	confirm	VERB
cuesj-1122	47	29	through	through	ADP
cuesj-1122	47	30	pcr	pcr	NOUN
cuesj-1122	47	31	using	use	VERB
cuesj-1122	47	32	sample	sample	NOUN
cuesj-1122	47	33	from	from	ADP
cuesj-1122	47	34	pharyngeal	pharyngeal	ADJ
cuesj-1122	47	35	or	or	CCONJ
cuesj-1122	47	36	nasal	nasal	ADJ
cuesj-1122	47	37	swabs	swab	NOUN
cuesj-1122	47	38	.	.	PUNCT
cuesj-1122	48	1	the	the	DET
cuesj-1122	48	2	patients	patient	NOUN
cuesj-1122	48	3	were	be	AUX
cuesj-1122	48	4	split	split	VERB
cuesj-1122	48	5	into	into	ADP
cuesj-1122	48	6	two	two	NUM
cuesj-1122	48	7	groups	group	NOUN
cuesj-1122	48	8	:	:	PUNCT
cuesj-1122	48	9	the	the	DET
cuesj-1122	48	10	unvaccinated	unvaccinated	ADJ
cuesj-1122	48	11	group	group	NOUN
cuesj-1122	48	12	,	,	PUNCT
cuesj-1122	48	13	comprising	comprise	VERB
cuesj-1122	48	14	26	26	NUM
cuesj-1122	48	15	male	male	ADJ
cuesj-1122	48	16	and	and	CCONJ
cuesj-1122	48	17	24	24	NUM
cuesj-1122	48	18	female	female	ADJ
cuesj-1122	48	19	patients	patient	NOUN
cuesj-1122	48	20	,	,	PUNCT
cuesj-1122	48	21	who	who	PRON
cuesj-1122	48	22	complained	complain	VERB
cuesj-1122	48	23	of	of	ADP
cuesj-1122	48	24	mild	mild	NOUN
cuesj-1122	48	25	to	to	ADP
cuesj-1122	48	26	severe	severe	ADJ
cuesj-1122	48	27	manifestations	manifestation	NOUN
cuesj-1122	48	28	;	;	PUNCT
cuesj-1122	48	29	and	and	CCONJ
cuesj-1122	48	30	the	the	DET
cuesj-1122	48	31	vaccinated	vaccinated	ADJ
cuesj-1122	48	32	group	group	NOUN
cuesj-1122	48	33	,	,	PUNCT
cuesj-1122	48	34	consisting	consist	VERB
cuesj-1122	48	35	of	of	ADP
cuesj-1122	48	36	26	26	NUM
cuesj-1122	48	37	male	male	ADJ
cuesj-1122	48	38	and	and	CCONJ
cuesj-1122	48	39	four	four	NUM
cuesj-1122	48	40	female	female	ADJ
cuesj-1122	48	41	patients	patient	NOUN
cuesj-1122	48	42	,	,	PUNCT
cuesj-1122	48	43	who	who	PRON
cuesj-1122	48	44	had	have	AUX
cuesj-1122	48	45	received	receive	VERB
cuesj-1122	48	46	two	two	NUM
cuesj-1122	48	47	doses	dose	NOUN
cuesj-1122	48	48	of	of	ADP
cuesj-1122	48	49	the	the	DET
cuesj-1122	48	50	bnt162b2	bnt162b2	NOUN
cuesj-1122	48	51	(	(	PUNCT
cuesj-1122	48	52	“	"	PUNCT
cuesj-1122	48	53	pfizer	pfizer	NOUN
cuesj-1122	48	54	-	-	PUNCT
cuesj-1122	48	55	biontech	biontech	NOUN
cuesj-1122	48	56	”	"	PUNCT
cuesj-1122	48	57	)	)	PUNCT
cuesj-1122	48	58	vaccine	vaccine	NOUN
cuesj-1122	48	59	before	before	ADP
cuesj-1122	48	60	becoming	become	VERB
cuesj-1122	48	61	ill	ill	ADJ
cuesj-1122	48	62	and	and	CCONJ
cuesj-1122	48	63	being	be	AUX
cuesj-1122	48	64	admitted	admit	VERB
cuesj-1122	48	65	to	to	ADP
cuesj-1122	48	66	the	the	DET
cuesj-1122	48	67	hospital	hospital	NOUN
cuesj-1122	48	68	.	.	PUNCT
cuesj-1122	49	1	in	in	ADP
cuesj-1122	49	2	addition	addition	NOUN
cuesj-1122	49	3	,	,	PUNCT
cuesj-1122	49	4	there	there	PRON
cuesj-1122	49	5	were	be	VERB
cuesj-1122	49	6	a	a	DET
cuesj-1122	49	7	total	total	NOUN
cuesj-1122	49	8	of	of	ADP
cuesj-1122	49	9	50	50	NUM
cuesj-1122	49	10	non	non	ADJ
cuesj-1122	49	11	-	-	ADJ
cuesj-1122	49	12	infected	infected	ADJ
cuesj-1122	49	13	people	people	NOUN
cuesj-1122	49	14	(	(	PUNCT
cuesj-1122	49	15	23	23	NUM
cuesj-1122	49	16	men	man	NOUN
cuesj-1122	49	17	and	and	CCONJ
cuesj-1122	49	18	27	27	NUM
cuesj-1122	49	19	women	woman	NOUN
cuesj-1122	49	20	)	)	PUNCT
cuesj-1122	49	21	.	.	PUNCT
cuesj-1122	50	1	blood	blood	NOUN
cuesj-1122	50	2	samples	sample	NOUN
cuesj-1122	50	3	for	for	ADP
cuesj-1122	50	4	every	every	DET
cuesj-1122	50	5	participant	participant	NOUN
cuesj-1122	50	6	,	,	PUNCT
cuesj-1122	50	7	a	a	DET
cuesj-1122	50	8	vein	vein	NOUN
cuesj-1122	50	9	-	-	PUNCT
cuesj-1122	50	10	based	base	VERB
cuesj-1122	50	11	blood	blood	NOUN
cuesj-1122	50	12	sample	sample	NOUN
cuesj-1122	50	13	(	(	PUNCT
cuesj-1122	50	14	approximate	approximate	ADJ
cuesj-1122	50	15	3	3	NUM
cuesj-1122	50	16	ml	ml	NOUN
cuesj-1122	50	17	)	)	PUNCT
cuesj-1122	50	18	was	be	AUX
cuesj-1122	50	19	taken	take	VERB
cuesj-1122	50	20	from	from	ADP
cuesj-1122	50	21	all	all	PRON
cuesj-1122	50	22	,	,	PUNCT
cuesj-1122	50	23	and	and	CCONJ
cuesj-1122	50	24	it	it	PRON
cuesj-1122	50	25	was	be	AUX
cuesj-1122	50	26	immediately	immediately	ADV
cuesj-1122	50	27	put	put	VERB
cuesj-1122	50	28	into	into	ADP
cuesj-1122	50	29	ahmed	ahmed	PROPN
cuesj-1122	50	30	,	,	PUNCT
cuesj-1122	50	31	et	et	PROPN
cuesj-1122	50	32	al	al	PROPN
cuesj-1122	50	33	.	.	PUNCT
cuesj-1122	50	34	:	:	PUNCT
cuesj-1122	51	1	comparison	comparison	NOUN
cuesj-1122	51	2	of	of	ADP
cuesj-1122	51	3	biochemical	biochemical	ADJ
cuesj-1122	51	4	parameters	parameter	NOUN
cuesj-1122	51	5	in	in	ADP
cuesj-1122	51	6	vaccinated	vaccinated	ADJ
cuesj-1122	51	7	48	48	NUM
cuesj-1122	51	8	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1122	51	9	cuesj	cuesj	NOUN
cuesj-1122	51	10	2024	2024	NUM
cuesj-1122	51	11	,	,	PUNCT
cuesj-1122	51	12	8	8	NUM
cuesj-1122	51	13	(	(	PUNCT
cuesj-1122	51	14	1	1	NUM
cuesj-1122	51	15	):	):	PUNCT
cuesj-1122	51	16	46	46	NUM
cuesj-1122	51	17	-	-	SYM
cuesj-1122	51	18	57	57	NUM
cuesj-1122	51	19	a	a	DET
cuesj-1122	51	20	serum	serum	NOUN
cuesj-1122	51	21	-	-	PUNCT
cuesj-1122	51	22	separating	separate	VERB
cuesj-1122	51	23	gel	gel	NOUN
cuesj-1122	51	24	tube	tube	NOUN
cuesj-1122	51	25	.	.	PUNCT
cuesj-1122	52	1	whole	whole	ADJ
cuesj-1122	52	2	blood	blood	NOUN
cuesj-1122	52	3	was	be	AUX
cuesj-1122	52	4	allowed	allow	VERB
cuesj-1122	52	5	to	to	PART
cuesj-1122	52	6	coagulate	coagulate	VERB
cuesj-1122	52	7	in	in	ADP
cuesj-1122	52	8	gel	gel	NOUN
cuesj-1122	52	9	tubes	tube	NOUN
cuesj-1122	52	10	for	for	ADP
cuesj-1122	52	11	30	30	NUM
cuesj-1122	52	12	min	min	NOUN
cuesj-1122	52	13	.	.	PROPN
cuesj-1122	52	14	to	to	PART
cuesj-1122	52	15	obtain	obtain	VERB
cuesj-1122	52	16	serum	serum	NOUN
cuesj-1122	52	17	for	for	ADP
cuesj-1122	52	18	serological	serological	ADJ
cuesj-1122	52	19	and	and	CCONJ
cuesj-1122	52	20	biochemical	biochemical	ADJ
cuesj-1122	52	21	testing	testing	NOUN
cuesj-1122	52	22	,	,	PUNCT
cuesj-1122	52	23	the	the	DET
cuesj-1122	52	24	specimens	specimen	NOUN
cuesj-1122	52	25	were	be	AUX
cuesj-1122	52	26	centrifuged	centrifuge	VERB
cuesj-1122	52	27	for	for	ADP
cuesj-1122	52	28	5	5	NUM
cuesj-1122	52	29	min	min	NOUN
cuesj-1122	52	30	at	at	ADP
cuesj-1122	52	31	4000	4000	NUM
cuesj-1122	52	32	rpm	rpm	NOUN
cuesj-1122	52	33	.	.	PUNCT
cuesj-1122	53	1	cobas	cobas	PROPN
cuesj-1122	53	2	e411	e411	PROPN
cuesj-1122	53	3	-	-	PROPN
cuesj-1122	53	4	roche	roche	PROPN
cuesj-1122	53	5	(	(	PUNCT
cuesj-1122	53	6	germany	germany	PROPN
cuesj-1122	53	7	)	)	PUNCT
cuesj-1122	53	8	was	be	AUX
cuesj-1122	53	9	used	use	VERB
cuesj-1122	53	10	to	to	PART
cuesj-1122	53	11	measure	measure	VERB
cuesj-1122	53	12	pth	pth	NOUN
cuesj-1122	53	13	and	and	CCONJ
cuesj-1122	53	14	tsh	tsh	NOUN
cuesj-1122	53	15	levels	level	NOUN
cuesj-1122	53	16	.	.	PUNCT
cuesj-1122	54	1	cobas	cobas	PROPN
cuesj-1122	54	2	c111	c111	PROPN
cuesj-1122	54	3	-	-	PUNCT
cuesj-1122	54	4	roche	roche	PROPN
cuesj-1122	54	5	(	(	PUNCT
cuesj-1122	54	6	germany	germany	PROPN
cuesj-1122	54	7	)	)	PUNCT
cuesj-1122	54	8	was	be	AUX
cuesj-1122	54	9	used	use	VERB
cuesj-1122	54	10	to	to	PART
cuesj-1122	54	11	estimate	estimate	VERB
cuesj-1122	54	12	the	the	DET
cuesj-1122	54	13	liver	liver	NOUN
cuesj-1122	54	14	parameters	parameter	NOUN
cuesj-1122	54	15	as	as	ADV
cuesj-1122	54	16	well	well	ADV
cuesj-1122	54	17	as	as	ADP
cuesj-1122	54	18	the	the	DET
cuesj-1122	54	19	remaining	remain	VERB
cuesj-1122	54	20	bone	bone	NOUN
cuesj-1122	54	21	markers	marker	NOUN
cuesj-1122	54	22	.	.	PUNCT
cuesj-1122	55	1	statistical	statistical	ADJ
cuesj-1122	55	2	analysis	analysis	NOUN
cuesj-1122	55	3	graph	graph	NOUN
cuesj-1122	55	4	pad	pad	NOUN
cuesj-1122	55	5	prism	prism	NOUN
cuesj-1122	55	6	9.0	9.0	NUM
cuesj-1122	55	7	was	be	AUX
cuesj-1122	55	8	used	use	VERB
cuesj-1122	55	9	for	for	ADP
cuesj-1122	55	10	analyzing	analyze	VERB
cuesj-1122	55	11	the	the	DET
cuesj-1122	55	12	data	datum	NOUN
cuesj-1122	55	13	.	.	PUNCT
cuesj-1122	56	1	the	the	DET
cuesj-1122	56	2	standard	standard	ADJ
cuesj-1122	56	3	error	error	NOUN
cuesj-1122	56	4	of	of	ADP
cuesj-1122	56	5	the	the	DET
cuesj-1122	56	6	mean	mean	NOUN
cuesj-1122	56	7	(	(	PUNCT
cuesj-1122	56	8	se	se	X
cuesj-1122	56	9	)	)	PUNCT
cuesj-1122	56	10	and	and	CCONJ
cuesj-1122	56	11	mean	mean	VERB
cuesj-1122	56	12	for	for	ADP
cuesj-1122	56	13	nonparametric	nonparametric	NOUN
cuesj-1122	56	14	variables	variable	NOUN
cuesj-1122	56	15	were	be	AUX
cuesj-1122	56	16	accurately	accurately	ADV
cuesj-1122	56	17	stated	state	VERB
cuesj-1122	56	18	.	.	PUNCT
cuesj-1122	57	1	the	the	PRON
cuesj-1122	57	2	one	one	NUM
cuesj-1122	57	3	-	-	PUNCT
cuesj-1122	57	4	way	way	NOUN
cuesj-1122	57	5	anova	anova	X
cuesj-1122	57	6	(	(	PUNCT
cuesj-1122	57	7	kruskal	kruskal	PROPN
cuesj-1122	57	8	–	–	PUNCT
cuesj-1122	57	9	wallis	wallis	PROPN
cuesj-1122	57	10	test	test	NOUN
cuesj-1122	57	11	)	)	PUNCT
cuesj-1122	57	12	was	be	AUX
cuesj-1122	57	13	utilized	utilize	VERB
cuesj-1122	57	14	to	to	PART
cuesj-1122	57	15	assess	assess	VERB
cuesj-1122	57	16	betweengroup	betweengroup	NOUN
cuesj-1122	57	17	comparisons	comparison	NOUN
cuesj-1122	57	18	for	for	ADP
cuesj-1122	57	19	categorical	categorical	ADJ
cuesj-1122	57	20	variables	variable	NOUN
cuesj-1122	57	21	using	use	VERB
cuesj-1122	57	22	the	the	DET
cuesj-1122	57	23	liver	liver	NOUN
cuesj-1122	57	24	variables	variable	NOUN
cuesj-1122	57	25	and	and	CCONJ
cuesj-1122	57	26	bone	bone	NOUN
cuesj-1122	57	27	markers	marker	NOUN
cuesj-1122	57	28	data	datum	NOUN
cuesj-1122	57	29	provided	provide	VERB
cuesj-1122	57	30	in	in	ADP
cuesj-1122	57	31	this	this	DET
cuesj-1122	57	32	study	study	NOUN
cuesj-1122	57	33	.	.	PUNCT
cuesj-1122	58	1	the	the	DET
cuesj-1122	58	2	study	study	NOUN
cuesj-1122	58	3	’s	’s	PART
cuesj-1122	58	4	predictive	predictive	ADJ
cuesj-1122	58	5	value	value	NOUN
cuesj-1122	58	6	determined	determine	VERB
cuesj-1122	58	7	severity	severity	NOUN
cuesj-1122	58	8	through	through	ADP
cuesj-1122	58	9	receiver	receiver	NOUN
cuesj-1122	58	10	operating	operate	VERB
cuesj-1122	58	11	characteristic	characteristic	NOUN
cuesj-1122	58	12	(	(	PUNCT
cuesj-1122	58	13	roc	roc	PROPN
cuesj-1122	58	14	)	)	PUNCT
cuesj-1122	58	15	curve	curve	NOUN
cuesj-1122	58	16	in	in	ADP
cuesj-1122	58	17	which	which	DET
cuesj-1122	58	18	area	area	NOUN
cuesj-1122	58	19	under	under	ADP
cuesj-1122	58	20	the	the	DET
cuesj-1122	58	21	curve	curve	NOUN
cuesj-1122	58	22	(	(	PUNCT
cuesj-1122	58	23	auc	auc	NOUN
cuesj-1122	58	24	)	)	PUNCT
cuesj-1122	58	25	,	,	PUNCT
cuesj-1122	58	26	cutoff	cutoff	NOUN
cuesj-1122	58	27	value	value	NOUN
cuesj-1122	58	28	,	,	PUNCT
cuesj-1122	58	29	specificity	specificity	NOUN
cuesj-1122	58	30	,	,	PUNCT
cuesj-1122	58	31	and	and	CCONJ
cuesj-1122	58	32	sensitivity	sensitivity	NOUN
cuesj-1122	58	33	were	be	AUX
cuesj-1122	58	34	utilized	utilize	VERB
cuesj-1122	58	35	to	to	PART
cuesj-1122	58	36	show	show	VERB
cuesj-1122	58	37	the	the	DET
cuesj-1122	58	38	results	result	NOUN
cuesj-1122	58	39	.	.	PUNCT
cuesj-1122	59	1	to	to	PART
cuesj-1122	59	2	evaluate	evaluate	VERB
cuesj-1122	59	3	statistical	statistical	ADJ
cuesj-1122	59	4	significance	significance	NOUN
cuesj-1122	59	5	,	,	PUNCT
cuesj-1122	59	6	a	a	PRON
cuesj-1122	59	7	p	p	NOUN
cuesj-1122	59	8	=	=	NOUN
cuesj-1122	59	9	0.05	0.05	NUM
cuesj-1122	59	10	utilized	utilize	VERB
cuesj-1122	59	11	as	as	ADP
cuesj-1122	59	12	significant	significant	ADJ
cuesj-1122	59	13	.	.	PUNCT
cuesj-1122	60	1	non	non	ADJ
cuesj-1122	60	2	-	-	ADJ
cuesj-1122	60	3	significant	significant	ADJ
cuesj-1122	60	4	group	group	NOUN
cuesj-1122	60	5	differences	difference	NOUN
cuesj-1122	60	6	are	be	AUX
cuesj-1122	60	7	shown	show	VERB
cuesj-1122	60	8	by	by	ADP
cuesj-1122	60	9	the	the	DET
cuesj-1122	60	10	sign	sign	NOUN
cuesj-1122	60	11	of	of	ADP
cuesj-1122	60	12	(	(	PUNCT
cuesj-1122	60	13	ns	ns	NUM
cuesj-1122	60	14	)	)	PUNCT
cuesj-1122	60	15	,	,	PUNCT
cuesj-1122	60	16	whereas	whereas	SCONJ
cuesj-1122	60	17	highly	highly	ADV
cuesj-1122	60	18	significant	significant	ADJ
cuesj-1122	60	19	group	group	NOUN
cuesj-1122	60	20	differences	difference	NOUN
cuesj-1122	60	21	between	between	ADP
cuesj-1122	60	22	patients	patient	NOUN
cuesj-1122	60	23	and	and	CCONJ
cuesj-1122	60	24	healthy	healthy	ADJ
cuesj-1122	60	25	control	control	NOUN
cuesj-1122	60	26	groups	group	NOUN
cuesj-1122	60	27	are	be	AUX
cuesj-1122	60	28	indicated	indicate	VERB
cuesj-1122	60	29	by	by	ADP
cuesj-1122	60	30	the	the	DET
cuesj-1122	60	31	sign	sign	NOUN
cuesj-1122	60	32	of	of	ADP
cuesj-1122	60	33	(	(	PUNCT
cuesj-1122	60	34	*	*	NOUN
cuesj-1122	60	35	)	)	PUNCT
cuesj-1122	60	36	.	.	PUNCT
cuesj-1122	61	1	results	result	VERB
cuesj-1122	61	2	statistical	statistical	ADJ
cuesj-1122	61	3	analysis	analysis	NOUN
cuesj-1122	61	4	of	of	ADP
cuesj-1122	61	5	the	the	DET
cuesj-1122	61	6	current	current	ADJ
cuesj-1122	61	7	study	study	NOUN
cuesj-1122	61	8	summarized	summarize	VERB
cuesj-1122	61	9	in	in	ADP
cuesj-1122	61	10	[	[	X
cuesj-1122	61	11	table	table	NOUN
cuesj-1122	61	12	1	1	NUM
cuesj-1122	61	13	and	and	CCONJ
cuesj-1122	61	14	figures	figure	VERB
cuesj-1122	61	15	1	1	NUM
cuesj-1122	61	16	-	-	SYM
cuesj-1122	61	17	5	5	NUM
cuesj-1122	61	18	]	]	PUNCT
cuesj-1122	61	19	.	.	PUNCT
cuesj-1122	62	1	the	the	DET
cuesj-1122	62	2	values	value	NOUN
cuesj-1122	62	3	of	of	ADP
cuesj-1122	62	4	liver	liver	NOUN
cuesj-1122	62	5	function	function	NOUN
cuesj-1122	62	6	tests	test	NOUN
cuesj-1122	62	7	such	such	ADJ
cuesj-1122	62	8	as	as	ADP
cuesj-1122	62	9	(	(	PUNCT
cuesj-1122	62	10	alt	alt	ADJ
cuesj-1122	62	11	,	,	PUNCT
cuesj-1122	62	12	ast	ast	PROPN
cuesj-1122	62	13	,	,	PUNCT
cuesj-1122	62	14	alp	alp	PROPN
cuesj-1122	62	15	,	,	PUNCT
cuesj-1122	62	16	and	and	CCONJ
cuesj-1122	62	17	ldh	ldh	NOUN
cuesj-1122	62	18	)	)	PUNCT
cuesj-1122	62	19	were	be	AUX
cuesj-1122	62	20	significantly	significantly	ADV
cuesj-1122	62	21	increased	increase	VERB
cuesj-1122	62	22	in	in	ADP
cuesj-1122	62	23	unvaccinated	unvaccinate	VERB
cuesj-1122	62	24	covid-19	covid-19	PROPN
cuesj-1122	62	25	patients	patient	NOUN
cuesj-1122	62	26	when	when	SCONJ
cuesj-1122	62	27	compared	compare	VERB
cuesj-1122	62	28	with	with	ADP
cuesj-1122	62	29	vaccinated	vaccinated	ADJ
cuesj-1122	62	30	patients	patient	NOUN
cuesj-1122	62	31	and	and	CCONJ
cuesj-1122	62	32	the	the	DET
cuesj-1122	62	33	control	control	NOUN
cuesj-1122	62	34	healthy	healthy	ADJ
cuesj-1122	62	35	group	group	NOUN
cuesj-1122	62	36	.	.	PUNCT
cuesj-1122	63	1	the	the	DET
cuesj-1122	63	2	mean	mean	ADJ
cuesj-1122	63	3	±	±	PROPN
cuesj-1122	63	4	sd	sd	ADP
cuesj-1122	63	5	values	value	NOUN
cuesj-1122	63	6	of	of	ADP
cuesj-1122	63	7	alt	alt	ADJ
cuesj-1122	63	8	were	be	AUX
cuesj-1122	63	9	(	(	PUNCT
cuesj-1122	63	10	83.73	83.73	NUM
cuesj-1122	63	11	±	±	NUM
cuesj-1122	63	12	127.8	127.8	NUM
cuesj-1122	63	13	)	)	PUNCT
cuesj-1122	63	14	in	in	ADP
cuesj-1122	63	15	unvaccinated	unvaccinate	VERB
cuesj-1122	63	16	individuals	individual	NOUN
cuesj-1122	63	17	,	,	PUNCT
cuesj-1122	63	18	(	(	PUNCT
cuesj-1122	63	19	29.06	29.06	NUM
cuesj-1122	63	20	±	±	NUM
cuesj-1122	63	21	17.91	17.91	NUM
cuesj-1122	63	22	)	)	PUNCT
cuesj-1122	63	23	in	in	ADP
cuesj-1122	63	24	vaccinated	vaccinated	ADJ
cuesj-1122	63	25	patients	patient	NOUN
cuesj-1122	63	26	,	,	PUNCT
cuesj-1122	63	27	and	and	CCONJ
cuesj-1122	63	28	(	(	PUNCT
cuesj-1122	63	29	20.45	20.45	NUM
cuesj-1122	63	30	±	±	NUM
cuesj-1122	63	31	9.05	9.05	NUM
cuesj-1122	63	32	)	)	PUNCT
cuesj-1122	63	33	in	in	ADP
cuesj-1122	63	34	the	the	DET
cuesj-1122	63	35	control	control	NOUN
cuesj-1122	63	36	group	group	NOUN
cuesj-1122	63	37	.	.	PUNCT
cuesj-1122	64	1	roc	roc	PROPN
cuesj-1122	64	2	evaluation	evaluation	NOUN
cuesj-1122	64	3	identified	identify	VERB
cuesj-1122	64	4	that	that	SCONJ
cuesj-1122	64	5	the	the	DET
cuesj-1122	64	6	best	good	ADJ
cuesj-1122	64	7	cutoff	cutoff	NOUN
cuesj-1122	64	8	value	value	NOUN
cuesj-1122	64	9	of	of	ADP
cuesj-1122	64	10	alt	alt	NOUN
cuesj-1122	64	11	for	for	ADP
cuesj-1122	64	12	determining	determine	VERB
cuesj-1122	64	13	severity	severity	NOUN
cuesj-1122	64	14	in	in	ADP
cuesj-1122	64	15	unvaccinated	unvaccinated	ADJ
cuesj-1122	64	16	covid-19	covid-19	PROPN
cuesj-1122	64	17	patients	patient	NOUN
cuesj-1122	64	18	was	be	AUX
cuesj-1122	64	19	>	>	X
cuesj-1122	64	20	29.70	29.70	NUM
cuesj-1122	64	21	u	u	NOUN
cuesj-1122	64	22	/	/	SYM
cuesj-1122	64	23	l	l	NOUN
cuesj-1122	64	24	(	(	PUNCT
cuesj-1122	64	25	sensitivity	sensitivity	NOUN
cuesj-1122	64	26	=	=	SYM
cuesj-1122	64	27	77.78	77.78	NUM
cuesj-1122	64	28	%	%	NOUN
cuesj-1122	64	29	;	;	PUNCT
cuesj-1122	64	30	specificity	specificity	NOUN
cuesj-1122	64	31	=	=	SYM
cuesj-1122	64	32	91.67	91.67	NUM
cuesj-1122	64	33	%	%	NOUN
cuesj-1122	64	34	;	;	PUNCT
cuesj-1122	64	35	auc=	auc=	PROPN
cuesj-1122	64	36	0.879	0.879	NUM
cuesj-1122	64	37	)	)	PUNCT
cuesj-1122	64	38	with	with	ADP
cuesj-1122	64	39	p	p	X
cuesj-1122	64	40	<	<	X
cuesj-1122	64	41	0.0001	0.0001	NUM
cuesj-1122	64	42	,	,	PUNCT
cuesj-1122	64	43	while	while	SCONJ
cuesj-1122	64	44	in	in	ADP
cuesj-1122	64	45	vaccinated	vaccinated	ADJ
cuesj-1122	64	46	patients	patient	NOUN
cuesj-1122	64	47	was	be	AUX
cuesj-1122	64	48	20.85	20.85	NUM
cuesj-1122	64	49	u	u	NOUN
cuesj-1122	64	50	/	/	SYM
cuesj-1122	64	51	l	l	NOUN
cuesj-1122	64	52	(	(	PUNCT
cuesj-1122	64	53	sensitivity	sensitivity	NOUN
cuesj-1122	64	54	=	=	SYM
cuesj-1122	64	55	78.89	78.89	NUM
cuesj-1122	64	56	%	%	NOUN
cuesj-1122	64	57	;	;	PUNCT
cuesj-1122	64	58	specificity	specificity	NOUN
cuesj-1122	64	59	=	=	SYM
cuesj-1122	64	60	56.25	56.25	NUM
cuesj-1122	64	61	%	%	NOUN
cuesj-1122	64	62	;	;	PUNCT
cuesj-1122	64	63	auc	auc	NOUN
cuesj-1122	64	64	=	=	NUM
cuesj-1122	64	65	0.697	0.697	NUM
cuesj-1122	64	66	)	)	PUNCT
cuesj-1122	64	67	with	with	ADP
cuesj-1122	64	68	p	p	NOUN
cuesj-1122	64	69	value	value	NOUN
cuesj-1122	64	70	=	=	PROPN
cuesj-1122	64	71	0.0027	0.0027	NUM
cuesj-1122	64	72	.	.	PUNCT
cuesj-1122	65	1	the	the	DET
cuesj-1122	65	2	ast	ast	NOUN
cuesj-1122	65	3	values	value	NOUN
cuesj-1122	65	4	were	be	AUX
cuesj-1122	65	5	(	(	PUNCT
cuesj-1122	65	6	56.15	56.15	NUM
cuesj-1122	65	7	±	±	NUM
cuesj-1122	65	8	65.86	65.86	NUM
cuesj-1122	65	9	in	in	ADP
cuesj-1122	65	10	unvaccinated	unvaccinated	ADJ
cuesj-1122	65	11	patients	patient	NOUN
cuesj-1122	65	12	,	,	PUNCT
cuesj-1122	65	13	28.57	28.57	NUM
cuesj-1122	65	14	±	±	NUM
cuesj-1122	65	15	23.47	23.47	NUM
cuesj-1122	65	16	in	in	ADP
cuesj-1122	65	17	vaccinated	vaccinated	ADJ
cuesj-1122	65	18	and	and	CCONJ
cuesj-1122	65	19	21.63	21.63	NUM
cuesj-1122	65	20	±	±	NUM
cuesj-1122	65	21	12.08	12.08	NUM
cuesj-1122	65	22	in	in	ADP
cuesj-1122	65	23	control	control	NOUN
cuesj-1122	65	24	group	group	NOUN
cuesj-1122	65	25	)	)	PUNCT
cuesj-1122	65	26	.	.	PUNCT
cuesj-1122	66	1	by	by	ADP
cuesj-1122	66	2	using	use	VERB
cuesj-1122	66	3	the	the	DET
cuesj-1122	66	4	roc	roc	PROPN
cuesj-1122	66	5	evaluation	evaluation	NOUN
cuesj-1122	66	6	recognized	recognize	VERB
cuesj-1122	66	7	that	that	SCONJ
cuesj-1122	66	8	the	the	DET
cuesj-1122	66	9	best	good	ADJ
cuesj-1122	66	10	cutoff	cutoff	NOUN
cuesj-1122	66	11	value	value	NOUN
cuesj-1122	66	12	of	of	ADP
cuesj-1122	66	13	ast	ast	NOUN
cuesj-1122	66	14	for	for	ADP
cuesj-1122	66	15	determining	determine	VERB
cuesj-1122	66	16	severity	severity	NOUN
cuesj-1122	66	17	in	in	ADP
cuesj-1122	66	18	unvaccinated	unvaccinated	ADJ
cuesj-1122	66	19	cov-2	cov-2	PART
cuesj-1122	66	20	patients	patient	NOUN
cuesj-1122	66	21	was	be	AUX
cuesj-1122	66	22	>	>	X
cuesj-1122	66	23	21.65	21.65	NUM
cuesj-1122	66	24	u	u	NOUN
cuesj-1122	66	25	/	/	SYM
cuesj-1122	66	26	l	l	PROPN
cuesj-1122	66	27	(	(	PUNCT
cuesj-1122	66	28	sensitivity=	sensitivity=	NUM
cuesj-1122	66	29	77.27	77.27	NUM
cuesj-1122	66	30	%	%	NOUN
cuesj-1122	66	31	;	;	PUNCT
cuesj-1122	66	32	specificity	specificity	NOUN
cuesj-1122	66	33	=	=	SYM
cuesj-1122	66	34	62.50	62.50	NUM
cuesj-1122	66	35	%	%	NOUN
cuesj-1122	66	36	;	;	PUNCT
cuesj-1122	66	37	auc=	auc=	VERB
cuesj-1122	66	38	0.741	0.741	NUM
cuesj-1122	66	39	)	)	PUNCT
cuesj-1122	66	40	with	with	ADP
cuesj-1122	66	41	p	p	X
cuesj-1122	66	42	<	<	X
cuesj-1122	66	43	0.0001	0.0001	NUM
cuesj-1122	66	44	,	,	PUNCT
cuesj-1122	66	45	in	in	ADP
cuesj-1122	66	46	vaccinated	vaccinated	ADJ
cuesj-1122	66	47	patients	patient	NOUN
cuesj-1122	66	48	was	be	AUX
cuesj-1122	66	49	22.65	22.65	NUM
cuesj-1122	66	50	u	u	NOUN
cuesj-1122	66	51	/	/	SYM
cuesj-1122	66	52	l	l	NOUN
cuesj-1122	66	53	(	(	PUNCT
cuesj-1122	66	54	sensitivity	sensitivity	NOUN
cuesj-1122	66	55	,	,	PUNCT
cuesj-1122	66	56	specificity	specificity	NOUN
cuesj-1122	66	57	and	and	CCONJ
cuesj-1122	66	58	auc	auc	NOUN
cuesj-1122	66	59	were	be	AUX
cuesj-1122	66	60	54.55	54.55	NUM
cuesj-1122	66	61	%	%	NOUN
cuesj-1122	66	62	,	,	PUNCT
cuesj-1122	66	63	64.58	64.58	NUM
cuesj-1122	66	64	%	%	NOUN
cuesj-1122	66	65	and	and	CCONJ
cuesj-1122	66	66	0.597	0.597	NUM
cuesj-1122	66	67	,	,	PUNCT
cuesj-1122	66	68	respectively	respectively	ADV
cuesj-1122	66	69	)	)	PUNCT
cuesj-1122	66	70	with	with	ADP
cuesj-1122	66	71	p	p	NOUN
cuesj-1122	66	72	=	=	NOUN
cuesj-1122	66	73	0.137	0.137	NUM
cuesj-1122	66	74	.	.	PUNCT
cuesj-1122	67	1	in	in	ADP
cuesj-1122	67	2	addition	addition	NOUN
cuesj-1122	67	3	,	,	PUNCT
cuesj-1122	67	4	the	the	DET
cuesj-1122	67	5	mean	mean	ADJ
cuesj-1122	67	6	concentration	concentration	NOUN
cuesj-1122	67	7	of	of	ADP
cuesj-1122	67	8	alp	alp	NOUN
cuesj-1122	67	9	in	in	ADP
cuesj-1122	67	10	unvaccinated	unvaccinate	VERB
cuesj-1122	67	11	,	,	PUNCT
cuesj-1122	67	12	vaccinated	vaccinated	ADJ
cuesj-1122	67	13	,	,	PUNCT
cuesj-1122	67	14	and	and	CCONJ
cuesj-1122	67	15	control	control	NOUN
cuesj-1122	67	16	were	be	AUX
cuesj-1122	67	17	(	(	PUNCT
cuesj-1122	67	18	190.9	190.9	NUM
cuesj-1122	67	19	±	±	NUM
cuesj-1122	67	20	138.0	138.0	NUM
cuesj-1122	67	21	,	,	PUNCT
cuesj-1122	67	22	104.9	104.9	NUM
cuesj-1122	67	23	±	±	NUM
cuesj-1122	67	24	87.52	87.52	NUM
cuesj-1122	67	25	,	,	PUNCT
cuesj-1122	67	26	and	and	CCONJ
cuesj-1122	67	27	64.99	64.99	NUM
cuesj-1122	67	28	±	±	NUM
cuesj-1122	67	29	20.49	20.49	NUM
cuesj-1122	67	30	)	)	PUNCT
cuesj-1122	67	31	,	,	PUNCT
cuesj-1122	67	32	respectively	respectively	ADV
cuesj-1122	67	33	.	.	PUNCT
cuesj-1122	68	1	based	base	VERB
cuesj-1122	68	2	on	on	ADP
cuesj-1122	68	3	roc	roc	PROPN
cuesj-1122	68	4	curve	curve	NOUN
cuesj-1122	68	5	studies	study	NOUN
cuesj-1122	68	6	,	,	PUNCT
cuesj-1122	68	7	in	in	ADP
cuesj-1122	68	8	the	the	DET
cuesj-1122	68	9	vaccinated	vaccinated	ADJ
cuesj-1122	68	10	group	group	NOUN
cuesj-1122	68	11	,	,	PUNCT
cuesj-1122	68	12	the	the	DET
cuesj-1122	68	13	auc	auc	NOUN
cuesj-1122	68	14	was	be	AUX
cuesj-1122	68	15	0.635	0.635	NUM
cuesj-1122	68	16	and	and	CCONJ
cuesj-1122	68	17	the	the	DET
cuesj-1122	68	18	cutoff	cutoff	NOUN
cuesj-1122	68	19	value	value	NOUN
cuesj-1122	68	20	serum	serum	NOUN
cuesj-1122	68	21	of	of	ADP
cuesj-1122	68	22	alp	alp	PROPN
cuesj-1122	68	23	level	level	NOUN
cuesj-1122	68	24	was	be	AUX
cuesj-1122	68	25	>	>	X
cuesj-1122	68	26	65.43	65.43	NUM
cuesj-1122	68	27	u	u	NOUN
cuesj-1122	68	28	/	/	SYM
cuesj-1122	68	29	l	l	NOUN
cuesj-1122	68	30	with	with	ADP
cuesj-1122	68	31	a	a	DET
cuesj-1122	68	32	sensitivity	sensitivity	NOUN
cuesj-1122	68	33	of	of	ADP
cuesj-1122	68	34	66.67	66.67	NUM
cuesj-1122	68	35	%	%	NOUN
cuesj-1122	68	36	and	and	CCONJ
cuesj-1122	68	37	specificity	specificity	NOUN
cuesj-1122	68	38	of	of	ADP
cuesj-1122	68	39	52.08	52.08	NUM
cuesj-1122	68	40	%	%	NOUN
cuesj-1122	68	41	.	.	PUNCT
cuesj-1122	69	1	while	while	SCONJ
cuesj-1122	69	2	the	the	DET
cuesj-1122	69	3	non	non	ADJ
cuesj-1122	69	4	-	-	ADJ
cuesj-1122	69	5	vaccinated	vaccinated	ADJ
cuesj-1122	69	6	group	group	NOUN
cuesj-1122	69	7	occupied	occupy	VERB
cuesj-1122	69	8	a	a	DET
cuesj-1122	69	9	significant	significant	ADJ
cuesj-1122	69	10	auc	auc	NOUN
cuesj-1122	69	11	,	,	PUNCT
cuesj-1122	69	12	which	which	PRON
cuesj-1122	69	13	was	be	AUX
cuesj-1122	69	14	0.850	0.850	NUM
cuesj-1122	69	15	(	(	PUNCT
cuesj-1122	69	16	p	p	X
cuesj-1122	69	17	<	<	X
cuesj-1122	69	18	0.0001	0.0001	NUM
cuesj-1122	69	19	)	)	PUNCT
cuesj-1122	69	20	;	;	PUNCT
cuesj-1122	69	21	the	the	DET
cuesj-1122	69	22	cutoff	cutoff	NOUN
cuesj-1122	69	23	value	value	NOUN
cuesj-1122	69	24	was	be	AUX
cuesj-1122	69	25	>	>	X
cuesj-1122	69	26	85.65	85.65	NUM
cuesj-1122	69	27	u	u	NOUN
cuesj-1122	69	28	/	/	SYM
cuesj-1122	69	29	l	l	NOUN
cuesj-1122	69	30	of	of	ADP
cuesj-1122	69	31	serum	serum	NOUN
cuesj-1122	69	32	tsh	tsh	NOUN
cuesj-1122	69	33	level	level	NOUN
cuesj-1122	69	34	,	,	PUNCT
cuesj-1122	69	35	table	table	NOUN
cuesj-1122	69	36	1	1	NUM
cuesj-1122	69	37	:	:	PUNCT
cuesj-1122	69	38	comparison	comparison	NOUN
cuesj-1122	69	39	of	of	ADP
cuesj-1122	69	40	liver	liver	NOUN
cuesj-1122	69	41	parameters	parameter	NOUN
cuesj-1122	69	42	between	between	ADP
cuesj-1122	69	43	control	control	NOUN
cuesj-1122	69	44	and	and	CCONJ
cuesj-1122	69	45	patient	patient	ADJ
cuesj-1122	69	46	groups	group	NOUN
cuesj-1122	69	47	liver	liver	NOUN
cuesj-1122	69	48	markers	marker	NOUN
cuesj-1122	69	49	control	control	NOUN
cuesj-1122	69	50	patients	patient	NOUN
cuesj-1122	69	51	p	p	NOUN
cuesj-1122	69	52	value	value	NOUN
cuesj-1122	69	53	vaccinated	vaccinate	VERB
cuesj-1122	69	54	non	non	ADJ
cuesj-1122	69	55	-	-	ADJ
cuesj-1122	69	56	vaccinated	vaccinated	ADJ
cuesj-1122	69	57	alt	alt	NOUN
cuesj-1122	69	58	(	(	PUNCT
cuesj-1122	69	59	iu	iu	PROPN
cuesj-1122	69	60	/	/	SYM
cuesj-1122	69	61	l	l	NOUN
cuesj-1122	69	62	)	)	PUNCT
cuesj-1122	69	63	20.45±9.05	20.45±9.05	NOUN
cuesj-1122	69	64	29.06±17.91	29.06±17.91	NOUN
cuesj-1122	69	65	83.73±127.8	83.73±127.8	NUM
cuesj-1122	69	66	0.0001	0.0001	NUM
cuesj-1122	69	67	ast	ast	NOUN
cuesj-1122	69	68	(	(	PUNCT
cuesj-1122	69	69	iu	iu	PROPN
cuesj-1122	69	70	/	/	SYM
cuesj-1122	69	71	l	l	NOUN
cuesj-1122	69	72	)	)	PUNCT
cuesj-1122	69	73	21.63±12.08	21.63±12.08	NUM
cuesj-1122	69	74	28.57±23.47	28.57±23.47	NUM
cuesj-1122	69	75	56.15±65.86	56.15±65.86	NUM
cuesj-1122	69	76	0.0001	0.0001	NUM
cuesj-1122	69	77	alp	alp	NOUN
cuesj-1122	69	78	(	(	PUNCT
cuesj-1122	69	79	iu	iu	PROPN
cuesj-1122	69	80	/	/	SYM
cuesj-1122	69	81	l	l	NOUN
cuesj-1122	69	82	)	)	PUNCT
cuesj-1122	69	83	64.99±20.49	64.99±20.49	NUM
cuesj-1122	69	84	104.9±87.52	104.9±87.52	NUM
cuesj-1122	69	85	190.9±138.0	190.9±138.0	NUM
cuesj-1122	69	86	0.0001	0.0001	NUM
cuesj-1122	69	87	tsb	tsb	ADJ
cuesj-1122	69	88	(	(	PUNCT
cuesj-1122	69	89	mg	mg	PROPN
cuesj-1122	69	90	/	/	SYM
cuesj-1122	69	91	dl	dl	NOUN
cuesj-1122	69	92	)	)	PUNCT
cuesj-1122	69	93	0.72±0.33	0.72±0.33	NOUN
cuesj-1122	69	94	0.58±0.32	0.58±0.32	ADJ
cuesj-1122	69	95	0.78±0.43	0.78±0.43	ADJ
cuesj-1122	69	96	0.0873	0.0873	NUM
cuesj-1122	69	97	ldh	ldh	NOUN
cuesj-1122	69	98	(	(	PUNCT
cuesj-1122	69	99	iu	iu	PROPN
cuesj-1122	69	100	/	/	SYM
cuesj-1122	69	101	l	l	NOUN
cuesj-1122	69	102	)	)	PUNCT
cuesj-1122	69	103	271.1±103.9	271.1±103.9	NOUN
cuesj-1122	69	104	290.8±82.19	290.8±82.19	NUM
cuesj-1122	69	105	621.6±277.6	621.6±277.6	NOUN
cuesj-1122	69	106	0.0001	0.0001	NUM
cuesj-1122	69	107	albumin	albumin	NOUN
cuesj-1122	69	108	(	(	PUNCT
cuesj-1122	69	109	mg	mg	PROPN
cuesj-1122	69	110	/	/	SYM
cuesj-1122	69	111	dl	dl	PROPN
cuesj-1122	69	112	)	)	PUNCT
cuesj-1122	69	113	4.80±0.29	4.80±0.29	NOUN
cuesj-1122	69	114	4.65±0.57	4.65±0.57	NOUN
cuesj-1122	69	115	3.79±0.86	3.79±0.86	NUM
cuesj-1122	69	116	0.0001	0.0001	NUM
cuesj-1122	69	117	figure	figure	NOUN
cuesj-1122	69	118	1	1	NUM
cuesj-1122	69	119	:	:	PUNCT
cuesj-1122	69	120	(	(	PUNCT
cuesj-1122	69	121	a	a	X
cuesj-1122	69	122	)	)	PUNCT
cuesj-1122	69	123	comparison	comparison	NOUN
cuesj-1122	69	124	of	of	ADP
cuesj-1122	69	125	alt	alt	ADJ
cuesj-1122	69	126	concentration	concentration	NOUN
cuesj-1122	69	127	in	in	ADP
cuesj-1122	69	128	control	control	NOUN
cuesj-1122	69	129	and	and	CCONJ
cuesj-1122	69	130	patient	patient	ADJ
cuesj-1122	69	131	groups	group	NOUN
cuesj-1122	69	132	.	.	PUNCT
cuesj-1122	70	1	(	(	PUNCT
cuesj-1122	70	2	b	b	X
cuesj-1122	70	3	)	)	PUNCT
cuesj-1122	70	4	the	the	DET
cuesj-1122	70	5	area	area	NOUN
cuesj-1122	70	6	under	under	ADP
cuesj-1122	70	7	the	the	DET
cuesj-1122	70	8	curve	curve	NOUN
cuesj-1122	70	9	value	value	NOUN
cuesj-1122	70	10	shows	show	NOUN
cuesj-1122	70	11	alt	alt	VERB
cuesj-1122	70	12	as	as	ADP
cuesj-1122	70	13	a	a	DET
cuesj-1122	70	14	biomarker	biomarker	NOUN
cuesj-1122	70	15	of	of	ADP
cuesj-1122	70	16	the	the	DET
cuesj-1122	70	17	patients	patient	NOUN
cuesj-1122	70	18	’	'	PUNCT
cuesj-1122	70	19	group	group	NOUN
cuesj-1122	70	20	ba	ba	PROPN
cuesj-1122	70	21	ahmed	ahmed	PROPN
cuesj-1122	70	22	,	,	PUNCT
cuesj-1122	70	23	et	et	PROPN
cuesj-1122	70	24	al	al	PROPN
cuesj-1122	70	25	.	.	PUNCT
cuesj-1122	70	26	:	:	PUNCT
cuesj-1122	71	1	comparison	comparison	NOUN
cuesj-1122	71	2	of	of	ADP
cuesj-1122	71	3	biochemical	biochemical	ADJ
cuesj-1122	71	4	parameters	parameter	NOUN
cuesj-1122	71	5	in	in	ADP
cuesj-1122	71	6	vaccinated	vaccinated	ADJ
cuesj-1122	71	7	49	49	NUM
cuesj-1122	71	8	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1122	71	9	cuesj	cuesj	NOUN
cuesj-1122	71	10	2024	2024	NUM
cuesj-1122	71	11	,	,	PUNCT
cuesj-1122	71	12	8	8	NUM
cuesj-1122	71	13	(	(	PUNCT
cuesj-1122	71	14	1	1	NUM
cuesj-1122	71	15	):	):	PUNCT
cuesj-1122	71	16	46	46	NUM
cuesj-1122	71	17	-	-	SYM
cuesj-1122	71	18	57	57	NUM
cuesj-1122	71	19	figure	figure	NOUN
cuesj-1122	71	20	2	2	NUM
cuesj-1122	71	21	:	:	PUNCT
cuesj-1122	71	22	(	(	PUNCT
cuesj-1122	71	23	a	a	X
cuesj-1122	71	24	)	)	PUNCT
cuesj-1122	71	25	comparison	comparison	NOUN
cuesj-1122	71	26	of	of	ADP
cuesj-1122	71	27	ast	ast	NOUN
cuesj-1122	71	28	concentration	concentration	NOUN
cuesj-1122	71	29	in	in	ADP
cuesj-1122	71	30	control	control	NOUN
cuesj-1122	71	31	and	and	CCONJ
cuesj-1122	71	32	patient	patient	ADJ
cuesj-1122	71	33	groups	group	NOUN
cuesj-1122	71	34	.	.	PUNCT
cuesj-1122	72	1	(	(	PUNCT
cuesj-1122	72	2	b	b	X
cuesj-1122	72	3	)	)	PUNCT
cuesj-1122	72	4	the	the	DET
cuesj-1122	72	5	area	area	NOUN
cuesj-1122	72	6	under	under	ADP
cuesj-1122	72	7	the	the	DET
cuesj-1122	72	8	curve	curve	NOUN
cuesj-1122	72	9	value	value	NOUN
cuesj-1122	72	10	shows	show	VERB
cuesj-1122	72	11	ast	ast	NOUN
cuesj-1122	72	12	as	as	ADP
cuesj-1122	72	13	a	a	DET
cuesj-1122	72	14	biomarker	biomarker	NOUN
cuesj-1122	72	15	of	of	ADP
cuesj-1122	72	16	the	the	DET
cuesj-1122	72	17	patients	patient	NOUN
cuesj-1122	72	18	’	'	PUNCT
cuesj-1122	72	19	group	group	NOUN
cuesj-1122	72	20	ba	ba	PROPN
cuesj-1122	72	21	figure	figure	NOUN
cuesj-1122	72	22	3	3	NUM
cuesj-1122	72	23	:	:	PUNCT
cuesj-1122	72	24	(	(	PUNCT
cuesj-1122	72	25	a	a	X
cuesj-1122	72	26	)	)	PUNCT
cuesj-1122	72	27	comparison	comparison	NOUN
cuesj-1122	72	28	of	of	ADP
cuesj-1122	72	29	alp	alp	PROPN
cuesj-1122	72	30	concentration	concentration	NOUN
cuesj-1122	72	31	in	in	ADP
cuesj-1122	72	32	control	control	NOUN
cuesj-1122	72	33	and	and	CCONJ
cuesj-1122	72	34	patient	patient	ADJ
cuesj-1122	72	35	groups	group	NOUN
cuesj-1122	72	36	.	.	PUNCT
cuesj-1122	73	1	(	(	PUNCT
cuesj-1122	73	2	b	b	X
cuesj-1122	73	3	)	)	PUNCT
cuesj-1122	73	4	the	the	DET
cuesj-1122	73	5	area	area	NOUN
cuesj-1122	73	6	under	under	ADP
cuesj-1122	73	7	the	the	DET
cuesj-1122	73	8	curve	curve	NOUN
cuesj-1122	73	9	value	value	NOUN
cuesj-1122	73	10	shows	show	VERB
cuesj-1122	73	11	alp	alp	PROPN
cuesj-1122	73	12	as	as	ADP
cuesj-1122	73	13	a	a	DET
cuesj-1122	73	14	biomarker	biomarker	NOUN
cuesj-1122	73	15	of	of	ADP
cuesj-1122	73	16	the	the	DET
cuesj-1122	73	17	patients	patient	NOUN
cuesj-1122	73	18	’	'	PUNCT
cuesj-1122	73	19	group	group	NOUN
cuesj-1122	73	20	a	a	DET
cuesj-1122	73	21	b	b	PROPN
cuesj-1122	73	22	figure	figure	NOUN
cuesj-1122	73	23	4	4	NUM
cuesj-1122	73	24	:	:	PUNCT
cuesj-1122	73	25	(	(	PUNCT
cuesj-1122	73	26	a	a	X
cuesj-1122	73	27	)	)	PUNCT
cuesj-1122	73	28	comparison	comparison	NOUN
cuesj-1122	73	29	of	of	ADP
cuesj-1122	73	30	tsb	tsb	ADJ
cuesj-1122	73	31	concentration	concentration	NOUN
cuesj-1122	73	32	in	in	ADP
cuesj-1122	73	33	control	control	NOUN
cuesj-1122	73	34	and	and	CCONJ
cuesj-1122	73	35	patient	patient	ADJ
cuesj-1122	73	36	groups	group	NOUN
cuesj-1122	73	37	.	.	PUNCT
cuesj-1122	74	1	(	(	PUNCT
cuesj-1122	74	2	b	b	X
cuesj-1122	74	3	)	)	PUNCT
cuesj-1122	74	4	the	the	DET
cuesj-1122	74	5	area	area	NOUN
cuesj-1122	74	6	under	under	ADP
cuesj-1122	74	7	the	the	DET
cuesj-1122	74	8	curve	curve	NOUN
cuesj-1122	74	9	value	value	NOUN
cuesj-1122	74	10	shows	shows	AUX
cuesj-1122	74	11	tsb	tsb	VERB
cuesj-1122	74	12	as	as	ADP
cuesj-1122	74	13	a	a	DET
cuesj-1122	74	14	biomarker	biomarker	NOUN
cuesj-1122	74	15	of	of	ADP
cuesj-1122	74	16	the	the	DET
cuesj-1122	74	17	patients	patient	NOUN
cuesj-1122	74	18	’	'	PUNCT
cuesj-1122	74	19	group	group	NOUN
cuesj-1122	74	20	ba	ba	PROPN
cuesj-1122	74	21	ahmed	ahmed	PROPN
cuesj-1122	74	22	,	,	PUNCT
cuesj-1122	74	23	et	et	PROPN
cuesj-1122	74	24	al	al	PROPN
cuesj-1122	74	25	.	.	PUNCT
cuesj-1122	74	26	:	:	PUNCT
cuesj-1122	75	1	comparison	comparison	NOUN
cuesj-1122	75	2	of	of	ADP
cuesj-1122	75	3	biochemical	biochemical	ADJ
cuesj-1122	75	4	parameters	parameter	NOUN
cuesj-1122	75	5	in	in	ADP
cuesj-1122	75	6	vaccinated	vaccinated	ADJ
cuesj-1122	75	7	50	50	NUM
cuesj-1122	75	8	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1122	75	9	cuesj	cuesj	NOUN
cuesj-1122	75	10	2024	2024	NUM
cuesj-1122	75	11	,	,	PUNCT
cuesj-1122	75	12	8	8	NUM
cuesj-1122	75	13	(	(	PUNCT
cuesj-1122	75	14	1	1	NUM
cuesj-1122	75	15	):	):	PUNCT
cuesj-1122	75	16	46	46	NUM
cuesj-1122	75	17	-	-	SYM
cuesj-1122	75	18	57	57	NUM
cuesj-1122	75	19	the	the	DET
cuesj-1122	75	20	sensitivity	sensitivity	NOUN
cuesj-1122	75	21	and	and	CCONJ
cuesj-1122	75	22	specificity	specificity	NOUN
cuesj-1122	75	23	were	be	AUX
cuesj-1122	75	24	76.60	76.60	NUM
cuesj-1122	75	25	%	%	NOUN
cuesj-1122	75	26	and	and	CCONJ
cuesj-1122	75	27	85.42	85.42	NUM
cuesj-1122	75	28	%	%	NOUN
cuesj-1122	75	29	,	,	PUNCT
cuesj-1122	75	30	respectively	respectively	ADV
cuesj-1122	75	31	[	[	X
cuesj-1122	75	32	table	table	NOUN
cuesj-1122	75	33	2	2	NUM
cuesj-1122	75	34	and	and	CCONJ
cuesj-1122	75	35	figure	figure	VERB
cuesj-1122	75	36	3b	3b	NUM
cuesj-1122	75	37	]	]	PUNCT
cuesj-1122	75	38	.	.	PUNCT
cuesj-1122	76	1	moreover	moreover	ADV
cuesj-1122	76	2	,	,	PUNCT
cuesj-1122	76	3	the	the	DET
cuesj-1122	76	4	mean	mean	NOUN
cuesj-1122	76	5	of	of	ADP
cuesj-1122	76	6	ldh	ldh	PROPN
cuesj-1122	76	7	value	value	NOUN
cuesj-1122	76	8	significantly	significantly	ADV
cuesj-1122	76	9	rose	rise	VERB
cuesj-1122	76	10	to	to	ADP
cuesj-1122	76	11	(	(	PUNCT
cuesj-1122	76	12	621.6	621.6	NUM
cuesj-1122	76	13	±	±	NUM
cuesj-1122	76	14	277.6	277.6	NUM
cuesj-1122	76	15	)	)	PUNCT
cuesj-1122	76	16	in	in	ADP
cuesj-1122	76	17	unvaccinated	unvaccinate	VERB
cuesj-1122	76	18	patients	patient	NOUN
cuesj-1122	76	19	and	and	CCONJ
cuesj-1122	76	20	(	(	PUNCT
cuesj-1122	76	21	290.8	290.8	NUM
cuesj-1122	76	22	±	±	NUM
cuesj-1122	76	23	82.19	82.19	NUM
cuesj-1122	76	24	)	)	PUNCT
cuesj-1122	76	25	in	in	ADP
cuesj-1122	76	26	vaccinated	vaccinated	ADJ
cuesj-1122	76	27	patients	patient	NOUN
cuesj-1122	76	28	as	as	SCONJ
cuesj-1122	76	29	compared	compare	VERB
cuesj-1122	76	30	to	to	ADP
cuesj-1122	76	31	the	the	DET
cuesj-1122	76	32	control	control	NOUN
cuesj-1122	76	33	group	group	NOUN
cuesj-1122	76	34	(	(	PUNCT
cuesj-1122	76	35	271.1	271.1	NUM
cuesj-1122	76	36	±	±	NUM
cuesj-1122	76	37	103.9	103.9	NUM
cuesj-1122	76	38	)	)	PUNCT
cuesj-1122	76	39	with	with	ADP
cuesj-1122	76	40	p	p	NOUN
cuesj-1122	76	41	value	value	NOUN
cuesj-1122	76	42	of	of	ADP
cuesj-1122	76	43	<	<	X
cuesj-1122	76	44	0.0001	0.0001	NUM
cuesj-1122	76	45	.	.	PUNCT
cuesj-1122	77	1	“	"	PUNCT
cuesj-1122	77	2	the	the	DET
cuesj-1122	77	3	cutoff	cutoff	NOUN
cuesj-1122	77	4	values	value	NOUN
cuesj-1122	77	5	of	of	ADP
cuesj-1122	77	6	ldh	ldh	NOUN
cuesj-1122	77	7	for	for	ADP
cuesj-1122	77	8	predicting	predict	VERB
cuesj-1122	77	9	severity	severity	NOUN
cuesj-1122	77	10	in	in	ADP
cuesj-1122	77	11	covid-19	covid-19	PROPN
cuesj-1122	77	12	patients	patient	NOUN
cuesj-1122	77	13	were	be	AUX
cuesj-1122	77	14	determined	determine	VERB
cuesj-1122	77	15	by	by	ADP
cuesj-1122	77	16	(	(	PUNCT
cuesj-1122	77	17	roc	roc	PROPN
cuesj-1122	77	18	)	)	PUNCT
cuesj-1122	77	19	curve	curve	NOUN
cuesj-1122	77	20	analysis	analysis	NOUN
cuesj-1122	77	21	for	for	ADP
cuesj-1122	77	22	unvaccinated	unvaccinate	VERB
cuesj-1122	77	23	337.0	337.0	NUM
cuesj-1122	77	24	u	u	NOUN
cuesj-1122	77	25	/	/	SYM
cuesj-1122	77	26	l	l	NOUN
cuesj-1122	77	27	(	(	PUNCT
cuesj-1122	77	28	sensitivity=	sensitivity=	NUM
cuesj-1122	77	29	83.33	83.33	NUM
cuesj-1122	77	30	%	%	NOUN
cuesj-1122	77	31	;	;	PUNCT
cuesj-1122	77	32	specificity=81.25	specificity=81.25	NOUN
cuesj-1122	77	33	%	%	NOUN
cuesj-1122	77	34	;	;	PUNCT
cuesj-1122	77	35	(	(	PUNCT
cuesj-1122	77	36	auc	auc	NOUN
cuesj-1122	77	37	)	)	PUNCT
cuesj-1122	77	38	=	=	SYM
cuesj-1122	77	39	0.898	0.898	NUM
cuesj-1122	77	40	)	)	PUNCT
cuesj-1122	77	41	,	,	PUNCT
cuesj-1122	77	42	vaccinated	vaccinate	VERB
cuesj-1122	77	43	278.0	278.0	NUM
cuesj-1122	77	44	u	u	NOUN
cuesj-1122	77	45	/	/	SYM
cuesj-1122	77	46	l	l	NOUN
cuesj-1122	77	47	(	(	PUNCT
cuesj-1122	77	48	sensitivity	sensitivity	NOUN
cuesj-1122	77	49	,	,	PUNCT
cuesj-1122	77	50	specificity	specificity	NOUN
cuesj-1122	77	51	,	,	PUNCT
cuesj-1122	77	52	and	and	CCONJ
cuesj-1122	77	53	auc	auc	NOUN
cuesj-1122	77	54	were	be	AUX
cuesj-1122	77	55	66.67	66.67	NUM
cuesj-1122	77	56	%	%	NOUN
cuesj-1122	77	57	,	,	PUNCT
cuesj-1122	77	58	68.75	68.75	NUM
cuesj-1122	77	59	%	%	NOUN
cuesj-1122	77	60	and	and	CCONJ
cuesj-1122	77	61	0.606	0.606	NUM
cuesj-1122	77	62	,	,	PUNCT
cuesj-1122	77	63	respectively	respectively	ADV
cuesj-1122	77	64	)	)	PUNCT
cuesj-1122	77	65	”	"	PUNCT
cuesj-1122	77	66	.	.	PUNCT
cuesj-1122	78	1	as	as	SCONJ
cuesj-1122	78	2	shown	show	VERB
cuesj-1122	78	3	in	in	ADP
cuesj-1122	78	4	[	[	X
cuesj-1122	78	5	table	table	NOUN
cuesj-1122	78	6	1	1	NUM
cuesj-1122	78	7	and	and	CCONJ
cuesj-1122	78	8	figure	figure	VERB
cuesj-1122	78	9	4	4	NUM
cuesj-1122	78	10	]	]	PUNCT
cuesj-1122	78	11	,	,	PUNCT
cuesj-1122	78	12	the	the	DET
cuesj-1122	78	13	mean	mean	ADJ
cuesj-1122	78	14	±	±	PROPN
cuesj-1122	78	15	sd	sd	NOUN
cuesj-1122	78	16	of	of	ADP
cuesj-1122	78	17	total	total	ADJ
cuesj-1122	78	18	bilirubin	bilirubin	NOUN
cuesj-1122	78	19	slightly	slightly	ADV
cuesj-1122	78	20	increased	increase	VERB
cuesj-1122	78	21	from	from	ADP
cuesj-1122	78	22	(	(	PUNCT
cuesj-1122	78	23	0.72	0.72	NUM
cuesj-1122	78	24	±	±	NUM
cuesj-1122	78	25	0.33	0.33	NUM
cuesj-1122	78	26	)	)	PUNCT
cuesj-1122	78	27	in	in	ADP
cuesj-1122	78	28	the	the	DET
cuesj-1122	78	29	control	control	NOUN
cuesj-1122	78	30	group	group	NOUN
cuesj-1122	78	31	to	to	ADP
cuesj-1122	78	32	(	(	PUNCT
cuesj-1122	78	33	0.78	0.78	NUM
cuesj-1122	78	34	±	±	NOUN
cuesj-1122	78	35	0.43	0.43	NUM
cuesj-1122	78	36	)	)	PUNCT
cuesj-1122	78	37	in	in	ADP
cuesj-1122	78	38	unvaccinated	unvaccinated	ADJ
cuesj-1122	78	39	patients	patient	NOUN
cuesj-1122	78	40	,	,	PUNCT
cuesj-1122	78	41	while	while	SCONJ
cuesj-1122	78	42	this	this	DET
cuesj-1122	78	43	value	value	NOUN
cuesj-1122	78	44	declined	decline	VERB
cuesj-1122	78	45	to	to	ADP
cuesj-1122	78	46	(	(	PUNCT
cuesj-1122	78	47	0.58	0.58	NUM
cuesj-1122	78	48	±	±	NOUN
cuesj-1122	78	49	0.32	0.32	NUM
cuesj-1122	78	50	)	)	PUNCT
cuesj-1122	78	51	in	in	ADP
cuesj-1122	78	52	the	the	DET
cuesj-1122	78	53	vaccinated	vaccinated	ADJ
cuesj-1122	78	54	group	group	NOUN
cuesj-1122	78	55	but	but	CCONJ
cuesj-1122	78	56	did	do	AUX
cuesj-1122	78	57	not	not	PART
cuesj-1122	78	58	reach	reach	VERB
cuesj-1122	78	59	at	at	ADP
cuesj-1122	78	60	a	a	DET
cuesj-1122	78	61	significant	significant	ADJ
cuesj-1122	78	62	level	level	NOUN
cuesj-1122	78	63	.	.	PUNCT
cuesj-1122	79	1	the	the	DET
cuesj-1122	79	2	results	result	NOUN
cuesj-1122	79	3	of	of	ADP
cuesj-1122	79	4	the	the	DET
cuesj-1122	79	5	(	(	PUNCT
cuesj-1122	79	6	roc	roc	PROPN
cuesj-1122	79	7	)	)	PUNCT
cuesj-1122	79	8	curve	curve	NOUN
cuesj-1122	79	9	indicated	indicate	VERB
cuesj-1122	79	10	that	that	SCONJ
cuesj-1122	79	11	the	the	DET
cuesj-1122	79	12	cutoff	cutoff	NOUN
cuesj-1122	79	13	values	value	NOUN
cuesj-1122	79	14	of	of	ADP
cuesj-1122	79	15	tsb	tsb	PROPN
cuesj-1122	79	16	for	for	ADP
cuesj-1122	79	17	predicting	predict	VERB
cuesj-1122	79	18	severity	severity	NOUN
cuesj-1122	79	19	in	in	ADP
cuesj-1122	79	20	covid-19	covid-19	PROPN
cuesj-1122	79	21	patients	patient	NOUN
cuesj-1122	79	22	were	be	AUX
cuesj-1122	79	23	<	<	X
cuesj-1122	79	24	0.565	0.565	NUM
cuesj-1122	79	25	mg	mg	NUM
cuesj-1122	79	26	/	/	SYM
cuesj-1122	79	27	ml	ml	PROPN
cuesj-1122	79	28	(	(	PUNCT
cuesj-1122	79	29	sensitivity	sensitivity	NOUN
cuesj-1122	79	30	,	,	PUNCT
cuesj-1122	79	31	specificity	specificity	NOUN
cuesj-1122	79	32	,	,	PUNCT
cuesj-1122	79	33	and	and	CCONJ
cuesj-1122	79	34	auc	auc	NOUN
cuesj-1122	79	35	were	be	AUX
cuesj-1122	79	36	=	=	PROPN
cuesj-1122	79	37	60.61	60.61	NUM
cuesj-1122	79	38	%	%	NOUN
cuesj-1122	79	39	,	,	PUNCT
cuesj-1122	79	40	66.67	66.67	NUM
cuesj-1122	79	41	%	%	NOUN
cuesj-1122	79	42	,	,	PUNCT
cuesj-1122	79	43	and	and	CCONJ
cuesj-1122	79	44	0.627	0.627	NUM
cuesj-1122	79	45	,	,	PUNCT
cuesj-1122	79	46	respectively	respectively	ADV
cuesj-1122	79	47	)	)	PUNCT
cuesj-1122	79	48	in	in	ADP
cuesj-1122	79	49	the	the	DET
cuesj-1122	79	50	vaccinated	vaccinated	ADJ
cuesj-1122	79	51	group	group	NOUN
cuesj-1122	79	52	and	and	CCONJ
cuesj-1122	79	53	<	<	X
cuesj-1122	79	54	0.985	0.985	NUM
cuesj-1122	79	55	mg	mg	NUM
cuesj-1122	79	56	/	/	SYM
cuesj-1122	79	57	ml	ml	NOUN
cuesj-1122	79	58	(	(	PUNCT
cuesj-1122	79	59	sensitivity	sensitivity	NOUN
cuesj-1122	79	60	=	=	SYM
cuesj-1122	79	61	34.62	34.62	NUM
cuesj-1122	79	62	%	%	NOUN
cuesj-1122	79	63	;	;	PUNCT
cuesj-1122	79	64	specificity	specificity	NOUN
cuesj-1122	79	65	=	=	SYM
cuesj-1122	79	66	75.00	75.00	NUM
cuesj-1122	79	67	%	%	NOUN
cuesj-1122	79	68	;	;	PUNCT
cuesj-1122	79	69	(	(	PUNCT
cuesj-1122	79	70	auc	auc	NOUN
cuesj-1122	79	71	)	)	PUNCT
cuesj-1122	79	72	=	=	SYM
cuesj-1122	80	1	0.523	0.523	NUM
cuesj-1122	80	2	)	)	PUNCT
cuesj-1122	80	3	in	in	ADP
cuesj-1122	80	4	unvaccinated	unvaccinated	ADJ
cuesj-1122	80	5	groups	group	NOUN
cuesj-1122	80	6	.	.	PUNCT
cuesj-1122	81	1	on	on	ADP
cuesj-1122	81	2	the	the	DET
cuesj-1122	81	3	other	other	ADJ
cuesj-1122	81	4	hand	hand	NOUN
cuesj-1122	81	5	,	,	PUNCT
cuesj-1122	81	6	serum	serum	NOUN
cuesj-1122	81	7	albumin	albumin	ADJ
cuesj-1122	81	8	level	level	NOUN
cuesj-1122	81	9	is	be	AUX
cuesj-1122	81	10	crucial	crucial	ADJ
cuesj-1122	81	11	biomarkers	biomarker	NOUN
cuesj-1122	81	12	in	in	ADP
cuesj-1122	81	13	sars	sar	NOUN
cuesj-1122	81	14	-	-	PUNCT
cuesj-1122	81	15	cov-2	cov-2	PART
cuesj-1122	81	16	patients	patient	NOUN
cuesj-1122	81	17	.	.	PUNCT
cuesj-1122	82	1	the	the	DET
cuesj-1122	82	2	mean	mean	ADJ
cuesj-1122	82	3	value	value	NOUN
cuesj-1122	82	4	of	of	ADP
cuesj-1122	82	5	albumin	albumin	NOUN
cuesj-1122	82	6	significantly	significantly	ADV
cuesj-1122	82	7	(	(	PUNCT
cuesj-1122	82	8	p	p	X
cuesj-1122	82	9	<	<	X
cuesj-1122	82	10	0.0001	0.0001	NUM
cuesj-1122	82	11	)	)	PUNCT
cuesj-1122	82	12	decreased	decrease	VERB
cuesj-1122	82	13	from	from	ADP
cuesj-1122	82	14	(	(	PUNCT
cuesj-1122	82	15	4.80	4.80	NUM
cuesj-1122	82	16	±	±	NUM
cuesj-1122	82	17	0.29	0.29	NUM
cuesj-1122	82	18	mg	mg	PROPN
cuesj-1122	82	19	/	/	SYM
cuesj-1122	82	20	dl	dl	NOUN
cuesj-1122	82	21	)	)	PUNCT
cuesj-1122	82	22	in	in	ADP
cuesj-1122	82	23	control	control	NOUN
cuesj-1122	82	24	group	group	NOUN
cuesj-1122	82	25	to	to	ADP
cuesj-1122	82	26	(	(	PUNCT
cuesj-1122	82	27	3.79	3.79	NUM
cuesj-1122	82	28	±	±	NUM
cuesj-1122	82	29	0.86	0.86	NUM
cuesj-1122	82	30	mg	mg	PROPN
cuesj-1122	82	31	/	/	SYM
cuesj-1122	82	32	dl	dl	PROPN
cuesj-1122	82	33	and	and	CCONJ
cuesj-1122	82	34	4.65	4.65	NUM
cuesj-1122	82	35	±	±	NUM
cuesj-1122	82	36	0.57	0.57	NUM
cuesj-1122	82	37	mg	mg	PROPN
cuesj-1122	82	38	/	/	SYM
cuesj-1122	82	39	dl	dl	PROPN
cuesj-1122	82	40	in	in	ADP
cuesj-1122	82	41	unvaccinated	unvaccinated	ADJ
cuesj-1122	82	42	and	and	CCONJ
cuesj-1122	82	43	vaccinated	vaccinated	ADJ
cuesj-1122	82	44	patients	patient	NOUN
cuesj-1122	82	45	,	,	PUNCT
cuesj-1122	82	46	respectively	respectively	ADV
cuesj-1122	82	47	.	.	PUNCT
cuesj-1122	83	1	as	as	SCONJ
cuesj-1122	83	2	shown	show	VERB
cuesj-1122	83	3	in	in	ADP
cuesj-1122	83	4	table	table	NOUN
cuesj-1122	83	5	1	1	NUM
cuesj-1122	83	6	and	and	CCONJ
cuesj-1122	83	7	figures	figure	VERB
cuesj-1122	83	8	6a	6a	NOUN
cuesj-1122	83	9	and	and	CCONJ
cuesj-1122	83	10	b	b	NOUN
cuesj-1122	83	11	,	,	PUNCT
cuesj-1122	83	12	cutoff	cutoff	ADJ
cuesj-1122	83	13	values	value	NOUN
cuesj-1122	83	14	of	of	ADP
cuesj-1122	83	15	albumin	albumin	NOUN
cuesj-1122	83	16	to	to	PART
cuesj-1122	83	17	identify	identify	VERB
cuesj-1122	83	18	severity	severity	NOUN
cuesj-1122	83	19	in	in	ADP
cuesj-1122	83	20	covid-19	covid-19	PROPN
cuesj-1122	83	21	patients	patient	NOUN
cuesj-1122	83	22	were	be	AUX
cuesj-1122	83	23	determined	determined	ADJ
cuesj-1122	83	24	table	table	NOUN
cuesj-1122	83	25	2	2	NUM
cuesj-1122	83	26	:	:	PUNCT
cuesj-1122	83	27	roc	roc	PROPN
cuesj-1122	83	28	curve	curve	NOUN
cuesj-1122	83	29	analysis	analysis	NOUN
cuesj-1122	83	30	of	of	ADP
cuesj-1122	83	31	liver	liver	NOUN
cuesj-1122	83	32	biomarkers	biomarker	NOUN
cuesj-1122	83	33	in	in	ADP
cuesj-1122	83	34	sars	sar	NOUN
cuesj-1122	83	35	-	-	PUNCT
cuesj-1122	83	36	cov-2	cov-2	PART
cuesj-1122	83	37	patients	patient	NOUN
cuesj-1122	83	38	liver	liver	VERB
cuesj-1122	83	39	markers	marker	NOUN
cuesj-1122	83	40	auc	auc	X
cuesj-1122	83	41	cut	cut	NOUN
cuesj-1122	83	42	-	-	PUNCT
cuesj-1122	83	43	off	off	ADP
cuesj-1122	83	44	value	value	NOUN
cuesj-1122	83	45	sensitivity	sensitivity	NOUN
cuesj-1122	83	46	(	(	PUNCT
cuesj-1122	83	47	%	%	INTJ
cuesj-1122	83	48	)	)	PUNCT
cuesj-1122	83	49	specificity	specificity	NOUN
cuesj-1122	83	50	(	(	PUNCT
cuesj-1122	83	51	%	%	INTJ
cuesj-1122	83	52	)	)	PUNCT
cuesj-1122	83	53	p	p	NOUN
cuesj-1122	83	54	value	value	NOUN
cuesj-1122	83	55	alt	alt	NOUN
cuesj-1122	83	56	(	(	PUNCT
cuesj-1122	83	57	iu	iu	PROPN
cuesj-1122	83	58	/	/	SYM
cuesj-1122	83	59	l	l	NOUN
cuesj-1122	83	60	)	)	PUNCT
cuesj-1122	83	61	vaccinated	vaccinate	VERB
cuesj-1122	83	62	0.697	0.697	NUM
cuesj-1122	83	63	20.85	20.85	NUM
cuesj-1122	83	64	78.79	78.79	NUM
cuesj-1122	83	65	56.25	56.25	NUM
cuesj-1122	83	66	0.0027	0.0027	NUM
cuesj-1122	83	67	non	non	ADJ
cuesj-1122	83	68	-	-	ADJ
cuesj-1122	83	69	vaccinated	vaccinate	VERB
cuesj-1122	83	70	0.879	0.879	NUM
cuesj-1122	83	71	29.70	29.70	NUM
cuesj-1122	83	72	77.78	77.78	NUM
cuesj-1122	83	73	91.67	91.67	NUM
cuesj-1122	83	74	0.0001	0.0001	NUM
cuesj-1122	83	75	ast	ast	NOUN
cuesj-1122	83	76	(	(	PUNCT
cuesj-1122	83	77	iu	iu	PROPN
cuesj-1122	83	78	/	/	SYM
cuesj-1122	83	79	l	l	NOUN
cuesj-1122	83	80	)	)	PUNCT
cuesj-1122	83	81	vaccinated	vaccinate	VERB
cuesj-1122	83	82	0.597	0.597	NUM
cuesj-1122	83	83	22.65	22.65	NUM
cuesj-1122	83	84	54.55	54.55	NUM
cuesj-1122	83	85	64.58	64.58	NUM
cuesj-1122	83	86	0.1375	0.1375	NUM
cuesj-1122	83	87	non	non	ADJ
cuesj-1122	83	88	-	-	ADJ
cuesj-1122	83	89	vaccinated	vaccinate	VERB
cuesj-1122	83	90	0.741	0.741	NUM
cuesj-1122	83	91	21.65	21.65	NUM
cuesj-1122	83	92	77.27	77.27	NUM
cuesj-1122	83	93	62.50	62.50	NUM
cuesj-1122	83	94	0.0001	0.0001	NUM
cuesj-1122	83	95	alp	alp	NOUN
cuesj-1122	83	96	(	(	PUNCT
cuesj-1122	83	97	iu	iu	PROPN
cuesj-1122	83	98	/	/	SYM
cuesj-1122	83	99	l	l	NOUN
cuesj-1122	83	100	)	)	PUNCT
cuesj-1122	83	101	vaccinated	vaccinate	VERB
cuesj-1122	83	102	0.635	0.635	NUM
cuesj-1122	83	103	65.43	65.43	NUM
cuesj-1122	83	104	66.67	66.67	NUM
cuesj-1122	83	105	52.08	52.08	NUM
cuesj-1122	83	106	0.0392	0.0392	NUM
cuesj-1122	83	107	non	non	ADJ
cuesj-1122	83	108	-	-	ADJ
cuesj-1122	83	109	vaccinated	vaccinate	VERB
cuesj-1122	83	110	0.850	0.850	NUM
cuesj-1122	83	111	85.65	85.65	NUM
cuesj-1122	83	112	76.60	76.60	NUM
cuesj-1122	83	113	85.42	85.42	NUM
cuesj-1122	83	114	0.0001	0.0001	NUM
cuesj-1122	83	115	tsb	tsb	ADJ
cuesj-1122	83	116	(	(	PUNCT
cuesj-1122	83	117	mg	mg	PROPN
cuesj-1122	83	118	/	/	SYM
cuesj-1122	83	119	dl	dl	NOUN
cuesj-1122	83	120	)	)	PUNCT
cuesj-1122	83	121	vaccinated	vaccinate	VERB
cuesj-1122	83	122	0.627	0.627	NUM
cuesj-1122	83	123	0.565	0.565	NUM
cuesj-1122	83	124	60.61	60.61	NUM
cuesj-1122	83	125	66.67	66.67	NUM
cuesj-1122	83	126	0.0516	0.0516	NUM
cuesj-1122	83	127	non	non	ADJ
cuesj-1122	83	128	-	-	ADJ
cuesj-1122	83	129	vaccinated	vaccinated	ADJ
cuesj-1122	83	130	0.523	0.523	NUM
cuesj-1122	83	131	0.985	0.985	NUM
cuesj-1122	83	132	34.62	34.62	NUM
cuesj-1122	83	133	75.00	75.00	NUM
cuesj-1122	83	134	0.7426	0.7426	NUM
cuesj-1122	83	135	ldh	ldh	NOUN
cuesj-1122	83	136	(	(	PUNCT
cuesj-1122	83	137	iu	iu	PROPN
cuesj-1122	83	138	/	/	SYM
cuesj-1122	83	139	l	l	NOUN
cuesj-1122	83	140	)	)	PUNCT
cuesj-1122	83	141	vaccinated	vaccinate	VERB
cuesj-1122	83	142	0.606	0.606	NUM
cuesj-1122	83	143	278.0	278.0	NUM
cuesj-1122	83	144	66.67	66.67	NUM
cuesj-1122	83	145	68.75	68.75	NUM
cuesj-1122	83	146	0.1053	0.1053	NUM
cuesj-1122	83	147	non	non	ADJ
cuesj-1122	83	148	-	-	ADJ
cuesj-1122	83	149	vaccinated	vaccinate	VERB
cuesj-1122	83	150	0.898	0.898	NUM
cuesj-1122	83	151	337.0	337.0	NUM
cuesj-1122	83	152	83.33	83.33	NUM
cuesj-1122	83	153	81.25	81.25	NUM
cuesj-1122	83	154	0.0001	0.0001	NUM
cuesj-1122	83	155	albumin	albumin	NOUN
cuesj-1122	83	156	(	(	PUNCT
cuesj-1122	83	157	mg	mg	PROPN
cuesj-1122	83	158	/	/	SYM
cuesj-1122	83	159	dl	dl	NOUN
cuesj-1122	83	160	)	)	PUNCT
cuesj-1122	83	161	vaccinated	vaccinate	VERB
cuesj-1122	83	162	0.618	0.618	NUM
cuesj-1122	83	163	4.605	4.605	NUM
cuesj-1122	83	164	51.52	51.52	NUM
cuesj-1122	83	165	76.19	76.19	NUM
cuesj-1122	83	166	0.0800	0.0800	NUM
cuesj-1122	83	167	non	non	ADJ
cuesj-1122	83	168	-	-	ADJ
cuesj-1122	83	169	vaccinated	vaccinate	VERB
cuesj-1122	83	170	0.821	0.821	NUM
cuesj-1122	83	171	4.535	4.535	NUM
cuesj-1122	83	172	76.00	76.00	NUM
cuesj-1122	83	173	85.71	85.71	NUM
cuesj-1122	83	174	0.0001	0.0001	NUM
cuesj-1122	83	175	figure	figure	NOUN
cuesj-1122	83	176	5	5	NUM
cuesj-1122	83	177	:	:	PUNCT
cuesj-1122	83	178	(	(	PUNCT
cuesj-1122	83	179	a	a	X
cuesj-1122	83	180	)	)	PUNCT
cuesj-1122	83	181	comparison	comparison	NOUN
cuesj-1122	83	182	of	of	ADP
cuesj-1122	83	183	ldh	ldh	ADJ
cuesj-1122	83	184	concentration	concentration	NOUN
cuesj-1122	83	185	in	in	ADP
cuesj-1122	83	186	control	control	NOUN
cuesj-1122	83	187	and	and	CCONJ
cuesj-1122	83	188	patient	patient	ADJ
cuesj-1122	83	189	groups	group	NOUN
cuesj-1122	83	190	.	.	PUNCT
cuesj-1122	84	1	(	(	PUNCT
cuesj-1122	84	2	b	b	X
cuesj-1122	84	3	)	)	PUNCT
cuesj-1122	84	4	the	the	DET
cuesj-1122	84	5	area	area	NOUN
cuesj-1122	84	6	under	under	ADP
cuesj-1122	84	7	the	the	DET
cuesj-1122	84	8	curve	curve	NOUN
cuesj-1122	84	9	value	value	NOUN
cuesj-1122	84	10	shows	show	VERB
cuesj-1122	84	11	ldh	ldh	NOUN
cuesj-1122	84	12	as	as	ADP
cuesj-1122	84	13	a	a	DET
cuesj-1122	84	14	biomarker	biomarker	NOUN
cuesj-1122	84	15	of	of	ADP
cuesj-1122	84	16	the	the	DET
cuesj-1122	84	17	patients	patient	NOUN
cuesj-1122	84	18	’	'	PUNCT
cuesj-1122	84	19	group	group	NOUN
cuesj-1122	84	20	ba	ba	PROPN
cuesj-1122	84	21	ahmed	ahmed	PROPN
cuesj-1122	84	22	,	,	PUNCT
cuesj-1122	84	23	et	et	PROPN
cuesj-1122	84	24	al	al	PROPN
cuesj-1122	84	25	.	.	PUNCT
cuesj-1122	84	26	:	:	PUNCT
cuesj-1122	85	1	comparison	comparison	NOUN
cuesj-1122	85	2	of	of	ADP
cuesj-1122	85	3	biochemical	biochemical	ADJ
cuesj-1122	85	4	parameters	parameter	NOUN
cuesj-1122	85	5	in	in	ADP
cuesj-1122	85	6	vaccinated	vaccinated	ADJ
cuesj-1122	85	7	51	51	NUM
cuesj-1122	85	8	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1122	85	9	cuesj	cuesj	NOUN
cuesj-1122	85	10	2024	2024	NUM
cuesj-1122	85	11	,	,	PUNCT
cuesj-1122	85	12	8	8	NUM
cuesj-1122	85	13	(	(	PUNCT
cuesj-1122	85	14	1	1	NUM
cuesj-1122	85	15	):	):	PUNCT
cuesj-1122	85	16	46	46	NUM
cuesj-1122	85	17	-	-	SYM
cuesj-1122	85	18	57	57	NUM
cuesj-1122	85	19	through	through	ADP
cuesj-1122	85	20	roc	roc	PROPN
cuesj-1122	85	21	curve	curve	NOUN
cuesj-1122	85	22	analysis	analysis	NOUN
cuesj-1122	85	23	.	.	PUNCT
cuesj-1122	86	1	for	for	ADP
cuesj-1122	86	2	the	the	DET
cuesj-1122	86	3	unvaccinated	unvaccinated	ADJ
cuesj-1122	86	4	group	group	NOUN
cuesj-1122	86	5	,	,	PUNCT
cuesj-1122	86	6	these	these	DET
cuesj-1122	86	7	values	value	NOUN
cuesj-1122	86	8	were	be	AUX
cuesj-1122	86	9	<	<	X
cuesj-1122	86	10	4.535	4.535	NUM
cuesj-1122	86	11	mg	mg	PROPN
cuesj-1122	86	12	/	/	SYM
cuesj-1122	86	13	dl	dl	PROPN
cuesj-1122	86	14	,	,	PUNCT
cuesj-1122	86	15	(	(	PUNCT
cuesj-1122	86	16	sensitivity	sensitivity	NOUN
cuesj-1122	86	17	=	=	SYM
cuesj-1122	86	18	76.00	76.00	NUM
cuesj-1122	86	19	%	%	NOUN
cuesj-1122	86	20	;	;	PUNCT
cuesj-1122	86	21	specificity	specificity	NOUN
cuesj-1122	86	22	=	=	SYM
cuesj-1122	86	23	85.71	85.71	NUM
cuesj-1122	86	24	%	%	NOUN
cuesj-1122	86	25	;	;	PUNCT
cuesj-1122	86	26	auc	auc	NOUN
cuesj-1122	86	27	=	=	NUM
cuesj-1122	86	28	0.821	0.821	NUM
cuesj-1122	86	29	)	)	PUNCT
cuesj-1122	86	30	;	;	PUNCT
cuesj-1122	86	31	for	for	ADP
cuesj-1122	86	32	the	the	DET
cuesj-1122	86	33	vaccine	vaccine	NOUN
cuesj-1122	86	34	-	-	PUNCT
cuesj-1122	86	35	receiving	receive	VERB
cuesj-1122	86	36	group	group	NOUN
cuesj-1122	86	37	,	,	PUNCT
cuesj-1122	86	38	they	they	PRON
cuesj-1122	86	39	were	be	AUX
cuesj-1122	86	40	<	<	X
cuesj-1122	86	41	4.605	4.605	NUM
cuesj-1122	86	42	mg	mg	PROPN
cuesj-1122	86	43	/	/	SYM
cuesj-1122	86	44	dl	dl	PROPN
cuesj-1122	86	45	,	,	PUNCT
cuesj-1122	86	46	(	(	PUNCT
cuesj-1122	86	47	sensitivity	sensitivity	NOUN
cuesj-1122	86	48	=	=	PUNCT
cuesj-1122	86	49	51.52	51.52	NUM
cuesj-1122	86	50	%	%	NOUN
cuesj-1122	86	51	;	;	PUNCT
cuesj-1122	86	52	specificity	specificity	NOUN
cuesj-1122	86	53	=	=	SYM
cuesj-1122	86	54	76.19	76.19	NUM
cuesj-1122	86	55	%	%	NOUN
cuesj-1122	86	56	;	;	PUNCT
cuesj-1122	86	57	auc	auc	NOUN
cuesj-1122	86	58	=	=	NUM
cuesj-1122	86	59	0.618	0.618	NUM
cuesj-1122	86	60	)	)	PUNCT
cuesj-1122	86	61	.	.	PUNCT
cuesj-1122	87	1	the	the	DET
cuesj-1122	87	2	level	level	NOUN
cuesj-1122	87	3	of	of	ADP
cuesj-1122	87	4	bone	bone	NOUN
cuesj-1122	87	5	markers	marker	NOUN
cuesj-1122	87	6	shown	show	VERB
cuesj-1122	87	7	in	in	ADP
cuesj-1122	87	8	(	(	PUNCT
cuesj-1122	87	9	table	table	NOUN
cuesj-1122	87	10	3	3	NUM
cuesj-1122	87	11	)	)	PUNCT
cuesj-1122	87	12	,	,	PUNCT
cuesj-1122	87	13	in	in	ADP
cuesj-1122	87	14	which	which	PRON
cuesj-1122	87	15	the	the	DET
cuesj-1122	87	16	mean	mean	ADJ
cuesj-1122	87	17	±	±	NUM
cuesj-1122	87	18	standard	standard	ADJ
cuesj-1122	87	19	deviation	deviation	NOUN
cuesj-1122	87	20	of	of	ADP
cuesj-1122	87	21	ca	ca	NOUN
cuesj-1122	87	22	level	level	NOUN
cuesj-1122	87	23	values	value	NOUN
cuesj-1122	87	24	decreased	decrease	VERB
cuesj-1122	87	25	somewhat	somewhat	ADV
cuesj-1122	87	26	,	,	PUNCT
cuesj-1122	87	27	from	from	ADP
cuesj-1122	87	28	9.40	9.40	NUM
cuesj-1122	87	29	±	±	NUM
cuesj-1122	87	30	1.19	1.19	NUM
cuesj-1122	87	31	mg	mg	PROPN
cuesj-1122	87	32	/	/	SYM
cuesj-1122	87	33	dl	dl	PROPN
cuesj-1122	87	34	in	in	ADP
cuesj-1122	87	35	the	the	DET
cuesj-1122	87	36	control	control	NOUN
cuesj-1122	87	37	group	group	NOUN
cuesj-1122	87	38	to	to	ADP
cuesj-1122	87	39	8.88	8.88	NUM
cuesj-1122	87	40	±	±	NUM
cuesj-1122	87	41	1.28	1.28	NUM
cuesj-1122	87	42	mg	mg	PROPN
cuesj-1122	87	43	/	/	SYM
cuesj-1122	87	44	dl	dl	PROPN
cuesj-1122	87	45	and	and	CCONJ
cuesj-1122	87	46	9.27	9.27	NUM
cuesj-1122	87	47	±	±	NUM
cuesj-1122	87	48	1.21	1.21	NUM
cuesj-1122	87	49	mg	mg	PROPN
cuesj-1122	87	50	/	/	SYM
cuesj-1122	87	51	dl	dl	PROPN
cuesj-1122	87	52	in	in	ADP
cuesj-1122	87	53	the	the	DET
cuesj-1122	87	54	vaccinated	vaccinate	VERB
cuesj-1122	87	55	and	and	CCONJ
cuesj-1122	87	56	unvaccinated	unvaccinate	VERB
cuesj-1122	87	57	patient	patient	NOUN
cuesj-1122	87	58	categories	category	NOUN
cuesj-1122	87	59	,	,	PUNCT
cuesj-1122	87	60	respectively	respectively	ADV
cuesj-1122	87	61	,	,	PUNCT
cuesj-1122	87	62	but	but	CCONJ
cuesj-1122	87	63	not	not	PART
cuesj-1122	87	64	to	to	ADP
cuesj-1122	87	65	a	a	DET
cuesj-1122	87	66	significant	significant	ADJ
cuesj-1122	87	67	degree	degree	NOUN
cuesj-1122	87	68	.	.	PUNCT
cuesj-1122	88	1	table	table	NOUN
cuesj-1122	88	2	4	4	NUM
cuesj-1122	88	3	and	and	CCONJ
cuesj-1122	88	4	figures	figure	VERB
cuesj-1122	88	5	7a	7a	NUM
cuesj-1122	88	6	and	and	CCONJ
cuesj-1122	88	7	7b	7b	NOUN
cuesj-1122	88	8	demonstrate	demonstrate	VERB
cuesj-1122	88	9	the	the	DET
cuesj-1122	88	10	optimal	optimal	ADJ
cuesj-1122	88	11	cut	cut	NOUN
cuesj-1122	88	12	-	-	PUNCT
cuesj-1122	88	13	off	off	ADP
cuesj-1122	88	14	values	value	NOUN
cuesj-1122	88	15	of	of	ADP
cuesj-1122	88	16	calcium	calcium	NOUN
cuesj-1122	88	17	for	for	ADP
cuesj-1122	88	18	predicting	predict	VERB
cuesj-1122	88	19	severity	severity	NOUN
cuesj-1122	88	20	in	in	ADP
cuesj-1122	88	21	covid-19	covid-19	PROPN
cuesj-1122	88	22	patients	patient	NOUN
cuesj-1122	88	23	.	.	PUNCT
cuesj-1122	89	1	vaccinated	vaccinate	VERB
cuesj-1122	89	2	patients	patient	NOUN
cuesj-1122	89	3	had	have	VERB
cuesj-1122	89	4	cutoff	cutoff	ADJ
cuesj-1122	89	5	values	value	NOUN
cuesj-1122	89	6	of	of	ADP
cuesj-1122	89	7	less	less	ADJ
cuesj-1122	89	8	than	than	ADP
cuesj-1122	89	9	9.635	9.635	NUM
cuesj-1122	89	10	mg	mg	NUM
cuesj-1122	89	11	/	/	SYM
cuesj-1122	89	12	ml	ml	NOUN
cuesj-1122	89	13	,	,	PUNCT
cuesj-1122	89	14	with	with	ADP
cuesj-1122	89	15	sensitivity	sensitivity	NOUN
cuesj-1122	89	16	,	,	PUNCT
cuesj-1122	89	17	specificity	specificity	NOUN
cuesj-1122	89	18	,	,	PUNCT
cuesj-1122	89	19	and	and	CCONJ
cuesj-1122	89	20	auc	auc	NOUN
cuesj-1122	89	21	of	of	ADP
cuesj-1122	89	22	75.76	75.76	NUM
cuesj-1122	89	23	%	%	NOUN
cuesj-1122	89	24	,	,	PUNCT
cuesj-1122	89	25	47.92	47.92	NUM
cuesj-1122	89	26	%	%	NOUN
cuesj-1122	89	27	,	,	PUNCT
cuesj-1122	89	28	and	and	CCONJ
cuesj-1122	89	29	0.616	0.616	NUM
cuesj-1122	89	30	,	,	PUNCT
cuesj-1122	89	31	respectively	respectively	ADV
cuesj-1122	89	32	.	.	PUNCT
cuesj-1122	90	1	non	non	ADJ
cuesj-1122	90	2	-	-	ADJ
cuesj-1122	90	3	vaccinated	vaccinated	ADJ
cuesj-1122	90	4	patients	patient	NOUN
cuesj-1122	90	5	had	have	AUX
cuesj-1122	90	6	cut	cut	VERB
cuesj-1122	90	7	-	-	PUNCT
cuesj-1122	90	8	off	off	ADP
cuesj-1122	90	9	values	value	NOUN
cuesj-1122	90	10	of	of	ADP
cuesj-1122	90	11	less	less	ADJ
cuesj-1122	90	12	than	than	ADP
cuesj-1122	90	13	9.635	9.635	NUM
cuesj-1122	90	14	mg	mg	NUM
cuesj-1122	90	15	/	/	SYM
cuesj-1122	90	16	ml	ml	NOUN
cuesj-1122	90	17	,	,	PUNCT
cuesj-1122	90	18	with	with	ADP
cuesj-1122	90	19	sensitivity	sensitivity	NOUN
cuesj-1122	90	20	,	,	PUNCT
cuesj-1122	90	21	specificity	specificity	NOUN
cuesj-1122	90	22	,	,	PUNCT
cuesj-1122	90	23	and	and	CCONJ
cuesj-1122	90	24	auc	auc	NOUN
cuesj-1122	90	25	of	of	ADP
cuesj-1122	90	26	66.67	66.67	NUM
cuesj-1122	90	27	%	%	NOUN
cuesj-1122	90	28	,	,	PUNCT
cuesj-1122	90	29	47.92	47.92	NUM
cuesj-1122	90	30	%	%	NOUN
cuesj-1122	90	31	,	,	PUNCT
cuesj-1122	90	32	and	and	CCONJ
cuesj-1122	90	33	0.540	0.540	NUM
cuesj-1122	90	34	,	,	PUNCT
cuesj-1122	90	35	respectively	respectively	ADV
cuesj-1122	90	36	.	.	PUNCT
cuesj-1122	91	1	regarding	regard	VERB
cuesj-1122	91	2	the	the	DET
cuesj-1122	91	3	concentration	concentration	NOUN
cuesj-1122	91	4	of	of	ADP
cuesj-1122	91	5	the	the	DET
cuesj-1122	91	6	serum	serum	NOUN
cuesj-1122	91	7	phosphate	phosphate	NOUN
cuesj-1122	91	8	,	,	PUNCT
cuesj-1122	91	9	we	we	PRON
cuesj-1122	91	10	found	find	VERB
cuesj-1122	91	11	that	that	DET
cuesj-1122	91	12	value	value	NOUN
cuesj-1122	91	13	of	of	ADP
cuesj-1122	91	14	phosphate	phosphate	NOUN
cuesj-1122	91	15	significantly	significantly	ADV
cuesj-1122	91	16	decreased	decrease	VERB
cuesj-1122	91	17	from	from	ADP
cuesj-1122	91	18	(	(	PUNCT
cuesj-1122	91	19	3.85	3.85	NUM
cuesj-1122	91	20	±	±	NUM
cuesj-1122	91	21	0.48	0.48	NUM
cuesj-1122	91	22	mg	mg	PROPN
cuesj-1122	91	23	/	/	SYM
cuesj-1122	91	24	dl	dl	NOUN
cuesj-1122	91	25	)	)	PUNCT
cuesj-1122	91	26	in	in	ADP
cuesj-1122	91	27	healthy	healthy	ADJ
cuesj-1122	91	28	individuals	individual	NOUN
cuesj-1122	91	29	to	to	ADP
cuesj-1122	91	30	(	(	PUNCT
cuesj-1122	91	31	3.35	3.35	NUM
cuesj-1122	91	32	±	±	NUM
cuesj-1122	91	33	0.74	0.74	NUM
cuesj-1122	91	34	mg	mg	PROPN
cuesj-1122	91	35	/	/	SYM
cuesj-1122	91	36	dl	dl	NOUN
cuesj-1122	91	37	)	)	PUNCT
cuesj-1122	91	38	in	in	ADP
cuesj-1122	91	39	vaccinated	vaccinated	ADJ
cuesj-1122	91	40	patients	patient	NOUN
cuesj-1122	91	41	and	and	CCONJ
cuesj-1122	91	42	somewhat	somewhat	ADV
cuesj-1122	91	43	reduced	reduce	VERB
cuesj-1122	91	44	to	to	ADP
cuesj-1122	91	45	(	(	PUNCT
cuesj-1122	91	46	3.65	3.65	NUM
cuesj-1122	91	47	±	±	NUM
cuesj-1122	91	48	1.02	1.02	NUM
cuesj-1122	91	49	mg	mg	PROPN
cuesj-1122	91	50	/	/	SYM
cuesj-1122	91	51	dl	dl	NOUN
cuesj-1122	91	52	)	)	PUNCT
cuesj-1122	91	53	in	in	ADP
cuesj-1122	91	54	patients	patient	NOUN
cuesj-1122	91	55	who	who	PRON
cuesj-1122	91	56	did	do	AUX
cuesj-1122	91	57	not	not	PART
cuesj-1122	91	58	take	take	VERB
cuesj-1122	91	59	table	table	NOUN
cuesj-1122	91	60	4	4	NUM
cuesj-1122	91	61	:	:	PUNCT
cuesj-1122	91	62	roc	roc	NOUN
cuesj-1122	91	63	curve	curve	NOUN
cuesj-1122	91	64	analysis	analysis	NOUN
cuesj-1122	91	65	of	of	ADP
cuesj-1122	91	66	bone	bone	NOUN
cuesj-1122	91	67	markers	marker	NOUN
cuesj-1122	91	68	in	in	ADP
cuesj-1122	91	69	sars	sar	NOUN
cuesj-1122	91	70	-	-	PUNCT
cuesj-1122	91	71	cov-2	cov-2	PART
cuesj-1122	91	72	patients	patient	NOUN
cuesj-1122	91	73	auc	auc	VERB
cuesj-1122	91	74	cut	cut	VERB
cuesj-1122	91	75	off	off	ADP
cuesj-1122	91	76	value	value	NOUN
cuesj-1122	91	77	sensitivity	sensitivity	NOUN
cuesj-1122	91	78	(	(	PUNCT
cuesj-1122	91	79	%	%	INTJ
cuesj-1122	91	80	)	)	PUNCT
cuesj-1122	91	81	specificity	specificity	NOUN
cuesj-1122	91	82	(	(	PUNCT
cuesj-1122	91	83	%	%	INTJ
cuesj-1122	91	84	)	)	PUNCT
cuesj-1122	91	85	p	p	NOUN
cuesj-1122	91	86	value	value	NOUN
cuesj-1122	91	87	pth	pth	NOUN
cuesj-1122	91	88	(	(	PUNCT
cuesj-1122	91	89	pg	pg	NOUN
cuesj-1122	91	90	/	/	SYM
cuesj-1122	91	91	ml	ml	VERB
cuesj-1122	91	92	)	)	PUNCT
cuesj-1122	91	93	vaccinated	vaccinate	VERB
cuesj-1122	91	94	0.814	0.814	NUM
cuesj-1122	91	95	27.76	27.76	NUM
cuesj-1122	91	96	73.53	73.53	NUM
cuesj-1122	91	97	88.64	88.64	NUM
cuesj-1122	91	98	0.0001	0.0001	NUM
cuesj-1122	91	99	non	non	ADJ
cuesj-1122	91	100	-	-	ADJ
cuesj-1122	91	101	vaccinated	vaccinate	VERB
cuesj-1122	91	102	0.875	0.875	NUM
cuesj-1122	91	103	27.34	27.34	NUM
cuesj-1122	91	104	82.35	82.35	NUM
cuesj-1122	91	105	88.64	88.64	NUM
cuesj-1122	91	106	0.0001	0.0001	NUM
cuesj-1122	91	107	tsh	tsh	NOUN
cuesj-1122	91	108	(	(	PUNCT
cuesj-1122	91	109	uiu	uiu	PROPN
cuesj-1122	91	110	/	/	SYM
cuesj-1122	91	111	ml	ml	NOUN
cuesj-1122	91	112	)	)	PUNCT
cuesj-1122	91	113	vaccinated	vaccinate	VERB
cuesj-1122	91	114	0.594	0.594	NUM
cuesj-1122	91	115	3.705	3.705	NUM
cuesj-1122	91	116	100.0	100.0	NUM
cuesj-1122	91	117	23.40	23.40	NUM
cuesj-1122	91	118	0.1588	0.1588	NUM
cuesj-1122	91	119	non	non	ADJ
cuesj-1122	91	120	-	-	ADJ
cuesj-1122	91	121	vaccinated	vaccinate	VERB
cuesj-1122	91	122	0.679	0.679	NUM
cuesj-1122	91	123	1.025	1.025	NUM
cuesj-1122	91	124	46.43	46.43	NUM
cuesj-1122	91	125	91.49	91.49	NUM
cuesj-1122	91	126	0.0096	0.0096	NUM
cuesj-1122	91	127	calcium	calcium	NOUN
cuesj-1122	91	128	(	(	PUNCT
cuesj-1122	91	129	mg	mg	NOUN
cuesj-1122	91	130	/	/	SYM
cuesj-1122	91	131	ml	ml	NOUN
cuesj-1122	91	132	)	)	PUNCT
cuesj-1122	91	133	vaccinated	vaccinate	VERB
cuesj-1122	91	134	0.616	0.616	NUM
cuesj-1122	91	135	9.635	9.635	NUM
cuesj-1122	91	136	75.76	75.76	NUM
cuesj-1122	91	137	47.92	47.92	NUM
cuesj-1122	91	138	0.0754	0.0754	NUM
cuesj-1122	91	139	non	non	ADJ
cuesj-1122	91	140	-	-	ADJ
cuesj-1122	91	141	vaccinated	vaccinate	VERB
cuesj-1122	91	142	0.540	0.540	NUM
cuesj-1122	91	143	9.635	9.635	NUM
cuesj-1122	91	144	66.67	66.67	NUM
cuesj-1122	91	145	47.92	47.92	NUM
cuesj-1122	91	146	0.5046	0.5046	NUM
cuesj-1122	91	147	phosphate	phosphate	NOUN
cuesj-1122	91	148	(	(	PUNCT
cuesj-1122	91	149	mg	mg	NOUN
cuesj-1122	91	150	/	/	SYM
cuesj-1122	91	151	ml	ml	NOUN
cuesj-1122	91	152	)	)	PUNCT
cuesj-1122	91	153	vaccinated	vaccinate	VERB
cuesj-1122	91	154	0.762	0.762	NUM
cuesj-1122	91	155	3.66	3.66	NUM
cuesj-1122	91	156	74.07	74.07	NUM
cuesj-1122	91	157	70.45	70.45	NUM
cuesj-1122	91	158	0.0002	0.0002	NUM
cuesj-1122	91	159	non	non	ADJ
cuesj-1122	91	160	-	-	ADJ
cuesj-1122	91	161	vaccinated	vaccinated	ADJ
cuesj-1122	91	162	0.605	0.605	NUM
cuesj-1122	91	163	3.43	3.43	NUM
cuesj-1122	91	164	46.67	46.67	NUM
cuesj-1122	91	165	90.91	90.91	NUM
cuesj-1122	91	166	0.1259	0.1259	NUM
cuesj-1122	91	167	table	table	NOUN
cuesj-1122	91	168	3	3	NUM
cuesj-1122	91	169	:	:	PUNCT
cuesj-1122	91	170	comparison	comparison	NOUN
cuesj-1122	91	171	of	of	ADP
cuesj-1122	91	172	bone	bone	NOUN
cuesj-1122	91	173	markers	marker	NOUN
cuesj-1122	91	174	between	between	ADP
cuesj-1122	91	175	control	control	NOUN
cuesj-1122	91	176	and	and	CCONJ
cuesj-1122	91	177	patient	patient	ADJ
cuesj-1122	91	178	groups	group	NOUN
cuesj-1122	91	179	bone	bone	NOUN
cuesj-1122	91	180	markers	marker	NOUN
cuesj-1122	91	181	control	control	NOUN
cuesj-1122	91	182	covid-19	covid-19	PROPN
cuesj-1122	91	183	patients	patient	NOUN
cuesj-1122	91	184	p	p	NOUN
cuesj-1122	91	185	value	value	NOUN
cuesj-1122	91	186	vaccinated	vaccinate	VERB
cuesj-1122	91	187	non	non	ADJ
cuesj-1122	91	188	-	-	ADJ
cuesj-1122	91	189	vaccinated	vaccinated	ADJ
cuesj-1122	91	190	pth	pth	NOUN
cuesj-1122	91	191	(	(	PUNCT
cuesj-1122	91	192	pg	pg	NOUN
cuesj-1122	91	193	/	/	SYM
cuesj-1122	91	194	ml	ml	VERB
cuesj-1122	91	195	)	)	PUNCT
cuesj-1122	91	196	45.53±21.37	45.53±21.37	NUM
cuesj-1122	92	1	25.96±16.81	25.96±16.81	NUM
cuesj-1122	93	1	21.06±15.22	21.06±15.22	NUM
cuesj-1122	93	2	0.0001	0.0001	NUM
cuesj-1122	93	3	tsh	tsh	NOUN
cuesj-1122	93	4	(	(	PUNCT
cuesj-1122	93	5	uiu	uiu	PROPN
cuesj-1122	93	6	/	/	SYM
cuesj-1122	93	7	ml	ml	NOUN
cuesj-1122	93	8	)	)	PUNCT
cuesj-1122	93	9	2.79±2.70	2.79±2.70	NUM
cuesj-1122	93	10	1.68±0.95	1.68±0.95	NUM
cuesj-1122	93	11	1.52±1.28	1.52±1.28	NUM
cuesj-1122	93	12	0.0295	0.0295	NUM
cuesj-1122	93	13	calcium	calcium	NOUN
cuesj-1122	93	14	(	(	PUNCT
cuesj-1122	93	15	mg	mg	NOUN
cuesj-1122	93	16	/	/	SYM
cuesj-1122	93	17	ml	ml	NOUN
cuesj-1122	93	18	)	)	PUNCT
cuesj-1122	93	19	9.40±1.19	9.40±1.19	NOUN
cuesj-1122	93	20	8.88±1.28	8.88±1.28	NOUN
cuesj-1122	93	21	9.27±1.21	9.27±1.21	NOUN
cuesj-1122	93	22	0.2188	0.2188	NUM
cuesj-1122	93	23	phosphate	phosphate	NOUN
cuesj-1122	93	24	(	(	PUNCT
cuesj-1122	93	25	mg	mg	NOUN
cuesj-1122	93	26	/	/	SYM
cuesj-1122	93	27	ml	ml	NOUN
cuesj-1122	93	28	)	)	PUNCT
cuesj-1122	93	29	3.85±0.48	3.85±0.48	NOUN
cuesj-1122	93	30	3.35±0.74	3.35±0.74	NUM
cuesj-1122	93	31	3.65±1.02	3.65±1.02	NUM
cuesj-1122	93	32	0.0022	0.0022	NUM
cuesj-1122	93	33	figure	figure	NOUN
cuesj-1122	93	34	6	6	NUM
cuesj-1122	93	35	:	:	PUNCT
cuesj-1122	93	36	(	(	PUNCT
cuesj-1122	93	37	a	a	X
cuesj-1122	93	38	)	)	PUNCT
cuesj-1122	93	39	comparison	comparison	NOUN
cuesj-1122	93	40	of	of	ADP
cuesj-1122	93	41	albumin	albumin	ADJ
cuesj-1122	93	42	concentration	concentration	NOUN
cuesj-1122	93	43	in	in	ADP
cuesj-1122	93	44	control	control	NOUN
cuesj-1122	93	45	and	and	CCONJ
cuesj-1122	93	46	patient	patient	ADJ
cuesj-1122	93	47	groups	group	NOUN
cuesj-1122	93	48	.	.	PUNCT
cuesj-1122	94	1	(	(	PUNCT
cuesj-1122	94	2	b	b	X
cuesj-1122	94	3	)	)	PUNCT
cuesj-1122	94	4	the	the	DET
cuesj-1122	94	5	area	area	NOUN
cuesj-1122	94	6	under	under	ADP
cuesj-1122	94	7	the	the	DET
cuesj-1122	94	8	curve	curve	NOUN
cuesj-1122	94	9	value	value	NOUN
cuesj-1122	94	10	shows	show	VERB
cuesj-1122	94	11	albumin	albumin	NOUN
cuesj-1122	94	12	as	as	ADP
cuesj-1122	94	13	a	a	DET
cuesj-1122	94	14	biomarker	biomarker	NOUN
cuesj-1122	94	15	of	of	ADP
cuesj-1122	94	16	the	the	DET
cuesj-1122	94	17	patients	patient	NOUN
cuesj-1122	94	18	’	'	PUNCT
cuesj-1122	94	19	group	group	NOUN
cuesj-1122	94	20	ba	ba	PROPN
cuesj-1122	94	21	ahmed	ahmed	PROPN
cuesj-1122	94	22	,	,	PUNCT
cuesj-1122	94	23	et	et	PROPN
cuesj-1122	94	24	al	al	PROPN
cuesj-1122	94	25	.	.	PUNCT
cuesj-1122	94	26	:	:	PUNCT
cuesj-1122	95	1	comparison	comparison	NOUN
cuesj-1122	95	2	of	of	ADP
cuesj-1122	95	3	biochemical	biochemical	ADJ
cuesj-1122	95	4	parameters	parameter	NOUN
cuesj-1122	95	5	in	in	ADP
cuesj-1122	95	6	vaccinated	vaccinated	ADJ
cuesj-1122	95	7	52	52	NUM
cuesj-1122	95	8	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1122	95	9	cuesj	cuesj	NOUN
cuesj-1122	95	10	2024	2024	NUM
cuesj-1122	95	11	,	,	PUNCT
cuesj-1122	95	12	8	8	NUM
cuesj-1122	95	13	(	(	PUNCT
cuesj-1122	95	14	1	1	NUM
cuesj-1122	95	15	):	):	PUNCT
cuesj-1122	95	16	46	46	NUM
cuesj-1122	95	17	-	-	SYM
cuesj-1122	95	18	57	57	NUM
cuesj-1122	95	19	vaccine	vaccine	NOUN
cuesj-1122	95	20	against	against	ADP
cuesj-1122	95	21	sars	sar	NOUN
cuesj-1122	95	22	-	-	PUNCT
cuesj-1122	95	23	cov-2	cov-2	NUM
cuesj-1122	95	24	;	;	PUNCT
cuesj-1122	95	25	however	however	ADV
cuesj-1122	95	26	,	,	PUNCT
cuesj-1122	95	27	it	it	PRON
cuesj-1122	95	28	did	do	AUX
cuesj-1122	95	29	not	not	PART
cuesj-1122	95	30	reach	reach	VERB
cuesj-1122	95	31	at	at	ADP
cuesj-1122	95	32	a	a	DET
cuesj-1122	95	33	significant	significant	ADJ
cuesj-1122	95	34	level	level	NOUN
cuesj-1122	95	35	as	as	SCONJ
cuesj-1122	95	36	demonstrated	demonstrate	VERB
cuesj-1122	95	37	in	in	ADP
cuesj-1122	95	38	[	[	PUNCT
cuesj-1122	95	39	figure	figure	NOUN
cuesj-1122	95	40	8	8	NUM
cuesj-1122	95	41	and	and	CCONJ
cuesj-1122	95	42	table	table	NOUN
cuesj-1122	95	43	2	2	NUM
cuesj-1122	95	44	]	]	PUNCT
cuesj-1122	95	45	.	.	PUNCT
cuesj-1122	96	1	the	the	DET
cuesj-1122	96	2	roc	roc	PROPN
cuesj-1122	96	3	was	be	AUX
cuesj-1122	96	4	used	use	VERB
cuesj-1122	96	5	to	to	PART
cuesj-1122	96	6	estimate	estimate	VERB
cuesj-1122	96	7	the	the	DET
cuesj-1122	96	8	values	value	NOUN
cuesj-1122	96	9	of	of	ADP
cuesj-1122	96	10	cut	cut	NOUN
cuesj-1122	96	11	-	-	PUNCT
cuesj-1122	96	12	off	off	NOUN
cuesj-1122	96	13	for	for	ADP
cuesj-1122	96	14	phosphate	phosphate	NOUN
cuesj-1122	96	15	that	that	PRON
cuesj-1122	96	16	determine	determine	VERB
cuesj-1122	96	17	severity	severity	NOUN
cuesj-1122	96	18	in	in	ADP
cuesj-1122	96	19	sars	sar	NOUN
cuesj-1122	96	20	-	-	PUNCT
cuesj-1122	96	21	cov-2	cov-2	NOUN
cuesj-1122	96	22	patients	patient	NOUN
cuesj-1122	96	23	in	in	ADP
cuesj-1122	96	24	vaccinated	vaccinated	ADJ
cuesj-1122	96	25	were	be	AUX
cuesj-1122	96	26	<	<	X
cuesj-1122	96	27	3.66	3.66	NUM
cuesj-1122	96	28	mg	mg	PROPN
cuesj-1122	96	29	/	/	SYM
cuesj-1122	96	30	dl	dl	PROPN
cuesj-1122	96	31	,	,	PUNCT
cuesj-1122	96	32	sensitivity	sensitivity	NOUN
cuesj-1122	96	33	=	=	SYM
cuesj-1122	96	34	74.07	74.07	NUM
cuesj-1122	96	35	%	%	NOUN
cuesj-1122	96	36	;	;	PUNCT
cuesj-1122	96	37	specificity	specificity	NOUN
cuesj-1122	96	38	=	=	SYM
cuesj-1122	96	39	70.45	70.45	NUM
cuesj-1122	96	40	%	%	NOUN
cuesj-1122	96	41	;	;	PUNCT
cuesj-1122	96	42	auc=	auc=	VERB
cuesj-1122	96	43	0.762	0.762	NUM
cuesj-1122	96	44	with	with	ADP
cuesj-1122	96	45	p	p	NOUN
cuesj-1122	96	46	=	=	SYM
cuesj-1122	96	47	0.0002	0.0002	NUM
cuesj-1122	96	48	and	and	CCONJ
cuesj-1122	96	49	nonvaccinated	nonvaccinate	VERB
cuesj-1122	96	50	<	<	X
cuesj-1122	96	51	3.43	3.43	NUM
cuesj-1122	96	52	mg	mg	NUM
cuesj-1122	96	53	/	/	SYM
cuesj-1122	96	54	ml	ml	NOUN
cuesj-1122	96	55	,	,	PUNCT
cuesj-1122	96	56	sensitivity	sensitivity	NOUN
cuesj-1122	96	57	=	=	SYM
cuesj-1122	96	58	46.67	46.67	NUM
cuesj-1122	96	59	%	%	NOUN
cuesj-1122	96	60	;	;	PUNCT
cuesj-1122	96	61	specificity	specificity	NOUN
cuesj-1122	96	62	=	=	SYM
cuesj-1122	96	63	90.91	90.91	NUM
cuesj-1122	96	64	%	%	NOUN
cuesj-1122	96	65	;	;	PUNCT
cuesj-1122	96	66	auc	auc	NOUN
cuesj-1122	96	67	=	=	PUNCT
cuesj-1122	96	68	0.605	0.605	NUM
cuesj-1122	96	69	[	[	NOUN
cuesj-1122	96	70	table	table	NOUN
cuesj-1122	96	71	4	4	NUM
cuesj-1122	96	72	]	]	PUNCT
cuesj-1122	96	73	.	.	PUNCT
cuesj-1122	97	1	following	follow	VERB
cuesj-1122	97	2	the	the	DET
cuesj-1122	97	3	statistical	statistical	ADJ
cuesj-1122	97	4	analysis	analysis	NOUN
cuesj-1122	97	5	,	,	PUNCT
cuesj-1122	97	6	as	as	ADP
cuesj-1122	97	7	table	table	NOUN
cuesj-1122	97	8	2	2	NUM
cuesj-1122	97	9	and	and	CCONJ
cuesj-1122	97	10	figure	figure	NOUN
cuesj-1122	97	11	9a	9a	NOUN
cuesj-1122	97	12	show	show	NOUN
cuesj-1122	97	13	,	,	PUNCT
cuesj-1122	97	14	it	it	PRON
cuesj-1122	97	15	was	be	AUX
cuesj-1122	97	16	found	find	VERB
cuesj-1122	97	17	that	that	SCONJ
cuesj-1122	97	18	the	the	DET
cuesj-1122	97	19	level	level	NOUN
cuesj-1122	97	20	of	of	ADP
cuesj-1122	97	21	the	the	DET
cuesj-1122	97	22	serum	serum	NOUN
cuesj-1122	97	23	pth	pth	NOUN
cuesj-1122	97	24	in	in	ADP
cuesj-1122	97	25	the	the	DET
cuesj-1122	97	26	vaccinated	vaccinate	VERB
cuesj-1122	97	27	and	and	CCONJ
cuesj-1122	97	28	unvaccinated	unvaccinate	VERB
cuesj-1122	97	29	covid-19	covid-19	PROPN
cuesj-1122	97	30	groups	group	NOUN
cuesj-1122	97	31	considerably	considerably	ADV
cuesj-1122	97	32	less	less	ADJ
cuesj-1122	97	33	than	than	ADP
cuesj-1122	97	34	what	what	PRON
cuesj-1122	97	35	the	the	DET
cuesj-1122	97	36	healthy	healthy	ADJ
cuesj-1122	97	37	group	group	NOUN
cuesj-1122	97	38	’s	’s	PART
cuesj-1122	97	39	serum	serum	NOUN
cuesj-1122	97	40	pth	pth	NOUN
cuesj-1122	97	41	levels	level	NOUN
cuesj-1122	97	42	showed	show	VERB
cuesj-1122	97	43	(	(	PUNCT
cuesj-1122	97	44	p	p	X
cuesj-1122	97	45	<	<	X
cuesj-1122	97	46	0.0001	0.0001	NUM
cuesj-1122	97	47	)	)	PUNCT
cuesj-1122	97	48	,	,	PUNCT
cuesj-1122	97	49	while	while	SCONJ
cuesj-1122	97	50	the	the	DET
cuesj-1122	97	51	serum	serum	NOUN
cuesj-1122	97	52	levels	level	NOUN
cuesj-1122	97	53	of	of	ADP
cuesj-1122	97	54	pth	pth	NOUN
cuesj-1122	97	55	between	between	ADP
cuesj-1122	97	56	covid-19	covid-19	PROPN
cuesj-1122	97	57	patient	patient	NOUN
cuesj-1122	97	58	groups	group	NOUN
cuesj-1122	97	59	were	be	AUX
cuesj-1122	97	60	non	non	ADJ
cuesj-1122	97	61	-	-	ADJ
cuesj-1122	97	62	significant	significant	ADJ
cuesj-1122	97	63	.	.	PUNCT
cuesj-1122	98	1	in	in	ADP
cuesj-1122	98	2	healthy	healthy	ADJ
cuesj-1122	98	3	group	group	NOUN
cuesj-1122	98	4	,	,	PUNCT
cuesj-1122	98	5	the	the	DET
cuesj-1122	98	6	mean	mean	ADJ
cuesj-1122	98	7	±	±	NOUN
cuesj-1122	98	8	sd	sd	NOUN
cuesj-1122	98	9	of	of	ADP
cuesj-1122	98	10	parathyroid	parathyroid	ADJ
cuesj-1122	98	11	hormone	hormone	NOUN
cuesj-1122	98	12	was	be	AUX
cuesj-1122	98	13	45.53	45.53	NUM
cuesj-1122	98	14	±	±	NUM
cuesj-1122	98	15	21.37	21.37	NUM
cuesj-1122	98	16	pg	pg	NOUN
cuesj-1122	98	17	/	/	SYM
cuesj-1122	98	18	ml	ml	ADP
cuesj-1122	98	19	,	,	PUNCT
cuesj-1122	98	20	whereas	whereas	SCONJ
cuesj-1122	98	21	in	in	ADP
cuesj-1122	98	22	a	a	DET
cuesj-1122	98	23	vaccinated	vaccinated	ADJ
cuesj-1122	98	24	group	group	NOUN
cuesj-1122	98	25	of	of	ADP
cuesj-1122	98	26	patients	patient	NOUN
cuesj-1122	98	27	,	,	PUNCT
cuesj-1122	98	28	it	it	PRON
cuesj-1122	98	29	was	be	AUX
cuesj-1122	98	30	25.96	25.96	NUM
cuesj-1122	98	31	±16.81	±16.81	NOUN
cuesj-1122	98	32	pg	pg	X
cuesj-1122	98	33	/	/	SYM
cuesj-1122	98	34	ml	ml	ADP
cuesj-1122	98	35	,	,	PUNCT
cuesj-1122	98	36	and	and	CCONJ
cuesj-1122	98	37	in	in	ADP
cuesj-1122	98	38	unvaccinated	unvaccinated	ADJ
cuesj-1122	98	39	group	group	NOUN
cuesj-1122	98	40	of	of	ADP
cuesj-1122	98	41	patients	patient	NOUN
cuesj-1122	98	42	was	be	AUX
cuesj-1122	98	43	21.06	21.06	NUM
cuesj-1122	98	44	±	±	NUM
cuesj-1122	98	45	15.22	15.22	NUM
cuesj-1122	98	46	pg	pg	NOUN
cuesj-1122	98	47	/	/	SYM
cuesj-1122	98	48	ml	ml	NOUN
cuesj-1122	98	49	.	.	PUNCT
cuesj-1122	99	1	roc	roc	NOUN
cuesj-1122	99	2	analysis	analysis	NOUN
cuesj-1122	99	3	was	be	AUX
cuesj-1122	99	4	carried	carry	VERB
cuesj-1122	99	5	out	out	ADP
cuesj-1122	99	6	to	to	PART
cuesj-1122	99	7	assess	assess	VERB
cuesj-1122	99	8	the	the	DET
cuesj-1122	99	9	diagnostic	diagnostic	ADJ
cuesj-1122	99	10	significance	significance	NOUN
cuesj-1122	99	11	of	of	ADP
cuesj-1122	99	12	pth	pth	NOUN
cuesj-1122	99	13	levels	level	NOUN
cuesj-1122	99	14	among	among	ADP
cuesj-1122	99	15	covid-19	covid-19	PROPN
cuesj-1122	99	16	patients	patient	NOUN
cuesj-1122	99	17	.	.	PUNCT
cuesj-1122	100	1	roc	roc	PROPN
cuesj-1122	100	2	curve	curve	NOUN
cuesj-1122	100	3	results	result	NOUN
cuesj-1122	100	4	show	show	VERB
cuesj-1122	100	5	that	that	SCONJ
cuesj-1122	100	6	the	the	DET
cuesj-1122	100	7	auc	auc	NOUN
cuesj-1122	100	8	in	in	ADP
cuesj-1122	100	9	vaccinated	vaccinated	ADJ
cuesj-1122	100	10	and	and	CCONJ
cuesj-1122	100	11	non	non	ADJ
cuesj-1122	100	12	-	-	ADJ
cuesj-1122	100	13	vaccinated	vaccinated	ADJ
cuesj-1122	100	14	patients	patient	NOUN
cuesj-1122	100	15	respectively	respectively	ADV
cuesj-1122	100	16	were	be	AUX
cuesj-1122	100	17	0.814	0.814	NUM
cuesj-1122	100	18	and	and	CCONJ
cuesj-1122	100	19	0.875	0.875	NUM
cuesj-1122	100	20	with	with	ADP
cuesj-1122	100	21	a	a	DET
cuesj-1122	100	22	p	p	NOUN
cuesj-1122	100	23	-	-	PUNCT
cuesj-1122	100	24	value	value	NOUN
cuesj-1122	100	25	<	<	X
cuesj-1122	100	26	0.0001	0.0001	NUM
cuesj-1122	100	27	.	.	PUNCT
cuesj-1122	101	1	thus	thus	ADV
cuesj-1122	101	2	,	,	PUNCT
cuesj-1122	101	3	the	the	DET
cuesj-1122	101	4	cutoff	cutoff	NOUN
cuesj-1122	101	5	value	value	NOUN
cuesj-1122	101	6	of	of	ADP
cuesj-1122	101	7	pth	pth	NOUN
cuesj-1122	101	8	to	to	PART
cuesj-1122	101	9	predict	predict	VERB
cuesj-1122	101	10	disease	disease	NOUN
cuesj-1122	101	11	severity	severity	NOUN
cuesj-1122	101	12	,	,	PUNCT
cuesj-1122	101	13	sensitivity	sensitivity	NOUN
cuesj-1122	101	14	and	and	CCONJ
cuesj-1122	101	15	specificity	specificity	NOUN
cuesj-1122	101	16	for	for	ADP
cuesj-1122	101	17	vaccinated	vaccinated	ADJ
cuesj-1122	101	18	were	be	AUX
cuesj-1122	101	19	(	(	PUNCT
cuesj-1122	101	20	27.76	27.76	NUM
cuesj-1122	101	21	pg	pg	NOUN
cuesj-1122	101	22	/	/	SYM
cuesj-1122	101	23	ml	ml	PROPN
cuesj-1122	101	24	,	,	PUNCT
cuesj-1122	101	25	73.53	73.53	NUM
cuesj-1122	101	26	%	%	NOUN
cuesj-1122	101	27	and	and	CCONJ
cuesj-1122	101	28	88.64	88.64	NUM
cuesj-1122	101	29	%	%	NOUN
cuesj-1122	101	30	)	)	PUNCT
cuesj-1122	101	31	,	,	PUNCT
cuesj-1122	101	32	unvaccinated	unvaccinate	VERB
cuesj-1122	101	33	group	group	NOUN
cuesj-1122	101	34	was	be	AUX
cuesj-1122	101	35	(	(	PUNCT
cuesj-1122	101	36	27.34	27.34	NUM
cuesj-1122	101	37	pg	pg	NOUN
cuesj-1122	101	38	/	/	SYM
cuesj-1122	101	39	ml	ml	ADP
cuesj-1122	101	40	,	,	PUNCT
cuesj-1122	101	41	82.35	82.35	NUM
cuesj-1122	101	42	,	,	PUNCT
cuesj-1122	101	43	and	and	CCONJ
cuesj-1122	101	44	88.64	88.64	NUM
cuesj-1122	101	45	%	%	NOUN
cuesj-1122	101	46	)	)	PUNCT
cuesj-1122	101	47	respectively	respectively	ADV
cuesj-1122	101	48	,	,	PUNCT
cuesj-1122	101	49	[	[	X
cuesj-1122	101	50	figure	figure	NOUN
cuesj-1122	101	51	9b	9b	NOUN
cuesj-1122	101	52	and	and	CCONJ
cuesj-1122	101	53	table	table	NOUN
cuesj-1122	101	54	4	4	NUM
cuesj-1122	101	55	]	]	PUNCT
cuesj-1122	101	56	.	.	PUNCT
cuesj-1122	102	1	when	when	SCONJ
cuesj-1122	102	2	comparing	compare	VERB
cuesj-1122	102	3	the	the	DET
cuesj-1122	102	4	non	non	ADJ
cuesj-1122	102	5	-	-	ADJ
cuesj-1122	102	6	vaccinated	vaccinated	ADJ
cuesj-1122	102	7	group	group	NOUN
cuesj-1122	102	8	patients	patient	NOUN
cuesj-1122	102	9	to	to	ADP
cuesj-1122	102	10	the	the	DET
cuesj-1122	102	11	control	control	NOUN
cuesj-1122	102	12	category	category	NOUN
cuesj-1122	102	13	,	,	PUNCT
cuesj-1122	102	14	a	a	DET
cuesj-1122	102	15	significant	significant	ADJ
cuesj-1122	102	16	drop	drop	NOUN
cuesj-1122	102	17	in	in	ADP
cuesj-1122	102	18	tsh	tsh	NOUN
cuesj-1122	102	19	was	be	AUX
cuesj-1122	102	20	seen	see	VERB
cuesj-1122	102	21	(	(	PUNCT
cuesj-1122	102	22	p	p	NOUN
cuesj-1122	102	23	=	=	NOUN
cuesj-1122	102	24	0.0295	0.0295	NUM
cuesj-1122	102	25	)	)	PUNCT
cuesj-1122	102	26	,	,	PUNCT
cuesj-1122	102	27	whereas	whereas	SCONJ
cuesj-1122	102	28	the	the	DET
cuesj-1122	102	29	serum	serum	NOUN
cuesj-1122	102	30	concentration	concentration	NOUN
cuesj-1122	102	31	of	of	ADP
cuesj-1122	102	32	tsh	tsh	NOUN
cuesj-1122	102	33	between	between	ADP
cuesj-1122	102	34	vaccinated	vaccinated	ADJ
cuesj-1122	102	35	and	and	CCONJ
cuesj-1122	102	36	non	non	ADJ
cuesj-1122	102	37	-	-	ADJ
cuesj-1122	102	38	vaccinated	vaccinated	ADJ
cuesj-1122	102	39	covid-19	covid-19	PROPN
cuesj-1122	102	40	patients	patient	NOUN
cuesj-1122	102	41	was	be	AUX
cuesj-1122	102	42	non	non	ADJ
cuesj-1122	102	43	-	-	ADJ
cuesj-1122	102	44	significant	significant	ADJ
cuesj-1122	102	45	[	[	X
cuesj-1122	102	46	figure	figure	NOUN
cuesj-1122	102	47	10a	10a	NOUN
cuesj-1122	102	48	]	]	PUNCT
cuesj-1122	102	49	.	.	PUNCT
cuesj-1122	103	1	the	the	DET
cuesj-1122	103	2	mean	mean	ADJ
cuesj-1122	103	3	value	value	NOUN
cuesj-1122	103	4	of	of	ADP
cuesj-1122	103	5	healthy	healthy	ADJ
cuesj-1122	103	6	individuals	individual	NOUN
cuesj-1122	103	7	significantly	significantly	ADV
cuesj-1122	103	8	diminished	diminish	VERB
cuesj-1122	103	9	from	from	ADP
cuesj-1122	103	10	(	(	PUNCT
cuesj-1122	103	11	2.79	2.79	NUM
cuesj-1122	103	12	±2.70	±2.70	PROPN
cuesj-1122	103	13	uiu	uiu	PROPN
cuesj-1122	103	14	/	/	SYM
cuesj-1122	103	15	ml	ml	NOUN
cuesj-1122	103	16	)	)	PUNCT
cuesj-1122	103	17	to	to	ADP
cuesj-1122	103	18	(	(	PUNCT
cuesj-1122	103	19	1.68	1.68	NUM
cuesj-1122	103	20	±	±	NUM
cuesj-1122	103	21	0.95	0.95	NUM
cuesj-1122	103	22	uiu	uiu	PROPN
cuesj-1122	103	23	/	/	SYM
cuesj-1122	103	24	ml	ml	NOUN
cuesj-1122	103	25	)	)	PUNCT
cuesj-1122	103	26	and	and	CCONJ
cuesj-1122	103	27	(	(	PUNCT
cuesj-1122	103	28	1.52	1.52	NUM
cuesj-1122	103	29	±	±	NUM
cuesj-1122	103	30	1.28	1.28	NUM
cuesj-1122	103	31	uiu	uiu	NOUN
cuesj-1122	103	32	/	/	SYM
cuesj-1122	103	33	ml	ml	NOUN
cuesj-1122	103	34	)	)	PUNCT
cuesj-1122	103	35	in	in	ADP
cuesj-1122	103	36	vaccinated	vaccinated	ADJ
cuesj-1122	103	37	and	and	CCONJ
cuesj-1122	103	38	unvaccinated	unvaccinated	ADJ
cuesj-1122	103	39	groups	group	NOUN
cuesj-1122	103	40	,	,	PUNCT
cuesj-1122	103	41	respectively	respectively	ADV
cuesj-1122	103	42	.	.	PUNCT
cuesj-1122	104	1	to	to	PART
cuesj-1122	104	2	determine	determine	VERB
cuesj-1122	104	3	the	the	DET
cuesj-1122	104	4	diagnostic	diagnostic	ADJ
cuesj-1122	104	5	value	value	NOUN
cuesj-1122	104	6	of	of	ADP
cuesj-1122	104	7	tsh	tsh	NOUN
cuesj-1122	104	8	,	,	PUNCT
cuesj-1122	104	9	roc	roc	NOUN
cuesj-1122	104	10	analysis	analysis	NOUN
cuesj-1122	104	11	was	be	AUX
cuesj-1122	104	12	performed	perform	VERB
cuesj-1122	104	13	.	.	PUNCT
cuesj-1122	105	1	in	in	ADP
cuesj-1122	105	2	vaccinated	vaccinated	ADJ
cuesj-1122	105	3	group	group	NOUN
cuesj-1122	105	4	,	,	PUNCT
cuesj-1122	105	5	the	the	DET
cuesj-1122	105	6	auc	auc	NOUN
cuesj-1122	105	7	was	be	AUX
cuesj-1122	105	8	0.594	0.594	NUM
cuesj-1122	105	9	and	and	CCONJ
cuesj-1122	105	10	the	the	DET
cuesj-1122	105	11	cutoff	cutoff	NOUN
cuesj-1122	105	12	value	value	NOUN
cuesj-1122	105	13	serum	serum	NOUN
cuesj-1122	105	14	of	of	ADP
cuesj-1122	105	15	tsh	tsh	ADJ
cuesj-1122	105	16	level	level	NOUN
cuesj-1122	105	17	was	be	AUX
cuesj-1122	105	18	3.705	3.705	NUM
cuesj-1122	105	19	uiu	uiu	NOUN
cuesj-1122	105	20	/	/	SYM
cuesj-1122	105	21	ml	ml	NOUN
cuesj-1122	105	22	with	with	ADP
cuesj-1122	105	23	a	a	DET
cuesj-1122	105	24	sensitivity	sensitivity	NOUN
cuesj-1122	105	25	of	of	ADP
cuesj-1122	105	26	100.0	100.0	NUM
cuesj-1122	105	27	%	%	NOUN
cuesj-1122	105	28	and	and	CCONJ
cuesj-1122	105	29	specificity	specificity	NOUN
cuesj-1122	105	30	of	of	ADP
cuesj-1122	105	31	23.40	23.40	NUM
cuesj-1122	105	32	%	%	NOUN
cuesj-1122	105	33	.	.	PUNCT
cuesj-1122	106	1	while	while	SCONJ
cuesj-1122	106	2	the	the	DET
cuesj-1122	106	3	non	non	ADJ
cuesj-1122	106	4	-	-	ADJ
cuesj-1122	106	5	vaccinated	vaccinated	ADJ
cuesj-1122	106	6	group	group	NOUN
cuesj-1122	106	7	occupied	occupy	VERB
cuesj-1122	106	8	a	a	DET
cuesj-1122	106	9	significant	significant	ADJ
cuesj-1122	106	10	auc	auc	NOUN
cuesj-1122	106	11	,	,	PUNCT
cuesj-1122	106	12	which	which	PRON
cuesj-1122	106	13	was	be	AUX
cuesj-1122	106	14	0.679	0.679	NUM
cuesj-1122	106	15	(	(	PUNCT
cuesj-1122	106	16	p	p	X
cuesj-1122	106	17	=	=	PROPN
cuesj-1122	106	18	0.0096	0.0096	NUM
cuesj-1122	106	19	)	)	PUNCT
cuesj-1122	106	20	;	;	PUNCT
cuesj-1122	106	21	the	the	DET
cuesj-1122	106	22	cutoff	cutoff	NOUN
cuesj-1122	106	23	value	value	NOUN
cuesj-1122	106	24	was	be	AUX
cuesj-1122	106	25	1.025	1.025	NUM
cuesj-1122	106	26	uiu	uiu	NOUN
cuesj-1122	106	27	/	/	SYM
cuesj-1122	106	28	ml	ml	PROPN
cuesj-1122	106	29	of	of	ADP
cuesj-1122	106	30	serum	serum	NOUN
cuesj-1122	106	31	tsh	tsh	NOUN
cuesj-1122	106	32	level	level	NOUN
cuesj-1122	106	33	,	,	PUNCT
cuesj-1122	106	34	the	the	DET
cuesj-1122	106	35	sensitivity	sensitivity	NOUN
cuesj-1122	106	36	and	and	CCONJ
cuesj-1122	106	37	specificity	specificity	NOUN
cuesj-1122	106	38	were	be	AUX
cuesj-1122	106	39	46.43	46.43	NUM
cuesj-1122	106	40	%	%	NOUN
cuesj-1122	106	41	and	and	CCONJ
cuesj-1122	106	42	91.49	91.49	NUM
cuesj-1122	106	43	%	%	NOUN
cuesj-1122	106	44	,	,	PUNCT
cuesj-1122	106	45	respectively	respectively	ADV
cuesj-1122	107	1	[	[	X
cuesj-1122	107	2	figure	figure	NOUN
cuesj-1122	107	3	10b	10b	NOUN
cuesj-1122	107	4	and	and	CCONJ
cuesj-1122	107	5	table	table	NOUN
cuesj-1122	107	6	4	4	NUM
cuesj-1122	107	7	]	]	PUNCT
cuesj-1122	107	8	.	.	PUNCT
cuesj-1122	108	1	figure	figure	VERB
cuesj-1122	108	2	7	7	NUM
cuesj-1122	108	3	:	:	PUNCT
cuesj-1122	108	4	(	(	PUNCT
cuesj-1122	108	5	a	a	X
cuesj-1122	108	6	)	)	PUNCT
cuesj-1122	108	7	comparison	comparison	NOUN
cuesj-1122	108	8	of	of	ADP
cuesj-1122	108	9	calcium	calcium	NOUN
cuesj-1122	108	10	concentration	concentration	NOUN
cuesj-1122	108	11	in	in	ADP
cuesj-1122	108	12	control	control	NOUN
cuesj-1122	108	13	and	and	CCONJ
cuesj-1122	108	14	patient	patient	ADJ
cuesj-1122	108	15	groups	group	NOUN
cuesj-1122	108	16	.	.	PUNCT
cuesj-1122	109	1	(	(	PUNCT
cuesj-1122	109	2	b	b	X
cuesj-1122	109	3	)	)	PUNCT
cuesj-1122	109	4	the	the	DET
cuesj-1122	109	5	area	area	NOUN
cuesj-1122	109	6	under	under	ADP
cuesj-1122	109	7	the	the	DET
cuesj-1122	109	8	curve	curve	NOUN
cuesj-1122	109	9	value	value	NOUN
cuesj-1122	109	10	shows	show	VERB
cuesj-1122	109	11	calcium	calcium	NOUN
cuesj-1122	109	12	as	as	ADP
cuesj-1122	109	13	a	a	DET
cuesj-1122	109	14	biomarker	biomarker	NOUN
cuesj-1122	109	15	of	of	ADP
cuesj-1122	109	16	the	the	DET
cuesj-1122	109	17	patients	patient	NOUN
cuesj-1122	109	18	’	'	PUNCT
cuesj-1122	109	19	group	group	NOUN
cuesj-1122	109	20	ba	ba	PROPN
cuesj-1122	109	21	figure	figure	NOUN
cuesj-1122	109	22	8	8	NUM
cuesj-1122	109	23	:	:	PUNCT
cuesj-1122	109	24	(	(	PUNCT
cuesj-1122	109	25	a	a	X
cuesj-1122	109	26	)	)	PUNCT
cuesj-1122	109	27	comparison	comparison	NOUN
cuesj-1122	109	28	of	of	ADP
cuesj-1122	109	29	phosphate	phosphate	ADJ
cuesj-1122	109	30	concentration	concentration	NOUN
cuesj-1122	109	31	in	in	ADP
cuesj-1122	109	32	control	control	NOUN
cuesj-1122	109	33	and	and	CCONJ
cuesj-1122	109	34	patient	patient	ADJ
cuesj-1122	109	35	groups	group	NOUN
cuesj-1122	109	36	.	.	PUNCT
cuesj-1122	110	1	(	(	PUNCT
cuesj-1122	110	2	b	b	X
cuesj-1122	110	3	)	)	PUNCT
cuesj-1122	110	4	the	the	DET
cuesj-1122	110	5	area	area	NOUN
cuesj-1122	110	6	under	under	ADP
cuesj-1122	110	7	the	the	DET
cuesj-1122	110	8	curve	curve	NOUN
cuesj-1122	110	9	value	value	NOUN
cuesj-1122	110	10	shows	shows	AUX
cuesj-1122	110	11	phosphate	phosphate	VERB
cuesj-1122	110	12	as	as	ADP
cuesj-1122	110	13	a	a	DET
cuesj-1122	110	14	biomarker	biomarker	NOUN
cuesj-1122	110	15	of	of	ADP
cuesj-1122	110	16	the	the	DET
cuesj-1122	110	17	patients	patient	NOUN
cuesj-1122	110	18	’	'	PUNCT
cuesj-1122	110	19	group	group	NOUN
cuesj-1122	110	20	ba	ba	PROPN
cuesj-1122	110	21	ahmed	ahmed	PROPN
cuesj-1122	110	22	,	,	PUNCT
cuesj-1122	110	23	et	et	PROPN
cuesj-1122	110	24	al	al	PROPN
cuesj-1122	110	25	.	.	PUNCT
cuesj-1122	110	26	:	:	PUNCT
cuesj-1122	111	1	comparison	comparison	NOUN
cuesj-1122	111	2	of	of	ADP
cuesj-1122	111	3	biochemical	biochemical	ADJ
cuesj-1122	111	4	parameters	parameter	NOUN
cuesj-1122	111	5	in	in	ADP
cuesj-1122	111	6	vaccinated	vaccinated	ADJ
cuesj-1122	111	7	53	53	NUM
cuesj-1122	111	8	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1122	111	9	cuesj	cuesj	NOUN
cuesj-1122	111	10	2024	2024	NUM
cuesj-1122	111	11	,	,	PUNCT
cuesj-1122	111	12	8	8	NUM
cuesj-1122	111	13	(	(	PUNCT
cuesj-1122	111	14	1	1	NUM
cuesj-1122	111	15	):	):	PUNCT
cuesj-1122	111	16	46	46	NUM
cuesj-1122	111	17	-	-	SYM
cuesj-1122	111	18	57	57	NUM
cuesj-1122	111	19	discussion	discussion	NOUN
cuesj-1122	111	20	“	"	PUNCT
cuesj-1122	111	21	covid-19	covid-19	PROPN
cuesj-1122	111	22	represents	represent	VERB
cuesj-1122	111	23	a	a	DET
cuesj-1122	111	24	wide	wide	ADJ
cuesj-1122	111	25	spectrum	spectrum	NOUN
cuesj-1122	111	26	of	of	ADP
cuesj-1122	111	27	clinical	clinical	ADJ
cuesj-1122	111	28	presentations	presentation	NOUN
cuesj-1122	111	29	,	,	PUNCT
cuesj-1122	111	30	from	from	ADP
cuesj-1122	111	31	asymptomatic	asymptomatic	ADJ
cuesj-1122	111	32	to	to	ADP
cuesj-1122	111	33	critical	critical	ADJ
cuesj-1122	111	34	pneumonia	pneumonia	NOUN
cuesj-1122	111	35	,	,	PUNCT
cuesj-1122	111	36	acute	acute	ADJ
cuesj-1122	111	37	respiratory	respiratory	ADJ
cuesj-1122	111	38	distress	distress	NOUN
cuesj-1122	111	39	syndrome	syndrome	NOUN
cuesj-1122	111	40	(	(	PUNCT
cuesj-1122	111	41	ards	ard	NOUN
cuesj-1122	111	42	)	)	PUNCT
cuesj-1122	111	43	,	,	PUNCT
cuesj-1122	111	44	and	and	CCONJ
cuesj-1122	111	45	even	even	ADV
cuesj-1122	111	46	death.[30	death.[30	X
cuesj-1122	111	47	]	]	PUNCT
cuesj-1122	111	48	in	in	ADP
cuesj-1122	111	49	this	this	DET
cuesj-1122	111	50	study	study	NOUN
cuesj-1122	111	51	,	,	PUNCT
cuesj-1122	111	52	vaccinated	vaccinated	ADJ
cuesj-1122	111	53	and	and	CCONJ
cuesj-1122	111	54	non	non	ADJ
cuesj-1122	111	55	-	-	ADJ
cuesj-1122	111	56	vaccinated	vaccinated	ADJ
cuesj-1122	111	57	covid-19	covid-19	PROPN
cuesj-1122	111	58	patients	patient	NOUN
cuesj-1122	111	59	were	be	AUX
cuesj-1122	111	60	admitted	admit	VERB
cuesj-1122	111	61	.	.	PUNCT
cuesj-1122	112	1	laboratory	laboratory	NOUN
cuesj-1122	112	2	tests	test	NOUN
cuesj-1122	112	3	provide	provide	VERB
cuesj-1122	112	4	critical	critical	ADJ
cuesj-1122	112	5	support	support	NOUN
cuesj-1122	112	6	for	for	ADP
cuesj-1122	112	7	the	the	DET
cuesj-1122	112	8	proper	proper	ADJ
cuesj-1122	112	9	clinical	clinical	ADJ
cuesj-1122	112	10	management	management	NOUN
cuesj-1122	112	11	of	of	ADP
cuesj-1122	112	12	covid-19	covid-19	PROPN
cuesj-1122	112	13	from	from	ADP
cuesj-1122	112	14	screening	screen	VERB
cuesj-1122	112	15	to	to	ADP
cuesj-1122	112	16	diagnosis	diagnosis	NOUN
cuesj-1122	112	17	,	,	PUNCT
cuesj-1122	112	18	prognosis	prognosis	NOUN
cuesj-1122	112	19	,	,	PUNCT
cuesj-1122	112	20	and	and	CCONJ
cuesj-1122	112	21	monitoring.[31	monitoring.[31	PROPN
cuesj-1122	112	22	]	]	PUNCT
cuesj-1122	112	23	liver	liver	NOUN
cuesj-1122	112	24	damage	damage	NOUN
cuesj-1122	112	25	is	be	AUX
cuesj-1122	112	26	prevalent	prevalent	ADJ
cuesj-1122	112	27	in	in	ADP
cuesj-1122	112	28	covid-19	covid-19	PROPN
cuesj-1122	112	29	patients	patient	NOUN
cuesj-1122	112	30	,	,	PUNCT
cuesj-1122	112	31	and	and	CCONJ
cuesj-1122	112	32	it	it	PRON
cuesj-1122	112	33	can	can	AUX
cuesj-1122	112	34	be	be	AUX
cuesj-1122	112	35	brought	bring	VERB
cuesj-1122	112	36	on	on	ADP
cuesj-1122	112	37	by	by	ADP
cuesj-1122	112	38	an	an	DET
cuesj-1122	112	39	antiviral	antiviral	ADJ
cuesj-1122	112	40	medication	medication	NOUN
cuesj-1122	112	41	’s	’s	PART
cuesj-1122	112	42	functional	functional	ADJ
cuesj-1122	112	43	impairment	impairment	NOUN
cuesj-1122	112	44	or	or	CCONJ
cuesj-1122	112	45	a	a	DET
cuesj-1122	112	46	viral	viral	ADJ
cuesj-1122	112	47	infection	infection	NOUN
cuesj-1122	112	48	of	of	ADP
cuesj-1122	112	49	the	the	DET
cuesj-1122	112	50	bile	bile	NOUN
cuesj-1122	112	51	duct	duct	NOUN
cuesj-1122	112	52	cells	cell	NOUN
cuesj-1122	112	53	.	.	PUNCT
cuesj-1122	113	1	changes	change	NOUN
cuesj-1122	113	2	in	in	ADP
cuesj-1122	113	3	the	the	DET
cuesj-1122	113	4	primary	primary	ADJ
cuesj-1122	113	5	liver	liver	NOUN
cuesj-1122	113	6	disease	disease	NOUN
cuesj-1122	113	7	should	should	AUX
cuesj-1122	113	8	be	be	AUX
cuesj-1122	113	9	monitored	monitor	VERB
cuesj-1122	113	10	in	in	ADP
cuesj-1122	113	11	patients	patient	NOUN
cuesj-1122	113	12	with	with	ADP
cuesj-1122	113	13	liver	liver	NOUN
cuesj-1122	113	14	illnesses	illness	NOUN
cuesj-1122	113	15	,	,	PUNCT
cuesj-1122	113	16	and	and	CCONJ
cuesj-1122	113	17	individuals	individual	NOUN
cuesj-1122	113	18	with	with	ADP
cuesj-1122	113	19	severe	severe	ADJ
cuesj-1122	113	20	diseases	disease	NOUN
cuesj-1122	113	21	should	should	AUX
cuesj-1122	113	22	have	have	VERB
cuesj-1122	113	23	more	more	ADJ
cuesj-1122	113	24	frequent	frequent	ADJ
cuesj-1122	113	25	monitoring	monitoring	NOUN
cuesj-1122	113	26	and	and	CCONJ
cuesj-1122	113	27	evaluation	evaluation	NOUN
cuesj-1122	113	28	of	of	ADP
cuesj-1122	113	29	their	their	PRON
cuesj-1122	113	30	liver	liver	NOUN
cuesj-1122	113	31	function	function	NOUN
cuesj-1122	113	32	during	during	ADP
cuesj-1122	113	33	medication.[32	medication.[32	PROPN
cuesj-1122	113	34	]	]	PUNCT
cuesj-1122	113	35	according	accord	VERB
cuesj-1122	113	36	to	to	ADP
cuesj-1122	113	37	the	the	DET
cuesj-1122	113	38	results	result	NOUN
cuesj-1122	113	39	of	of	ADP
cuesj-1122	113	40	the	the	DET
cuesj-1122	113	41	present	present	ADJ
cuesj-1122	113	42	study	study	NOUN
cuesj-1122	113	43	,	,	PUNCT
cuesj-1122	113	44	the	the	DET
cuesj-1122	113	45	alterations	alteration	NOUN
cuesj-1122	113	46	were	be	AUX
cuesj-1122	113	47	identified	identify	VERB
cuesj-1122	113	48	in	in	ADP
cuesj-1122	113	49	the	the	DET
cuesj-1122	113	50	average	average	ADJ
cuesj-1122	113	51	levels	level	NOUN
cuesj-1122	113	52	of	of	ADP
cuesj-1122	113	53	alt	alt	ADJ
cuesj-1122	113	54	,	,	PUNCT
cuesj-1122	113	55	ast	ast	PROPN
cuesj-1122	113	56	,	,	PUNCT
cuesj-1122	113	57	alp	alp	PROPN
cuesj-1122	113	58	,	,	PUNCT
cuesj-1122	113	59	ldh	ldh	PROPN
cuesj-1122	113	60	,	,	PUNCT
cuesj-1122	113	61	tsb	tsb	ADJ
cuesj-1122	113	62	,	,	PUNCT
cuesj-1122	113	63	and	and	CCONJ
cuesj-1122	113	64	albumin	albumin	NOUN
cuesj-1122	113	65	.	.	PUNCT
cuesj-1122	113	66	”	"	PUNCT
cuesj-1122	114	1	this	this	DET
cuesj-1122	114	2	result	result	NOUN
cuesj-1122	114	3	supported	support	VERB
cuesj-1122	114	4	by	by	ADP
cuesj-1122	114	5	wu	wu	PROPN
cuesj-1122	114	6	et	et	PROPN
cuesj-1122	114	7	al.[33	al.[33	PROPN
cuesj-1122	114	8	]	]	PUNCT
cuesj-1122	114	9	who	who	PRON
cuesj-1122	114	10	stated	state	VERB
cuesj-1122	114	11	that	that	SCONJ
cuesj-1122	114	12	decreased	decrease	VERB
cuesj-1122	114	13	albumin	albumin	ADJ
cuesj-1122	114	14	levels	level	NOUN
cuesj-1122	114	15	and	and	CCONJ
cuesj-1122	114	16	increased	increase	VERB
cuesj-1122	114	17	ggt	ggt	PROPN
cuesj-1122	114	18	,	,	PUNCT
cuesj-1122	114	19	ast	ast	NOUN
cuesj-1122	114	20	,	,	PUNCT
cuesj-1122	114	21	and	and	CCONJ
cuesj-1122	114	22	alt	alt	VERB
cuesj-1122	114	23	levels	level	NOUN
cuesj-1122	114	24	are	be	AUX
cuesj-1122	114	25	present	present	ADJ
cuesj-1122	114	26	in	in	ADP
cuesj-1122	114	27	individuals	individual	NOUN
cuesj-1122	114	28	with	with	ADP
cuesj-1122	114	29	severe	severe	ADJ
cuesj-1122	114	30	covid-19	covid-19	PROPN
cuesj-1122	114	31	.	.	PUNCT
cuesj-1122	115	1	liver	liver	NOUN
cuesj-1122	115	2	tests	test	NOUN
cuesj-1122	115	3	including	include	VERB
cuesj-1122	115	4	the	the	DET
cuesj-1122	115	5	liver	liver	NOUN
cuesj-1122	115	6	enzymes	enzyme	NOUN
cuesj-1122	115	7	should	should	AUX
cuesj-1122	115	8	be	be	AUX
cuesj-1122	115	9	monitored	monitor	VERB
cuesj-1122	115	10	for	for	ADP
cuesj-1122	115	11	diagnosing	diagnose	VERB
cuesj-1122	115	12	liver	liver	NOUN
cuesj-1122	115	13	damage.[34	damage.[34	PROPN
cuesj-1122	115	14	]	]	PUNCT
cuesj-1122	115	15	while	while	SCONJ
cuesj-1122	115	16	some	some	DET
cuesj-1122	115	17	research	research	NOUN
cuesj-1122	115	18	revealed	reveal	VERB
cuesj-1122	115	19	no	no	DET
cuesj-1122	115	20	correlation	correlation	NOUN
cuesj-1122	115	21	between	between	ADP
cuesj-1122	115	22	abnormal	abnormal	ADJ
cuesj-1122	115	23	lfts	lft	NOUN
cuesj-1122	115	24	and	and	CCONJ
cuesj-1122	115	25	death	death	NOUN
cuesj-1122	115	26	,	,	PUNCT
cuesj-1122	115	27	disease	disease	NOUN
cuesj-1122	115	28	progression	progression	NOUN
cuesj-1122	115	29	,	,	PUNCT
cuesj-1122	115	30	icu	icu	PROPN
cuesj-1122	115	31	admission	admission	NOUN
cuesj-1122	115	32	,	,	PUNCT
cuesj-1122	115	33	or	or	CCONJ
cuesj-1122	115	34	length	length	NOUN
cuesj-1122	115	35	of	of	ADP
cuesj-1122	115	36	hospital	hospital	NOUN
cuesj-1122	115	37	stay	stay	NOUN
cuesj-1122	115	38	,	,	PUNCT
cuesj-1122	115	39	other	other	ADJ
cuesj-1122	115	40	studies	study	NOUN
cuesj-1122	115	41	identified	identify	VERB
cuesj-1122	115	42	a	a	DET
cuesj-1122	115	43	relationship	relationship	NOUN
cuesj-1122	115	44	between	between	ADP
cuesj-1122	115	45	abnormal	abnormal	ADJ
cuesj-1122	115	46	liver	liver	NOUN
cuesj-1122	115	47	function	function	NOUN
cuesj-1122	115	48	tests	test	NOUN
cuesj-1122	115	49	(	(	PUNCT
cuesj-1122	115	50	lfts	lft	NOUN
cuesj-1122	115	51	)	)	PUNCT
cuesj-1122	115	52	and	and	CCONJ
cuesj-1122	115	53	increased	increase	VERB
cuesj-1122	115	54	disease	disease	NOUN
cuesj-1122	115	55	severity	severity	NOUN
cuesj-1122	115	56	and	and	CCONJ
cuesj-1122	115	57	death	death	NOUN
cuesj-1122	115	58	rates	rate	NOUN
cuesj-1122	115	59	,	,	PUNCT
cuesj-1122	115	60	particularly	particularly	ADV
cuesj-1122	115	61	raised	raise	VERB
cuesj-1122	115	62	ast	ast	NOUN
cuesj-1122	115	63	and	and	CCONJ
cuesj-1122	115	64	alt.[35	alt.[35	NOUN
cuesj-1122	115	65	]	]	X
cuesj-1122	115	66	the	the	DET
cuesj-1122	115	67	higher	high	ADJ
cuesj-1122	115	68	expression	expression	NOUN
cuesj-1122	115	69	levels	level	NOUN
cuesj-1122	115	70	of	of	ADP
cuesj-1122	115	71	ace2	ace2	PROPN
cuesj-1122	115	72	in	in	ADP
cuesj-1122	115	73	the	the	DET
cuesj-1122	115	74	cholangiocytes	cholangiocyte	NOUN
cuesj-1122	115	75	and	and	CCONJ
cuesj-1122	115	76	the	the	DET
cuesj-1122	115	77	changes	change	NOUN
cuesj-1122	115	78	in	in	ADP
cuesj-1122	115	79	liver	liver	NOUN
cuesj-1122	115	80	parameters	parameter	NOUN
cuesj-1122	115	81	in	in	ADP
cuesj-1122	115	82	individuals	individual	NOUN
cuesj-1122	115	83	with	with	ADP
cuesj-1122	115	84	acute	acute	ADJ
cuesj-1122	115	85	and	and	CCONJ
cuesj-1122	115	86	prolonged	prolong	VERB
cuesj-1122	115	87	covid-19	covid-19	PROPN
cuesj-1122	115	88	,	,	PUNCT
cuesj-1122	115	89	without	without	ADP
cuesj-1122	115	90	concurrent	concurrent	ADJ
cuesj-1122	115	91	increase	increase	NOUN
cuesj-1122	115	92	of	of	ADP
cuesj-1122	115	93	tsb	tsb	NOUN
cuesj-1122	115	94	levels	level	NOUN
cuesj-1122	115	95	,	,	PUNCT
cuesj-1122	115	96	point	point	VERB
cuesj-1122	115	97	to	to	ADP
cuesj-1122	115	98	a	a	DET
cuesj-1122	115	99	persistent	persistent	ADJ
cuesj-1122	115	100	systemic	systemic	ADJ
cuesj-1122	115	101	inflammatory	inflammatory	ADJ
cuesj-1122	115	102	response	response	NOUN
cuesj-1122	115	103	in	in	ADP
cuesj-1122	115	104	these	these	DET
cuesj-1122	115	105	patients.[36	patients.[36	NOUN
cuesj-1122	115	106	]	]	PUNCT
cuesj-1122	115	107	patients	patient	NOUN
cuesj-1122	115	108	with	with	ADP
cuesj-1122	115	109	severe	severe	ADJ
cuesj-1122	115	110	covid-19	covid-19	PROPN
cuesj-1122	115	111	had	have	VERB
cuesj-1122	115	112	higher	high	ADJ
cuesj-1122	115	113	levels	level	NOUN
cuesj-1122	115	114	of	of	ADP
cuesj-1122	115	115	ast	ast	NOUN
cuesj-1122	115	116	and	and	CCONJ
cuesj-1122	115	117	alt	alt	ADJ
cuesj-1122	115	118	,	,	PUNCT
cuesj-1122	115	119	according	accord	VERB
cuesj-1122	115	120	to	to	ADP
cuesj-1122	115	121	findings	finding	NOUN
cuesj-1122	115	122	from	from	ADP
cuesj-1122	115	123	china.[37	china.[37	PROPN
cuesj-1122	115	124	-	-	PUNCT
cuesj-1122	115	125	39	39	NUM
cuesj-1122	115	126	]	]	PUNCT
cuesj-1122	115	127	numerous	numerous	ADJ
cuesj-1122	115	128	investigations	investigation	NOUN
cuesj-1122	115	129	have	have	AUX
cuesj-1122	115	130	revealed	reveal	VERB
cuesj-1122	115	131	varying	vary	VERB
cuesj-1122	115	132	degrees	degree	NOUN
cuesj-1122	115	133	of	of	ADP
cuesj-1122	115	134	elevated	elevated	ADJ
cuesj-1122	115	135	liver	liver	NOUN
cuesj-1122	115	136	enzymes	enzyme	NOUN
cuesj-1122	115	137	in	in	ADP
cuesj-1122	115	138	covid-19	covid-19	PROPN
cuesj-1122	115	139	individuals	individual	NOUN
cuesj-1122	115	140	,	,	PUNCT
cuesj-1122	115	141	primarily	primarily	ADV
cuesj-1122	115	142	manifested	manifest	VERB
cuesj-1122	115	143	by	by	ADP
cuesj-1122	115	144	abnormal	abnormal	ADJ
cuesj-1122	115	145	amounts	amount	NOUN
cuesj-1122	115	146	of	of	ADP
cuesj-1122	115	147	ast	ast	NOUN
cuesj-1122	115	148	and	and	CCONJ
cuesj-1122	115	149	alt	alt	ADJ
cuesj-1122	115	150	,	,	PUNCT
cuesj-1122	115	151	along	along	ADP
cuesj-1122	115	152	with	with	ADP
cuesj-1122	115	153	modestly	modestly	ADV
cuesj-1122	115	154	raised	raise	VERB
cuesj-1122	115	155	levels	level	NOUN
cuesj-1122	115	156	of	of	ADP
cuesj-1122	115	157	ggt	ggt	PROPN
cuesj-1122	115	158	,	,	PUNCT
cuesj-1122	115	159	alp	alp	PROPN
cuesj-1122	115	160	,	,	PUNCT
cuesj-1122	115	161	and	and	CCONJ
cuesj-1122	115	162	tsb.[40	tsb.[40	X
cuesj-1122	115	163	]	]	PUNCT
cuesj-1122	115	164	“	"	PUNCT
cuesj-1122	115	165	in	in	ADP
cuesj-1122	115	166	addition	addition	NOUN
cuesj-1122	115	167	,	,	PUNCT
cuesj-1122	115	168	piano	piano	NOUN
cuesj-1122	115	169	et	et	NOUN
cuesj-1122	115	170	al.[41	al.[41	PROPN
cuesj-1122	115	171	]	]	PUNCT
cuesj-1122	115	172	showed	show	VERB
cuesj-1122	115	173	that	that	SCONJ
cuesj-1122	115	174	lfts	lfts	ADJ
cuesj-1122	115	175	abnormality	abnormality	NOUN
cuesj-1122	115	176	is	be	AUX
cuesj-1122	115	177	commonly	commonly	ADV
cuesj-1122	115	178	observed	observe	VERB
cuesj-1122	115	179	on	on	ADP
cuesj-1122	115	180	admission	admission	NOUN
cuesj-1122	115	181	in	in	ADP
cuesj-1122	115	182	patients	patient	NOUN
cuesj-1122	115	183	with	with	ADP
cuesj-1122	115	184	covid-19	covid-19	PROPN
cuesj-1122	115	185	and	and	CCONJ
cuesj-1122	115	186	it	it	PRON
cuesj-1122	115	187	is	be	AUX
cuesj-1122	115	188	associated	associate	VERB
cuesj-1122	115	189	with	with	ADP
cuesj-1122	115	190	systemic	systemic	ADJ
cuesj-1122	115	191	inflammation	inflammation	NOUN
cuesj-1122	115	192	,	,	PUNCT
cuesj-1122	115	193	organ	organ	NOUN
cuesj-1122	115	194	dysfunction	dysfunction	NOUN
cuesj-1122	115	195	and	and	CCONJ
cuesj-1122	115	196	is	be	AUX
cuesj-1122	115	197	an	an	DET
cuesj-1122	115	198	independent	independent	ADJ
cuesj-1122	115	199	predictor	predictor	NOUN
cuesj-1122	115	200	of	of	ADP
cuesj-1122	115	201	transfer	transfer	NOUN
cuesj-1122	115	202	to	to	ADP
cuesj-1122	115	203	the	the	DET
cuesj-1122	115	204	icu	icu	NOUN
cuesj-1122	115	205	or	or	CCONJ
cuesj-1122	115	206	death	death	NOUN
cuesj-1122	115	207	during	during	ADP
cuesj-1122	115	208	the	the	DET
cuesj-1122	115	209	hospitalization	hospitalization	NOUN
cuesj-1122	115	210	.	.	PUNCT
cuesj-1122	116	1	in	in	ADP
cuesj-1122	116	2	covid-19	covid-19	PROPN
cuesj-1122	116	3	disease	disease	NOUN
cuesj-1122	116	4	a	a	DET
cuesj-1122	116	5	similar	similar	ADJ
cuesj-1122	116	6	trend	trend	NOUN
cuesj-1122	116	7	was	be	AUX
cuesj-1122	116	8	found	find	VERB
cuesj-1122	116	9	;	;	PUNCT
cuesj-1122	116	10	analysis	analysis	NOUN
cuesj-1122	116	11	of	of	ADP
cuesj-1122	116	12	11	11	NUM
cuesj-1122	116	13	studies	study	NOUN
cuesj-1122	116	14	aziz	aziz	PROPN
cuesj-1122	116	15	et	et	PROPN
cuesj-1122	116	16	al.[42	al.[42	PROPN
cuesj-1122	116	17	]	]	PUNCT
cuesj-1122	116	18	which	which	PRON
cuesj-1122	116	19	showed	show	VERB
cuesj-1122	116	20	that	that	SCONJ
cuesj-1122	116	21	the	the	DET
cuesj-1122	116	22	mean	mean	ADJ
cuesj-1122	116	23	serum	serum	NOUN
cuesj-1122	116	24	of	of	ADP
cuesj-1122	116	25	albumin	albumin	NOUN
cuesj-1122	116	26	on	on	ADP
cuesj-1122	116	27	admission	admission	NOUN
cuesj-1122	116	28	was	be	AUX
cuesj-1122	116	29	3.50	3.50	NUM
cuesj-1122	116	30	g	g	NOUN
cuesj-1122	116	31	/	/	SYM
cuesj-1122	116	32	dl	dl	PROPN
cuesj-1122	116	33	and	and	CCONJ
cuesj-1122	116	34	4.05	4.05	NUM
cuesj-1122	116	35	g	g	NOUN
cuesj-1122	116	36	/	/	SYM
cuesj-1122	116	37	dl	dl	PROPN
cuesj-1122	116	38	in	in	ADP
cuesj-1122	116	39	severe	severe	ADJ
cuesj-1122	116	40	and	and	CCONJ
cuesj-1122	116	41	non	non	ADJ
cuesj-1122	116	42	-	-	ADJ
cuesj-1122	116	43	severe	severe	ADJ
cuesj-1122	116	44	covid-19	covid-19	PROPN
cuesj-1122	116	45	,	,	PUNCT
cuesj-1122	116	46	figure	figure	VERB
cuesj-1122	116	47	9	9	NUM
cuesj-1122	116	48	:	:	PUNCT
cuesj-1122	116	49	(	(	PUNCT
cuesj-1122	116	50	a	a	X
cuesj-1122	116	51	)	)	PUNCT
cuesj-1122	116	52	comparison	comparison	NOUN
cuesj-1122	116	53	of	of	ADP
cuesj-1122	116	54	pth	pth	NOUN
cuesj-1122	116	55	concentration	concentration	NOUN
cuesj-1122	116	56	in	in	ADP
cuesj-1122	116	57	control	control	NOUN
cuesj-1122	116	58	and	and	CCONJ
cuesj-1122	116	59	patient	patient	ADJ
cuesj-1122	116	60	groups	group	NOUN
cuesj-1122	116	61	.	.	PUNCT
cuesj-1122	117	1	(	(	PUNCT
cuesj-1122	117	2	b	b	X
cuesj-1122	117	3	)	)	PUNCT
cuesj-1122	117	4	the	the	DET
cuesj-1122	117	5	area	area	NOUN
cuesj-1122	117	6	under	under	ADP
cuesj-1122	117	7	the	the	DET
cuesj-1122	117	8	curve	curve	NOUN
cuesj-1122	117	9	value	value	NOUN
cuesj-1122	117	10	shows	show	VERB
cuesj-1122	117	11	pth	pth	NOUN
cuesj-1122	117	12	as	as	ADP
cuesj-1122	117	13	a	a	DET
cuesj-1122	117	14	biomarker	biomarker	NOUN
cuesj-1122	117	15	of	of	ADP
cuesj-1122	117	16	the	the	DET
cuesj-1122	117	17	patients	patient	NOUN
cuesj-1122	117	18	’	'	PUNCT
cuesj-1122	117	19	group	group	NOUN
cuesj-1122	117	20	ba	ba	PROPN
cuesj-1122	117	21	figure	figure	NOUN
cuesj-1122	117	22	10	10	NUM
cuesj-1122	117	23	:	:	PUNCT
cuesj-1122	117	24	(	(	PUNCT
cuesj-1122	117	25	a	a	X
cuesj-1122	117	26	)	)	PUNCT
cuesj-1122	117	27	comparison	comparison	NOUN
cuesj-1122	117	28	of	of	ADP
cuesj-1122	117	29	tsh	tsh	ADJ
cuesj-1122	117	30	concentration	concentration	NOUN
cuesj-1122	117	31	in	in	ADP
cuesj-1122	117	32	control	control	NOUN
cuesj-1122	117	33	and	and	CCONJ
cuesj-1122	117	34	patient	patient	ADJ
cuesj-1122	117	35	groups	group	NOUN
cuesj-1122	117	36	.	.	PUNCT
cuesj-1122	118	1	(	(	PUNCT
cuesj-1122	118	2	b	b	X
cuesj-1122	118	3	)	)	PUNCT
cuesj-1122	118	4	the	the	DET
cuesj-1122	118	5	area	area	NOUN
cuesj-1122	118	6	under	under	ADP
cuesj-1122	118	7	the	the	DET
cuesj-1122	118	8	curve	curve	NOUN
cuesj-1122	118	9	value	value	NOUN
cuesj-1122	118	10	shows	show	VERB
cuesj-1122	118	11	tsh	tsh	NOUN
cuesj-1122	118	12	as	as	ADP
cuesj-1122	118	13	a	a	DET
cuesj-1122	118	14	biomarker	biomarker	NOUN
cuesj-1122	118	15	of	of	ADP
cuesj-1122	118	16	the	the	DET
cuesj-1122	118	17	patients	patient	NOUN
cuesj-1122	118	18	’	'	PUNCT
cuesj-1122	118	19	group	group	NOUN
cuesj-1122	118	20	ba	ba	PROPN
cuesj-1122	118	21	ahmed	ahmed	PROPN
cuesj-1122	118	22	,	,	PUNCT
cuesj-1122	118	23	et	et	PROPN
cuesj-1122	118	24	al	al	PROPN
cuesj-1122	118	25	.	.	PUNCT
cuesj-1122	118	26	:	:	PUNCT
cuesj-1122	119	1	comparison	comparison	NOUN
cuesj-1122	119	2	of	of	ADP
cuesj-1122	119	3	biochemical	biochemical	ADJ
cuesj-1122	119	4	parameters	parameter	NOUN
cuesj-1122	119	5	in	in	ADP
cuesj-1122	119	6	vaccinated	vaccinated	ADJ
cuesj-1122	119	7	54	54	NUM
cuesj-1122	119	8	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1122	119	9	cuesj	cuesj	NOUN
cuesj-1122	119	10	2024	2024	NUM
cuesj-1122	119	11	,	,	PUNCT
cuesj-1122	119	12	8	8	NUM
cuesj-1122	119	13	(	(	PUNCT
cuesj-1122	119	14	1	1	NUM
cuesj-1122	119	15	):	):	PUNCT
cuesj-1122	119	16	46	46	NUM
cuesj-1122	119	17	-	-	SYM
cuesj-1122	119	18	57	57	NUM
cuesj-1122	119	19	respectively	respectively	ADV
cuesj-1122	119	20	”	"	PUNCT
cuesj-1122	119	21	.	.	PUNCT
cuesj-1122	120	1	our	our	PRON
cuesj-1122	120	2	results	result	NOUN
cuesj-1122	120	3	also	also	ADV
cuesj-1122	120	4	are	be	AUX
cuesj-1122	120	5	consistent	consistent	ADJ
cuesj-1122	120	6	with	with	ADP
cuesj-1122	120	7	a	a	DET
cuesj-1122	120	8	recent	recent	ADJ
cuesj-1122	120	9	study	study	NOUN
cuesj-1122	120	10	by	by	ADP
cuesj-1122	120	11	petimani	petimani	PROPN
cuesj-1122	120	12	et	et	PROPN
cuesj-1122	120	13	al.[43	al.[43	PROPN
cuesj-1122	120	14	]	]	PUNCT
cuesj-1122	120	15	who	who	PRON
cuesj-1122	120	16	showed	show	VERB
cuesj-1122	120	17	that	that	PRON
cuesj-1122	120	18	total	total	ADJ
cuesj-1122	120	19	and	and	CCONJ
cuesj-1122	120	20	direct	direct	ADJ
cuesj-1122	120	21	bilirubin	bilirubin	NOUN
cuesj-1122	120	22	,	,	PUNCT
cuesj-1122	120	23	alt	alt	ADJ
cuesj-1122	120	24	,	,	PUNCT
cuesj-1122	120	25	ast	ast	ADJ
cuesj-1122	120	26	,	,	PUNCT
cuesj-1122	120	27	and	and	CCONJ
cuesj-1122	120	28	alp	alp	PROPN
cuesj-1122	120	29	levels	level	NOUN
cuesj-1122	120	30	were	be	AUX
cuesj-1122	120	31	highly	highly	ADV
cuesj-1122	120	32	increased	increase	VERB
cuesj-1122	120	33	in	in	ADP
cuesj-1122	120	34	unvaccinated	unvaccinate	VERB
cuesj-1122	120	35	group	group	NOUN
cuesj-1122	120	36	.	.	PUNCT
cuesj-1122	121	1	as	as	ADV
cuesj-1122	121	2	well	well	ADV
cuesj-1122	121	3	as	as	ADP
cuesj-1122	122	1	fewer	few	ADJ
cuesj-1122	122	2	levels	level	NOUN
cuesj-1122	122	3	serum	serum	VERB
cuesj-1122	122	4	albumins	albumin	NOUN
cuesj-1122	122	5	and	and	CCONJ
cuesj-1122	122	6	total	total	ADJ
cuesj-1122	122	7	protein	protein	NOUN
cuesj-1122	122	8	were	be	AUX
cuesj-1122	122	9	noted	note	VERB
cuesj-1122	122	10	in	in	ADP
cuesj-1122	122	11	the	the	DET
cuesj-1122	122	12	unvaccinated	unvaccinate	VERB
cuesj-1122	122	13	patients	patient	NOUN
cuesj-1122	122	14	compared	compare	VERB
cuesj-1122	122	15	to	to	ADP
cuesj-1122	122	16	vaccinated	vaccinated	ADJ
cuesj-1122	122	17	individuals	individual	NOUN
cuesj-1122	122	18	.	.	PUNCT
cuesj-1122	123	1	in	in	ADP
cuesj-1122	123	2	addition	addition	NOUN
cuesj-1122	123	3	,	,	PUNCT
cuesj-1122	123	4	in	in	ADP
cuesj-1122	123	5	their	their	PRON
cuesj-1122	123	6	retrospective	retrospective	ADJ
cuesj-1122	123	7	analysis,[44	analysis,[44	NOUN
cuesj-1122	123	8	]	]	PUNCT
cuesj-1122	123	9	found	find	VERB
cuesj-1122	123	10	that	that	SCONJ
cuesj-1122	123	11	the	the	DET
cuesj-1122	123	12	concentration	concentration	NOUN
cuesj-1122	123	13	of	of	ADP
cuesj-1122	123	14	serum	serum	NOUN
cuesj-1122	123	15	alt	alt	NOUN
cuesj-1122	123	16	and	and	CCONJ
cuesj-1122	123	17	ast	ast	VERB
cuesj-1122	123	18	in	in	ADP
cuesj-1122	123	19	unvaccinated	unvaccinate	VERB
cuesj-1122	123	20	patients	patient	NOUN
cuesj-1122	123	21	with	with	ADP
cuesj-1122	123	22	cov-2	cov-2	X
cuesj-1122	123	23	significantly	significantly	ADV
cuesj-1122	123	24	higher	higher	ADV
cuesj-1122	123	25	(	(	PUNCT
cuesj-1122	123	26	p<0.01	p<0.01	PROPN
cuesj-1122	123	27	)	)	PUNCT
cuesj-1122	123	28	than	than	ADP
cuesj-1122	123	29	those	those	PRON
cuesj-1122	123	30	in	in	ADP
cuesj-1122	123	31	vaccinated	vaccinated	ADJ
cuesj-1122	123	32	group	group	NOUN
cuesj-1122	123	33	patients	patient	NOUN
cuesj-1122	123	34	.	.	PUNCT
cuesj-1122	124	1	there	there	PRON
cuesj-1122	124	2	is	be	VERB
cuesj-1122	124	3	strong	strong	ADJ
cuesj-1122	124	4	evidence	evidence	NOUN
cuesj-1122	124	5	that	that	SCONJ
cuesj-1122	124	6	the	the	DET
cuesj-1122	124	7	onset	onset	NOUN
cuesj-1122	124	8	of	of	ADP
cuesj-1122	124	9	covid-19	covid-19	PROPN
cuesj-1122	124	10	illness	illness	NOUN
cuesj-1122	124	11	is	be	AUX
cuesj-1122	124	12	correlated	correlate	VERB
cuesj-1122	124	13	with	with	ADP
cuesj-1122	124	14	ldh	ldh	PROPN
cuesj-1122	124	15	levels.[45	levels.[45	PROPN
cuesj-1122	124	16	]	]	PUNCT
cuesj-1122	124	17	according	accord	VERB
cuesj-1122	124	18	to	to	ADP
cuesj-1122	124	19	a	a	DET
cuesj-1122	124	20	study	study	NOUN
cuesj-1122	124	21	,	,	PUNCT
cuesj-1122	124	22	intensive	intensive	ADJ
cuesj-1122	124	23	care	care	NOUN
cuesj-1122	124	24	unit	unit	NOUN
cuesj-1122	124	25	(	(	PUNCT
cuesj-1122	124	26	icu	icu	PROPN
cuesj-1122	124	27	)	)	PUNCT
cuesj-1122	124	28	patients	patient	NOUN
cuesj-1122	124	29	had	have	VERB
cuesj-1122	124	30	far	far	ADV
cuesj-1122	124	31	higher	high	ADJ
cuesj-1122	124	32	levels	level	NOUN
cuesj-1122	124	33	of	of	ADP
cuesj-1122	124	34	ldh	ldh	PROPN
cuesj-1122	124	35	than	than	ADP
cuesj-1122	124	36	non	non	ADJ
cuesj-1122	124	37	-	-	ADJ
cuesj-1122	124	38	icu	icu	ADJ
cuesj-1122	124	39	patients	patient	NOUN
cuesj-1122	124	40	(	(	PUNCT
cuesj-1122	124	41	248	248	NUM
cuesj-1122	124	42	u	u	NOUN
cuesj-1122	124	43	/	/	SYM
cuesj-1122	124	44	l	l	NOUN
cuesj-1122	124	45	vs.	vs.	ADP
cuesj-1122	124	46	151	151	NUM
cuesj-1122	124	47	u	u	NOUN
cuesj-1122	124	48	/	/	SYM
cuesj-1122	124	49	l	l	NOUN
cuesj-1122	124	50	,	,	PUNCT
cuesj-1122	124	51	p	p	X
cuesj-1122	124	52	=	=	NOUN
cuesj-1122	124	53	0.002	0.002	NUM
cuesj-1122	124	54	)	)	PUNCT
cuesj-1122	124	55	.	.	PUNCT
cuesj-1122	125	1	ldh	ldh	PROPN
cuesj-1122	125	2	might	might	AUX
cuesj-1122	125	3	be	be	AUX
cuesj-1122	125	4	a	a	DET
cuesj-1122	125	5	severe	severe	ADJ
cuesj-1122	125	6	disease	disease	NOUN
cuesj-1122	125	7	indicator	indicator	NOUN
cuesj-1122	125	8	that	that	PRON
cuesj-1122	125	9	can	can	AUX
cuesj-1122	125	10	be	be	AUX
cuesj-1122	125	11	predicted.[46	predicted.[46	PROPN
cuesj-1122	125	12	]	]	PUNCT
cuesj-1122	125	13	furthermore	furthermore	ADV
cuesj-1122	125	14	,	,	PUNCT
cuesj-1122	125	15	malik	malik	PROPN
cuesj-1122	125	16	et	et	PROPN
cuesj-1122	125	17	al.[47	al.[47	PROPN
cuesj-1122	125	18	]	]	PUNCT
cuesj-1122	125	19	found	find	VERB
cuesj-1122	125	20	a	a	DET
cuesj-1122	125	21	significant	significant	ADJ
cuesj-1122	125	22	association	association	NOUN
cuesj-1122	125	23	of	of	ADP
cuesj-1122	125	24	covid-19	covid-19	PROPN
cuesj-1122	125	25	severity	severity	NOUN
cuesj-1122	125	26	with	with	ADP
cuesj-1122	125	27	different	different	ADJ
cuesj-1122	125	28	biomarkers	biomarker	NOUN
cuesj-1122	125	29	among	among	ADP
cuesj-1122	125	30	them	they	PRON
cuesj-1122	125	31	elevated	elevated	ADJ
cuesj-1122	125	32	levels	level	NOUN
cuesj-1122	125	33	of	of	ADP
cuesj-1122	125	34	alt	alt	PROPN
cuesj-1122	125	35	and	and	CCONJ
cuesj-1122	125	36	ldh	ldh	PROPN
cuesj-1122	125	37	.	.	PROPN
cuesj-1122	125	38	likeness	likeness	NOUN
cuesj-1122	125	39	to	to	ADP
cuesj-1122	125	40	our	our	PRON
cuesj-1122	125	41	study	study	NOUN
cuesj-1122	125	42	,	,	PUNCT
cuesj-1122	125	43	the	the	DET
cuesj-1122	125	44	findings	finding	NOUN
cuesj-1122	125	45	of	of	ADP
cuesj-1122	125	46	a	a	DET
cuesj-1122	125	47	prior	prior	ADJ
cuesj-1122	125	48	study	study	NOUN
cuesj-1122	125	49	conducted	conduct	VERB
cuesj-1122	125	50	by	by	ADP
cuesj-1122	125	51	fatima	fatima	PROPN
cuesj-1122	125	52	et	et	PROPN
cuesj-1122	125	53	al.[9	al.[9	PROPN
cuesj-1122	125	54	]	]	PUNCT
cuesj-1122	125	55	who	who	PRON
cuesj-1122	125	56	documented	document	VERB
cuesj-1122	125	57	that	that	SCONJ
cuesj-1122	125	58	ldh	ldh	PROPN
cuesj-1122	125	59	value	value	NOUN
cuesj-1122	125	60	significantly	significantly	ADV
cuesj-1122	125	61	decreased	decrease	VERB
cuesj-1122	125	62	from	from	ADP
cuesj-1122	125	63	(	(	PUNCT
cuesj-1122	125	64	419	419	NUM
cuesj-1122	125	65	iu	iu	PROPN
cuesj-1122	125	66	/	/	SYM
cuesj-1122	125	67	l	l	NOUN
cuesj-1122	125	68	)	)	PUNCT
cuesj-1122	125	69	in	in	ADP
cuesj-1122	125	70	non	non	ADJ
cuesj-1122	125	71	-	-	ADJ
cuesj-1122	125	72	vaccinated	vaccinated	ADJ
cuesj-1122	125	73	patients	patient	NOUN
cuesj-1122	125	74	to	to	ADP
cuesj-1122	125	75	(	(	PUNCT
cuesj-1122	125	76	367	367	NUM
cuesj-1122	125	77	iu	iu	PROPN
cuesj-1122	125	78	/	/	SYM
cuesj-1122	125	79	l	l	NOUN
cuesj-1122	125	80	)	)	PUNCT
cuesj-1122	125	81	in	in	ADP
cuesj-1122	125	82	vaccinated	vaccinated	ADJ
cuesj-1122	125	83	individuals	individual	NOUN
cuesj-1122	125	84	.	.	PUNCT
cuesj-1122	126	1	this	this	DET
cuesj-1122	126	2	finding	finding	NOUN
cuesj-1122	126	3	is	be	AUX
cuesj-1122	126	4	in	in	ADP
cuesj-1122	126	5	line	line	NOUN
cuesj-1122	126	6	with	with	ADP
cuesj-1122	126	7	research	research	NOUN
cuesj-1122	126	8	conducted	conduct	VERB
cuesj-1122	126	9	by	by	ADP
cuesj-1122	126	10	raza	raza	PROPN
cuesj-1122	126	11	et	et	PROPN
cuesj-1122	126	12	al.[8	al.[8	PROPN
cuesj-1122	126	13	]	]	PUNCT
cuesj-1122	126	14	who	who	PRON
cuesj-1122	126	15	explained	explain	VERB
cuesj-1122	126	16	that	that	SCONJ
cuesj-1122	126	17	the	the	DET
cuesj-1122	126	18	mean	mean	ADJ
cuesj-1122	126	19	blood	blood	NOUN
cuesj-1122	126	20	ldh	ldh	PROPN
cuesj-1122	126	21	concentration	concentration	NOUN
cuesj-1122	126	22	was	be	AUX
cuesj-1122	126	23	much	much	ADV
cuesj-1122	126	24	higher	high	ADJ
cuesj-1122	126	25	(	(	PUNCT
cuesj-1122	126	26	p	p	X
cuesj-1122	126	27	<	<	X
cuesj-1122	126	28	0.01	0.01	NUM
cuesj-1122	126	29	)	)	PUNCT
cuesj-1122	126	30	in	in	ADP
cuesj-1122	126	31	unvaccinated	unvaccinate	VERB
cuesj-1122	126	32	patients	patient	NOUN
cuesj-1122	126	33	than	than	ADP
cuesj-1122	126	34	in	in	ADP
cuesj-1122	126	35	vaccinated	vaccinated	ADJ
cuesj-1122	126	36	group	group	NOUN
cuesj-1122	126	37	.	.	PUNCT
cuesj-1122	127	1	elevated	elevate	VERB
cuesj-1122	127	2	quantities	quantity	NOUN
cuesj-1122	127	3	of	of	ADP
cuesj-1122	127	4	ldh	ldh	NOUN
cuesj-1122	127	5	are	be	AUX
cuesj-1122	127	6	indicative	indicative	ADJ
cuesj-1122	127	7	of	of	ADP
cuesj-1122	127	8	cellular	cellular	ADJ
cuesj-1122	127	9	damage	damage	NOUN
cuesj-1122	127	10	brought	bring	VERB
cuesj-1122	127	11	on	on	ADP
cuesj-1122	127	12	by	by	ADP
cuesj-1122	127	13	plasma	plasma	NOUN
cuesj-1122	127	14	membrane	membrane	NOUN
cuesj-1122	127	15	destruction	destruction	NOUN
cuesj-1122	127	16	,	,	PUNCT
cuesj-1122	127	17	and	and	CCONJ
cuesj-1122	127	18	pulmonary	pulmonary	ADJ
cuesj-1122	127	19	damage	damage	NOUN
cuesj-1122	127	20	can	can	AUX
cuesj-1122	127	21	be	be	AUX
cuesj-1122	127	22	well	well	ADV
cuesj-1122	127	23	predicted	predict	VERB
cuesj-1122	127	24	by	by	ADP
cuesj-1122	127	25	measuring	measure	VERB
cuesj-1122	127	26	ldh	ldh	ADJ
cuesj-1122	127	27	levels	level	NOUN
cuesj-1122	127	28	in	in	ADP
cuesj-1122	127	29	the	the	DET
cuesj-1122	127	30	early	early	ADJ
cuesj-1122	127	31	stages	stage	NOUN
cuesj-1122	127	32	of	of	ADP
cuesj-1122	127	33	severe	severe	ADJ
cuesj-1122	127	34	covid-19	covid-19	PROPN
cuesj-1122	127	35	patients.[48	patients.[48	NOUN
cuesj-1122	127	36	]	]	PUNCT
cuesj-1122	127	37	another	another	DET
cuesj-1122	127	38	research	research	NOUN
cuesj-1122	127	39	that	that	SCONJ
cuesj-1122	127	40	in	in	ADP
cuesj-1122	127	41	line	line	NOUN
cuesj-1122	127	42	with	with	ADP
cuesj-1122	127	43	our	our	PRON
cuesj-1122	127	44	findings[49	findings[49	NOUN
cuesj-1122	127	45	]	]	PUNCT
cuesj-1122	127	46	demonstrated	demonstrate	VERB
cuesj-1122	127	47	that	that	SCONJ
cuesj-1122	127	48	ldh	ldh	PROPN
cuesj-1122	127	49	levels	level	NOUN
cuesj-1122	127	50	were	be	AUX
cuesj-1122	127	51	much	much	ADV
cuesj-1122	127	52	lower	low	ADJ
cuesj-1122	127	53	in	in	ADP
cuesj-1122	127	54	patients	patient	NOUN
cuesj-1122	127	55	who	who	PRON
cuesj-1122	127	56	received	receive	VERB
cuesj-1122	127	57	vaccines	vaccine	NOUN
cuesj-1122	127	58	than	than	ADP
cuesj-1122	127	59	those	those	PRON
cuesj-1122	127	60	who	who	PRON
cuesj-1122	127	61	did	do	AUX
cuesj-1122	127	62	not	not	PART
cuesj-1122	127	63	receive	receive	VERB
cuesj-1122	127	64	vaccines	vaccine	NOUN
cuesj-1122	127	65	.	.	PUNCT
cuesj-1122	128	1	thus	thus	ADV
cuesj-1122	128	2	,	,	PUNCT
cuesj-1122	128	3	given	give	VERB
cuesj-1122	128	4	that	that	SCONJ
cuesj-1122	128	5	altered	alter	VERB
cuesj-1122	128	6	hepatic	hepatic	ADJ
cuesj-1122	128	7	enzymes	enzyme	NOUN
cuesj-1122	128	8	have	have	AUX
cuesj-1122	128	9	been	be	AUX
cuesj-1122	128	10	linked	link	VERB
cuesj-1122	128	11	to	to	ADP
cuesj-1122	128	12	an	an	DET
cuesj-1122	128	13	increased	increase	VERB
cuesj-1122	128	14	risk	risk	NOUN
cuesj-1122	128	15	of	of	ADP
cuesj-1122	128	16	icu	icu	PROPN
cuesj-1122	128	17	support	support	NOUN
cuesj-1122	128	18	,	,	PUNCT
cuesj-1122	128	19	death	death	NOUN
cuesj-1122	128	20	rates	rate	NOUN
cuesj-1122	128	21	,	,	PUNCT
cuesj-1122	128	22	ards	ard	NOUN
cuesj-1122	128	23	,	,	PUNCT
cuesj-1122	128	24	and	and	CCONJ
cuesj-1122	128	25	comorbidities	comorbiditie	NOUN
cuesj-1122	128	26	,	,	PUNCT
cuesj-1122	128	27	the	the	DET
cuesj-1122	128	28	effect	effect	NOUN
cuesj-1122	128	29	of	of	ADP
cuesj-1122	128	30	vaccination	vaccination	NOUN
cuesj-1122	128	31	status	status	NOUN
cuesj-1122	128	32	on	on	ADP
cuesj-1122	128	33	liver	liver	NOUN
cuesj-1122	128	34	markers	marker	NOUN
cuesj-1122	128	35	might	might	AUX
cuesj-1122	128	36	be	be	AUX
cuesj-1122	128	37	considerable	considerable	ADJ
cuesj-1122	128	38	.	.	PUNCT
cuesj-1122	129	1	the	the	DET
cuesj-1122	129	2	process	process	NOUN
cuesj-1122	129	3	of	of	ADP
cuesj-1122	129	4	bone	bone	NOUN
cuesj-1122	129	5	mineralization	mineralization	NOUN
cuesj-1122	129	6	requires	require	VERB
cuesj-1122	129	7	the	the	DET
cuesj-1122	129	8	minerals	mineral	NOUN
cuesj-1122	129	9	calcium	calcium	NOUN
cuesj-1122	129	10	and	and	CCONJ
cuesj-1122	129	11	phosphorus	phosphorus	NOUN
cuesj-1122	129	12	.	.	PUNCT
cuesj-1122	130	1	these	these	DET
cuesj-1122	130	2	two	two	NUM
cuesj-1122	130	3	elements	element	NOUN
cuesj-1122	130	4	can	can	AUX
cuesj-1122	130	5	be	be	AUX
cuesj-1122	130	6	dissolved	dissolve	VERB
cuesj-1122	130	7	in	in	ADP
cuesj-1122	130	8	serum	serum	NOUN
cuesj-1122	130	9	or	or	CCONJ
cuesj-1122	130	10	located	locate	VERB
cuesj-1122	130	11	intracellularly	intracellularly	ADV
cuesj-1122	130	12	in	in	ADP
cuesj-1122	130	13	soft	soft	ADJ
cuesj-1122	130	14	tissues	tissue	NOUN
cuesj-1122	130	15	;	;	PUNCT
cuesj-1122	130	16	they	they	PRON
cuesj-1122	130	17	are	be	AUX
cuesj-1122	130	18	present	present	ADJ
cuesj-1122	130	19	in	in	ADP
cuesj-1122	130	20	bones.[20	bones.[20	NOUN
cuesj-1122	130	21	]	]	PUNCT
cuesj-1122	130	22	three	three	NUM
cuesj-1122	130	23	hormones	hormone	NOUN
cuesj-1122	130	24	mainly	mainly	ADV
cuesj-1122	130	25	regulate	regulate	VERB
cuesj-1122	130	26	phosphorus	phosphorus	NOUN
cuesj-1122	130	27	and	and	CCONJ
cuesj-1122	130	28	calcium	calcium	NOUN
cuesj-1122	130	29	levels	level	NOUN
cuesj-1122	130	30	in	in	ADP
cuesj-1122	130	31	the	the	DET
cuesj-1122	130	32	body	body	NOUN
cuesj-1122	130	33	:	:	PUNCT
cuesj-1122	130	34	parathyroid	parathyroid	ADJ
cuesj-1122	130	35	hormone	hormone	NOUN
cuesj-1122	130	36	(	(	PUNCT
cuesj-1122	130	37	pth	pth	NOUN
cuesj-1122	130	38	)	)	PUNCT
cuesj-1122	130	39	,	,	PUNCT
cuesj-1122	130	40	fibroblast	fibroblast	ADJ
cuesj-1122	130	41	growth	growth	NOUN
cuesj-1122	130	42	factor	factor	NOUN
cuesj-1122	130	43	and	and	CCONJ
cuesj-1122	130	44	vitamin	vitamin	NOUN
cuesj-1122	130	45	d	d	X
cuesj-1122	130	46	25	25	NUM
cuesj-1122	130	47	(	(	PUNCT
cuesj-1122	130	48	oh).[50	oh).[50	PROPN
cuesj-1122	130	49	]	]	PUNCT
cuesj-1122	130	50	according	accord	VERB
cuesj-1122	130	51	to	to	ADP
cuesj-1122	130	52	our	our	PRON
cuesj-1122	130	53	result	result	NOUN
cuesj-1122	130	54	,	,	PUNCT
cuesj-1122	130	55	we	we	PRON
cuesj-1122	130	56	found	find	VERB
cuesj-1122	130	57	that	that	SCONJ
cuesj-1122	130	58	the	the	DET
cuesj-1122	130	59	concentration	concentration	NOUN
cuesj-1122	130	60	of	of	ADP
cuesj-1122	130	61	pth	pth	NOUN
cuesj-1122	130	62	in	in	ADP
cuesj-1122	130	63	vaccinated	vaccinate	VERB
cuesj-1122	130	64	and	and	CCONJ
cuesj-1122	130	65	unvaccinated	unvaccinate	VERB
cuesj-1122	130	66	covid-19	covid-19	PROPN
cuesj-1122	130	67	patients	patient	NOUN
cuesj-1122	130	68	was	be	AUX
cuesj-1122	130	69	significantly	significantly	ADV
cuesj-1122	130	70	lower	low	ADJ
cuesj-1122	130	71	than	than	ADP
cuesj-1122	130	72	that	that	PRON
cuesj-1122	130	73	in	in	ADP
cuesj-1122	130	74	the	the	DET
cuesj-1122	130	75	serum	serum	NOUN
cuesj-1122	130	76	pth	pth	NOUN
cuesj-1122	130	77	of	of	ADP
cuesj-1122	130	78	the	the	DET
cuesj-1122	130	79	healthy	healthy	ADJ
cuesj-1122	130	80	group	group	NOUN
cuesj-1122	130	81	,	,	PUNCT
cuesj-1122	130	82	additionally	additionally	ADV
cuesj-1122	130	83	,	,	PUNCT
cuesj-1122	130	84	calcium	calcium	NOUN
cuesj-1122	130	85	and	and	CCONJ
cuesj-1122	130	86	phosphate	phosphate	NOUN
cuesj-1122	130	87	decreased	decrease	VERB
cuesj-1122	130	88	in	in	ADP
cuesj-1122	130	89	covid-19	covid-19	PROPN
cuesj-1122	130	90	patients	patient	NOUN
cuesj-1122	130	91	when	when	SCONJ
cuesj-1122	130	92	compared	compare	VERB
cuesj-1122	130	93	to	to	ADP
cuesj-1122	130	94	the	the	DET
cuesj-1122	130	95	control	control	NOUN
cuesj-1122	130	96	group	group	NOUN
cuesj-1122	130	97	.	.	PUNCT
cuesj-1122	131	1	“	"	PUNCT
cuesj-1122	131	2	the	the	DET
cuesj-1122	131	3	first	first	ADJ
cuesj-1122	131	4	report	report	NOUN
cuesj-1122	131	5	of	of	ADP
cuesj-1122	131	6	a	a	DET
cuesj-1122	131	7	severely	severely	ADV
cuesj-1122	131	8	hypocalcemic	hypocalcemic	ADJ
cuesj-1122	131	9	covid-19	covid-19	PROPN
cuesj-1122	131	10	patient	patient	NOUN
cuesj-1122	131	11	was	be	AUX
cuesj-1122	131	12	made	make	VERB
cuesj-1122	131	13	in	in	ADP
cuesj-1122	131	14	april	april	PROPN
cuesj-1122	131	15	2020	2020	NUM
cuesj-1122	131	16	.	.	PUNCT
cuesj-1122	132	1	since	since	SCONJ
cuesj-1122	132	2	then	then	ADV
cuesj-1122	132	3	,	,	PUNCT
cuesj-1122	132	4	several	several	ADJ
cuesj-1122	132	5	studies	study	NOUN
cuesj-1122	132	6	have	have	AUX
cuesj-1122	132	7	reported	report	VERB
cuesj-1122	132	8	that	that	SCONJ
cuesj-1122	132	9	hypocalcemia	hypocalcemia	NOUN
cuesj-1122	132	10	is	be	AUX
cuesj-1122	132	11	correlated	correlate	VERB
cuesj-1122	132	12	with	with	ADP
cuesj-1122	132	13	inflammation	inflammation	NOUN
cuesj-1122	132	14	,	,	PUNCT
cuesj-1122	132	15	biomarkers	biomarker	NOUN
cuesj-1122	132	16	of	of	ADP
cuesj-1122	132	17	thrombosis	thrombosis	NOUN
cuesj-1122	132	18	,	,	PUNCT
cuesj-1122	132	19	disease	disease	NOUN
cuesj-1122	132	20	severity	severity	NOUN
cuesj-1122	132	21	,	,	PUNCT
cuesj-1122	132	22	and	and	CCONJ
cuesj-1122	132	23	mortality	mortality	NOUN
cuesj-1122	132	24	in	in	ADP
cuesj-1122	132	25	covid-19	covid-19	PROPN
cuesj-1122	132	26	patients”.[21	patients”.[21	PROPN
cuesj-1122	132	27	]	]	PUNCT
cuesj-1122	132	28	our	our	PRON
cuesj-1122	132	29	findings	finding	NOUN
cuesj-1122	132	30	were	be	AUX
cuesj-1122	132	31	consistent	consistent	ADJ
cuesj-1122	132	32	with	with	ADP
cuesj-1122	132	33	the	the	DET
cuesj-1122	132	34	study	study	NOUN
cuesj-1122	132	35	of	of	ADP
cuesj-1122	132	36	yang	yang	PROPN
cuesj-1122	132	37	et	et	PROPN
cuesj-1122	132	38	al	al	PROPN
cuesj-1122	132	39	.	.	PROPN
cuesj-1122	132	40	and	and	CCONJ
cuesj-1122	132	41	cappellini	cappellini	PROPN
cuesj-1122	132	42	et	et	PROPN
cuesj-1122	132	43	al.[23,51	al.[23,51	PROPN
cuesj-1122	132	44	]	]	PUNCT
cuesj-1122	132	45	they	they	PRON
cuesj-1122	132	46	arrived	arrive	VERB
cuesj-1122	132	47	at	at	ADP
cuesj-1122	132	48	the	the	DET
cuesj-1122	132	49	conclusion	conclusion	NOUN
cuesj-1122	132	50	that	that	SCONJ
cuesj-1122	132	51	deficiencies	deficiency	NOUN
cuesj-1122	132	52	of	of	ADP
cuesj-1122	132	53	calcium	calcium	NOUN
cuesj-1122	132	54	and	and	CCONJ
cuesj-1122	132	55	phosphorus	phosphorus	NOUN
cuesj-1122	132	56	could	could	AUX
cuesj-1122	132	57	serve	serve	VERB
cuesj-1122	132	58	as	as	ADP
cuesj-1122	132	59	promising	promise	VERB
cuesj-1122	132	60	clinical	clinical	ADJ
cuesj-1122	132	61	biomarkers	biomarker	NOUN
cuesj-1122	132	62	for	for	ADP
cuesj-1122	132	63	discriminative	discriminative	NOUN
cuesj-1122	132	64	assessment	assessment	NOUN
cuesj-1122	132	65	,	,	PUNCT
cuesj-1122	132	66	suggesting	suggest	VERB
cuesj-1122	132	67	the	the	DET
cuesj-1122	132	68	severity	severity	NOUN
cuesj-1122	132	69	of	of	ADP
cuesj-1122	132	70	covid-19	covid-19	PROPN
cuesj-1122	132	71	patients	patient	NOUN
cuesj-1122	132	72	.	.	PUNCT
cuesj-1122	133	1	studies	study	NOUN
cuesj-1122	133	2	have	have	AUX
cuesj-1122	133	3	found	find	VERB
cuesj-1122	133	4	that	that	SCONJ
cuesj-1122	133	5	patients	patient	NOUN
cuesj-1122	133	6	with	with	ADP
cuesj-1122	133	7	osteoporosis	osteoporosis	NOUN
cuesj-1122	133	8	are	be	AUX
cuesj-1122	133	9	more	more	ADV
cuesj-1122	133	10	likely	likely	ADJ
cuesj-1122	133	11	to	to	PART
cuesj-1122	133	12	be	be	AUX
cuesj-1122	133	13	infected	infect	VERB
cuesj-1122	133	14	with	with	ADP
cuesj-1122	133	15	sars	sar	NOUN
cuesj-1122	133	16	-	-	PUNCT
cuesj-1122	133	17	cov-2	cov-2	PUNCT
cuesj-1122	133	18	and	and	CCONJ
cuesj-1122	133	19	have	have	VERB
cuesj-1122	133	20	more	more	ADV
cuesj-1122	133	21	severe	severe	ADJ
cuesj-1122	133	22	osteoporosis	osteoporosis	NOUN
cuesj-1122	133	23	after	after	ADP
cuesj-1122	133	24	sars	sar	NOUN
cuesj-1122	133	25	-	-	PUNCT
cuesj-1122	133	26	cov-2	cov-2	NOUN
cuesj-1122	133	27	,	,	PUNCT
cuesj-1122	133	28	and	and	CCONJ
cuesj-1122	133	29	some	some	DET
cuesj-1122	133	30	patients	patient	NOUN
cuesj-1122	133	31	have	have	VERB
cuesj-1122	133	32	osteoporosis	osteoporosis	NOUN
cuesj-1122	133	33	as	as	ADP
cuesj-1122	133	34	a	a	DET
cuesj-1122	133	35	complication.[18	complication.[18	PROPN
cuesj-1122	133	36	]	]	PUNCT
cuesj-1122	133	37	the	the	DET
cuesj-1122	133	38	research	research	NOUN
cuesj-1122	133	39	results	result	NOUN
cuesj-1122	133	40	of	of	ADP
cuesj-1122	133	41	elham	elham	PROPN
cuesj-1122	133	42	et	et	PROPN
cuesj-1122	133	43	al.[52	al.[52	PROPN
cuesj-1122	133	44	]	]	PUNCT
cuesj-1122	133	45	demonstrated	demonstrate	VERB
cuesj-1122	133	46	that	that	SCONJ
cuesj-1122	133	47	covid-19	covid-19	PROPN
cuesj-1122	133	48	patients	patient	NOUN
cuesj-1122	133	49	’	'	PUNCT
cuesj-1122	133	50	serum	serum	NOUN
cuesj-1122	133	51	concentration	concentration	NOUN
cuesj-1122	133	52	of	of	ADP
cuesj-1122	133	53	calcium	calcium	NOUN
cuesj-1122	133	54	,	,	PUNCT
cuesj-1122	133	55	vitamin	vitamin	NOUN
cuesj-1122	133	56	d	d	NOUN
cuesj-1122	133	57	,	,	PUNCT
cuesj-1122	133	58	and	and	CCONJ
cuesj-1122	133	59	zinc	zinc	NOUN
cuesj-1122	133	60	were	be	AUX
cuesj-1122	133	61	lower	low	ADJ
cuesj-1122	133	62	than	than	ADP
cuesj-1122	133	63	those	those	PRON
cuesj-1122	133	64	of	of	ADP
cuesj-1122	133	65	the	the	DET
cuesj-1122	133	66	healthy	healthy	ADJ
cuesj-1122	133	67	groups	group	NOUN
cuesj-1122	133	68	.	.	PUNCT
cuesj-1122	134	1	furthermore	furthermore	ADV
cuesj-1122	134	2	,	,	PUNCT
cuesj-1122	134	3	cappellini	cappellini	PROPN
cuesj-1122	134	4	et	et	PROPN
cuesj-1122	134	5	al.[51	al.[51	PROPN
cuesj-1122	134	6	]	]	PUNCT
cuesj-1122	134	7	documented	document	VERB
cuesj-1122	134	8	that	that	SCONJ
cuesj-1122	134	9	serum	serum	NOUN
cuesj-1122	134	10	calcium	calcium	NOUN
cuesj-1122	134	11	modifications	modification	NOUN
cuesj-1122	134	12	may	may	AUX
cuesj-1122	134	13	be	be	AUX
cuesj-1122	134	14	due	due	ADJ
cuesj-1122	134	15	to	to	ADP
cuesj-1122	134	16	alterations	alteration	NOUN
cuesj-1122	134	17	in	in	ADP
cuesj-1122	134	18	intestinal	intestinal	ADJ
cuesj-1122	134	19	absorption	absorption	NOUN
cuesj-1122	134	20	,	,	PUNCT
cuesj-1122	134	21	imbalance	imbalance	NOUN
cuesj-1122	134	22	in	in	ADP
cuesj-1122	134	23	the	the	DET
cuesj-1122	134	24	regulatory	regulatory	ADJ
cuesj-1122	134	25	mechanism	mechanism	NOUN
cuesj-1122	134	26	involving	involve	VERB
cuesj-1122	134	27	pth	pth	NOUN
cuesj-1122	134	28	and	and	CCONJ
cuesj-1122	134	29	d	d	NOUN
cuesj-1122	134	30	-	-	NOUN
cuesj-1122	134	31	vitamin	vitamin	ADJ
cuesj-1122	134	32	,	,	PUNCT
cuesj-1122	134	33	or	or	CCONJ
cuesj-1122	134	34	a	a	DET
cuesj-1122	134	35	direct	direct	ADJ
cuesj-1122	134	36	effect	effect	NOUN
cuesj-1122	134	37	caused	cause	VERB
cuesj-1122	134	38	by	by	ADP
cuesj-1122	134	39	sars	sar	NOUN
cuesj-1122	134	40	-	-	PUNCT
cuesj-1122	134	41	cov-2	cov-2	NOUN
cuesj-1122	134	42	.	.	PUNCT
cuesj-1122	135	1	similarity	similarity	NOUN
cuesj-1122	135	2	,	,	PUNCT
cuesj-1122	135	3	bajpai	bajpai	PROPN
cuesj-1122	135	4	et	et	PROPN
cuesj-1122	135	5	al.[53	al.[53	PROPN
cuesj-1122	135	6	]	]	PUNCT
cuesj-1122	135	7	compared	compare	VERB
cuesj-1122	135	8	the	the	DET
cuesj-1122	135	9	severity	severity	NOUN
cuesj-1122	135	10	of	of	ADP
cuesj-1122	135	11	covid-19	covid-19	PROPN
cuesj-1122	135	12	pneumonia	pneumonia	NOUN
cuesj-1122	135	13	in	in	ADP
cuesj-1122	135	14	vaccinated	vaccinate	VERB
cuesj-1122	135	15	with	with	ADP
cuesj-1122	135	16	non	non	ADJ
cuesj-1122	135	17	-	-	ADJ
cuesj-1122	135	18	vaccinated	vaccinated	ADJ
cuesj-1122	135	19	patients	patient	NOUN
cuesj-1122	135	20	from	from	ADP
cuesj-1122	135	21	a	a	DET
cuesj-1122	135	22	tertiary	tertiary	ADJ
cuesj-1122	135	23	care	care	NOUN
cuesj-1122	135	24	center	center	NOUN
cuesj-1122	135	25	in	in	ADP
cuesj-1122	135	26	india	india	PROPN
cuesj-1122	135	27	,	,	PUNCT
cuesj-1122	135	28	they	they	PRON
cuesj-1122	135	29	demonstrated	demonstrate	VERB
cuesj-1122	135	30	that	that	SCONJ
cuesj-1122	135	31	serum	serum	NOUN
cuesj-1122	135	32	calcium	calcium	NOUN
cuesj-1122	135	33	slightly	slightly	ADV
cuesj-1122	135	34	fewer	few	ADJ
cuesj-1122	135	35	in	in	ADP
cuesj-1122	135	36	non	non	ADJ
cuesj-1122	135	37	-	-	ADJ
cuesj-1122	135	38	vaccinated	vaccinated	ADJ
cuesj-1122	135	39	group	group	NOUN
cuesj-1122	135	40	than	than	ADP
cuesj-1122	135	41	in	in	ADP
cuesj-1122	135	42	patients	patient	NOUN
cuesj-1122	135	43	who	who	PRON
cuesj-1122	135	44	received	receive	VERB
cuesj-1122	135	45	vaccine	vaccine	NOUN
cuesj-1122	135	46	.	.	PUNCT
cuesj-1122	136	1	serum	serum	NOUN
cuesj-1122	136	2	phosphate	phosphate	PROPN
cuesj-1122	136	3	dysregulation	dysregulation	NOUN
cuesj-1122	136	4	in	in	ADP
cuesj-1122	136	5	covid-19	covid-19	PROPN
cuesj-1122	136	6	patients	patient	NOUN
cuesj-1122	136	7	may	may	AUX
cuesj-1122	136	8	be	be	AUX
cuesj-1122	136	9	linked	link	VERB
cuesj-1122	136	10	to	to	ADP
cuesj-1122	136	11	many	many	ADJ
cuesj-1122	136	12	disorders	disorder	NOUN
cuesj-1122	136	13	.	.	PUNCT
cuesj-1122	137	1	low	low	ADJ
cuesj-1122	137	2	serum	serum	NOUN
cuesj-1122	137	3	phosphorus	phosphorus	NOUN
cuesj-1122	137	4	is	be	AUX
cuesj-1122	137	5	associated	associate	VERB
cuesj-1122	137	6	with	with	ADP
cuesj-1122	137	7	a	a	DET
cuesj-1122	137	8	number	number	NOUN
cuesj-1122	137	9	of	of	ADP
cuesj-1122	137	10	clinical	clinical	ADJ
cuesj-1122	137	11	problems	problem	NOUN
cuesj-1122	137	12	,	,	PUNCT
cuesj-1122	137	13	especially	especially	ADV
cuesj-1122	137	14	in	in	ADP
cuesj-1122	137	15	critically	critically	ADV
cuesj-1122	137	16	ill	ill	ADJ
cuesj-1122	137	17	and	and	CCONJ
cuesj-1122	137	18	icu	icu	PROPN
cuesj-1122	137	19	patients.[54	patients.[54	PROPN
cuesj-1122	137	20	]	]	PUNCT
cuesj-1122	137	21	a	a	DET
cuesj-1122	137	22	study	study	NOUN
cuesj-1122	137	23	of	of	ADP
cuesj-1122	137	24	javdani	javdani	ADJ
cuesj-1122	137	25	et	et	PROPN
cuesj-1122	137	26	al.[22	al.[22	PROPN
cuesj-1122	137	27	]	]	PUNCT
cuesj-1122	137	28	demonstrated	demonstrate	VERB
cuesj-1122	137	29	how	how	SCONJ
cuesj-1122	137	30	hypophosphatemia	hypophosphatemia	NOUN
cuesj-1122	137	31	is	be	AUX
cuesj-1122	137	32	linked	link	VERB
cuesj-1122	137	33	to	to	ADP
cuesj-1122	137	34	serious	serious	ADJ
cuesj-1122	137	35	lung	lung	NOUN
cuesj-1122	137	36	damage	damage	NOUN
cuesj-1122	137	37	,	,	PUNCT
cuesj-1122	137	38	while	while	SCONJ
cuesj-1122	137	39	greater	great	ADJ
cuesj-1122	137	40	phosphate	phosphate	ADJ
cuesj-1122	137	41	levels	level	NOUN
cuesj-1122	137	42	may	may	AUX
cuesj-1122	137	43	be	be	AUX
cuesj-1122	137	44	associated	associate	VERB
cuesj-1122	137	45	with	with	ADP
cuesj-1122	137	46	improved	improved	ADJ
cuesj-1122	137	47	lung	lung	NOUN
cuesj-1122	137	48	outcomes	outcome	NOUN
cuesj-1122	137	49	from	from	ADP
cuesj-1122	137	50	covid-19	covid-19	PROPN
cuesj-1122	137	51	computed	computed	ADJ
cuesj-1122	137	52	tomography	tomography	NOUN
cuesj-1122	137	53	(	(	PUNCT
cuesj-1122	137	54	ct	ct	NOUN
cuesj-1122	137	55	)	)	PUNCT
cuesj-1122	137	56	scans	scan	NOUN
cuesj-1122	137	57	.	.	PUNCT
cuesj-1122	138	1	this	this	PRON
cuesj-1122	138	2	may	may	AUX
cuesj-1122	138	3	establish	establish	VERB
cuesj-1122	138	4	a	a	DET
cuesj-1122	138	5	connection	connection	NOUN
cuesj-1122	138	6	between	between	ADP
cuesj-1122	138	7	the	the	DET
cuesj-1122	138	8	parathyroid	parathyroid	ADJ
cuesj-1122	138	9	gland	gland	NOUN
cuesj-1122	138	10	and	and	CCONJ
cuesj-1122	138	11	covid-19	covid-19	PROPN
cuesj-1122	138	12	and	and	CCONJ
cuesj-1122	138	13	aid	aid	NOUN
cuesj-1122	138	14	physicians	physician	NOUN
cuesj-1122	138	15	in	in	ADP
cuesj-1122	138	16	the	the	DET
cuesj-1122	138	17	management	management	NOUN
cuesj-1122	138	18	of	of	ADP
cuesj-1122	138	19	hospitalized	hospitalize	VERB
cuesj-1122	138	20	patients	patient	NOUN
cuesj-1122	138	21	.	.	PUNCT
cuesj-1122	139	1	hypophosphatemia	hypophosphatemia	NOUN
cuesj-1122	139	2	in	in	ADP
cuesj-1122	139	3	covid-19	covid-19	PROPN
cuesj-1122	139	4	individuals	individual	NOUN
cuesj-1122	139	5	can	can	AUX
cuesj-1122	139	6	be	be	AUX
cuesj-1122	139	7	caused	cause	VERB
cuesj-1122	139	8	by	by	ADP
cuesj-1122	139	9	renal	renal	ADJ
cuesj-1122	139	10	loss	loss	NOUN
cuesj-1122	139	11	,	,	PUNCT
cuesj-1122	139	12	large	large	ADJ
cuesj-1122	139	13	bowel	bowel	NOUN
cuesj-1122	139	14	dysfunction	dysfunction	NOUN
cuesj-1122	139	15	,	,	PUNCT
cuesj-1122	139	16	acute	acute	ADJ
cuesj-1122	139	17	kidney	kidney	NOUN
cuesj-1122	139	18	injury	injury	NOUN
cuesj-1122	139	19	(	(	PUNCT
cuesj-1122	139	20	aki	aki	NOUN
cuesj-1122	139	21	)	)	PUNCT
cuesj-1122	139	22	,	,	PUNCT
cuesj-1122	139	23	insufficient	insufficient	ADJ
cuesj-1122	139	24	intake	intake	NOUN
cuesj-1122	139	25	,	,	PUNCT
cuesj-1122	139	26	and	and	CCONJ
cuesj-1122	139	27	pulmonary	pulmonary	ADJ
cuesj-1122	139	28	alkalosis.[54,55	alkalosis.[54,55	PROPN
cuesj-1122	139	29	]	]	PUNCT
cuesj-1122	139	30	severe	severe	ADJ
cuesj-1122	139	31	and	and	CCONJ
cuesj-1122	139	32	critically	critically	ADV
cuesj-1122	139	33	ill	ill	ADJ
cuesj-1122	139	34	covid-19	covid-19	PROPN
cuesj-1122	139	35	patients	patient	NOUN
cuesj-1122	139	36	have	have	AUX
cuesj-1122	139	37	disrupted	disrupt	VERB
cuesj-1122	139	38	ca	ca	NOUN
cuesj-1122	139	39	and	and	CCONJ
cuesj-1122	139	40	p	p	NOUN
cuesj-1122	139	41	homeostasis	homeostasis	NOUN
cuesj-1122	139	42	.	.	PUNCT
cuesj-1122	140	1	for	for	ADP
cuesj-1122	140	2	individuals	individual	NOUN
cuesj-1122	140	3	with	with	ADP
cuesj-1122	140	4	covid-19	covid-19	PROPN
cuesj-1122	140	5	at	at	ADP
cuesj-1122	140	6	a	a	DET
cuesj-1122	140	7	severe	severe	ADJ
cuesj-1122	140	8	or	or	CCONJ
cuesj-1122	140	9	critical	critical	ADJ
cuesj-1122	140	10	stage	stage	NOUN
cuesj-1122	140	11	,	,	PUNCT
cuesj-1122	140	12	it	it	PRON
cuesj-1122	140	13	is	be	AUX
cuesj-1122	140	14	crucial	crucial	ADJ
cuesj-1122	140	15	to	to	PART
cuesj-1122	140	16	increase	increase	VERB
cuesj-1122	140	17	the	the	DET
cuesj-1122	140	18	monitoring	monitoring	NOUN
cuesj-1122	140	19	of	of	ADP
cuesj-1122	140	20	serum	serum	NOUN
cuesj-1122	140	21	ca	ca	NOUN
cuesj-1122	140	22	and	and	CCONJ
cuesj-1122	140	23	p	p	NOUN
cuesj-1122	140	24	levels	level	NOUN
cuesj-1122	140	25	and	and	CCONJ
cuesj-1122	140	26	to	to	PART
cuesj-1122	140	27	start	start	VERB
cuesj-1122	140	28	treatment	treatment	NOUN
cuesj-1122	140	29	as	as	ADV
cuesj-1122	140	30	soon	soon	ADV
cuesj-1122	140	31	as	as	ADP
cuesj-1122	140	32	possible	possible	ADJ
cuesj-1122	140	33	to	to	PART
cuesj-1122	140	34	improve	improve	VERB
cuesj-1122	140	35	the	the	DET
cuesj-1122	140	36	prognosis.[23	prognosis.[23	NOUN
cuesj-1122	140	37	]	]	PUNCT
cuesj-1122	140	38	the	the	DET
cuesj-1122	140	39	findings	finding	NOUN
cuesj-1122	140	40	of	of	ADP
cuesj-1122	140	41	abobaker	abobaker	PROPN
cuesj-1122	140	42	et	et	NOUN
cuesj-1122	140	43	al.[24	al.[24	PROPN
cuesj-1122	140	44	]	]	PUNCT
cuesj-1122	140	45	stated	state	VERB
cuesj-1122	140	46	that	that	SCONJ
cuesj-1122	140	47	there	there	PRON
cuesj-1122	140	48	are	be	VERB
cuesj-1122	140	49	two	two	NUM
cuesj-1122	140	50	potential	potential	ADJ
cuesj-1122	140	51	ways	way	NOUN
cuesj-1122	140	52	in	in	ADP
cuesj-1122	140	53	which	which	PRON
cuesj-1122	140	54	covid-19	covid-19	PROPN
cuesj-1122	140	55	may	may	AUX
cuesj-1122	140	56	impact	impact	VERB
cuesj-1122	140	57	parathyroid	parathyroid	ADJ
cuesj-1122	140	58	gland	gland	NOUN
cuesj-1122	140	59	function	function	NOUN
cuesj-1122	140	60	:	:	PUNCT
cuesj-1122	140	61	directly	directly	ADV
cuesj-1122	140	62	,	,	PUNCT
cuesj-1122	140	63	through	through	ADP
cuesj-1122	140	64	the	the	DET
cuesj-1122	140	65	sars	sar	NOUN
cuesj-1122	140	66	-	-	PUNCT
cuesj-1122	140	67	cov-2	cov-2	PART
cuesj-1122	140	68	virus	virus	NOUN
cuesj-1122	140	69	invading	invade	VERB
cuesj-1122	140	70	parathyroid	parathyroid	ADJ
cuesj-1122	140	71	gland	gland	NOUN
cuesj-1122	140	72	tissues	tissue	NOUN
cuesj-1122	140	73	,	,	PUNCT
cuesj-1122	140	74	or	or	CCONJ
cuesj-1122	140	75	indirectly	indirectly	ADV
cuesj-1122	140	76	,	,	PUNCT
cuesj-1122	140	77	through	through	ADP
cuesj-1122	140	78	lung	lung	NOUN
cuesj-1122	140	79	damage	damage	NOUN
cuesj-1122	140	80	and	and	CCONJ
cuesj-1122	140	81	chronic	chronic	ADJ
cuesj-1122	140	82	alkalosis	alkalosis	NOUN
cuesj-1122	140	83	of	of	ADP
cuesj-1122	140	84	the	the	DET
cuesj-1122	140	85	lungs	lung	NOUN
cuesj-1122	140	86	.	.	PUNCT
cuesj-1122	141	1	these	these	DET
cuesj-1122	141	2	latter	latter	ADJ
cuesj-1122	141	3	two	two	NUM
cuesj-1122	141	4	mechanisms	mechanism	NOUN
cuesj-1122	141	5	may	may	AUX
cuesj-1122	141	6	be	be	AUX
cuesj-1122	141	7	further	further	ADJ
cuesj-1122	141	8	explanations	explanation	NOUN
cuesj-1122	141	9	for	for	ADP
cuesj-1122	141	10	the	the	DET
cuesj-1122	141	11	high	high	ADJ
cuesj-1122	141	12	incidence	incidence	NOUN
cuesj-1122	141	13	of	of	ADP
cuesj-1122	141	14	hypocalcemia	hypocalcemia	NOUN
cuesj-1122	141	15	in	in	ADP
cuesj-1122	141	16	covid-19	covid-19	PROPN
cuesj-1122	141	17	patients	patient	NOUN
cuesj-1122	141	18	.	.	PUNCT
cuesj-1122	142	1	inflammatory	inflammatory	ADJ
cuesj-1122	142	2	cytokines	cytokine	NOUN
cuesj-1122	142	3	and	and	CCONJ
cuesj-1122	142	4	immune	immune	ADJ
cuesj-1122	142	5	system	system	NOUN
cuesj-1122	142	6	activation	activation	NOUN
cuesj-1122	142	7	can	can	AUX
cuesj-1122	142	8	lead	lead	VERB
cuesj-1122	142	9	to	to	ADP
cuesj-1122	142	10	alterations	alteration	NOUN
cuesj-1122	142	11	in	in	ADP
cuesj-1122	142	12	the	the	DET
cuesj-1122	142	13	concentrations	concentration	NOUN
cuesj-1122	142	14	of	of	ADP
cuesj-1122	142	15	parathyroid	parathyroid	ADJ
cuesj-1122	142	16	hormone	hormone	NOUN
cuesj-1122	142	17	,	,	PUNCT
cuesj-1122	142	18	phosphorus	phosphorus	NOUN
cuesj-1122	142	19	,	,	PUNCT
cuesj-1122	142	20	and	and	CCONJ
cuesj-1122	142	21	calcium.[50	calcium.[50	NOUN
cuesj-1122	142	22	]	]	PUNCT
cuesj-1122	142	23	in	in	ADP
cuesj-1122	142	24	covid-19	covid-19	PROPN
cuesj-1122	142	25	patients	patient	NOUN
cuesj-1122	142	26	,	,	PUNCT
cuesj-1122	142	27	thyroid	thyroid	NOUN
cuesj-1122	142	28	function	function	NOUN
cuesj-1122	142	29	problems	problem	NOUN
cuesj-1122	142	30	are	be	AUX
cuesj-1122	142	31	common	common	ADJ
cuesj-1122	142	32	,	,	PUNCT
cuesj-1122	142	33	particularly	particularly	ADV
cuesj-1122	142	34	in	in	ADP
cuesj-1122	142	35	severe	severe	ADJ
cuesj-1122	142	36	cases	case	NOUN
cuesj-1122	142	37	.	.	PUNCT
cuesj-1122	143	1	the	the	DET
cuesj-1122	143	2	non	non	ADJ
cuesj-1122	143	3	-	-	ADJ
cuesj-1122	143	4	thyroidal	thyroidal	ADJ
cuesj-1122	143	5	disease	disease	NOUN
cuesj-1122	143	6	syndrome	syndrome	NOUN
cuesj-1122	143	7	could	could	AUX
cuesj-1122	143	8	help	help	VERB
cuesj-1122	143	9	to	to	PART
cuesj-1122	143	10	partially	partially	ADV
cuesj-1122	143	11	explain	explain	VERB
cuesj-1122	143	12	this.[56	this.[56	PROPN
cuesj-1122	143	13	]	]	PUNCT
cuesj-1122	143	14	on	on	ADP
cuesj-1122	143	15	the	the	DET
cuesj-1122	143	16	basis	basis	NOUN
cuesj-1122	143	17	of	of	ADP
cuesj-1122	143	18	our	our	PRON
cuesj-1122	143	19	study	study	NOUN
cuesj-1122	143	20	,	,	PUNCT
cuesj-1122	143	21	the	the	DET
cuesj-1122	143	22	serum	serum	NOUN
cuesj-1122	143	23	level	level	NOUN
cuesj-1122	143	24	of	of	ADP
cuesj-1122	143	25	tsh	tsh	NOUN
cuesj-1122	143	26	significantly	significantly	ADV
cuesj-1122	143	27	decreased	decrease	VERB
cuesj-1122	143	28	in	in	ADP
cuesj-1122	143	29	unvaccinated	unvaccinate	VERB
cuesj-1122	143	30	covid-19	covid-19	PROPN
cuesj-1122	143	31	patients	patient	NOUN
cuesj-1122	143	32	and	and	CCONJ
cuesj-1122	143	33	somewhat	somewhat	ADV
cuesj-1122	143	34	depletion	depletion	NOUN
cuesj-1122	143	35	in	in	ADP
cuesj-1122	143	36	vaccinated	vaccinated	ADJ
cuesj-1122	143	37	individuals	individual	NOUN
cuesj-1122	143	38	as	as	SCONJ
cuesj-1122	143	39	compared	compare	VERB
cuesj-1122	143	40	to	to	ADP
cuesj-1122	143	41	the	the	DET
cuesj-1122	143	42	control	control	NOUN
cuesj-1122	143	43	group	group	NOUN
cuesj-1122	143	44	.	.	PUNCT
cuesj-1122	144	1	omit	omit	VERB
cuesj-1122	144	2	it	it	PRON
cuesj-1122	144	3	that	that	SCONJ
cuesj-1122	144	4	results	result	NOUN
cuesj-1122	144	5	are	be	AUX
cuesj-1122	144	6	in	in	ADP
cuesj-1122	144	7	line	line	NOUN
cuesj-1122	144	8	with	with	ADP
cuesj-1122	144	9	previous	previous	ADJ
cuesj-1122	144	10	study	study	NOUN
cuesj-1122	144	11	of	of	ADP
cuesj-1122	144	12	gong	gong	PROPN
cuesj-1122	144	13	et	et	PROPN
cuesj-1122	144	14	al.[26	al.[26	PROPN
cuesj-1122	144	15	]	]	PUNCT
cuesj-1122	144	16	who	who	PRON
cuesj-1122	144	17	indicated	indicate	VERB
cuesj-1122	144	18	that	that	SCONJ
cuesj-1122	144	19	decreased	decrease	VERB
cuesj-1122	144	20	tsh	tsh	NOUN
cuesj-1122	144	21	levels	level	NOUN
cuesj-1122	144	22	were	be	AUX
cuesj-1122	144	23	a	a	DET
cuesj-1122	144	24	separate	separate	ADJ
cuesj-1122	144	25	risk	risk	NOUN
cuesj-1122	144	26	factor	factor	NOUN
cuesj-1122	144	27	for	for	ADP
cuesj-1122	144	28	death	death	NOUN
cuesj-1122	144	29	in	in	ADP
cuesj-1122	144	30	these	these	DET
cuesj-1122	144	31	patients	patient	NOUN
cuesj-1122	144	32	,	,	PUNCT
cuesj-1122	144	33	and	and	CCONJ
cuesj-1122	144	34	that	that	SCONJ
cuesj-1122	144	35	reduced	reduce	VERB
cuesj-1122	144	36	ft4	ft4	PROPN
cuesj-1122	144	37	and	and	CCONJ
cuesj-1122	144	38	tsh	tsh	NOUN
cuesj-1122	144	39	levels	level	NOUN
cuesj-1122	144	40	were	be	AUX
cuesj-1122	144	41	linked	link	VERB
cuesj-1122	144	42	to	to	ADP
cuesj-1122	144	43	mortality	mortality	NOUN
cuesj-1122	144	44	in	in	ADP
cuesj-1122	144	45	individuals	individual	NOUN
cuesj-1122	144	46	with	with	ADP
cuesj-1122	144	47	both	both	CCONJ
cuesj-1122	144	48	covid-19	covid-19	PROPN
cuesj-1122	144	49	and	and	CCONJ
cuesj-1122	144	50	non	non	ADJ
cuesj-1122	144	51	-	-	ADJ
cuesj-1122	144	52	thyroidal	thyroidal	ADJ
cuesj-1122	144	53	disease	disease	NOUN
cuesj-1122	144	54	syndrome	syndrome	NOUN
cuesj-1122	144	55	.	.	PUNCT
cuesj-1122	145	1	furthermore	furthermore	ADV
cuesj-1122	145	2	,	,	PUNCT
cuesj-1122	145	3	chen	chen	PROPN
cuesj-1122	145	4	et	et	PROPN
cuesj-1122	145	5	al.[25	al.[25	PROPN
cuesj-1122	145	6	]	]	PUNCT
cuesj-1122	145	7	reported	report	VERB
cuesj-1122	145	8	that	that	SCONJ
cuesj-1122	145	9	after	after	ADP
cuesj-1122	145	10	admission	admission	NOUN
cuesj-1122	145	11	,	,	PUNCT
cuesj-1122	145	12	the	the	DET
cuesj-1122	145	13	tsh	tsh	NOUN
cuesj-1122	145	14	and	and	CCONJ
cuesj-1122	145	15	ft4	ft4	NOUN
cuesj-1122	145	16	levels	level	NOUN
cuesj-1122	145	17	of	of	ADP
cuesj-1122	145	18	verified	verify	VERB
cuesj-1122	145	19	covid-19	covid-19	PROPN
cuesj-1122	145	20	-	-	PUNCT
cuesj-1122	145	21	positive	positive	ADJ
cuesj-1122	145	22	individuals	individual	NOUN
cuesj-1122	145	23	were	be	AUX
cuesj-1122	145	24	low	low	ADJ
cuesj-1122	145	25	,	,	PUNCT
cuesj-1122	145	26	but	but	CCONJ
cuesj-1122	145	27	on	on	ADP
cuesj-1122	145	28	their	their	PRON
cuesj-1122	145	29	recovery	recovery	NOUN
cuesj-1122	145	30	,	,	PUNCT
cuesj-1122	145	31	the	the	DET
cuesj-1122	145	32	levels	level	NOUN
cuesj-1122	145	33	rebounded	rebound	VERB
cuesj-1122	145	34	to	to	ADP
cuesj-1122	145	35	normal	normal	ADJ
cuesj-1122	145	36	.	.	PUNCT
cuesj-1122	146	1	similarity	similarity	NOUN
cuesj-1122	146	2	,	,	PUNCT
cuesj-1122	146	3	khoo	khoo	PROPN
cuesj-1122	146	4	et	et	PROPN
cuesj-1122	146	5	al.[57	al.[57	PROPN
cuesj-1122	146	6	]	]	PUNCT
cuesj-1122	146	7	conducted	conduct	VERB
cuesj-1122	146	8	a	a	DET
cuesj-1122	146	9	research	research	NOUN
cuesj-1122	146	10	on	on	ADP
cuesj-1122	146	11	456	456	NUM
cuesj-1122	146	12	individuals	individual	NOUN
cuesj-1122	146	13	in	in	ADP
cuesj-1122	146	14	london	london	PROPN
cuesj-1122	146	15	and	and	CCONJ
cuesj-1122	146	16	found	find	VERB
cuesj-1122	146	17	modest	modest	ADJ
cuesj-1122	146	18	decreases	decrease	NOUN
cuesj-1122	146	19	in	in	ADP
cuesj-1122	146	20	tsh	tsh	NOUN
cuesj-1122	146	21	and	and	CCONJ
cuesj-1122	146	22	ft4	ft4	NOUN
cuesj-1122	146	23	,	,	PUNCT
cuesj-1122	146	24	consistent	consistent	ADJ
cuesj-1122	146	25	with	with	ADP
cuesj-1122	146	26	a	a	DET
cuesj-1122	146	27	non	non	ADJ
cuesj-1122	146	28	-	-	ADJ
cuesj-1122	146	29	thyroidal	thyroidal	ADJ
cuesj-1122	146	30	disease	disease	NOUN
cuesj-1122	146	31	condition	condition	NOUN
cuesj-1122	146	32	.	.	PUNCT
cuesj-1122	147	1	on	on	ADP
cuesj-1122	147	2	the	the	DET
cuesj-1122	147	3	other	other	ADJ
cuesj-1122	147	4	hand	hand	NOUN
cuesj-1122	147	5	,	,	PUNCT
cuesj-1122	147	6	in	in	ADP
cuesj-1122	147	7	a	a	DET
cuesj-1122	147	8	study	study	NOUN
cuesj-1122	147	9	of	of	ADP
cuesj-1122	147	10	chen	chen	PROPN
cuesj-1122	147	11	et	et	PROPN
cuesj-1122	147	12	al.[58	al.[58	PROPN
cuesj-1122	147	13	]	]	PUNCT
cuesj-1122	147	14	in	in	ADP
cuesj-1122	147	15	china	china	PROPN
cuesj-1122	147	16	of	of	ADP
cuesj-1122	147	17	50	50	NUM
cuesj-1122	147	18	patients	patient	NOUN
cuesj-1122	147	19	with	with	ADP
cuesj-1122	147	20	covid-19	covid-19	PROPN
cuesj-1122	147	21	,	,	PUNCT
cuesj-1122	147	22	they	they	PRON
cuesj-1122	147	23	noted	note	VERB
cuesj-1122	147	24	a	a	DET
cuesj-1122	147	25	generalized	generalized	ADJ
cuesj-1122	147	26	reduction	reduction	NOUN
cuesj-1122	147	27	in	in	ADP
cuesj-1122	147	28	tsh	tsh	PROPN
cuesj-1122	147	29	,	,	PUNCT
cuesj-1122	147	30	t4	t4	PROPN
cuesj-1122	147	31	,	,	PUNCT
cuesj-1122	147	32	and	and	CCONJ
cuesj-1122	147	33	t3	t3	NOUN
cuesj-1122	147	34	more	more	ADV
cuesj-1122	147	35	consistent	consistent	ADJ
cuesj-1122	147	36	with	with	ADP
cuesj-1122	147	37	a	a	DET
cuesj-1122	147	38	non	non	ADJ
cuesj-1122	147	39	-	-	ADJ
cuesj-1122	147	40	thyroidal	thyroidal	ADJ
cuesj-1122	147	41	illness	illness	NOUN
cuesj-1122	147	42	pattern	pattern	NOUN
cuesj-1122	147	43	.	.	PUNCT
cuesj-1122	148	1	the	the	DET
cuesj-1122	148	2	studies	study	NOUN
cuesj-1122	148	3	indicated	indicate	VERB
cuesj-1122	148	4	that	that	SCONJ
cuesj-1122	148	5	tsh	tsh	NOUN
cuesj-1122	148	6	inhibits	inhibit	VERB
cuesj-1122	148	7	osteoclastogenesis	osteoclastogenesis	NOUN
cuesj-1122	148	8	,	,	PUNCT
cuesj-1122	148	9	which	which	PRON
cuesj-1122	148	10	protects	protect	VERB
cuesj-1122	148	11	bone.[59	bone.[59	PROPN
cuesj-1122	148	12	]	]	X
cuesj-1122	148	13	it	it	PRON
cuesj-1122	148	14	’	'	PUNCT
cuesj-1122	148	15	is	be	AUX
cuesj-1122	148	16	been	be	AUX
cuesj-1122	148	17	suggested	suggest	VERB
cuesj-1122	148	18	that	that	SCONJ
cuesj-1122	148	19	tsh	tsh	NOUN
cuesj-1122	148	20	might	might	AUX
cuesj-1122	148	21	directly	directly	ADV
cuesj-1122	148	22	inhibit	inhibit	VERB
cuesj-1122	148	23	bone	bone	NOUN
cuesj-1122	148	24	turnover	turnover	NOUN
cuesj-1122	148	25	by	by	ADP
cuesj-1122	148	26	acting	act	VERB
cuesj-1122	148	27	on	on	ADP
cuesj-1122	148	28	both	both	DET
cuesj-1122	148	29	osteoblasts	osteoblast	NOUN
cuesj-1122	148	30	and	and	CCONJ
cuesj-1122	148	31	osteoclasts	osteoclast	NOUN
cuesj-1122	148	32	’	'	PUNCT
cuesj-1122	148	33	ahmed	ahmed	PROPN
cuesj-1122	148	34	,	,	PUNCT
cuesj-1122	148	35	et	et	PROPN
cuesj-1122	148	36	al	al	PROPN
cuesj-1122	148	37	.	.	PUNCT
cuesj-1122	148	38	:	:	PUNCT
cuesj-1122	149	1	comparison	comparison	NOUN
cuesj-1122	149	2	of	of	ADP
cuesj-1122	149	3	biochemical	biochemical	ADJ
cuesj-1122	149	4	parameters	parameter	NOUN
cuesj-1122	149	5	in	in	ADP
cuesj-1122	149	6	vaccinated	vaccinated	ADJ
cuesj-1122	149	7	55	55	NUM
cuesj-1122	149	8	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1122	149	9	cuesj	cuesj	NOUN
cuesj-1122	149	10	2024	2024	NUM
cuesj-1122	149	11	,	,	PUNCT
cuesj-1122	149	12	8	8	NUM
cuesj-1122	149	13	(	(	PUNCT
cuesj-1122	149	14	1	1	NUM
cuesj-1122	149	15	):	):	PUNCT
cuesj-1122	149	16	46	46	NUM
cuesj-1122	149	17	-	-	SYM
cuesj-1122	149	18	57	57	NUM
cuesj-1122	149	19	tsh	tsh	NOUN
cuesj-1122	149	20	receptors.[60	receptors.[60	PROPN
cuesj-1122	149	21	]	]	PUNCT
cuesj-1122	149	22	hence	hence	ADV
cuesj-1122	149	23	,	,	PUNCT
cuesj-1122	149	24	these	these	DET
cuesj-1122	149	25	clinical	clinical	ADJ
cuesj-1122	149	26	parameters	parameter	NOUN
cuesj-1122	149	27	are	be	AUX
cuesj-1122	149	28	helpful	helpful	ADJ
cuesj-1122	149	29	for	for	ADP
cuesj-1122	149	30	the	the	DET
cuesj-1122	149	31	diagnosis	diagnosis	NOUN
cuesj-1122	149	32	and	and	CCONJ
cuesj-1122	149	33	monitoring	monitoring	NOUN
cuesj-1122	149	34	of	of	ADP
cuesj-1122	149	35	covid‐19	covid‐19	PROPN
cuesj-1122	149	36	patients	patient	NOUN
cuesj-1122	149	37	vaccinated	vaccinate	VERB
cuesj-1122	149	38	persons	person	NOUN
cuesj-1122	149	39	are	be	AUX
cuesj-1122	149	40	now	now	ADV
cuesj-1122	149	41	generally	generally	ADV
cuesj-1122	149	42	acknowledged	acknowledge	VERB
cuesj-1122	149	43	to	to	PART
cuesj-1122	149	44	be	be	AUX
cuesj-1122	149	45	less	less	ADV
cuesj-1122	149	46	risky	risky	ADJ
cuesj-1122	149	47	than	than	ADP
cuesj-1122	149	48	unvaccinated	unvaccinated	ADJ
cuesj-1122	149	49	individuals	individual	NOUN
cuesj-1122	149	50	.	.	PUNCT
cuesj-1122	150	1	an	an	DET
cuesj-1122	150	2	israeli	israeli	ADJ
cuesj-1122	150	3	study	study	NOUN
cuesj-1122	150	4	found	find	VERB
cuesj-1122	150	5	that	that	SCONJ
cuesj-1122	150	6	those	those	PRON
cuesj-1122	150	7	who	who	PRON
cuesj-1122	150	8	received	receive	VERB
cuesj-1122	150	9	the	the	DET
cuesj-1122	150	10	pfizer	pfizer	NOUN
cuesj-1122	150	11	-	-	PUNCT
cuesj-1122	150	12	biontech	biontech	NOUN
cuesj-1122	150	13	vaccination	vaccination	NOUN
cuesj-1122	150	14	had	have	VERB
cuesj-1122	150	15	a	a	DET
cuesj-1122	150	16	higher	high	ADJ
cuesj-1122	150	17	level	level	NOUN
cuesj-1122	150	18	of	of	ADP
cuesj-1122	150	19	long	long	ADJ
cuesj-1122	150	20	-	-	PUNCT
cuesj-1122	150	21	term	term	NOUN
cuesj-1122	150	22	safety	safety	NOUN
cuesj-1122	150	23	from	from	ADP
cuesj-1122	150	24	covid-19	covid-19	PROPN
cuesj-1122	150	25	syndrome	syndrome	NOUN
cuesj-1122	150	26	than	than	ADP
cuesj-1122	150	27	those	those	PRON
cuesj-1122	150	28	who	who	PRON
cuesj-1122	150	29	did	do	AUX
cuesj-1122	150	30	not	not	PART
cuesj-1122	150	31	receive	receive	VERB
cuesj-1122	150	32	the	the	DET
cuesj-1122	150	33	vaccination.[61	vaccination.[61	NOUN
cuesj-1122	150	34	]	]	PUNCT
cuesj-1122	150	35	an	an	DET
cuesj-1122	150	36	additional	additional	ADJ
cuesj-1122	150	37	study	study	NOUN
cuesj-1122	150	38	conducted	conduct	VERB
cuesj-1122	150	39	in	in	ADP
cuesj-1122	150	40	israel	israel	PROPN
cuesj-1122	150	41	using	use	VERB
cuesj-1122	150	42	data	datum	NOUN
cuesj-1122	150	43	from	from	ADP
cuesj-1122	150	44	5526	5526	NUM
cuesj-1122	150	45	unvaccinated	unvaccinated	ADJ
cuesj-1122	150	46	covid-19	covid-19	PROPN
cuesj-1122	150	47	cases	case	NOUN
cuesj-1122	150	48	revealed	reveal	VERB
cuesj-1122	150	49	that	that	SCONJ
cuesj-1122	150	50	4.6	4.6	NUM
cuesj-1122	150	51	out	out	ADP
cuesj-1122	150	52	of	of	ADP
cuesj-1122	150	53	100,000	100,000	NUM
cuesj-1122	150	54	infected	infected	ADJ
cuesj-1122	150	55	persons	person	NOUN
cuesj-1122	150	56	required	require	VERB
cuesj-1122	150	57	hospitalization	hospitalization	NOUN
cuesj-1122	150	58	,	,	PUNCT
cuesj-1122	150	59	compared	compare	VERB
cuesj-1122	150	60	to	to	ADP
cuesj-1122	150	61	0.3	0.3	NUM
cuesj-1122	150	62	out	out	ADP
cuesj-1122	150	63	of	of	ADP
cuesj-1122	150	64	100,000	100,000	NUM
cuesj-1122	150	65	in	in	ADP
cuesj-1122	150	66	the	the	DET
cuesj-1122	150	67	vaccinated	vaccinated	ADJ
cuesj-1122	150	68	community	community	NOUN
cuesj-1122	150	69	.	.	PUNCT
cuesj-1122	151	1	only	only	ADV
cuesj-1122	151	2	596	596	NUM
cuesj-1122	151	3	cases	case	NOUN
cuesj-1122	151	4	were	be	AUX
cuesj-1122	151	5	available	available	ADJ
cuesj-1122	151	6	for	for	ADP
cuesj-1122	151	7	the	the	DET
cuesj-1122	151	8	vaccinated	vaccinated	ADJ
cuesj-1122	151	9	population	population	NOUN
cuesj-1122	151	10	,	,	PUNCT
cuesj-1122	151	11	though	though	ADV
cuesj-1122	151	12	.	.	PUNCT
cuesj-1122	152	1	comparably	comparably	ADV
cuesj-1122	152	2	,	,	PUNCT
cuesj-1122	152	3	the	the	DET
cuesj-1122	152	4	statistics	statistic	NOUN
cuesj-1122	152	5	showed	show	VERB
cuesj-1122	152	6	that	that	SCONJ
cuesj-1122	152	7	for	for	ADP
cuesj-1122	152	8	the	the	DET
cuesj-1122	152	9	unvaccinated	unvaccinated	ADJ
cuesj-1122	152	10	group	group	NOUN
cuesj-1122	152	11	,	,	PUNCT
cuesj-1122	152	12	the	the	DET
cuesj-1122	152	13	death	death	NOUN
cuesj-1122	152	14	rate	rate	NOUN
cuesj-1122	152	15	was	be	AUX
cuesj-1122	152	16	0.6	0.6	NUM
cuesj-1122	152	17	per	per	ADP
cuesj-1122	152	18	100,000	100,000	NUM
cuesj-1122	152	19	,	,	PUNCT
cuesj-1122	152	20	while	while	SCONJ
cuesj-1122	152	21	for	for	ADP
cuesj-1122	152	22	the	the	DET
cuesj-1122	152	23	vaccinated	vaccinated	ADJ
cuesj-1122	152	24	population	population	NOUN
cuesj-1122	152	25	,	,	PUNCT
cuesj-1122	152	26	it	it	PRON
cuesj-1122	152	27	was	be	AUX
cuesj-1122	152	28	0.1	0.1	NUM
cuesj-1122	152	29	per	per	ADP
cuesj-1122	152	30	100,000.[62	100,000.[62	NUM
cuesj-1122	152	31	]	]	PUNCT
cuesj-1122	152	32	in	in	ADP
cuesj-1122	152	33	additions	addition	NOUN
cuesj-1122	152	34	,	,	PUNCT
cuesj-1122	152	35	havers	haver	NOUN
cuesj-1122	152	36	et	et	NOUN
cuesj-1122	152	37	al.[5	al.[5	PROPN
cuesj-1122	152	38	]	]	PUNCT
cuesj-1122	152	39	according	accord	VERB
cuesj-1122	152	40	to	to	ADP
cuesj-1122	152	41	the	the	DET
cuesj-1122	152	42	results	result	NOUN
cuesj-1122	152	43	of	of	ADP
cuesj-1122	152	44	their	their	PRON
cuesj-1122	152	45	descriptive	descriptive	ADJ
cuesj-1122	152	46	investigation	investigation	NOUN
cuesj-1122	152	47	,	,	PUNCT
cuesj-1122	152	48	unvaccinated	unvaccinate	VERB
cuesj-1122	152	49	adults	adult	NOUN
cuesj-1122	152	50	’	'	PUNCT
cuesj-1122	152	51	hospitalization	hospitalization	NOUN
cuesj-1122	152	52	rates	rate	NOUN
cuesj-1122	152	53	for	for	ADP
cuesj-1122	152	54	covid-19	covid-19	PROPN
cuesj-1122	152	55	were	be	AUX
cuesj-1122	152	56	more	more	ADJ
cuesj-1122	152	57	than	than	ADP
cuesj-1122	152	58	ten	ten	NUM
cuesj-1122	152	59	times	time	NOUN
cuesj-1122	152	60	greater	great	ADJ
cuesj-1122	152	61	than	than	ADP
cuesj-1122	152	62	those	those	PRON
cuesj-1122	152	63	of	of	ADP
cuesj-1122	152	64	vaccinated	vaccinated	ADJ
cuesj-1122	152	65	individuals	individual	NOUN
cuesj-1122	152	66	during	during	ADP
cuesj-1122	152	67	the	the	DET
cuesj-1122	152	68	1st	1st	ADJ
cuesj-1122	152	69	year	year	NOUN
cuesj-1122	152	70	the	the	DET
cuesj-1122	152	71	vaccine	vaccine	NOUN
cuesj-1122	152	72	was	be	AUX
cuesj-1122	152	73	made	make	VERB
cuesj-1122	152	74	available	available	ADJ
cuesj-1122	152	75	in	in	ADP
cuesj-1122	152	76	the	the	DET
cuesj-1122	152	77	us	us	PROPN
cuesj-1122	152	78	.	.	PUNCT
cuesj-1122	153	1	conclusion	conclusion	NOUN
cuesj-1122	153	2	this	this	DET
cuesj-1122	153	3	study	study	NOUN
cuesj-1122	153	4	demonstrates	demonstrate	VERB
cuesj-1122	153	5	that	that	SCONJ
cuesj-1122	153	6	covid-19	covid-19	PROPN
cuesj-1122	153	7	vaccination	vaccination	NOUN
cuesj-1122	153	8	can	can	AUX
cuesj-1122	153	9	be	be	AUX
cuesj-1122	153	10	helpful	helpful	ADJ
cuesj-1122	153	11	at	at	ADP
cuesj-1122	153	12	minimizing	minimize	VERB
cuesj-1122	153	13	the	the	DET
cuesj-1122	153	14	disease	disease	NOUN
cuesj-1122	153	15	’s	’s	PART
cuesj-1122	153	16	severity	severity	NOUN
cuesj-1122	153	17	.	.	PUNCT
cuesj-1122	154	1	vaccinated	vaccinate	VERB
cuesj-1122	154	2	patients	patient	NOUN
cuesj-1122	154	3	had	have	VERB
cuesj-1122	154	4	milder	mild	ADJ
cuesj-1122	154	5	disease	disease	NOUN
cuesj-1122	154	6	with	with	ADP
cuesj-1122	154	7	less	less	ADJ
cuesj-1122	154	8	abnormality	abnormality	NOUN
cuesj-1122	154	9	of	of	ADP
cuesj-1122	154	10	liver	liver	NOUN
cuesj-1122	154	11	parameters	parameter	NOUN
cuesj-1122	154	12	and	and	CCONJ
cuesj-1122	154	13	bone	bone	NOUN
cuesj-1122	154	14	markers	marker	NOUN
cuesj-1122	154	15	compared	compare	VERB
cuesj-1122	154	16	to	to	ADP
cuesj-1122	154	17	the	the	DET
cuesj-1122	154	18	unvaccinated	unvaccinate	VERB
cuesj-1122	154	19	group	group	NOUN
cuesj-1122	154	20	.	.	PUNCT
cuesj-1122	155	1	increased	increase	VERB
cuesj-1122	155	2	serum	serum	NOUN
cuesj-1122	155	3	level	level	NOUN
cuesj-1122	155	4	of	of	ADP
cuesj-1122	155	5	liver	liver	NOUN
cuesj-1122	155	6	enzymes	enzyme	NOUN
cuesj-1122	155	7	including	include	VERB
cuesj-1122	155	8	alt	alt	ADJ
cuesj-1122	155	9	,	,	PUNCT
cuesj-1122	155	10	ast	ast	PROPN
cuesj-1122	155	11	,	,	PUNCT
cuesj-1122	155	12	alp	alp	PROPN
cuesj-1122	155	13	,	,	PUNCT
cuesj-1122	155	14	tsb	tsb	PROPN
cuesj-1122	155	15	,	,	PUNCT
cuesj-1122	155	16	and	and	CCONJ
cuesj-1122	155	17	ldh	ldh	PROPN
cuesj-1122	155	18	,	,	PUNCT
cuesj-1122	155	19	as	as	ADV
cuesj-1122	155	20	well	well	ADV
cuesj-1122	155	21	as	as	ADP
cuesj-1122	155	22	decreased	decrease	VERB
cuesj-1122	155	23	serum	serum	NOUN
cuesj-1122	155	24	albumin	albumin	NOUN
cuesj-1122	155	25	were	be	AUX
cuesj-1122	155	26	correlated	correlate	VERB
cuesj-1122	155	27	with	with	ADP
cuesj-1122	155	28	non	non	ADJ
cuesj-1122	155	29	-	-	ADJ
cuesj-1122	155	30	vaccinated	vaccinated	ADJ
cuesj-1122	155	31	covid-19	covid-19	PROPN
cuesj-1122	155	32	patients	patient	NOUN
cuesj-1122	155	33	when	when	SCONJ
cuesj-1122	155	34	compared	compare	VERB
cuesj-1122	155	35	to	to	ADP
cuesj-1122	155	36	the	the	DET
cuesj-1122	155	37	vaccinated	vaccinated	ADJ
cuesj-1122	155	38	group	group	NOUN
cuesj-1122	155	39	.	.	PUNCT
cuesj-1122	156	1	in	in	ADP
cuesj-1122	156	2	addition	addition	NOUN
cuesj-1122	156	3	,	,	PUNCT
cuesj-1122	156	4	according	accord	VERB
cuesj-1122	156	5	to	to	ADP
cuesj-1122	156	6	bone	bone	NOUN
cuesj-1122	156	7	markers	marker	NOUN
cuesj-1122	156	8	,	,	PUNCT
cuesj-1122	156	9	we	we	PRON
cuesj-1122	156	10	found	find	VERB
cuesj-1122	156	11	that	that	SCONJ
cuesj-1122	156	12	sars	sar	NOUN
cuesj-1122	156	13	-	-	PUNCT
cuesj-1122	156	14	cov-2	cov-2	NUM
cuesj-1122	156	15	either	either	CCONJ
cuesj-1122	156	16	directly	directly	ADV
cuesj-1122	156	17	or	or	CCONJ
cuesj-1122	156	18	indirectly	indirectly	ADV
cuesj-1122	156	19	affects	affect	VERB
cuesj-1122	156	20	bone	bone	NOUN
cuesj-1122	156	21	health	health	NOUN
cuesj-1122	156	22	.	.	PUNCT
cuesj-1122	157	1	low	low	ADJ
cuesj-1122	157	2	level	level	NOUN
cuesj-1122	157	3	of	of	ADP
cuesj-1122	157	4	serum	serum	NOUN
cuesj-1122	157	5	ca	ca	PROPN
cuesj-1122	157	6	,	,	PUNCT
cuesj-1122	157	7	p	p	NOUN
cuesj-1122	157	8	,	,	PUNCT
cuesj-1122	157	9	pth	pth	NOUN
cuesj-1122	157	10	,	,	PUNCT
cuesj-1122	157	11	and	and	CCONJ
cuesj-1122	157	12	tsh	tsh	NOUN
cuesj-1122	157	13	concentrations	concentration	NOUN
cuesj-1122	157	14	were	be	AUX
cuesj-1122	157	15	associated	associate	VERB
cuesj-1122	157	16	with	with	ADP
cuesj-1122	157	17	both	both	CCONJ
cuesj-1122	157	18	vaccinated	vaccinated	ADJ
cuesj-1122	157	19	and	and	CCONJ
cuesj-1122	157	20	non	non	ADJ
cuesj-1122	157	21	-	-	ADJ
cuesj-1122	157	22	vaccinated	vaccinated	ADJ
cuesj-1122	157	23	covid-19	covid-19	PROPN
cuesj-1122	157	24	patients	patient	NOUN
cuesj-1122	157	25	.	.	PUNCT
cuesj-1122	158	1	therefore	therefore	ADV
cuesj-1122	158	2	,	,	PUNCT
cuesj-1122	158	3	the	the	DET
cuesj-1122	158	4	bone	bone	NOUN
cuesj-1122	158	5	health	health	NOUN
cuesj-1122	158	6	status	status	NOUN
cuesj-1122	158	7	of	of	ADP
cuesj-1122	158	8	covid-19	covid-19	PROPN
cuesj-1122	158	9	patients	patient	NOUN
cuesj-1122	158	10	and	and	CCONJ
cuesj-1122	158	11	liver	liver	NOUN
cuesj-1122	158	12	biomarkers	biomarker	NOUN
cuesj-1122	158	13	are	be	AUX
cuesj-1122	158	14	important	important	ADJ
cuesj-1122	158	15	for	for	ADP
cuesj-1122	158	16	the	the	DET
cuesj-1122	158	17	monitoring	monitoring	NOUN
cuesj-1122	158	18	and	and	CCONJ
cuesj-1122	158	19	diagnosis	diagnosis	NOUN
cuesj-1122	158	20	of	of	ADP
cuesj-1122	158	21	disease	disease	NOUN
cuesj-1122	158	22	severity	severity	NOUN
cuesj-1122	158	23	in	in	ADP
cuesj-1122	158	24	sars	sar	NOUN
cuesj-1122	158	25	-	-	PUNCT
cuesj-1122	158	26	cov-2	cov-2	PART
cuesj-1122	158	27	patients	patient	NOUN
cuesj-1122	158	28	.	.	PUNCT
cuesj-1122	159	1	covid-19	covid-19	PROPN
cuesj-1122	159	2	vaccines	vaccine	NOUN
cuesj-1122	159	3	can	can	AUX
cuesj-1122	159	4	not	not	PART
cuesj-1122	159	5	prevent	prevent	VERB
cuesj-1122	159	6	infection	infection	NOUN
cuesj-1122	159	7	with	with	ADP
cuesj-1122	159	8	sars	sar	NOUN
cuesj-1122	159	9	-	-	PUNCT
cuesj-1122	159	10	cov-2	cov-2	NOUN
cuesj-1122	159	11	,	,	PUNCT
cuesj-1122	159	12	but	but	CCONJ
cuesj-1122	159	13	they	they	PRON
cuesj-1122	159	14	decrease	decrease	VERB
cuesj-1122	159	15	hospitalization	hospitalization	NOUN
cuesj-1122	159	16	rate	rate	NOUN
cuesj-1122	159	17	and	and	CCONJ
cuesj-1122	159	18	disease	disease	NOUN
cuesj-1122	159	19	severity	severity	NOUN
cuesj-1122	159	20	in	in	ADP
cuesj-1122	159	21	most	most	ADJ
cuesj-1122	159	22	patients	patient	NOUN
cuesj-1122	159	23	.	.	PUNCT
cuesj-1122	160	1	references	reference	NOUN
cuesj-1122	160	2	1	1	NUM
cuesj-1122	160	3	.	.	PUNCT
cuesj-1122	160	4	f.	f.	PROPN
cuesj-1122	160	5	shahi	shahi	PROPN
cuesj-1122	160	6	,	,	PUNCT
cuesj-1122	160	7	s.	s.	PROPN
cuesj-1122	160	8	r.	r.	PROPN
cuesj-1122	160	9	safaee	safaee	PROPN
cuesj-1122	160	10	nodehi	nodehi	NOUN
cuesj-1122	160	11	,	,	PUNCT
cuesj-1122	160	12	s.	s.	PROPN
cuesj-1122	160	13	fekrvand	fekrvand	PROPN
cuesj-1122	160	14	,	,	PUNCT
cuesj-1122	160	15	f.	f.	PROPN
cuesj-1122	160	16	fathi	fathi	PROPN
cuesj-1122	160	17	,	,	PUNCT
cuesj-1122	160	18	m.	m.	PROPN
cuesj-1122	160	19	r.	r.	PROPN
cuesj-1122	160	20	dabiri	dabiri	PROPN
cuesj-1122	160	21	,	,	PUNCT
cuesj-1122	160	22	a.	a.	NOUN
cuesj-1122	160	23	abdollahi	abdollahi	PROPN
cuesj-1122	160	24	and	and	CCONJ
cuesj-1122	160	25	h.	h.	PROPN
cuesj-1122	160	26	hosseini	hosseini	PROPN
cuesj-1122	160	27	.	.	PUNCT
cuesj-1122	161	1	the	the	DET
cuesj-1122	161	2	evaluation	evaluation	NOUN
cuesj-1122	161	3	of	of	ADP
cuesj-1122	161	4	hematological	hematological	ADJ
cuesj-1122	161	5	parameters	parameter	NOUN
cuesj-1122	161	6	and	and	CCONJ
cuesj-1122	161	7	their	their	PRON
cuesj-1122	161	8	correlation	correlation	NOUN
cuesj-1122	161	9	with	with	ADP
cuesj-1122	161	10	disease	disease	NOUN
cuesj-1122	161	11	prognosis	prognosis	NOUN
cuesj-1122	161	12	in	in	ADP
cuesj-1122	161	13	covid-19	covid-19	PROPN
cuesj-1122	161	14	disease	disease	NOUN
cuesj-1122	161	15	in	in	ADP
cuesj-1122	161	16	iran	iran	PROPN
cuesj-1122	161	17	.	.	PUNCT
cuesj-1122	162	1	international	international	ADJ
cuesj-1122	162	2	journal	journal	PROPN
cuesj-1122	162	3	of	of	ADP
cuesj-1122	162	4	hematologyoncology	hematologyoncology	NOUN
cuesj-1122	162	5	and	and	CCONJ
cuesj-1122	162	6	stem	stem	NOUN
cuesj-1122	162	7	cell	cell	NOUN
cuesj-1122	162	8	research	research	NOUN
cuesj-1122	162	9	,	,	PUNCT
cuesj-1122	162	10	vol	vol	NOUN
cuesj-1122	162	11	.	.	PROPN
cuesj-1122	162	12	17	17	NUM
cuesj-1122	162	13	,	,	PUNCT
cuesj-1122	162	14	pp	pp	ADJ
cuesj-1122	162	15	.	.	PUNCT
cuesj-1122	162	16	89	89	NUM
cuesj-1122	162	17	-	-	SYM
cuesj-1122	162	18	99	99	NUM
cuesj-1122	162	19	,	,	PUNCT
cuesj-1122	162	20	2023	2023	NUM
cuesj-1122	162	21	.	.	PUNCT
cuesj-1122	163	1	2	2	X
cuesj-1122	163	2	.	.	X
cuesj-1122	163	3	d.	d.	PROPN
cuesj-1122	163	4	yesudhas	yesudhas	PROPN
cuesj-1122	163	5	,	,	PUNCT
cuesj-1122	163	6	a.	a.	PROPN
cuesj-1122	163	7	srivastava	srivastava	PROPN
cuesj-1122	163	8	and	and	CCONJ
cuesj-1122	163	9	m.	m.	NOUN
cuesj-1122	163	10	m.	m.	NOUN
cuesj-1122	163	11	gromiha	gromiha	PROPN
cuesj-1122	163	12	.	.	PUNCT
cuesj-1122	164	1	covid-19	covid-19	PROPN
cuesj-1122	164	2	outbreak	outbreak	NOUN
cuesj-1122	164	3	:	:	PUNCT
cuesj-1122	164	4	history	history	NOUN
cuesj-1122	164	5	,	,	PUNCT
cuesj-1122	164	6	mechanism	mechanism	NOUN
cuesj-1122	164	7	,	,	PUNCT
cuesj-1122	164	8	transmission	transmission	NOUN
cuesj-1122	164	9	,	,	PUNCT
cuesj-1122	164	10	structural	structural	ADJ
cuesj-1122	164	11	studies	study	NOUN
cuesj-1122	164	12	and	and	CCONJ
cuesj-1122	164	13	therapeutics	therapeutic	NOUN
cuesj-1122	164	14	.	.	PUNCT
cuesj-1122	165	1	infection	infection	NOUN
cuesj-1122	165	2	,	,	PUNCT
cuesj-1122	165	3	vol	vol	NOUN
cuesj-1122	165	4	.	.	PROPN
cuesj-1122	165	5	49	49	NUM
cuesj-1122	165	6	,	,	PUNCT
cuesj-1122	165	7	no	no	INTJ
cuesj-1122	165	8	.	.	NOUN
cuesj-1122	165	9	2	2	NUM
cuesj-1122	165	10	,	,	PUNCT
cuesj-1122	165	11	pp	pp	ADJ
cuesj-1122	165	12	.	.	PUNCT
cuesj-1122	166	1	199	199	NUM
cuesj-1122	166	2	-	-	SYM
cuesj-1122	166	3	213	213	NUM
cuesj-1122	166	4	,	,	PUNCT
cuesj-1122	166	5	2021	2021	NUM
cuesj-1122	166	6	.	.	PUNCT
cuesj-1122	167	1	3	3	X
cuesj-1122	167	2	.	.	X
cuesj-1122	167	3	b.	b.	PROPN
cuesj-1122	167	4	popovska	popovska	PROPN
cuesj-1122	167	5	jovičić	jovičić	PROPN
cuesj-1122	167	6	,	,	PUNCT
cuesj-1122	167	7	i.	i.	NOUN
cuesj-1122	167	8	raković	raković	PROPN
cuesj-1122	167	9	,	,	PUNCT
cuesj-1122	167	10	j.	j.	PROPN
cuesj-1122	167	11	gavrilović	gavrilović	PROPN
cuesj-1122	167	12	,	,	PUNCT
cuesj-1122	167	13	s.	s.	PROPN
cuesj-1122	167	14	sekulić	sekulić	PROPN
cuesj-1122	167	15	marković	marković	PROPN
cuesj-1122	167	16	,	,	PUNCT
cuesj-1122	167	17	s.	s.	PROPN
cuesj-1122	167	18	petrović	petrović	PROPN
cuesj-1122	167	19	,	,	PUNCT
cuesj-1122	167	20	v.	v.	PROPN
cuesj-1122	167	21	marković	marković	PROPN
cuesj-1122	167	22	,	,	PUNCT
cuesj-1122	167	23	a.	a.	NOUN
cuesj-1122	167	24	pavković	pavković	PROPN
cuesj-1122	167	25	,	,	PUNCT
cuesj-1122	167	26	p.	p.	PROPN
cuesj-1122	167	27	čanović	čanović	PROPN
cuesj-1122	167	28	,	,	PUNCT
cuesj-1122	167	29	r.	r.	PROPN
cuesj-1122	167	30	radojević	radojević	PROPN
cuesj-1122	167	31	marjanović	marjanović	PROPN
cuesj-1122	167	32	,	,	PUNCT
cuesj-1122	167	33	v.	v.	ADP
cuesj-1122	167	34	irić	irić	NOUN
cuesj-1122	167	35	-	-	PUNCT
cuesj-1122	167	36	čupić	čupić	NOUN
cuesj-1122	167	37	,	,	PUNCT
cuesj-1122	167	38	l.	l.	PROPN
cuesj-1122	167	39	popović	popović	PROPN
cuesj-1122	167	40	dragonjić	dragonjić	NOUN
cuesj-1122	167	41	and	and	CCONJ
cuesj-1122	167	42	m.	m.	NOUN
cuesj-1122	167	43	z.	z.	PROPN
cuesj-1122	167	44	milosavljević	milosavljević	PROPN
cuesj-1122	167	45	.	.	PUNCT
cuesj-1122	168	1	vitamin	vitamin	PROPN
cuesj-1122	168	2	d	d	PROPN
cuesj-1122	168	3	,	,	PUNCT
cuesj-1122	168	4	albumin	albumin	NOUN
cuesj-1122	168	5	,	,	PUNCT
cuesj-1122	168	6	and	and	CCONJ
cuesj-1122	168	7	d	d	NOUN
cuesj-1122	168	8	-	-	PUNCT
cuesj-1122	168	9	dimer	dimer	NOUN
cuesj-1122	168	10	as	as	ADP
cuesj-1122	168	11	significant	significant	ADJ
cuesj-1122	168	12	prognostic	prognostic	ADJ
cuesj-1122	168	13	markers	marker	NOUN
cuesj-1122	168	14	in	in	ADP
cuesj-1122	168	15	early	early	ADJ
cuesj-1122	168	16	hospitalization	hospitalization	NOUN
cuesj-1122	168	17	in	in	ADP
cuesj-1122	168	18	patients	patient	NOUN
cuesj-1122	168	19	with	with	ADP
cuesj-1122	168	20	covid-19	covid-19	PROPN
cuesj-1122	168	21	.	.	PROPN
cuesj-1122	168	22	journal	journal	PROPN
cuesj-1122	168	23	of	of	ADP
cuesj-1122	168	24	clinical	clinical	ADJ
cuesj-1122	168	25	medicine	medicine	NOUN
cuesj-1122	168	26	,	,	PUNCT
cuesj-1122	168	27	vol	vol	NOUN
cuesj-1122	168	28	.	.	PROPN
cuesj-1122	168	29	12	12	NUM
cuesj-1122	168	30	,	,	PUNCT
cuesj-1122	168	31	no	no	INTJ
cuesj-1122	168	32	.	.	NOUN
cuesj-1122	168	33	8	8	NUM
cuesj-1122	168	34	,	,	PUNCT
cuesj-1122	168	35	2023	2023	NUM
cuesj-1122	168	36	.	.	PUNCT
cuesj-1122	169	1	4	4	NUM
cuesj-1122	169	2	.	.	PUNCT
cuesj-1122	169	3	s.	s.	PROPN
cuesj-1122	169	4	a.	a.	PROPN
cuesj-1122	169	5	tabatabaeizadeh	tabatabaeizadeh	PROPN
cuesj-1122	169	6	.	.	PUNCT
cuesj-1122	170	1	airborne	airborne	ADJ
cuesj-1122	170	2	transmission	transmission	NOUN
cuesj-1122	170	3	of	of	ADP
cuesj-1122	170	4	covid-19	covid-19	PROPN
cuesj-1122	170	5	and	and	CCONJ
cuesj-1122	170	6	the	the	DET
cuesj-1122	170	7	role	role	NOUN
cuesj-1122	170	8	of	of	ADP
cuesj-1122	170	9	face	face	NOUN
cuesj-1122	170	10	mask	mask	NOUN
cuesj-1122	170	11	to	to	PART
cuesj-1122	170	12	prevent	prevent	VERB
cuesj-1122	170	13	it	it	PRON
cuesj-1122	170	14	:	:	PUNCT
cuesj-1122	170	15	a	a	DET
cuesj-1122	170	16	systematic	systematic	ADJ
cuesj-1122	170	17	review	review	NOUN
cuesj-1122	170	18	and	and	CCONJ
cuesj-1122	170	19	metaanalysis	metaanalysis	NOUN
cuesj-1122	170	20	.	.	PUNCT
cuesj-1122	171	1	european	european	ADJ
cuesj-1122	171	2	journal	journal	PROPN
cuesj-1122	171	3	of	of	ADP
cuesj-1122	171	4	medical	medical	ADJ
cuesj-1122	171	5	research	research	NOUN
cuesj-1122	171	6	,	,	PUNCT
cuesj-1122	171	7	vol	vol	NOUN
cuesj-1122	171	8	.	.	PROPN
cuesj-1122	171	9	26	26	NUM
cuesj-1122	171	10	,	,	PUNCT
cuesj-1122	171	11	no	no	INTJ
cuesj-1122	171	12	.	.	NOUN
cuesj-1122	171	13	1	1	NUM
cuesj-1122	171	14	,	,	PUNCT
cuesj-1122	171	15	p.	p.	NOUN
cuesj-1122	171	16	1	1	NUM
cuesj-1122	171	17	,	,	PUNCT
cuesj-1122	171	18	2021	2021	NUM
cuesj-1122	171	19	.	.	PUNCT
cuesj-1122	172	1	5	5	NUM
cuesj-1122	172	2	.	.	PUNCT
cuesj-1122	172	3	f.	f.	PROPN
cuesj-1122	172	4	p.	p.	PROPN
cuesj-1122	172	5	havers	havers	PROPN
cuesj-1122	172	6	,	,	PUNCT
cuesj-1122	172	7	h.	h.	PROPN
cuesj-1122	172	8	pham	pham	PROPN
cuesj-1122	172	9	,	,	PUNCT
cuesj-1122	172	10	c.	c.	PROPN
cuesj-1122	172	11	a.	a.	PROPN
cuesj-1122	172	12	taylor	taylor	PROPN
cuesj-1122	172	13	,	,	PUNCT
cuesj-1122	172	14	m.	m.	NOUN
cuesj-1122	172	15	whitaker	whitaker	PROPN
cuesj-1122	172	16	,	,	PUNCT
cuesj-1122	172	17	k.	k.	PROPN
cuesj-1122	172	18	patel	patel	PROPN
cuesj-1122	172	19	,	,	PUNCT
cuesj-1122	172	20	o.	o.	PROPN
cuesj-1122	172	21	anglin	anglin	PROPN
cuesj-1122	172	22	,	,	PUNCT
cuesj-1122	173	1	a.	a.	PROPN
cuesj-1122	173	2	k.	k.	PROPN
cuesj-1122	173	3	kambhampati	kambhampati	PROPN
cuesj-1122	173	4	,	,	PUNCT
cuesj-1122	173	5	j.	j.	PROPN
cuesj-1122	173	6	milucky	milucky	PROPN
cuesj-1122	173	7	,	,	PUNCT
cuesj-1122	173	8	e.	e.	PROPN
cuesj-1122	173	9	zell	zell	PROPN
cuesj-1122	173	10	,	,	PUNCT
cuesj-1122	173	11	h.	h.	PROPN
cuesj-1122	173	12	l.	l.	PROPN
cuesj-1122	173	13	moline	moline	PROPN
cuesj-1122	173	14	,	,	PUNCT
cuesj-1122	173	15	s.	s.	PROPN
cuesj-1122	173	16	j.	j.	PROPN
cuesj-1122	173	17	chai	chai	PROPN
cuesj-1122	173	18	,	,	PUNCT
cuesj-1122	173	19	p.	p.	PROPN
cuesj-1122	173	20	d.	d.	PROPN
cuesj-1122	173	21	kirley	kirley	PROPN
cuesj-1122	173	22	,	,	PUNCT
cuesj-1122	173	23	n.	n.	PROPN
cuesj-1122	173	24	b.	b.	PROPN
cuesj-1122	173	25	alden	alden	PROPN
cuesj-1122	173	26	,	,	PUNCT
cuesj-1122	173	27	i.	i.	PROPN
cuesj-1122	173	28	armistead	armistead	PROPN
cuesj-1122	173	29	,	,	PUNCT
cuesj-1122	173	30	k.	k.	PROPN
cuesj-1122	173	31	yousey	yousey	ADJ
cuesj-1122	173	32	-	-	PUNCT
cuesj-1122	173	33	hindes	hinde	NOUN
cuesj-1122	173	34	,	,	PUNCT
cuesj-1122	173	35	j.	j.	PROPN
cuesj-1122	173	36	meek	meek	PROPN
cuesj-1122	173	37	,	,	PUNCT
cuesj-1122	173	38	k.	k.	PROPN
cuesj-1122	173	39	p.	p.	PROPN
cuesj-1122	173	40	openo	openo	PROPN
cuesj-1122	173	41	,	,	PUNCT
cuesj-1122	173	42	e.	e.	PROPN
cuesj-1122	173	43	j.	j.	PROPN
cuesj-1122	173	44	anderson	anderson	PROPN
cuesj-1122	173	45	,	,	PUNCT
cuesj-1122	173	46	l.	l.	PROPN
cuesj-1122	173	47	reeg	reeg	PROPN
cuesj-1122	173	48	,	,	PUNCT
cuesj-1122	173	49	…	…	PUNCT
cuesj-1122	173	50	&	&	CCONJ
cuesj-1122	173	51	a.	a.	PROPN
cuesj-1122	173	52	kohrman	kohrman	PROPN
cuesj-1122	173	53	,	,	PUNCT
cuesj-1122	173	54	covid-19	covid-19	PROPN
cuesj-1122	173	55	-	-	PUNCT
cuesj-1122	173	56	associated	associate	VERB
cuesj-1122	173	57	hospitalizations	hospitalization	NOUN
cuesj-1122	173	58	among	among	ADP
cuesj-1122	173	59	vaccinated	vaccinated	ADJ
cuesj-1122	173	60	and	and	CCONJ
cuesj-1122	173	61	unvaccinated	unvaccinated	ADJ
cuesj-1122	173	62	adults	adult	NOUN
cuesj-1122	173	63	18	18	NUM
cuesj-1122	173	64	years	year	NOUN
cuesj-1122	173	65	or	or	CCONJ
cuesj-1122	173	66	older	old	ADJ
cuesj-1122	173	67	in	in	ADP
cuesj-1122	173	68	13	13	NUM
cuesj-1122	173	69	us	us	PROPN
cuesj-1122	173	70	states	state	NOUN
cuesj-1122	173	71	,	,	PUNCT
cuesj-1122	173	72	january	january	PROPN
cuesj-1122	173	73	2021	2021	NUM
cuesj-1122	173	74	to	to	ADP
cuesj-1122	173	75	april	april	PROPN
cuesj-1122	173	76	2022	2022	NUM
cuesj-1122	173	77	.	.	PUNCT
cuesj-1122	174	1	jama	jama	PROPN
cuesj-1122	174	2	internal	internal	ADJ
cuesj-1122	174	3	medicine	medicine	NOUN
cuesj-1122	174	4	,	,	PUNCT
cuesj-1122	174	5	vol	vol	NOUN
cuesj-1122	174	6	.	.	PROPN
cuesj-1122	174	7	182	182	NUM
cuesj-1122	174	8	,	,	PUNCT
cuesj-1122	174	9	no	no	INTJ
cuesj-1122	174	10	.	.	NOUN
cuesj-1122	174	11	10	10	NUM
cuesj-1122	174	12	,	,	PUNCT
cuesj-1122	174	13	pp	pp	ADJ
cuesj-1122	174	14	.	.	PUNCT
cuesj-1122	175	1	1071	1071	NUM
cuesj-1122	175	2	-	-	SYM
cuesj-1122	175	3	1081	1081	NUM
cuesj-1122	175	4	,	,	PUNCT
cuesj-1122	175	5	2022	2022	NUM
cuesj-1122	175	6	.	.	PUNCT
cuesj-1122	176	1	6	6	NUM
cuesj-1122	176	2	.	.	PUNCT
cuesj-1122	176	3	j.	j.	PROPN
cuesj-1122	176	4	l.	l.	PROPN
cuesj-1122	176	5	excler	excler	PROPN
cuesj-1122	176	6	,	,	PUNCT
cuesj-1122	176	7	m.	m.	PROPN
cuesj-1122	176	8	saville	saville	PROPN
cuesj-1122	176	9	,	,	PUNCT
cuesj-1122	176	10	l.	l.	PROPN
cuesj-1122	176	11	privor	privor	PROPN
cuesj-1122	176	12	-	-	PUNCT
cuesj-1122	176	13	dumm	dumm	PROPN
cuesj-1122	176	14	,	,	PUNCT
cuesj-1122	176	15	l.	l.	PROPN
cuesj-1122	176	16	privor	privor	NOUN
cuesj-1122	176	17	-	-	PUNCT
cuesj-1122	176	18	dumm	dumm	PROPN
cuesj-1122	176	19	,	,	PUNCT
cuesj-1122	176	20	s.	s.	PROPN
cuesj-1122	176	21	gilbert	gilbert	PROPN
cuesj-1122	176	22	,	,	PUNCT
cuesj-1122	176	23	p.	p.	PROPN
cuesj-1122	176	24	j.	j.	PROPN
cuesj-1122	176	25	hotez	hotez	PROPN
cuesj-1122	176	26	,	,	PUNCT
cuesj-1122	176	27	d.	d.	PROPN
cuesj-1122	176	28	thompson	thompson	PROPN
cuesj-1122	176	29	,	,	PUNCT
cuesj-1122	176	30	s.	s.	PROPN
cuesj-1122	176	31	abdool	abdool	PROPN
cuesj-1122	176	32	-	-	PUNCT
cuesj-1122	176	33	karim	karim	PROPN
cuesj-1122	176	34	and	and	CCONJ
cuesj-1122	176	35	j.	j.	PROPN
cuesj-1122	176	36	h.	h.	PROPN
cuesj-1122	176	37	kim	kim	PROPN
cuesj-1122	176	38	.	.	PUNCT
cuesj-1122	177	1	factors	factor	NOUN
cuesj-1122	177	2	,	,	PUNCT
cuesj-1122	177	3	enablers	enabler	NOUN
cuesj-1122	177	4	and	and	CCONJ
cuesj-1122	177	5	challenges	challenge	NOUN
cuesj-1122	177	6	for	for	ADP
cuesj-1122	177	7	covid-19	covid-19	PROPN
cuesj-1122	177	8	vaccine	vaccine	NOUN
cuesj-1122	177	9	development	development	NOUN
cuesj-1122	177	10	.	.	PUNCT
cuesj-1122	178	1	bmj	bmj	PROPN
cuesj-1122	178	2	global	global	ADJ
cuesj-1122	178	3	health	health	NOUN
cuesj-1122	178	4	,	,	PUNCT
cuesj-1122	178	5	vol	vol	NOUN
cuesj-1122	178	6	.	.	PROPN
cuesj-1122	178	7	8	8	NUM
cuesj-1122	178	8	,	,	PUNCT
cuesj-1122	178	9	no	no	INTJ
cuesj-1122	178	10	.	.	NOUN
cuesj-1122	178	11	6	6	NUM
cuesj-1122	178	12	,	,	PUNCT
cuesj-1122	178	13	2023	2023	NUM
cuesj-1122	178	14	.	.	PUNCT
cuesj-1122	179	1	7	7	X
cuesj-1122	179	2	.	.	X
cuesj-1122	179	3	r.	r.	PROPN
cuesj-1122	179	4	b.	b.	PROPN
cuesj-1122	179	5	singh	singh	PROPN
cuesj-1122	179	6	,	,	PUNCT
cuesj-1122	179	7	u.	u.	PROPN
cuesj-1122	179	8	p.	p.	PROPN
cuesj-1122	179	9	s.	s.	PROPN
cuesj-1122	179	10	parmar	parmar	PROPN
cuesj-1122	179	11	,	,	PUNCT
cuesj-1122	179	12	f.	f.	PROPN
cuesj-1122	179	13	kahale	kahale	PROPN
cuesj-1122	179	14	,	,	PUNCT
cuesj-1122	179	15	a.	a.	PROPN
cuesj-1122	179	16	agarwal	agarwal	PROPN
cuesj-1122	179	17	and	and	CCONJ
cuesj-1122	179	18	e.	e.	PROPN
cuesj-1122	179	19	tsui	tsui	PROPN
cuesj-1122	179	20	.	.	PUNCT
cuesj-1122	180	1	vaccine	vaccine	NOUN
cuesj-1122	180	2	-	-	PUNCT
cuesj-1122	180	3	associated	associate	VERB
cuesj-1122	180	4	uveitis	uveitis	NOUN
cuesj-1122	180	5	after	after	ADP
cuesj-1122	180	6	covid-19	covid-19	PROPN
cuesj-1122	180	7	vaccination	vaccination	NOUN
cuesj-1122	180	8	:	:	PUNCT
cuesj-1122	180	9	vaccine	vaccine	NOUN
cuesj-1122	180	10	adverse	adverse	ADJ
cuesj-1122	180	11	event	event	NOUN
cuesj-1122	180	12	reporting	report	VERB
cuesj-1122	180	13	system	system	NOUN
cuesj-1122	180	14	database	database	NOUN
cuesj-1122	180	15	analysis	analysis	NOUN
cuesj-1122	180	16	.	.	PUNCT
cuesj-1122	181	1	ophthalmology	ophthalmology	NOUN
cuesj-1122	181	2	,	,	PUNCT
cuesj-1122	181	3	vol	vol	NOUN
cuesj-1122	181	4	.	.	PROPN
cuesj-1122	181	5	130	130	NUM
cuesj-1122	181	6	,	,	PUNCT
cuesj-1122	181	7	no	no	INTJ
cuesj-1122	181	8	.	.	NOUN
cuesj-1122	181	9	2	2	NUM
cuesj-1122	181	10	,	,	PUNCT
cuesj-1122	181	11	pp	pp	ADJ
cuesj-1122	181	12	.	.	PUNCT
cuesj-1122	182	1	179	179	NUM
cuesj-1122	182	2	-	-	SYM
cuesj-1122	182	3	186	186	NUM
cuesj-1122	182	4	,	,	PUNCT
cuesj-1122	182	5	2023	2023	NUM
cuesj-1122	182	6	.	.	PUNCT
cuesj-1122	183	1	8	8	NUM
cuesj-1122	183	2	.	.	PUNCT
cuesj-1122	183	3	s.	s.	PROPN
cuesj-1122	183	4	n.	n.	PROPN
cuesj-1122	183	5	raza	raza	PROPN
cuesj-1122	183	6	,	,	PUNCT
cuesj-1122	183	7	s.	s.	PROPN
cuesj-1122	183	8	kumar	kumar	PROPN
cuesj-1122	183	9	,	,	PUNCT
cuesj-1122	183	10	a.	a.	NOUN
cuesj-1122	183	11	khatoon	khatoon	PROPN
cuesj-1122	183	12	,	,	PUNCT
cuesj-1122	183	13	n.	n.	PROPN
cuesj-1122	183	14	hussain	hussain	PROPN
cuesj-1122	183	15	and	and	CCONJ
cuesj-1122	183	16	u.	u.	PROPN
cuesj-1122	183	17	kayani	kayani	PROPN
cuesj-1122	183	18	.	.	PUNCT
cuesj-1122	184	1	outcome	outcome	NOUN
cuesj-1122	184	2	and	and	CCONJ
cuesj-1122	184	3	severity	severity	NOUN
cuesj-1122	184	4	of	of	ADP
cuesj-1122	184	5	covid-19	covid-19	PROPN
cuesj-1122	184	6	in	in	ADP
cuesj-1122	184	7	vaccinated	vaccinated	ADJ
cuesj-1122	184	8	and	and	CCONJ
cuesj-1122	184	9	unvaccinated	unvaccinated	ADJ
cuesj-1122	184	10	patients	patient	NOUN
cuesj-1122	184	11	.	.	PUNCT
cuesj-1122	185	1	pakistan	pakistan	PROPN
cuesj-1122	185	2	journal	journal	PROPN
cuesj-1122	185	3	of	of	ADP
cuesj-1122	185	4	medical	medical	ADJ
cuesj-1122	185	5	and	and	CCONJ
cuesj-1122	185	6	health	health	NOUN
cuesj-1122	185	7	sciences	science	NOUN
cuesj-1122	185	8	,	,	PUNCT
cuesj-1122	185	9	vol	vol	NOUN
cuesj-1122	185	10	.	.	PROPN
cuesj-1122	185	11	17	17	NUM
cuesj-1122	185	12	,	,	PUNCT
cuesj-1122	185	13	no	no	INTJ
cuesj-1122	185	14	.	.	NOUN
cuesj-1122	185	15	6	6	NUM
cuesj-1122	185	16	,	,	PUNCT
cuesj-1122	185	17	pp	pp	ADJ
cuesj-1122	185	18	.	.	PUNCT
cuesj-1122	186	1	89	89	NUM
cuesj-1122	186	2	-	-	SYM
cuesj-1122	186	3	91	91	NUM
cuesj-1122	186	4	,	,	PUNCT
cuesj-1122	186	5	2023	2023	NUM
cuesj-1122	186	6	.	.	PUNCT
cuesj-1122	187	1	9	9	NUM
cuesj-1122	187	2	.	.	PUNCT
cuesj-1122	187	3	s.	s.	PROPN
cuesj-1122	187	4	fatima	fatima	PROPN
cuesj-1122	187	5	,	,	PUNCT
cuesj-1122	187	6	a.	a.	PROPN
cuesj-1122	187	7	zafar	zafar	PROPN
cuesj-1122	187	8	,	,	PUNCT
cuesj-1122	187	9	h.	h.	PROPN
cuesj-1122	187	10	afzal	afzal	PROPN
cuesj-1122	187	11	,	,	PUNCT
cuesj-1122	187	12	t.	t.	PROPN
cuesj-1122	187	13	ejaz	ejaz	PROPN
cuesj-1122	187	14	,	,	PUNCT
cuesj-1122	187	15	s.	s.	PROPN
cuesj-1122	187	16	shamim	shamim	PROPN
cuesj-1122	187	17	,	,	PUNCT
cuesj-1122	187	18	s.	s.	PROPN
cuesj-1122	187	19	saleemi	saleemi	PROPN
cuesj-1122	187	20	and	and	CCONJ
cuesj-1122	187	21	a.	a.	NOUN
cuesj-1122	187	22	subhan	subhan	PROPN
cuesj-1122	187	23	butt	butt	PROPN
cuesj-1122	187	24	.	.	PUNCT
cuesj-1122	188	1	covid-19	covid-19	PROPN
cuesj-1122	188	2	infection	infection	NOUN
cuesj-1122	188	3	among	among	ADP
cuesj-1122	188	4	vaccinated	vaccinated	ADJ
cuesj-1122	188	5	and	and	CCONJ
cuesj-1122	188	6	unvaccinated	unvaccinated	ADJ
cuesj-1122	188	7	:	:	PUNCT
cuesj-1122	188	8	does	do	AUX
cuesj-1122	188	9	it	it	PRON
cuesj-1122	188	10	make	make	VERB
cuesj-1122	188	11	any	any	DET
cuesj-1122	188	12	difference	difference	NOUN
cuesj-1122	188	13	?	?	PUNCT
cuesj-1122	189	1	plos	plos	PROPN
cuesj-1122	189	2	one	one	NUM
cuesj-1122	189	3	,	,	PUNCT
cuesj-1122	189	4	vol	vol	NOUN
cuesj-1122	189	5	.	.	PROPN
cuesj-1122	189	6	17	17	NUM
cuesj-1122	189	7	,	,	PUNCT
cuesj-1122	189	8	no	no	INTJ
cuesj-1122	189	9	.	.	NOUN
cuesj-1122	189	10	7	7	NUM
cuesj-1122	189	11	,	,	PUNCT
cuesj-1122	189	12	p.	p.	PROPN
cuesj-1122	189	13	e0270485	e0270485	PROPN
cuesj-1122	189	14	,	,	PUNCT
cuesj-1122	189	15	2022	2022	NUM
cuesj-1122	189	16	.	.	PUNCT
cuesj-1122	190	1	10	10	NUM
cuesj-1122	190	2	.	.	PUNCT
cuesj-1122	190	3	g.	g.	PROPN
cuesj-1122	190	4	ponti	ponti	PROPN
cuesj-1122	190	5	,	,	PUNCT
cuesj-1122	190	6	m.	m.	NOUN
cuesj-1122	190	7	maccaferri	maccaferri	PROPN
cuesj-1122	190	8	,	,	PUNCT
cuesj-1122	190	9	c.	c.	PROPN
cuesj-1122	190	10	ruini	ruini	PROPN
cuesj-1122	190	11	,	,	PUNCT
cuesj-1122	190	12	a.	a.	NOUN
cuesj-1122	190	13	tomasi	tomasi	PROPN
cuesj-1122	190	14	and	and	CCONJ
cuesj-1122	190	15	t.	t.	PROPN
cuesj-1122	190	16	ozben	ozben	PROPN
cuesj-1122	190	17	.	.	PUNCT
cuesj-1122	191	1	biomarkers	biomarker	NOUN
cuesj-1122	191	2	associated	associate	VERB
cuesj-1122	191	3	with	with	ADP
cuesj-1122	191	4	covid-19	covid-19	PROPN
cuesj-1122	191	5	disease	disease	NOUN
cuesj-1122	191	6	progression	progression	NOUN
cuesj-1122	191	7	.	.	PUNCT
cuesj-1122	192	1	critical	critical	ADJ
cuesj-1122	192	2	reviews	review	NOUN
cuesj-1122	192	3	in	in	ADP
cuesj-1122	192	4	clinical	clinical	ADJ
cuesj-1122	192	5	laboratory	laboratory	NOUN
cuesj-1122	192	6	sciences	science	NOUN
cuesj-1122	192	7	,	,	PUNCT
cuesj-1122	192	8	vol	vol	NOUN
cuesj-1122	192	9	.	.	PROPN
cuesj-1122	192	10	57	57	NUM
cuesj-1122	192	11	,	,	PUNCT
cuesj-1122	192	12	no	no	INTJ
cuesj-1122	192	13	.	.	NOUN
cuesj-1122	192	14	6	6	NUM
cuesj-1122	192	15	,	,	PUNCT
cuesj-1122	192	16	pp	pp	ADJ
cuesj-1122	192	17	.	.	PUNCT
cuesj-1122	193	1	389	389	NUM
cuesj-1122	193	2	-	-	SYM
cuesj-1122	193	3	399	399	NUM
cuesj-1122	193	4	,	,	PUNCT
cuesj-1122	193	5	2020	2020	NUM
cuesj-1122	193	6	.	.	PUNCT
cuesj-1122	194	1	11	11	NUM
cuesj-1122	194	2	.	.	PUNCT
cuesj-1122	194	3	x.	x.	PROPN
cuesj-1122	194	4	chai	chai	PROPN
cuesj-1122	194	5	,	,	PUNCT
cuesj-1122	194	6	l.	l.	PROPN
cuesj-1122	194	7	hu	hu	PROPN
cuesj-1122	194	8	,	,	PUNCT
cuesj-1122	194	9	y.	y.	PROPN
cuesj-1122	194	10	zhang	zhang	PROPN
cuesj-1122	194	11	,	,	PUNCT
cuesj-1122	194	12	w.	w.	PROPN
cuesj-1122	194	13	han	han	PROPN
cuesj-1122	194	14	,	,	PUNCT
cuesj-1122	194	15	z.	z.	PROPN
cuesj-1122	194	16	lu	lu	PROPN
cuesj-1122	194	17	,	,	PUNCT
cuesj-1122	194	18	a.	a.	PROPN
cuesj-1122	194	19	ke	ke	PROPN
cuesj-1122	194	20	,	,	PUNCT
cuesj-1122	194	21	j.	j.	PROPN
cuesj-1122	194	22	zhou	zhou	PROPN
cuesj-1122	194	23	,	,	PUNCT
cuesj-1122	194	24	g.	g.	PROPN
cuesj-1122	194	25	shi	shi	PROPN
cuesj-1122	194	26	,	,	PUNCT
cuesj-1122	194	27	n.	n.	PROPN
cuesj-1122	194	28	fang	fang	PROPN
cuesj-1122	194	29	,	,	PUNCT
cuesj-1122	194	30	j.	j.	PROPN
cuesj-1122	194	31	fan	fan	PROPN
cuesj-1122	194	32	,	,	PUNCT
cuesj-1122	194	33	j.	j.	PROPN
cuesj-1122	194	34	cai	cai	PROPN
cuesj-1122	194	35	,	,	PUNCT
cuesj-1122	194	36	j.	j.	PROPN
cuesj-1122	194	37	fan	fan	PROPN
cuesj-1122	194	38	and	and	CCONJ
cuesj-1122	194	39	f.	f.	PROPN
cuesj-1122	194	40	lan	lan	PROPN
cuesj-1122	194	41	.	.	PUNCT
cuesj-1122	195	1	specific	specific	ADJ
cuesj-1122	195	2	ace2	ace2	NOUN
cuesj-1122	195	3	expression	expression	NOUN
cuesj-1122	195	4	in	in	ADP
cuesj-1122	195	5	cholangiocytes	cholangiocyte	NOUN
cuesj-1122	195	6	may	may	AUX
cuesj-1122	195	7	cause	cause	VERB
cuesj-1122	195	8	liver	liver	NOUN
cuesj-1122	195	9	damage	damage	NOUN
cuesj-1122	195	10	after	after	ADP
cuesj-1122	195	11	2019	2019	NUM
cuesj-1122	195	12	-	-	PUNCT
cuesj-1122	195	13	ncov	ncov	NOUN
cuesj-1122	195	14	infection	infection	NOUN
cuesj-1122	195	15	.	.	PUNCT
cuesj-1122	196	1	biorxiv	biorxiv	NOUN
cuesj-1122	197	1	[	[	X
cuesj-1122	197	2	preprint	preprint	NOUN
cuesj-1122	197	3	]	]	X
cuesj-1122	197	4	,	,	PUNCT
cuesj-1122	197	5	2020	2020	NUM
cuesj-1122	197	6	.	.	PUNCT
cuesj-1122	198	1	12	12	NUM
cuesj-1122	198	2	.	.	PUNCT
cuesj-1122	198	3	i.	i.	PROPN
cuesj-1122	198	4	g.	g.	PROPN
cuesj-1122	198	5	lempesis	lempesis	PROPN
cuesj-1122	198	6	,	,	PUNCT
cuesj-1122	198	7	e.	e.	PROPN
cuesj-1122	198	8	karlafti	karlafti	PROPN
cuesj-1122	198	9	,	,	PUNCT
cuesj-1122	198	10	p.	p.	NOUN
cuesj-1122	198	11	papalexis	papalexis	PROPN
cuesj-1122	198	12	,	,	PUNCT
cuesj-1122	198	13	g.	g.	PROPN
cuesj-1122	198	14	fotakopoulos	fotakopoulos	PROPN
cuesj-1122	198	15	,	,	PUNCT
cuesj-1122	198	16	k.	k.	PROPN
cuesj-1122	198	17	tarantinos	tarantinos	PROPN
cuesj-1122	198	18	,	,	PUNCT
cuesj-1122	198	19	v.	v.	PROPN
cuesj-1122	198	20	lekakis	lekakis	PROPN
cuesj-1122	198	21	,	,	PUNCT
cuesj-1122	198	22	s.	s.	PROPN
cuesj-1122	198	23	p.	p.	PROPN
cuesj-1122	198	24	papadakos	papadakos	PROPN
cuesj-1122	198	25	and	and	CCONJ
cuesj-1122	198	26	e.	e.	PROPN
cuesj-1122	198	27	cholongitas	cholongitas	PROPN
cuesj-1122	198	28	.	.	PUNCT
cuesj-1122	199	1	georgakopoulou	georgakopoulou	ADP
cuesj-1122	199	2	vecovid-19	vecovid-19	PROPN
cuesj-1122	199	3	and	and	CCONJ
cuesj-1122	199	4	liver	liver	NOUN
cuesj-1122	199	5	injury	injury	NOUN
cuesj-1122	199	6	in	in	ADP
cuesj-1122	199	7	individuals	individual	NOUN
cuesj-1122	199	8	with	with	ADP
cuesj-1122	199	9	obesity	obesity	NOUN
cuesj-1122	199	10	.	.	PUNCT
cuesj-1122	200	1	world	world	PROPN
cuesj-1122	200	2	journal	journal	PROPN
cuesj-1122	200	3	of	of	ADP
cuesj-1122	200	4	gastroenterology	gastroenterology	NOUN
cuesj-1122	200	5	,	,	PUNCT
cuesj-1122	200	6	vol	vol	NOUN
cuesj-1122	200	7	.	.	PROPN
cuesj-1122	200	8	29	29	NUM
cuesj-1122	200	9	,	,	PUNCT
cuesj-1122	200	10	no	no	INTJ
cuesj-1122	200	11	.	.	NOUN
cuesj-1122	200	12	6	6	NUM
cuesj-1122	200	13	,	,	PUNCT
cuesj-1122	200	14	p.	p.	NOUN
cuesj-1122	200	15	908	908	NUM
cuesj-1122	200	16	,	,	PUNCT
cuesj-1122	200	17	2023	2023	NUM
cuesj-1122	200	18	.	.	PUNCT
cuesj-1122	201	1	13	13	NUM
cuesj-1122	201	2	.	.	PUNCT
cuesj-1122	201	3	n.	n.	NOUN
cuesj-1122	201	4	aghamohamadi	aghamohamadi	PROPN
cuesj-1122	201	5	,	,	PUNCT
cuesj-1122	201	6	f	f	PROPN
cuesj-1122	201	7	,	,	PUNCT
cuesj-1122	201	8	shahba	shahba	NOUN
cuesj-1122	201	9	,	,	PUNCT
cuesj-1122	201	10	a.	a.	NOUN
cuesj-1122	201	11	zarezadeh	zarezadeh	PROPN
cuesj-1122	201	12	mehrabadi	mehrabadi	PROPN
cuesj-1122	201	13	,	,	PUNCT
cuesj-1122	201	14	h.	h.	PROPN
cuesj-1122	201	15	khorramdelazad	khorramdelazad	PROPN
cuesj-1122	201	16	,	,	PUNCT
cuesj-1122	201	17	m.	m.	PROPN
cuesj-1122	201	18	karimi	karimi	PROPN
cuesj-1122	201	19	,	,	PUNCT
cuesj-1122	201	20	r.	r.	PROPN
cuesj-1122	201	21	falak	falak	PROPN
cuesj-1122	201	22	and	and	CCONJ
cuesj-1122	201	23	r.	r.	PROPN
cuesj-1122	201	24	z.	z.	PROPN
cuesj-1122	201	25	emameh	emameh	PROPN
cuesj-1122	201	26	.	.	PUNCT
cuesj-1122	202	1	age	age	NOUN
cuesj-1122	202	2	-	-	PUNCT
cuesj-1122	202	3	dependent	dependent	ADJ
cuesj-1122	202	4	immune	immune	ADJ
cuesj-1122	202	5	responses	response	NOUN
cuesj-1122	202	6	in	in	ADP
cuesj-1122	202	7	covid-19	covid-19	PROPN
cuesj-1122	202	8	-	-	PUNCT
cuesj-1122	202	9	mediated	mediate	VERB
cuesj-1122	202	10	liver	liver	NOUN
cuesj-1122	202	11	injury	injury	NOUN
cuesj-1122	202	12	:	:	PUNCT
cuesj-1122	202	13	focus	focus	VERB
cuesj-1122	202	14	on	on	ADP
cuesj-1122	202	15	cytokines	cytokine	NOUN
cuesj-1122	202	16	.	.	PUNCT
cuesj-1122	203	1	frontiers	frontier	NOUN
cuesj-1122	203	2	in	in	ADP
cuesj-1122	203	3	endocrinology	endocrinology	NOUN
cuesj-1122	203	4	(	(	PUNCT
cuesj-1122	203	5	lausanne	lausanne	PROPN
cuesj-1122	203	6	)	)	PUNCT
cuesj-1122	203	7	,	,	PUNCT
cuesj-1122	203	8	vol	vol	NOUN
cuesj-1122	203	9	.	.	PROPN
cuesj-1122	203	10	14	14	NUM
cuesj-1122	203	11	,	,	PUNCT
cuesj-1122	203	12	p.	p.	NOUN
cuesj-1122	203	13	1139692	1139692	NUM
cuesj-1122	203	14	,	,	PUNCT
cuesj-1122	203	15	2023	2023	NUM
cuesj-1122	203	16	.	.	PUNCT
cuesj-1122	204	1	14	14	NUM
cuesj-1122	204	2	.	.	PUNCT
cuesj-1122	205	1	s.	s.	PROPN
cuesj-1122	205	2	w.	w.	PROPN
cuesj-1122	205	3	zhao	zhao	PROPN
cuesj-1122	205	4	,	,	PUNCT
cuesj-1122	205	5	y.	y.	PROPN
cuesj-1122	205	6	m.	m.	PROPN
cuesj-1122	205	7	li	li	PROPN
cuesj-1122	205	8	,	,	PUNCT
cuesj-1122	205	9	y.	y.	PROPN
cuesj-1122	205	10	l.	l.	PROPN
cuesj-1122	205	11	li	li	PROPN
cuesj-1122	205	12	and	and	CCONJ
cuesj-1122	205	13	c.	c.	PROPN
cuesj-1122	205	14	su	su	PROPN
cuesj-1122	205	15	.	.	PROPN
cuesj-1122	205	16	liver	liver	PROPN
cuesj-1122	205	17	injury	injury	NOUN
cuesj-1122	205	18	in	in	ADP
cuesj-1122	205	19	covid-19	covid-19	PROPN
cuesj-1122	205	20	:	:	PUNCT
cuesj-1122	205	21	clinical	clinical	ADJ
cuesj-1122	205	22	features	feature	NOUN
cuesj-1122	205	23	,	,	PUNCT
cuesj-1122	205	24	potential	potential	ADJ
cuesj-1122	205	25	mechanisms	mechanism	NOUN
cuesj-1122	205	26	,	,	PUNCT
cuesj-1122	205	27	risk	risk	NOUN
cuesj-1122	205	28	factors	factor	NOUN
cuesj-1122	205	29	and	and	CCONJ
cuesj-1122	205	30	clinical	clinical	ADJ
cuesj-1122	205	31	treatments	treatment	NOUN
cuesj-1122	205	32	.	.	PUNCT
cuesj-1122	206	1	world	world	PROPN
cuesj-1122	206	2	journal	journal	PROPN
cuesj-1122	206	3	of	of	ADP
cuesj-1122	206	4	gastroenterology	gastroenterology	NOUN
cuesj-1122	206	5	,	,	PUNCT
cuesj-1122	206	6	vol	vol	NOUN
cuesj-1122	206	7	.	.	PROPN
cuesj-1122	206	8	29	29	NUM
cuesj-1122	206	9	,	,	PUNCT
cuesj-1122	206	10	no	no	INTJ
cuesj-1122	206	11	.	.	NOUN
cuesj-1122	206	12	2	2	NUM
cuesj-1122	206	13	,	,	PUNCT
cuesj-1122	206	14	pp	pp	ADJ
cuesj-1122	206	15	.	.	PUNCT
cuesj-1122	207	1	241	241	NUM
cuesj-1122	207	2	-	-	SYM
cuesj-1122	207	3	256	256	NUM
cuesj-1122	207	4	,	,	PUNCT
cuesj-1122	207	5	2023	2023	NUM
cuesj-1122	207	6	.	.	PUNCT
cuesj-1122	208	1	15	15	NUM
cuesj-1122	208	2	.	.	PUNCT
cuesj-1122	208	3	i.	i.	PROPN
cuesj-1122	208	4	c.	c.	PROPN
cuesj-1122	208	5	de	de	PROPN
cuesj-1122	208	6	lima	lima	PROPN
cuesj-1122	208	7	,	,	PUNCT
cuesj-1122	208	8	d.	d.	PROPN
cuesj-1122	208	9	c	c	X
cuesj-1122	208	10	,	,	PUNCT
cuesj-1122	208	11	de	de	PROPN
cuesj-1122	208	12	menezes	menezes	PROPN
cuesj-1122	208	13	,	,	PUNCT
cuesj-1122	208	14	j.	j.	PROPN
cuesj-1122	208	15	h.	h.	PROPN
cuesj-1122	208	16	e.	e.	PROPN
cuesj-1122	208	17	uesugi	uesugi	PROPN
cuesj-1122	208	18	,	,	PUNCT
cuesj-1122	208	19	c.	c.	PROPN
cuesj-1122	208	20	n.	n.	PROPN
cuesj-1122	208	21	c	c	PROPN
cuesj-1122	208	22	,	,	PUNCT
cuesj-1122	208	23	bichara	bichara	PROPN
cuesj-1122	208	24	,	,	PUNCT
cuesj-1122	209	1	p.	p.	PROPN
cuesj-1122	209	2	f.	f.	PROPN
cuesj-1122	209	3	da	da	PROPN
cuesj-1122	209	4	costa	costa	PROPN
cuesj-1122	209	5	vasconcelos	vasconcelos	PROPN
cuesj-1122	209	6	,	,	PUNCT
cuesj-1122	209	7	j.	j.	PROPN
cuesj-1122	209	8	a.	a.	PROPN
cuesj-1122	209	9	s	s	PROPN
cuesj-1122	209	10	,	,	PUNCT
cuesj-1122	209	11	quaresma	quaresma	PROPN
cuesj-1122	209	12	and	and	CCONJ
cuesj-1122	209	13	l.	l.	PROPN
cuesj-1122	209	14	f.	f.	PROPN
cuesj-1122	209	15	m.	m.	PROPN
cuesj-1122	209	16	falcão	falcão	PROPN
cuesj-1122	209	17	.	.	PUNCT
cuesj-1122	210	1	liver	liver	NOUN
cuesj-1122	210	2	function	function	NOUN
cuesj-1122	210	3	in	in	ADP
cuesj-1122	210	4	patients	patient	NOUN
cuesj-1122	210	5	with	with	ADP
cuesj-1122	210	6	long	long	ADJ
cuesj-1122	210	7	-	-	PUNCT
cuesj-1122	210	8	term	term	NOUN
cuesj-1122	210	9	coronavirus	coronavirus	NOUN
cuesj-1122	210	10	disease	disease	NOUN
cuesj-1122	210	11	2019	2019	NUM
cuesj-1122	210	12	of	of	ADP
cuesj-1122	210	13	up	up	ADP
cuesj-1122	210	14	to	to	PART
cuesj-1122	210	15	20	20	NUM
cuesj-1122	210	16	months	month	NOUN
cuesj-1122	210	17	:	:	PUNCT
cuesj-1122	210	18	a	a	DET
cuesj-1122	210	19	cross	cross	ADJ
cuesj-1122	210	20	-	-	ADJ
cuesj-1122	210	21	sectional	sectional	ADJ
cuesj-1122	210	22	study	study	NOUN
cuesj-1122	210	23	.	.	PUNCT
cuesj-1122	211	1	international	international	ADJ
cuesj-1122	211	2	journal	journal	PROPN
cuesj-1122	211	3	of	of	ADP
cuesj-1122	211	4	environmental	environmental	ADJ
cuesj-1122	211	5	research	research	NOUN
cuesj-1122	211	6	and	and	CCONJ
cuesj-1122	211	7	public	public	ADJ
cuesj-1122	211	8	health	health	NOUN
cuesj-1122	211	9	,	,	PUNCT
cuesj-1122	211	10	vol	vol	NOUN
cuesj-1122	211	11	.	.	PROPN
cuesj-1122	211	12	20	20	NUM
cuesj-1122	211	13	,	,	PUNCT
cuesj-1122	211	14	no	no	INTJ
cuesj-1122	211	15	.	.	NOUN
cuesj-1122	211	16	7	7	NUM
cuesj-1122	211	17	,	,	PUNCT
cuesj-1122	211	18	p.	p.	NOUN
cuesj-1122	211	19	5281	5281	NUM
cuesj-1122	211	20	,	,	PUNCT
cuesj-1122	211	21	2023	2023	NUM
cuesj-1122	211	22	.	.	PUNCT
cuesj-1122	212	1	16	16	NUM
cuesj-1122	212	2	.	.	PUNCT
cuesj-1122	212	3	r.	r.	PROPN
cuesj-1122	212	4	yang	yang	PROPN
cuesj-1122	212	5	,	,	PUNCT
cuesj-1122	212	6	j.	j.	PROPN
cuesj-1122	212	7	feng	feng	PROPN
cuesj-1122	212	8	,	,	PUNCT
cuesj-1122	212	9	h.	h.	PROPN
cuesj-1122	212	10	wan	wan	PROPN
cuesj-1122	212	11	,	,	PUNCT
cuesj-1122	212	12	x.	x.	PROPN
cuesj-1122	212	13	zeng	zeng	PROPN
cuesj-1122	212	14	,	,	PUNCT
cuesj-1122	212	15	p.	p.	PROPN
cuesj-1122	212	16	ji	ji	PROPN
cuesj-1122	212	17	and	and	CCONJ
cuesj-1122	212	18	j.	j.	PROPN
cuesj-1122	212	19	zhang	zhang	PROPN
cuesj-1122	212	20	.	.	PUNCT
cuesj-1122	213	1	liver	liver	NOUN
cuesj-1122	213	2	injury	injury	NOUN
cuesj-1122	213	3	associated	associate	VERB
cuesj-1122	213	4	with	with	ADP
cuesj-1122	213	5	the	the	DET
cuesj-1122	213	6	severity	severity	NOUN
cuesj-1122	213	7	of	of	ADP
cuesj-1122	213	8	covid-19	covid-19	PROPN
cuesj-1122	213	9	:	:	PUNCT
cuesj-1122	213	10	a	a	DET
cuesj-1122	213	11	meta	meta	ADJ
cuesj-1122	213	12	-	-	PUNCT
cuesj-1122	213	13	analysis	analysis	NOUN
cuesj-1122	213	14	.	.	PUNCT
cuesj-1122	214	1	front	front	ADJ
cuesj-1122	214	2	public	public	ADJ
cuesj-1122	214	3	health	health	NOUN
cuesj-1122	214	4	,	,	PUNCT
cuesj-1122	214	5	vol	vol	NOUN
cuesj-1122	214	6	.	.	PROPN
cuesj-1122	214	7	11	11	NUM
cuesj-1122	214	8	,	,	PUNCT
cuesj-1122	214	9	p.	p.	NOUN
cuesj-1122	214	10	1003352	1003352	NUM
cuesj-1122	214	11	,	,	PUNCT
cuesj-1122	214	12	2023	2023	NUM
cuesj-1122	214	13	.	.	PUNCT
cuesj-1122	215	1	17	17	NUM
cuesj-1122	215	2	.	.	PUNCT
cuesj-1122	216	1	k.	k.	PROPN
cuesj-1122	216	2	kerschan	kerschan	PROPN
cuesj-1122	216	3	-	-	PUNCT
cuesj-1122	216	4	schind	schind	NOUN
cuesj-1122	216	5	,	,	PUNCT
cuesj-1122	216	6	p.	p.	PROPN
cuesj-1122	216	7	dovjak	dovjak	PROPN
cuesj-1122	216	8	,	,	PUNCT
cuesj-1122	216	9	m.	m.	NOUN
cuesj-1122	216	10	butylina	butylina	PROPN
cuesj-1122	216	11	,	,	PUNCT
cuesj-1122	216	12	a.	a.	NOUN
cuesj-1122	216	13	rainer	rainer	PROPN
cuesj-1122	216	14	,	,	PUNCT
cuesj-1122	216	15	b.	b.	PROPN
cuesj-1122	216	16	mayr	mayr	PROPN
cuesj-1122	216	17	,	,	PUNCT
cuesj-1122	216	18	v.	v.	PROPN
cuesj-1122	216	19	röggla	röggla	PROPN
cuesj-1122	216	20	,	,	PUNCT
cuesj-1122	216	21	h.	h.	PROPN
cuesj-1122	216	22	haslacher	haslacher	PROPN
cuesj-1122	216	23	,	,	PUNCT
cuesj-1122	216	24	m.	m.	PROPN
cuesj-1122	216	25	weber	weber	PROPN
cuesj-1122	216	26	,	,	PUNCT
cuesj-1122	216	27	g.	g.	PROPN
cuesj-1122	216	28	jordakieva	jordakieva	PROPN
cuesj-1122	216	29	and	and	CCONJ
cuesj-1122	216	30	p.	p.	PROPN
cuesj-1122	216	31	pietschmann	pietschmann	PROPN
cuesj-1122	216	32	.	.	PUNCT
cuesj-1122	217	1	moderate	moderate	ADJ
cuesj-1122	217	2	covid-19	covid-19	PROPN
cuesj-1122	217	3	disease	disease	NOUN
cuesj-1122	217	4	is	be	AUX
cuesj-1122	217	5	associated	associate	VERB
cuesj-1122	217	6	with	with	ADP
cuesj-1122	217	7	reduced	reduce	VERB
cuesj-1122	217	8	bone	bone	NOUN
cuesj-1122	217	9	turnover	turnover	NOUN
cuesj-1122	217	10	.	.	PUNCT
cuesj-1122	218	1	journal	journal	NOUN
cuesj-1122	218	2	of	of	ADP
cuesj-1122	218	3	bone	bone	NOUN
cuesj-1122	218	4	and	and	CCONJ
cuesj-1122	218	5	mineral	mineral	NOUN
cuesj-1122	218	6	research	research	NOUN
cuesj-1122	218	7	,	,	PUNCT
cuesj-1122	218	8	vol	vol	NOUN
cuesj-1122	218	9	.	.	PROPN
cuesj-1122	218	10	38	38	NUM
cuesj-1122	218	11	,	,	PUNCT
cuesj-1122	218	12	no	no	INTJ
cuesj-1122	218	13	.	.	NOUN
cuesj-1122	218	14	7	7	NUM
cuesj-1122	218	15	,	,	PUNCT
cuesj-1122	218	16	pp	pp	ADJ
cuesj-1122	218	17	.	.	PUNCT
cuesj-1122	219	1	943	943	NUM
cuesj-1122	219	2	-	-	SYM
cuesj-1122	219	3	950	950	NUM
cuesj-1122	219	4	,	,	PUNCT
cuesj-1122	219	5	2023	2023	NUM
cuesj-1122	219	6	.	.	PUNCT
cuesj-1122	220	1	18	18	NUM
cuesj-1122	220	2	.	.	PUNCT
cuesj-1122	220	3	c.	c.	PROPN
cuesj-1122	220	4	l.	l.	PROPN
cuesj-1122	220	5	hu	hu	PROPN
cuesj-1122	220	6	,	,	PUNCT
cuesj-1122	220	7	m.	m.	PROPN
cuesj-1122	220	8	j.	j.	PROPN
cuesj-1122	220	9	zheng	zheng	PROPN
cuesj-1122	220	10	,	,	PUNCT
cuesj-1122	220	11	x.	x.	PROPN
cuesj-1122	220	12	x.	x.	NOUN
cuesj-1122	221	1	he	he	PRON
cuesj-1122	221	2	,	,	PUNCT
cuesj-1122	221	3	d.	d.	PROPN
cuesj-1122	221	4	c.	c.	PROPN
cuesj-1122	221	5	liu	liu	PROPN
cuesj-1122	221	6	,	,	PUNCT
cuesj-1122	221	7	z.	z.	PROPN
cuesj-1122	221	8	q.	q.	PROPN
cuesj-1122	221	9	jin	jin	PROPN
cuesj-1122	221	10	,	,	PUNCT
cuesj-1122	221	11	w.	w.	PROPN
cuesj-1122	221	12	h.	h.	PROPN
cuesj-1122	221	13	xu	xu	PROPN
cuesj-1122	221	14	,	,	PUNCT
cuesj-1122	221	15	p.	p.	PROPN
cuesj-1122	221	16	y.	y.	PROPN
cuesj-1122	221	17	lin	lin	PROPN
cuesj-1122	221	18	,	,	PUNCT
cuesj-1122	221	19	j.	j.	PROPN
cuesj-1122	221	20	w.	w.	PROPN
cuesj-1122	221	21	cheng	cheng	PROPN
cuesj-1122	221	22	and	and	CCONJ
cuesj-1122	221	23	q.	q.	PROPN
cuesj-1122	221	24	g.	g.	PROPN
cuesj-1122	221	25	wei	wei	PROPN
cuesj-1122	221	26	.	.	PUNCT
cuesj-1122	222	1	covid-19	covid-19	PROPN
cuesj-1122	222	2	and	and	CCONJ
cuesj-1122	222	3	bone	bone	NOUN
cuesj-1122	222	4	health	health	NOUN
cuesj-1122	222	5	.	.	PUNCT
cuesj-1122	223	1	european	european	PROPN
cuesj-1122	223	2	review	review	PROPN
cuesj-1122	223	3	for	for	ADP
cuesj-1122	223	4	medical	medical	ADJ
cuesj-1122	223	5	and	and	CCONJ
cuesj-1122	223	6	pharmacological	pharmacological	ADJ
cuesj-1122	223	7	sciences	science	NOUN
cuesj-1122	223	8	,	,	PUNCT
cuesj-1122	223	9	vol	vol	NOUN
cuesj-1122	223	10	.	.	PROPN
cuesj-1122	223	11	27	27	NUM
cuesj-1122	223	12	,	,	PUNCT
cuesj-1122	223	13	no	no	INTJ
cuesj-1122	223	14	.	.	NOUN
cuesj-1122	223	15	7	7	NUM
cuesj-1122	223	16	,	,	PUNCT
cuesj-1122	223	17	pp	pp	ADJ
cuesj-1122	223	18	.	.	PUNCT
cuesj-1122	224	1	3191	3191	NUM
cuesj-1122	224	2	-	-	SYM
cuesj-1122	224	3	3200	3200	NUM
cuesj-1122	224	4	,	,	PUNCT
cuesj-1122	224	5	2023	2023	NUM
cuesj-1122	224	6	.	.	PUNCT
cuesj-1122	225	1	19	19	NUM
cuesj-1122	225	2	.	.	PUNCT
cuesj-1122	225	3	a.	a.	PROPN
cuesj-1122	225	4	moretti	moretti	PROPN
cuesj-1122	225	5	,	,	PUNCT
cuesj-1122	225	6	s.	s.	PROPN
cuesj-1122	225	7	liguori	liguori	PROPN
cuesj-1122	225	8	,	,	PUNCT
cuesj-1122	225	9	m.	m.	NOUN
cuesj-1122	225	10	paoletta	paoletta	NOUN
cuesj-1122	225	11	,	,	PUNCT
cuesj-1122	225	12	s.	s.	PROPN
cuesj-1122	225	13	migliaccio	migliaccio	PROPN
cuesj-1122	225	14	and	and	CCONJ
cuesj-1122	225	15	g.	g.	PROPN
cuesj-1122	225	16	toro	toro	PROPN
cuesj-1122	225	17	,	,	PUNCT
cuesj-1122	225	18	f.	f.	PROPN
cuesj-1122	225	19	gimigliano	gimigliano	PROPN
cuesj-1122	225	20	,	,	PUNCT
cuesj-1122	225	21	iolascon	iolascon	PROPN
cuesj-1122	225	22	g.	g.	NOUN
cuesj-1122	225	23	bone	bone	NOUN
cuesj-1122	225	24	fragility	fragility	NOUN
cuesj-1122	225	25	during	during	ADP
cuesj-1122	225	26	the	the	DET
cuesj-1122	225	27	covid-19	covid-19	PROPN
cuesj-1122	225	28	pandemic	pandemic	NOUN
cuesj-1122	225	29	:	:	PUNCT
cuesj-1122	225	30	the	the	DET
cuesj-1122	225	31	role	role	NOUN
cuesj-1122	225	32	of	of	ADP
cuesj-1122	225	33	macro	macro	NOUN
cuesj-1122	225	34	-	-	PUNCT
cuesj-1122	225	35	and	and	CCONJ
cuesj-1122	225	36	micronutrients	micronutrient	NOUN
cuesj-1122	225	37	.	.	PUNCT
cuesj-1122	226	1	therapeutic	therapeutic	ADJ
cuesj-1122	226	2	advances	advance	NOUN
cuesj-1122	226	3	in	in	ADP
cuesj-1122	226	4	musculoskeletal	musculoskeletal	ADJ
cuesj-1122	226	5	disease	disease	NOUN
cuesj-1122	226	6	,	,	PUNCT
cuesj-1122	226	7	vol	vol	NOUN
cuesj-1122	226	8	.	.	PROPN
cuesj-1122	226	9	15	15	NUM
cuesj-1122	226	10	,	,	PUNCT
cuesj-1122	226	11	p.	p.	NOUN
cuesj-1122	226	12	1	1	NUM
cuesj-1122	226	13	-	-	SYM
cuesj-1122	226	14	23	23	NUM
cuesj-1122	226	15	,	,	PUNCT
cuesj-1122	226	16	2023	2023	NUM
cuesj-1122	226	17	.	.	PUNCT
cuesj-1122	227	1	20	20	NUM
cuesj-1122	227	2	.	.	PUNCT
cuesj-1122	227	3	l.	l.	PROPN
cuesj-1122	227	4	anghel	anghel	PROPN
cuesj-1122	227	5	,	,	PUNCT
cuesj-1122	227	6	c.	c.	PROPN
cuesj-1122	227	7	manole	manole	PROPN
cuesj-1122	227	8	,	,	PUNCT
cuesj-1122	227	9	a.	a.	NOUN
cuesj-1122	227	10	nechita	nechita	PROPN
cuesj-1122	227	11	,	,	PUNCT
cuesj-1122	227	12	a.	a.	PROPN
cuesj-1122	227	13	l.	l.	PROPN
cuesj-1122	227	14	tatu	tatu	PROPN
cuesj-1122	227	15	,	,	PUNCT
cuesj-1122	227	16	b.	b.	PROPN
cuesj-1122	227	17	i.	i.	PROPN
cuesj-1122	227	18	ștefănescu	ștefănescu	PROPN
cuesj-1122	227	19	,	,	PUNCT
cuesj-1122	227	20	ahmed	ahmed	PROPN
cuesj-1122	227	21	,	,	PUNCT
cuesj-1122	227	22	et	et	PROPN
cuesj-1122	227	23	al	al	PROPN
cuesj-1122	227	24	.	.	PUNCT
cuesj-1122	227	25	:	:	PUNCT
cuesj-1122	228	1	comparison	comparison	NOUN
cuesj-1122	228	2	of	of	ADP
cuesj-1122	228	3	biochemical	biochemical	ADJ
cuesj-1122	228	4	parameters	parameter	NOUN
cuesj-1122	228	5	in	in	ADP
cuesj-1122	228	6	vaccinated	vaccinated	ADJ
cuesj-1122	228	7	56	56	NUM
cuesj-1122	228	8	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1122	228	9	cuesj	cuesj	NOUN
cuesj-1122	228	10	2024	2024	NUM
cuesj-1122	228	11	,	,	PUNCT
cuesj-1122	228	12	8	8	NUM
cuesj-1122	228	13	(	(	PUNCT
cuesj-1122	228	14	1	1	NUM
cuesj-1122	228	15	):	):	PUNCT
cuesj-1122	228	16	46	46	NUM
cuesj-1122	228	17	-	-	SYM
cuesj-1122	228	18	57	57	NUM
cuesj-1122	228	19	l.	l.	PROPN
cuesj-1122	228	20	nechita	nechita	PROPN
cuesj-1122	228	21	,	,	PUNCT
cuesj-1122	228	22	c.	c.	PROPN
cuesj-1122	228	23	bușilă	bușilă	PROPN
cuesj-1122	228	24	,	,	PUNCT
cuesj-1122	228	25	p.	p.	PROPN
cuesj-1122	228	26	zainea	zainea	PROPN
cuesj-1122	228	27	,	,	PUNCT
cuesj-1122	228	28	l.	l.	PROPN
cuesj-1122	228	29	baroiu	baroiu	PROPN
cuesj-1122	228	30	and	and	CCONJ
cuesj-1122	228	31	c.	c.	PROPN
cuesj-1122	228	32	l.	l.	PROPN
cuesj-1122	228	33	mușat	mușat	PROPN
cuesj-1122	228	34	.	.	PUNCT
cuesj-1122	228	35	calcium	calcium	NOUN
cuesj-1122	228	36	,	,	PUNCT
cuesj-1122	228	37	phosphorus	phosphorus	NOUN
cuesj-1122	228	38	and	and	CCONJ
cuesj-1122	228	39	magnesium	magnesium	NOUN
cuesj-1122	228	40	abnormalities	abnormality	NOUN
cuesj-1122	228	41	associated	associate	VERB
cuesj-1122	228	42	with	with	ADP
cuesj-1122	228	43	covid-19	covid-19	PROPN
cuesj-1122	228	44	infection	infection	NOUN
cuesj-1122	228	45	,	,	PUNCT
cuesj-1122	228	46	and	and	CCONJ
cuesj-1122	228	47	beyond	beyond	ADP
cuesj-1122	228	48	.	.	PUNCT
cuesj-1122	229	1	biomedicines	biomedicine	NOUN
cuesj-1122	229	2	,	,	PUNCT
cuesj-1122	229	3	vol	vol	NOUN
cuesj-1122	229	4	.	.	PROPN
cuesj-1122	229	5	11	11	NUM
cuesj-1122	229	6	,	,	PUNCT
cuesj-1122	229	7	no	no	INTJ
cuesj-1122	229	8	.	.	NOUN
cuesj-1122	229	9	9	9	NUM
cuesj-1122	229	10	,	,	PUNCT
cuesj-1122	229	11	p.	p.	NOUN
cuesj-1122	229	12	2362	2362	NUM
cuesj-1122	229	13	,	,	PUNCT
cuesj-1122	229	14	2023	2023	NUM
cuesj-1122	229	15	.	.	PUNCT
cuesj-1122	230	1	21	21	NUM
cuesj-1122	230	2	.	.	PUNCT
cuesj-1122	230	3	b.	b.	PROPN
cuesj-1122	230	4	berktaş	berktaş	PROPN
cuesj-1122	230	5	,	,	PUNCT
cuesj-1122	230	6	a.	a.	NOUN
cuesj-1122	230	7	gökçek	gökçek	NOUN
cuesj-1122	230	8	,	,	PUNCT
cuesj-1122	230	9	n.	n.	NOUN
cuesj-1122	230	10	hoca	hoca	PROPN
cuesj-1122	230	11	and	and	CCONJ
cuesj-1122	230	12	a.	a.	PROPN
cuesj-1122	230	13	koyuncu	koyuncu	PROPN
cuesj-1122	230	14	.	.	PUNCT
cuesj-1122	231	1	covid-19	covid-19	PROPN
cuesj-1122	231	2	illness	illness	NOUN
cuesj-1122	231	3	and	and	CCONJ
cuesj-1122	231	4	treatment	treatment	NOUN
cuesj-1122	231	5	decrease	decrease	NOUN
cuesj-1122	231	6	bone	bone	NOUN
cuesj-1122	231	7	mineral	mineral	NOUN
cuesj-1122	231	8	density	density	NOUN
cuesj-1122	231	9	of	of	ADP
cuesj-1122	231	10	surviving	survive	VERB
cuesj-1122	231	11	hospitalized	hospitalize	VERB
cuesj-1122	231	12	patients	patient	NOUN
cuesj-1122	231	13	.	.	PUNCT
cuesj-1122	232	1	european	european	PROPN
cuesj-1122	232	2	review	review	PROPN
cuesj-1122	232	3	for	for	ADP
cuesj-1122	232	4	medical	medical	ADJ
cuesj-1122	232	5	and	and	CCONJ
cuesj-1122	232	6	pharmacological	pharmacological	ADJ
cuesj-1122	232	7	sciences	science	NOUN
cuesj-1122	232	8	,	,	PUNCT
cuesj-1122	232	9	vol	vol	NOUN
cuesj-1122	232	10	.	.	PROPN
cuesj-1122	232	11	26	26	NUM
cuesj-1122	232	12	,	,	PUNCT
cuesj-1122	232	13	no	no	INTJ
cuesj-1122	232	14	.	.	NOUN
cuesj-1122	232	15	8	8	NUM
cuesj-1122	232	16	,	,	PUNCT
cuesj-1122	232	17	pp	pp	ADJ
cuesj-1122	232	18	.	.	PUNCT
cuesj-1122	232	19	3046	3046	NUM
cuesj-1122	232	20	-	-	SYM
cuesj-1122	232	21	3056	3056	NUM
cuesj-1122	232	22	,	,	PUNCT
cuesj-1122	232	23	2022	2022	NUM
cuesj-1122	232	24	.	.	PUNCT
cuesj-1122	233	1	22	22	NUM
cuesj-1122	233	2	.	.	PUNCT
cuesj-1122	234	1	f.	f.	PROPN
cuesj-1122	234	2	javdani	javdani	PROPN
cuesj-1122	234	3	,	,	PUNCT
cuesj-1122	234	4	s.	s.	PROPN
cuesj-1122	234	5	parsa	parsa	PROPN
cuesj-1122	234	6	,	,	PUNCT
cuesj-1122	234	7	h.	h.	PROPN
cuesj-1122	234	8	shakeri	shakeri	PROPN
cuesj-1122	234	9	,	,	PUNCT
cuesj-1122	234	10	n.	n.	PROPN
cuesj-1122	234	11	hatami	hatami	PROPN
cuesj-1122	234	12	,	,	PUNCT
cuesj-1122	234	13	n.	n.	PROPN
cuesj-1122	234	14	kalani	kalani	PROPN
cuesj-1122	234	15	,	,	PUNCT
cuesj-1122	234	16	m.	m.	PROPN
cuesj-1122	234	17	haghbeen	haghbeen	PROPN
cuesj-1122	234	18	,	,	PUNCT
cuesj-1122	234	19	r.	r.	PROPN
cuesj-1122	234	20	raufi	raufi	PROPN
cuesj-1122	234	21	,	,	PUNCT
cuesj-1122	234	22	a.	a.	PROPN
cuesj-1122	234	23	abbasi	abbasi	PROPN
cuesj-1122	234	24	,	,	PUNCT
cuesj-1122	234	25	p.	p.	PROPN
cuesj-1122	234	26	keshavarz	keshavarz	PROPN
cuesj-1122	234	27	,	,	PUNCT
cuesj-1122	234	28	s.	s.	PROPN
cuesj-1122	234	29	a.	a.	PROPN
cuesj-1122	234	30	hashemi	hashemi	PROPN
cuesj-1122	234	31	and	and	CCONJ
cuesj-1122	234	32	a.	a.	NOUN
cuesj-1122	234	33	shafiee	shafiee	PROPN
cuesj-1122	234	34	.	.	PUNCT
cuesj-1122	235	1	phosphate	phosphate	ADJ
cuesj-1122	235	2	levels	level	NOUN
cuesj-1122	235	3	and	and	CCONJ
cuesj-1122	235	4	pulmonary	pulmonary	ADJ
cuesj-1122	235	5	damage	damage	NOUN
cuesj-1122	235	6	in	in	ADP
cuesj-1122	235	7	covid19	covid19	NOUN
cuesj-1122	235	8	patients	patient	NOUN
cuesj-1122	235	9	based	base	VERB
cuesj-1122	235	10	on	on	ADP
cuesj-1122	235	11	co	co	ADJ
cuesj-1122	235	12	-	-	ADJ
cuesj-1122	235	13	rads	rads	ADJ
cuesj-1122	235	14	scheme	scheme	NOUN
cuesj-1122	235	15	.	.	PUNCT
cuesj-1122	236	1	updates	update	NOUN
cuesj-1122	236	2	in	in	ADP
cuesj-1122	236	3	emergency	emergency	NOUN
cuesj-1122	236	4	medicine	medicine	NOUN
cuesj-1122	236	5	,	,	PUNCT
cuesj-1122	236	6	vol	vol	NOUN
cuesj-1122	236	7	.	.	PROPN
cuesj-1122	236	8	1	1	NUM
cuesj-1122	236	9	,	,	PUNCT
cuesj-1122	236	10	no	no	INTJ
cuesj-1122	236	11	.	.	NOUN
cuesj-1122	236	12	1	1	NUM
cuesj-1122	236	13	,	,	PUNCT
cuesj-1122	236	14	pp	pp	ADJ
cuesj-1122	236	15	.	.	PUNCT
cuesj-1122	237	1	15	15	NUM
cuesj-1122	237	2	-	-	SYM
cuesj-1122	237	3	20	20	NUM
cuesj-1122	237	4	,	,	PUNCT
cuesj-1122	237	5	2020	2020	NUM
cuesj-1122	237	6	.	.	PUNCT
cuesj-1122	238	1	23	23	NUM
cuesj-1122	238	2	.	.	PUNCT
cuesj-1122	239	1	c.	c.	PROPN
cuesj-1122	239	2	yang	yang	PROPN
cuesj-1122	239	3	,	,	PUNCT
cuesj-1122	239	4	x.	x.	PROPN
cuesj-1122	239	5	ma	ma	PROPN
cuesj-1122	239	6	,	,	PUNCT
cuesj-1122	239	7	j.	j.	PROPN
cuesj-1122	239	8	wu	wu	PROPN
cuesj-1122	239	9	,	,	PUNCT
cuesj-1122	239	10	j.	j.	PROPN
cuesj-1122	239	11	han	han	PROPN
cuesj-1122	239	12	,	,	PUNCT
cuesj-1122	239	13	z.	z.	PROPN
cuesj-1122	239	14	zheng	zheng	PROPN
cuesj-1122	239	15	,	,	PUNCT
cuesj-1122	239	16	h.	h.	PROPN
cuesj-1122	239	17	duan	duan	PROPN
cuesj-1122	239	18	,	,	PUNCT
cuesj-1122	239	19	q.	q.	PROPN
cuesj-1122	239	20	liu	liu	PROPN
cuesj-1122	239	21	,	,	PUNCT
cuesj-1122	239	22	c.	c.	PROPN
cuesj-1122	239	23	wu	wu	PROPN
cuesj-1122	239	24	and	and	CCONJ
cuesj-1122	239	25	y.	y.	PROPN
cuesj-1122	239	26	dong	dong	PROPN
cuesj-1122	239	27	,	,	PUNCT
cuesj-1122	239	28	l.	l.	PROPN
cuesj-1122	239	29	dong	dong	PROPN
cuesj-1122	239	30	.	.	PUNCT
cuesj-1122	240	1	low	low	PROPN
cuesj-1122	240	2	serum	serum	NOUN
cuesj-1122	240	3	calcium	calcium	NOUN
cuesj-1122	240	4	and	and	CCONJ
cuesj-1122	240	5	phosphorus	phosphorus	NOUN
cuesj-1122	240	6	and	and	CCONJ
cuesj-1122	240	7	their	their	PRON
cuesj-1122	240	8	clinical	clinical	ADJ
cuesj-1122	240	9	performance	performance	NOUN
cuesj-1122	240	10	in	in	ADP
cuesj-1122	240	11	detecting	detect	VERB
cuesj-1122	240	12	covid-19	covid-19	PROPN
cuesj-1122	240	13	patients	patient	NOUN
cuesj-1122	240	14	.	.	PUNCT
cuesj-1122	241	1	journal	journal	PROPN
cuesj-1122	241	2	of	of	ADP
cuesj-1122	241	3	medical	medical	ADJ
cuesj-1122	241	4	virology	virology	NOUN
cuesj-1122	241	5	,	,	PUNCT
cuesj-1122	241	6	vol	vol	NOUN
cuesj-1122	241	7	.	.	PROPN
cuesj-1122	241	8	93	93	NUM
cuesj-1122	241	9	,	,	PUNCT
cuesj-1122	241	10	no	no	INTJ
cuesj-1122	241	11	.	.	NOUN
cuesj-1122	241	12	3	3	NUM
cuesj-1122	241	13	,	,	PUNCT
cuesj-1122	241	14	pp	pp	ADJ
cuesj-1122	241	15	.	.	PUNCT
cuesj-1122	242	1	1639	1639	NUM
cuesj-1122	242	2	-	-	SYM
cuesj-1122	242	3	1651	1651	NUM
cuesj-1122	242	4	,	,	PUNCT
cuesj-1122	242	5	2021	2021	NUM
cuesj-1122	242	6	.	.	PUNCT
cuesj-1122	243	1	24	24	NUM
cuesj-1122	243	2	.	.	PUNCT
cuesj-1122	243	3	a.	a.	NOUN
cuesj-1122	243	4	abobaker	abobaker	NOUN
cuesj-1122	243	5	and	and	CCONJ
cuesj-1122	243	6	a.	a.	NOUN
cuesj-1122	243	7	alzwi	alzwi	PROPN
cuesj-1122	243	8	.	.	PUNCT
cuesj-1122	244	1	the	the	DET
cuesj-1122	244	2	effect	effect	NOUN
cuesj-1122	244	3	of	of	ADP
cuesj-1122	244	4	covid-19	covid-19	PROPN
cuesj-1122	244	5	on	on	ADP
cuesj-1122	244	6	parathyroid	parathyroid	ADJ
cuesj-1122	244	7	glands	gland	NOUN
cuesj-1122	244	8	.	.	PUNCT
cuesj-1122	245	1	journal	journal	NOUN
cuesj-1122	245	2	of	of	ADP
cuesj-1122	245	3	infection	infection	NOUN
cuesj-1122	245	4	and	and	CCONJ
cuesj-1122	245	5	public	public	ADJ
cuesj-1122	245	6	health	health	NOUN
cuesj-1122	245	7	,	,	PUNCT
cuesj-1122	245	8	vol	vol	NOUN
cuesj-1122	245	9	.	.	PROPN
cuesj-1122	245	10	14	14	NUM
cuesj-1122	245	11	,	,	PUNCT
cuesj-1122	245	12	no	no	INTJ
cuesj-1122	245	13	.	.	NOUN
cuesj-1122	245	14	6	6	NUM
cuesj-1122	245	15	,	,	PUNCT
cuesj-1122	245	16	pp	pp	ADJ
cuesj-1122	245	17	.	.	PUNCT
cuesj-1122	246	1	724	724	NUM
cuesj-1122	246	2	-	-	SYM
cuesj-1122	246	3	725	725	NUM
cuesj-1122	246	4	,	,	PUNCT
cuesj-1122	246	5	2021	2021	NUM
cuesj-1122	246	6	.	.	PUNCT
cuesj-1122	247	1	25	25	NUM
cuesj-1122	247	2	.	.	PUNCT
cuesj-1122	248	1	y.	y.	PROPN
cuesj-1122	248	2	chen	chen	PROPN
cuesj-1122	248	3	,	,	PUNCT
cuesj-1122	248	4	x.	x.	PROPN
cuesj-1122	248	5	li	li	PROPN
cuesj-1122	248	6	,	,	PUNCT
cuesj-1122	248	7	y.	y.	PROPN
cuesj-1122	248	8	dai	dai	PROPN
cuesj-1122	248	9	and	and	CCONJ
cuesj-1122	248	10	j.	j.	PROPN
cuesj-1122	248	11	zhang	zhang	PROPN
cuesj-1122	248	12	.	.	PUNCT
cuesj-1122	249	1	the	the	DET
cuesj-1122	249	2	association	association	NOUN
cuesj-1122	249	3	between	between	ADP
cuesj-1122	249	4	covid-19	covid-19	PROPN
cuesj-1122	249	5	and	and	CCONJ
cuesj-1122	249	6	thyroxine	thyroxine	NOUN
cuesj-1122	249	7	levels	level	NOUN
cuesj-1122	249	8	:	:	PUNCT
cuesj-1122	249	9	a	a	DET
cuesj-1122	249	10	meta	meta	ADJ
cuesj-1122	249	11	-	-	PUNCT
cuesj-1122	249	12	analysis	analysis	NOUN
cuesj-1122	249	13	.	.	PUNCT
cuesj-1122	250	1	front	front	ADJ
cuesj-1122	250	2	endocrinol	endocrinol	NOUN
cuesj-1122	250	3	(	(	PUNCT
cuesj-1122	250	4	lausanne	lausanne	PROPN
cuesj-1122	250	5	)	)	PUNCT
cuesj-1122	250	6	,	,	PUNCT
cuesj-1122	250	7	vol	vol	NOUN
cuesj-1122	250	8	.	.	PROPN
cuesj-1122	250	9	12	12	NUM
cuesj-1122	250	10	,	,	PUNCT
cuesj-1122	250	11	p.	p.	NOUN
cuesj-1122	250	12	779692	779692	NUM
cuesj-1122	250	13	,	,	PUNCT
cuesj-1122	250	14	2021	2021	NUM
cuesj-1122	250	15	.	.	PUNCT
cuesj-1122	251	1	26	26	NUM
cuesj-1122	251	2	.	.	PUNCT
cuesj-1122	252	1	j.	j.	PROPN
cuesj-1122	252	2	gong	gong	PROPN
cuesj-1122	252	3	,	,	PUNCT
cuesj-1122	252	4	d.	d.	PROPN
cuesj-1122	252	5	k.	k.	PROPN
cuesj-1122	252	6	wang	wang	PROPN
cuesj-1122	252	7	,	,	PUNCT
cuesj-1122	252	8	h.	h.	PROPN
cuesj-1122	252	9	dong	dong	PROPN
cuesj-1122	252	10	,	,	PUNCT
cuesj-1122	252	11	q.	q.	PROPN
cuesj-1122	252	12	s.	s.	PROPN
cuesj-1122	252	13	xia	xia	PROPN
cuesj-1122	252	14	,	,	PUNCT
cuesj-1122	252	15	z.	z.	PROPN
cuesj-1122	252	16	y.	y.	PROPN
cuesj-1122	252	17	huang	huang	PROPN
cuesj-1122	252	18	,	,	PUNCT
cuesj-1122	252	19	y.	y.	PROPN
cuesj-1122	252	20	zhao	zhao	PROPN
cuesj-1122	252	21	,	,	PUNCT
cuesj-1122	252	22	x.	x.	PROPN
cuesj-1122	252	23	chen	chen	PROPN
cuesj-1122	252	24	,	,	PUNCT
cuesj-1122	252	25	f.	f.	PROPN
cuesj-1122	252	26	yuan	yuan	PROPN
cuesj-1122	252	27	,	,	PUNCT
cuesj-1122	252	28	j.	j.	PROPN
cuesj-1122	252	29	b.	b.	PROPN
cuesj-1122	252	30	li	li	PROPN
cuesj-1122	252	31	and	and	CCONJ
cuesj-1122	252	32	f.	f.	PROPN
cuesj-1122	252	33	e.	e.	PROPN
cuesj-1122	252	34	lu	lu	PROPN
cuesj-1122	252	35	.	.	PUNCT
cuesj-1122	253	1	prognostic	prognostic	ADJ
cuesj-1122	253	2	significance	significance	NOUN
cuesj-1122	253	3	of	of	ADP
cuesj-1122	253	4	low	low	ADJ
cuesj-1122	253	5	tsh	tsh	NOUN
cuesj-1122	253	6	concentration	concentration	NOUN
cuesj-1122	253	7	in	in	ADP
cuesj-1122	253	8	patients	patient	NOUN
cuesj-1122	253	9	with	with	ADP
cuesj-1122	253	10	covid-19	covid-19	PROPN
cuesj-1122	253	11	presenting	present	VERB
cuesj-1122	253	12	with	with	ADP
cuesj-1122	253	13	non	non	ADJ
cuesj-1122	253	14	-	-	ADJ
cuesj-1122	253	15	thyroidal	thyroidal	ADJ
cuesj-1122	253	16	illness	illness	NOUN
cuesj-1122	253	17	syndrome	syndrome	NOUN
cuesj-1122	253	18	.	.	PUNCT
cuesj-1122	254	1	bmc	bmc	ADJ
cuesj-1122	254	2	endocrine	endocrine	NOUN
cuesj-1122	254	3	disorders	disorder	NOUN
cuesj-1122	254	4	,	,	PUNCT
cuesj-1122	254	5	vol	vol	NOUN
cuesj-1122	254	6	.	.	PROPN
cuesj-1122	254	7	21	21	NUM
cuesj-1122	254	8	,	,	PUNCT
cuesj-1122	254	9	no	no	INTJ
cuesj-1122	254	10	.	.	NOUN
cuesj-1122	254	11	1	1	NUM
cuesj-1122	254	12	,	,	PUNCT
cuesj-1122	254	13	p.	p.	NOUN
cuesj-1122	254	14	111	111	NUM
cuesj-1122	254	15	,	,	PUNCT
cuesj-1122	254	16	2021	2021	NUM
cuesj-1122	254	17	.	.	PUNCT
cuesj-1122	255	1	27	27	NUM
cuesj-1122	255	2	.	.	PUNCT
cuesj-1122	255	3	m.	m.	NOUN
cuesj-1122	255	4	zaidi	zaidi	PROPN
cuesj-1122	255	5	,	,	PUNCT
cuesj-1122	255	6	t.	t.	PROPN
cuesj-1122	255	7	f.	f.	PROPN
cuesj-1122	255	8	davies	davies	PROPN
cuesj-1122	255	9	,	,	PUNCT
cuesj-1122	255	10	a.	a.	NOUN
cuesj-1122	255	11	zallone	zallone	PROPN
cuesj-1122	255	12	,	,	PUNCT
cuesj-1122	255	13	h.	h.	PROPN
cuesj-1122	255	14	c.	c.	PROPN
cuesj-1122	255	15	blair	blair	PROPN
cuesj-1122	255	16	,	,	PUNCT
cuesj-1122	255	17	j.	j.	PROPN
cuesj-1122	255	18	iqbal	iqbal	PROPN
cuesj-1122	255	19	,	,	PUNCT
cuesj-1122	255	20	s.	s.	PROPN
cuesj-1122	255	21	s.	s.	PROPN
cuesj-1122	255	22	moonga	moonga	PROPN
cuesj-1122	255	23	,	,	PUNCT
cuesj-1122	255	24	j.	j.	PROPN
cuesj-1122	255	25	mechanick	mechanick	PROPN
cuesj-1122	255	26	and	and	CCONJ
cuesj-1122	255	27	l.	l.	PROPN
cuesj-1122	255	28	sun	sun	PROPN
cuesj-1122	255	29	.	.	PUNCT
cuesj-1122	255	30	thyroid	thyroid	NOUN
cuesj-1122	255	31	-	-	PUNCT
cuesj-1122	255	32	stimulating	stimulate	VERB
cuesj-1122	255	33	hormone	hormone	NOUN
cuesj-1122	255	34	,	,	PUNCT
cuesj-1122	255	35	thyroid	thyroid	NOUN
cuesj-1122	255	36	hormones	hormone	NOUN
cuesj-1122	255	37	,	,	PUNCT
cuesj-1122	255	38	and	and	CCONJ
cuesj-1122	255	39	bone	bone	NOUN
cuesj-1122	255	40	loss	loss	NOUN
cuesj-1122	255	41	.	.	PUNCT
cuesj-1122	256	1	current	current	ADJ
cuesj-1122	256	2	osteoporosis	osteoporosis	NOUN
cuesj-1122	256	3	reports	report	NOUN
cuesj-1122	256	4	,	,	PUNCT
cuesj-1122	256	5	vol	vol	NOUN
cuesj-1122	256	6	.	.	PROPN
cuesj-1122	257	1	7	7	NUM
cuesj-1122	257	2	,	,	PUNCT
cuesj-1122	257	3	no	no	INTJ
cuesj-1122	257	4	.	.	NOUN
cuesj-1122	257	5	2	2	NUM
cuesj-1122	257	6	,	,	PUNCT
cuesj-1122	257	7	pp	pp	ADJ
cuesj-1122	257	8	.	.	PUNCT
cuesj-1122	258	1	47	47	NUM
cuesj-1122	258	2	-	-	SYM
cuesj-1122	258	3	52	52	NUM
cuesj-1122	258	4	,	,	PUNCT
cuesj-1122	258	5	2009	2009	NUM
cuesj-1122	258	6	.	.	PUNCT
cuesj-1122	259	1	28	28	NUM
cuesj-1122	259	2	.	.	PUNCT
cuesj-1122	260	1	t.	t.	PROPN
cuesj-1122	260	2	deng	deng	PROPN
cuesj-1122	260	3	,	,	PUNCT
cuesj-1122	260	4	w.	w.	PROPN
cuesj-1122	260	5	zhang	zhang	PROPN
cuesj-1122	260	6	,	,	PUNCT
cuesj-1122	260	7	y.	y.	PROPN
cuesj-1122	260	8	zhang	zhang	PROPN
cuesj-1122	260	9	,	,	PUNCT
cuesj-1122	260	10	m.	m.	PROPN
cuesj-1122	260	11	zhang	zhang	PROPN
cuesj-1122	260	12	,	,	PUNCT
cuesj-1122	260	13	z.	z.	PROPN
cuesj-1122	260	14	huan	huan	PROPN
cuesj-1122	260	15	,	,	PUNCT
cuesj-1122	260	16	c.	c.	PROPN
cuesj-1122	260	17	yu	yu	PROPN
cuesj-1122	260	18	,	,	PUNCT
cuesj-1122	260	19	x.	x.	PROPN
cuesj-1122	260	20	zhang	zhang	PROPN
cuesj-1122	260	21	,	,	PUNCT
cuesj-1122	260	22	y.	y.	PROPN
cuesj-1122	260	23	wang	wang	PROPN
cuesj-1122	260	24	and	and	CCONJ
cuesj-1122	260	25	j.	j.	PROPN
cuesj-1122	260	26	xu	xu	PROPN
cuesj-1122	260	27	.	.	PUNCT
cuesj-1122	261	1	thyroid	thyroid	NOUN
cuesj-1122	261	2	-	-	PUNCT
cuesj-1122	261	3	stimulating	stimulate	VERB
cuesj-1122	261	4	hormone	hormone	NOUN
cuesj-1122	261	5	decreases	decrease	VERB
cuesj-1122	261	6	the	the	DET
cuesj-1122	261	7	risk	risk	NOUN
cuesj-1122	261	8	of	of	ADP
cuesj-1122	261	9	osteoporosis	osteoporosis	NOUN
cuesj-1122	261	10	by	by	ADP
cuesj-1122	261	11	regulating	regulate	VERB
cuesj-1122	261	12	osteoblast	osteoblast	ADJ
cuesj-1122	261	13	proliferation	proliferation	NOUN
cuesj-1122	261	14	and	and	CCONJ
cuesj-1122	261	15	differentiation	differentiation	NOUN
cuesj-1122	261	16	.	.	PUNCT
cuesj-1122	262	1	bmc	bmc	ADJ
cuesj-1122	262	2	endocrine	endocrine	NOUN
cuesj-1122	262	3	disorders	disorder	NOUN
cuesj-1122	262	4	,	,	PUNCT
cuesj-1122	262	5	vol	vol	NOUN
cuesj-1122	262	6	.	.	PROPN
cuesj-1122	262	7	21	21	NUM
cuesj-1122	262	8	,	,	PUNCT
cuesj-1122	262	9	no	no	INTJ
cuesj-1122	262	10	.	.	NOUN
cuesj-1122	262	11	1	1	NUM
cuesj-1122	262	12	,	,	PUNCT
cuesj-1122	262	13	p.	p.	NOUN
cuesj-1122	262	14	49	49	NUM
cuesj-1122	262	15	,	,	PUNCT
cuesj-1122	262	16	2021	2021	NUM
cuesj-1122	262	17	.	.	PUNCT
cuesj-1122	263	1	29	29	NUM
cuesj-1122	263	2	.	.	PUNCT
cuesj-1122	264	1	v.	v.	ADP
cuesj-1122	264	2	yanachkova	yanachkova	PROPN
cuesj-1122	264	3	,	,	PUNCT
cuesj-1122	264	4	t.	t.	PROPN
cuesj-1122	264	5	stankova	stankova	PROPN
cuesj-1122	264	6	and	and	CCONJ
cuesj-1122	264	7	r.	r.	PROPN
cuesj-1122	264	8	staynova	staynova	PROPN
cuesj-1122	264	9	.	.	PUNCT
cuesj-1122	265	1	thyroid	thyroid	VERB
cuesj-1122	265	2	dysfunction	dysfunction	NOUN
cuesj-1122	265	3	as	as	ADP
cuesj-1122	265	4	a	a	DET
cuesj-1122	265	5	long	long	ADJ
cuesj-1122	265	6	-	-	PUNCT
cuesj-1122	265	7	term	term	NOUN
cuesj-1122	265	8	post	post	ADJ
cuesj-1122	265	9	-	-	ADJ
cuesj-1122	265	10	covid-19	covid-19	ADJ
cuesj-1122	265	11	complication	complication	NOUN
cuesj-1122	265	12	in	in	ADP
cuesj-1122	265	13	mild	mild	ADJ
cuesj-1122	265	14	-	-	PUNCT
cuesj-1122	265	15	to	to	ADP
cuesj-1122	265	16	-	-	PUNCT
cuesj-1122	265	17	moderate	moderate	ADJ
cuesj-1122	265	18	covid-19	covid-19	PROPN
cuesj-1122	265	19	.	.	PUNCT
cuesj-1122	265	20	biotechnology	biotechnology	NOUN
cuesj-1122	265	21	and	and	CCONJ
cuesj-1122	265	22	biotechnological	biotechnological	ADJ
cuesj-1122	265	23	equipment	equipment	NOUN
cuesj-1122	265	24	,	,	PUNCT
cuesj-1122	265	25	vol	vol	NOUN
cuesj-1122	265	26	.	.	PROPN
cuesj-1122	266	1	37	37	NUM
cuesj-1122	266	2	,	,	PUNCT
cuesj-1122	266	3	no	no	INTJ
cuesj-1122	266	4	.	.	NOUN
cuesj-1122	266	5	1	1	NUM
cuesj-1122	266	6	,	,	PUNCT
cuesj-1122	266	7	pp	pp	ADJ
cuesj-1122	266	8	.	.	PUNCT
cuesj-1122	267	1	194	194	NUM
cuesj-1122	267	2	-	-	SYM
cuesj-1122	267	3	202	202	NUM
cuesj-1122	267	4	,	,	PUNCT
cuesj-1122	267	5	2023	2023	NUM
cuesj-1122	267	6	.	.	PUNCT
cuesj-1122	268	1	30	30	NUM
cuesj-1122	268	2	.	.	PUNCT
cuesj-1122	269	1	s.	s.	PROPN
cuesj-1122	269	2	kumari	kumari	PROPN
cuesj-1122	269	3	,	,	PUNCT
cuesj-1122	269	4	s.	s.	PROPN
cuesj-1122	269	5	nayak	nayak	PROPN
cuesj-1122	269	6	,	,	PUNCT
cuesj-1122	269	7	s.	s.	PROPN
cuesj-1122	269	8	tripathy	tripathy	PROPN
cuesj-1122	269	9	,	,	PUNCT
cuesj-1122	269	10	s.	s.	PROPN
cuesj-1122	269	11	bhuniya	bhuniya	PROPN
cuesj-1122	269	12	,	,	PUNCT
cuesj-1122	269	13	m.	m.	NOUN
cuesj-1122	269	14	mangaraj	mangaraj	NOUN
cuesj-1122	269	15	,	,	PUNCT
cuesj-1122	269	16	b.	b.	PROPN
cuesj-1122	269	17	ramadass	ramadass	PROPN
cuesj-1122	269	18	,	,	PUNCT
cuesj-1122	269	19	s.	s.	PROPN
cuesj-1122	269	20	sahu	sahu	PROPN
cuesj-1122	269	21	,	,	PUNCT
cuesj-1122	269	22	d.	d.	PROPN
cuesj-1122	269	23	bandyopadhyay	bandyopadhyay	PROPN
cuesj-1122	269	24	,	,	PUNCT
cuesj-1122	269	25	p.	p.	NOUN
cuesj-1122	269	26	dash	dash	NOUN
cuesj-1122	269	27	and	and	CCONJ
cuesj-1122	269	28	g.	g.	PROPN
cuesj-1122	269	29	k.	k.	PROPN
cuesj-1122	269	30	saharia	saharia	PROPN
cuesj-1122	269	31	.	.	PUNCT
cuesj-1122	270	1	analysis	analysis	NOUN
cuesj-1122	270	2	of	of	ADP
cuesj-1122	270	3	biochemical	biochemical	ADJ
cuesj-1122	270	4	and	and	CCONJ
cuesj-1122	270	5	inflammatory	inflammatory	ADJ
cuesj-1122	270	6	markers	marker	NOUN
cuesj-1122	270	7	for	for	ADP
cuesj-1122	270	8	predicting	predict	VERB
cuesj-1122	270	9	covid-19	covid-19	PROPN
cuesj-1122	270	10	severity	severity	NOUN
cuesj-1122	270	11	:	:	PUNCT
cuesj-1122	270	12	insights	insight	NOUN
cuesj-1122	270	13	from	from	ADP
cuesj-1122	270	14	a	a	DET
cuesj-1122	270	15	tertiary	tertiary	ADJ
cuesj-1122	270	16	healthcare	healthcare	NOUN
cuesj-1122	270	17	institution	institution	NOUN
cuesj-1122	270	18	of	of	ADP
cuesj-1122	270	19	eastern	eastern	PROPN
cuesj-1122	270	20	india	india	PROPN
cuesj-1122	270	21	.	.	PUNCT
cuesj-1122	271	1	cureus	cureus	PROPN
cuesj-1122	271	2	,	,	PUNCT
cuesj-1122	271	3	vol	vol	NOUN
cuesj-1122	271	4	.	.	PROPN
cuesj-1122	271	5	15	15	NUM
cuesj-1122	271	6	,	,	PUNCT
cuesj-1122	271	7	no	no	INTJ
cuesj-1122	271	8	.	.	NOUN
cuesj-1122	271	9	1	1	NUM
cuesj-1122	271	10	,	,	PUNCT
cuesj-1122	271	11	p.	p.	NOUN
cuesj-1122	271	12	e33893	e33893	NOUN
cuesj-1122	271	13	,	,	PUNCT
cuesj-1122	271	14	2023	2023	NUM
cuesj-1122	271	15	.	.	PUNCT
cuesj-1122	272	1	31	31	NUM
cuesj-1122	272	2	.	.	PUNCT
cuesj-1122	273	1	d.	d.	PROPN
cuesj-1122	273	2	a.	a.	PROPN
cuesj-1122	273	3	barbosa	barbosa	PROPN
cuesj-1122	273	4	,	,	PUNCT
cuesj-1122	273	5	p.	p.	PROPN
cuesj-1122	273	6	l.	l.	PROPN
cuesj-1122	273	7	zanão	zanão	PROPN
cuesj-1122	273	8	,	,	PUNCT
cuesj-1122	273	9	g.	g.	PROPN
cuesj-1122	273	10	s.	s.	PROPN
cuesj-1122	273	11	higino	higino	PROPN
cuesj-1122	273	12	,	,	PUNCT
cuesj-1122	273	13	j.	j.	PROPN
cuesj-1122	273	14	l.	l.	PROPN
cuesj-1122	273	15	grandi	grandi	PROPN
cuesj-1122	273	16	,	,	PUNCT
cuesj-1122	273	17	a.	a.	PROPN
cuesj-1122	273	18	g.	g.	PROPN
cuesj-1122	273	19	s.	s.	PROPN
cuesj-1122	273	20	belasco	belasco	PROPN
cuesj-1122	273	21	and	and	CCONJ
cuesj-1122	273	22	c.	c.	PROPN
cuesj-1122	273	23	d.	d.	PROPN
cuesj-1122	273	24	d.	d.	PROPN
cuesj-1122	273	25	fonseca	fonseca	PROPN
cuesj-1122	273	26	.	.	PUNCT
cuesj-1122	274	1	biochemical	biochemical	ADJ
cuesj-1122	274	2	changes	change	NOUN
cuesj-1122	274	3	in	in	ADP
cuesj-1122	274	4	patients	patient	NOUN
cuesj-1122	274	5	with	with	ADP
cuesj-1122	274	6	covid-19	covid-19	PROPN
cuesj-1122	274	7	.	.	PUNCT
cuesj-1122	274	8	acta	acta	PROPN
cuesj-1122	274	9	paulista	paulista	PROPN
cuesj-1122	274	10	de	de	PROPN
cuesj-1122	274	11	enfermagem	enfermagem	PROPN
cuesj-1122	274	12	,	,	PUNCT
cuesj-1122	274	13	vol	vol	NOUN
cuesj-1122	274	14	.	.	PROPN
cuesj-1122	274	15	36	36	NUM
cuesj-1122	274	16	,	,	PUNCT
cuesj-1122	274	17	p.	p.	NOUN
cuesj-1122	274	18	eape01112	eape01112	PROPN
cuesj-1122	274	19	,	,	PUNCT
cuesj-1122	274	20	2023	2023	NUM
cuesj-1122	274	21	.	.	PUNCT
cuesj-1122	275	1	32	32	NUM
cuesj-1122	275	2	.	.	PUNCT
cuesj-1122	276	1	j.	j.	PROPN
cuesj-1122	276	2	wu	wu	PROPN
cuesj-1122	276	3	,	,	PUNCT
cuesj-1122	276	4	s.	s.	PROPN
cuesj-1122	276	5	song	song	PROPN
cuesj-1122	276	6	,	,	PUNCT
cuesj-1122	276	7	h.	h.	PROPN
cuesj-1122	276	8	c.	c.	PROPN
cuesj-1122	276	9	cao	cao	PROPN
cuesj-1122	276	10	and	and	CCONJ
cuesj-1122	276	11	l.	l.	PROPN
cuesj-1122	276	12	j.	j.	PROPN
cuesj-1122	276	13	li	li	PROPN
cuesj-1122	276	14	.	.	PROPN
cuesj-1122	276	15	liver	liver	NOUN
cuesj-1122	276	16	diseases	disease	NOUN
cuesj-1122	276	17	in	in	ADP
cuesj-1122	276	18	covid-19	covid-19	PROPN
cuesj-1122	276	19	:	:	PUNCT
cuesj-1122	276	20	etiology	etiology	NOUN
cuesj-1122	276	21	,	,	PUNCT
cuesj-1122	276	22	treatment	treatment	NOUN
cuesj-1122	276	23	and	and	CCONJ
cuesj-1122	276	24	prognosis	prognosis	NOUN
cuesj-1122	276	25	.	.	PUNCT
cuesj-1122	277	1	world	world	PROPN
cuesj-1122	277	2	journal	journal	PROPN
cuesj-1122	277	3	of	of	ADP
cuesj-1122	277	4	gastroenterology	gastroenterology	NOUN
cuesj-1122	277	5	,	,	PUNCT
cuesj-1122	277	6	vol	vol	NOUN
cuesj-1122	277	7	.	.	PROPN
cuesj-1122	277	8	26	26	NUM
cuesj-1122	277	9	,	,	PUNCT
cuesj-1122	277	10	no	no	INTJ
cuesj-1122	277	11	.	.	NOUN
cuesj-1122	277	12	19	19	NUM
cuesj-1122	277	13	,	,	PUNCT
cuesj-1122	277	14	pp	pp	ADJ
cuesj-1122	277	15	.	.	PUNCT
cuesj-1122	278	1	2286	2286	NUM
cuesj-1122	278	2	-	-	SYM
cuesj-1122	278	3	2293	2293	NUM
cuesj-1122	278	4	,	,	PUNCT
cuesj-1122	278	5	2020	2020	NUM
cuesj-1122	278	6	.	.	PUNCT
cuesj-1122	279	1	[	[	X
cuesj-1122	279	2	in	in	ADP
cuesj-1122	279	3	english	english	PROPN
cuesj-1122	279	4	]	]	PUNCT
cuesj-1122	279	5	33	33	NUM
cuesj-1122	279	6	.	.	PUNCT
cuesj-1122	279	7	y.	y.	PROPN
cuesj-1122	279	8	wu	wu	PROPN
cuesj-1122	279	9	,	,	PUNCT
cuesj-1122	279	10	h.	h.	PROPN
cuesj-1122	279	11	li	li	PROPN
cuesj-1122	279	12	,	,	PUNCT
cuesj-1122	279	13	x.	x.	PROPN
cuesj-1122	279	14	guo	guo	PROPN
cuesj-1122	279	15	,	,	PUNCT
cuesj-1122	279	16	e.	e.	PROPN
cuesj-1122	279	17	m.	m.	PROPN
cuesj-1122	279	18	yoshida	yoshida	PROPN
cuesj-1122	279	19	,	,	PUNCT
cuesj-1122	279	20	n.	n.	PROPN
cuesj-1122	279	21	mendez	mendez	PROPN
cuesj-1122	279	22	-	-	PUNCT
cuesj-1122	279	23	sanchez	sanchez	PROPN
cuesj-1122	279	24	,	,	PUNCT
cuesj-1122	279	25	g.	g.	PROPN
cuesj-1122	279	26	b.	b.	PROPN
cuesj-1122	279	27	l.	l.	PROPN
cuesj-1122	279	28	sandri	sandri	PROPN
cuesj-1122	279	29	,	,	PUNCT
cuesj-1122	279	30	r.	r.	PROPN
cuesj-1122	279	31	teschke	teschke	PROPN
cuesj-1122	279	32	,	,	PUNCT
cuesj-1122	279	33	f.	f.	PROPN
cuesj-1122	279	34	g.	g.	PROPN
cuesj-1122	279	35	romeiro	romeiro	PROPN
cuesj-1122	279	36	,	,	PUNCT
cuesj-1122	279	37	a.	a.	NOUN
cuesj-1122	279	38	shukla	shukla	NOUN
cuesj-1122	279	39	and	and	CCONJ
cuesj-1122	279	40	x.	x.	NOUN
cuesj-1122	279	41	qi	qi	PROPN
cuesj-1122	279	42	.	.	PROPN
cuesj-1122	279	43	incidence	incidence	NOUN
cuesj-1122	279	44	,	,	PUNCT
cuesj-1122	279	45	risk	risk	NOUN
cuesj-1122	279	46	factors	factor	NOUN
cuesj-1122	279	47	,	,	PUNCT
cuesj-1122	279	48	and	and	CCONJ
cuesj-1122	279	49	prognosis	prognosis	NOUN
cuesj-1122	279	50	of	of	ADP
cuesj-1122	279	51	abnormal	abnormal	ADJ
cuesj-1122	279	52	liver	liver	NOUN
cuesj-1122	279	53	biochemical	biochemical	ADJ
cuesj-1122	279	54	tests	test	NOUN
cuesj-1122	279	55	in	in	ADP
cuesj-1122	279	56	covid-19	covid-19	PROPN
cuesj-1122	279	57	patients	patient	NOUN
cuesj-1122	279	58	:	:	PUNCT
cuesj-1122	279	59	a	a	DET
cuesj-1122	279	60	systematic	systematic	ADJ
cuesj-1122	279	61	review	review	NOUN
cuesj-1122	279	62	and	and	CCONJ
cuesj-1122	279	63	meta	meta	ADJ
cuesj-1122	279	64	-	-	PUNCT
cuesj-1122	279	65	analysis	analysis	NOUN
cuesj-1122	279	66	.	.	PUNCT
cuesj-1122	280	1	hepatology	hepatology	PROPN
cuesj-1122	280	2	international	international	ADJ
cuesj-1122	280	3	,	,	PUNCT
cuesj-1122	280	4	vol	vol	NOUN
cuesj-1122	280	5	.	.	PROPN
cuesj-1122	280	6	14	14	NUM
cuesj-1122	280	7	,	,	PUNCT
cuesj-1122	280	8	pp	pp	ADJ
cuesj-1122	280	9	.	.	PUNCT
cuesj-1122	281	1	621	621	NUM
cuesj-1122	281	2	-	-	SYM
cuesj-1122	281	3	637	637	NUM
cuesj-1122	281	4	,	,	PUNCT
cuesj-1122	281	5	2020	2020	NUM
cuesj-1122	281	6	.	.	PUNCT
cuesj-1122	282	1	34	34	NUM
cuesj-1122	282	2	.	.	PUNCT
cuesj-1122	283	1	j.	j.	PROPN
cuesj-1122	283	2	c.	c.	PROPN
cuesj-1122	283	3	kariyawasam	kariyawasam	PROPN
cuesj-1122	283	4	,	,	PUNCT
cuesj-1122	283	5	u.	u.	PROPN
cuesj-1122	283	6	jayarajah	jayarajah	PROPN
cuesj-1122	283	7	,	,	PUNCT
cuesj-1122	283	8	v.	v.	ADP
cuesj-1122	283	9	abeysuriya	abeysuriya	PROPN
cuesj-1122	283	10	,	,	PUNCT
cuesj-1122	283	11	r.	r.	PROPN
cuesj-1122	283	12	riza	riza	PROPN
cuesj-1122	283	13	and	and	CCONJ
cuesj-1122	283	14	s.	s.	PROPN
cuesj-1122	283	15	l.	l.	PROPN
cuesj-1122	283	16	seneviratne	seneviratne	PROPN
cuesj-1122	283	17	.	.	PUNCT
cuesj-1122	284	1	involvement	involvement	NOUN
cuesj-1122	284	2	of	of	ADP
cuesj-1122	284	3	the	the	DET
cuesj-1122	284	4	liver	liver	NOUN
cuesj-1122	284	5	in	in	ADP
cuesj-1122	284	6	covid-19	covid-19	PROPN
cuesj-1122	284	7	:	:	PUNCT
cuesj-1122	284	8	a	a	DET
cuesj-1122	284	9	systematic	systematic	ADJ
cuesj-1122	284	10	review	review	NOUN
cuesj-1122	284	11	.	.	PUNCT
cuesj-1122	285	1	american	american	PROPN
cuesj-1122	285	2	journal	journal	PROPN
cuesj-1122	285	3	of	of	ADP
cuesj-1122	285	4	tropical	tropical	ADJ
cuesj-1122	285	5	medicine	medicine	NOUN
cuesj-1122	285	6	and	and	CCONJ
cuesj-1122	285	7	hygiene	hygiene	NOUN
cuesj-1122	285	8	,	,	PUNCT
cuesj-1122	285	9	vol	vol	NOUN
cuesj-1122	285	10	.	.	PROPN
cuesj-1122	285	11	106	106	NUM
cuesj-1122	285	12	,	,	PUNCT
cuesj-1122	285	13	no	no	INTJ
cuesj-1122	285	14	.	.	NOUN
cuesj-1122	285	15	4	4	NUM
cuesj-1122	285	16	,	,	PUNCT
cuesj-1122	285	17	pp	pp	ADJ
cuesj-1122	285	18	.	.	PUNCT
cuesj-1122	286	1	1026	1026	NUM
cuesj-1122	286	2	-	-	SYM
cuesj-1122	286	3	1041	1041	NUM
cuesj-1122	286	4	,	,	PUNCT
cuesj-1122	286	5	2022	2022	NUM
cuesj-1122	286	6	.	.	PUNCT
cuesj-1122	287	1	35	35	NUM
cuesj-1122	287	2	.	.	PUNCT
cuesj-1122	287	3	a.	a.	NOUN
cuesj-1122	287	4	bertolini	bertolini	PROPN
cuesj-1122	287	5	,	,	PUNCT
cuesj-1122	287	6	i.	i.	PROPN
cuesj-1122	287	7	p.	p.	PROPN
cuesj-1122	287	8	van	van	PROPN
cuesj-1122	287	9	de	de	PROPN
cuesj-1122	287	10	peppel	peppel	PROPN
cuesj-1122	287	11	,	,	PUNCT
cuesj-1122	287	12	f.	f.	PROPN
cuesj-1122	287	13	a.	a.	PROPN
cuesj-1122	287	14	j.	j.	PROPN
cuesj-1122	287	15	a.	a.	PROPN
cuesj-1122	287	16	bodewes	bodewes	PROPN
cuesj-1122	287	17	,	,	PUNCT
cuesj-1122	287	18	h.	h.	NOUN
cuesj-1122	287	19	moshage	moshage	PROPN
cuesj-1122	287	20	,	,	PUNCT
cuesj-1122	287	21	a.	a.	NOUN
cuesj-1122	287	22	fantin	fantin	PROPN
cuesj-1122	287	23	,	,	PUNCT
cuesj-1122	287	24	f	f	PROPN
cuesj-1122	287	25	,	,	PUNCT
cuesj-1122	287	26	farinati	farinati	PROPN
cuesj-1122	287	27	,	,	PUNCT
cuesj-1122	287	28	r.	r.	NOUN
cuesj-1122	287	29	fiorotto	fiorotto	PROPN
cuesj-1122	287	30	,	,	PUNCT
cuesj-1122	287	31	j.	j.	PROPN
cuesj-1122	287	32	w.	w.	PROPN
cuesj-1122	287	33	jonker	jonker	PROPN
cuesj-1122	287	34	,	,	PUNCT
cuesj-1122	287	35	m.	m.	PROPN
cuesj-1122	287	36	strazzabosco	strazzabosco	PROPN
cuesj-1122	287	37	,	,	PUNCT
cuesj-1122	287	38	h.	h.	PROPN
cuesj-1122	287	39	j.	j.	PROPN
cuesj-1122	287	40	verkade	verkade	PROPN
cuesj-1122	287	41	and	and	CCONJ
cuesj-1122	287	42	g.	g.	PROPN
cuesj-1122	287	43	peserico	peserico	PROPN
cuesj-1122	287	44	.	.	PUNCT
cuesj-1122	288	1	abnormal	abnormal	ADJ
cuesj-1122	288	2	liver	liver	NOUN
cuesj-1122	288	3	function	function	NOUN
cuesj-1122	288	4	tests	test	NOUN
cuesj-1122	288	5	in	in	ADP
cuesj-1122	288	6	patients	patient	NOUN
cuesj-1122	288	7	with	with	ADP
cuesj-1122	288	8	covid-19	covid-19	PROPN
cuesj-1122	288	9	:	:	PUNCT
cuesj-1122	288	10	relevance	relevance	NOUN
cuesj-1122	288	11	and	and	CCONJ
cuesj-1122	288	12	potential	potential	ADJ
cuesj-1122	288	13	pathogenesis	pathogenesis	NOUN
cuesj-1122	288	14	.	.	PUNCT
cuesj-1122	289	1	hepatology	hepatology	NOUN
cuesj-1122	289	2	,	,	PUNCT
cuesj-1122	289	3	vol	vol	NOUN
cuesj-1122	289	4	.	.	PROPN
cuesj-1122	289	5	72	72	NUM
cuesj-1122	289	6	,	,	PUNCT
cuesj-1122	289	7	no	no	INTJ
cuesj-1122	289	8	.	.	NOUN
cuesj-1122	289	9	5	5	NUM
cuesj-1122	289	10	,	,	PUNCT
cuesj-1122	289	11	pp	pp	ADJ
cuesj-1122	289	12	.	.	PUNCT
cuesj-1122	289	13	1864	1864	NUM
cuesj-1122	289	14	-	-	SYM
cuesj-1122	289	15	1872	1872	NUM
cuesj-1122	289	16	,	,	PUNCT
cuesj-1122	289	17	2020	2020	NUM
cuesj-1122	289	18	.	.	PUNCT
cuesj-1122	290	1	[	[	X
cuesj-1122	290	2	in	in	ADP
cuesj-1122	290	3	english	english	PROPN
cuesj-1122	290	4	]	]	PUNCT
cuesj-1122	290	5	36	36	NUM
cuesj-1122	290	6	.	.	PUNCT
cuesj-1122	290	7	b.	b.	PROPN
cuesj-1122	290	8	e.	e.	PROPN
cuesj-1122	290	9	fan	fan	PROPN
cuesj-1122	290	10	,	,	PUNCT
cuesj-1122	290	11	v.	v.	PROPN
cuesj-1122	290	12	c.	c.	PROPN
cuesj-1122	290	13	l.	l.	PROPN
cuesj-1122	290	14	chong	chong	PROPN
cuesj-1122	290	15	,	,	PUNCT
cuesj-1122	290	16	s.	s.	PROPN
cuesj-1122	290	17	s.	s.	PROPN
cuesj-1122	290	18	w.	w.	PROPN
cuesj-1122	290	19	chan	chan	PROPN
cuesj-1122	290	20	,	,	PUNCT
cuesj-1122	290	21	g.	g.	PROPN
cuesj-1122	290	22	h.	h.	PROPN
cuesj-1122	290	23	lim	lim	PROPN
cuesj-1122	290	24	,	,	PUNCT
cuesj-1122	290	25	k.	k.	PROPN
cuesj-1122	290	26	g.	g.	PROPN
cuesj-1122	290	27	e.	e.	PROPN
cuesj-1122	290	28	lim	lim	PROPN
cuesj-1122	290	29	,	,	PUNCT
cuesj-1122	290	30	g.	g.	PROPN
cuesj-1122	290	31	b.	b.	PROPN
cuesj-1122	290	32	tan	tan	PROPN
cuesj-1122	290	33	,	,	PUNCT
cuesj-1122	290	34	s.	s.	PROPN
cuesj-1122	290	35	s.	s.	PROPN
cuesj-1122	290	36	mucheli	mucheli	PROPN
cuesj-1122	290	37	,	,	PUNCT
cuesj-1122	290	38	p.	p.	NOUN
cuesj-1122	290	39	kuperan	kuperan	NOUN
cuesj-1122	290	40	and	and	CCONJ
cuesj-1122	291	1	k.	k.	PROPN
cuesj-1122	291	2	h.	h.	PROPN
cuesj-1122	292	1	ong	ong	PROPN
cuesj-1122	292	2	.	.	PUNCT
cuesj-1122	293	1	hematologic	hematologic	NOUN
cuesj-1122	293	2	parameters	parameter	NOUN
cuesj-1122	293	3	in	in	ADP
cuesj-1122	293	4	patients	patient	NOUN
cuesj-1122	293	5	with	with	ADP
cuesj-1122	293	6	covid-19	covid-19	PROPN
cuesj-1122	293	7	infection	infection	NOUN
cuesj-1122	293	8	.	.	PUNCT
cuesj-1122	294	1	american	american	ADJ
cuesj-1122	294	2	journal	journal	PROPN
cuesj-1122	294	3	of	of	ADP
cuesj-1122	294	4	hematology	hematology	NOUN
cuesj-1122	294	5	,	,	PUNCT
cuesj-1122	294	6	vol	vol	NOUN
cuesj-1122	294	7	.	.	PROPN
cuesj-1122	294	8	95	95	NUM
cuesj-1122	294	9	,	,	PUNCT
cuesj-1122	294	10	no	no	INTJ
cuesj-1122	294	11	.	.	NOUN
cuesj-1122	294	12	6	6	NUM
cuesj-1122	294	13	,	,	PUNCT
cuesj-1122	294	14	pp	pp	ADJ
cuesj-1122	294	15	.	.	PUNCT
cuesj-1122	295	1	e131	e131	NUM
cuesj-1122	295	2	-	-	SYM
cuesj-1122	295	3	e134	e134	PROPN
cuesj-1122	295	4	,	,	PUNCT
cuesj-1122	295	5	2020	2020	NUM
cuesj-1122	295	6	.	.	PUNCT
cuesj-1122	296	1	37	37	NUM
cuesj-1122	296	2	.	.	PUNCT
cuesj-1122	297	1	c.	c.	PROPN
cuesj-1122	297	2	huang	huang	PROPN
cuesj-1122	297	3	,	,	PUNCT
cuesj-1122	297	4	y.	y.	PROPN
cuesj-1122	297	5	wang	wang	PROPN
cuesj-1122	297	6	,	,	PUNCT
cuesj-1122	297	7	x.	x.	PROPN
cuesj-1122	297	8	li	li	PROPN
cuesj-1122	297	9	,	,	PUNCT
cuesj-1122	297	10	l.	l.	PROPN
cuesj-1122	297	11	ren	ren	PROPN
cuesj-1122	297	12	,	,	PUNCT
cuesj-1122	297	13	j.	j.	PROPN
cuesj-1122	297	14	zhao	zhao	PROPN
cuesj-1122	297	15	,	,	PUNCT
cuesj-1122	297	16	y.	y.	PROPN
cuesj-1122	297	17	hu	hu	PROPN
cuesj-1122	297	18	,	,	PUNCT
cuesj-1122	297	19	l.	l.	PROPN
cuesj-1122	297	20	zhang	zhang	PROPN
cuesj-1122	297	21	,	,	PUNCT
cuesj-1122	297	22	g.	g.	PROPN
cuesj-1122	297	23	fan	fan	PROPN
cuesj-1122	297	24	,	,	PUNCT
cuesj-1122	297	25	j.	j.	PROPN
cuesj-1122	297	26	xu	xu	PROPN
cuesj-1122	297	27	,	,	PUNCT
cuesj-1122	297	28	x.	x.	PROPN
cuesj-1122	297	29	gu	gu	PROPN
cuesj-1122	297	30	,	,	PUNCT
cuesj-1122	297	31	z.	z.	PROPN
cuesj-1122	297	32	cheng	cheng	PROPN
cuesj-1122	297	33	,	,	PUNCT
cuesj-1122	297	34	t.	t.	PROPN
cuesj-1122	297	35	yu	yu	PROPN
cuesj-1122	297	36	,	,	PUNCT
cuesj-1122	297	37	j.	j.	PROPN
cuesj-1122	297	38	xia	xia	PROPN
cuesj-1122	297	39	,	,	PUNCT
cuesj-1122	297	40	y.	y.	PROPN
cuesj-1122	297	41	wei	wei	PROPN
cuesj-1122	297	42	,	,	PUNCT
cuesj-1122	297	43	w.	w.	PROPN
cuesj-1122	297	44	wu	wu	PROPN
cuesj-1122	297	45	,	,	PUNCT
cuesj-1122	297	46	x.	x.	PROPN
cuesj-1122	297	47	xie	xie	PROPN
cuesj-1122	297	48	,	,	PUNCT
cuesj-1122	297	49	w.	w.	PROPN
cuesj-1122	297	50	yin	yin	PROPN
cuesj-1122	297	51	,	,	PUNCT
cuesj-1122	297	52	…	…	PUNCT
cuesj-1122	297	53	&	&	CCONJ
cuesj-1122	297	54	h.	h.	PROPN
cuesj-1122	297	55	li	li	PROPN
cuesj-1122	297	56	.	.	PROPN
cuesj-1122	298	1	clinical	clinical	ADJ
cuesj-1122	298	2	features	feature	NOUN
cuesj-1122	298	3	of	of	ADP
cuesj-1122	298	4	patients	patient	NOUN
cuesj-1122	298	5	infected	infect	VERB
cuesj-1122	298	6	with	with	ADP
cuesj-1122	298	7	2019	2019	NUM
cuesj-1122	298	8	novel	novel	ADJ
cuesj-1122	298	9	coronavirus	coronavirus	NOUN
cuesj-1122	298	10	in	in	ADP
cuesj-1122	298	11	wuhan	wuhan	PROPN
cuesj-1122	298	12	,	,	PUNCT
cuesj-1122	298	13	china	china	PROPN
cuesj-1122	298	14	.	.	PUNCT
cuesj-1122	299	1	the	the	DET
cuesj-1122	299	2	lancet	lancet	PROPN
cuesj-1122	299	3	,	,	PUNCT
cuesj-1122	299	4	vol	vol	NOUN
cuesj-1122	299	5	.	.	PROPN
cuesj-1122	300	1	395	395	NUM
cuesj-1122	300	2	,	,	PUNCT
cuesj-1122	300	3	no	no	NOUN
cuesj-1122	300	4	.	.	NOUN
cuesj-1122	300	5	10223	10223	NUM
cuesj-1122	300	6	,	,	PUNCT
cuesj-1122	300	7	pp	pp	ADP
cuesj-1122	300	8	.	.	PUNCT
cuesj-1122	301	1	497	497	NUM
cuesj-1122	301	2	-	-	SYM
cuesj-1122	301	3	506	506	NUM
cuesj-1122	301	4	,	,	PUNCT
cuesj-1122	301	5	2020	2020	NUM
cuesj-1122	301	6	.	.	PUNCT
cuesj-1122	302	1	38	38	NUM
cuesj-1122	302	2	.	.	PUNCT
cuesj-1122	303	1	l.	l.	PROPN
cuesj-1122	303	2	xu	xu	PROPN
cuesj-1122	303	3	,	,	PUNCT
cuesj-1122	303	4	j.	j.	PROPN
cuesj-1122	303	5	liu	liu	PROPN
cuesj-1122	303	6	,	,	PUNCT
cuesj-1122	303	7	m.	m.	PROPN
cuesj-1122	303	8	lu	lu	PROPN
cuesj-1122	303	9	,	,	PUNCT
cuesj-1122	303	10	d.	d.	PROPN
cuesj-1122	303	11	yang	yang	PROPN
cuesj-1122	303	12	and	and	CCONJ
cuesj-1122	303	13	x.	x.	PROPN
cuesj-1122	303	14	zheng	zheng	PROPN
cuesj-1122	303	15	.	.	PUNCT
cuesj-1122	304	1	liver	liver	NOUN
cuesj-1122	304	2	injury	injury	NOUN
cuesj-1122	304	3	during	during	ADP
cuesj-1122	304	4	highly	highly	ADV
cuesj-1122	304	5	pathogenic	pathogenic	ADJ
cuesj-1122	304	6	human	human	ADJ
cuesj-1122	304	7	coronavirus	coronavirus	NOUN
cuesj-1122	304	8	infections	infection	NOUN
cuesj-1122	304	9	.	.	PUNCT
cuesj-1122	305	1	liver	liver	PROPN
cuesj-1122	305	2	international	international	ADJ
cuesj-1122	305	3	,	,	PUNCT
cuesj-1122	305	4	vol	vol	NOUN
cuesj-1122	305	5	.	.	PROPN
cuesj-1122	305	6	40	40	NUM
cuesj-1122	305	7	,	,	PUNCT
cuesj-1122	305	8	no	no	INTJ
cuesj-1122	305	9	.	.	NOUN
cuesj-1122	305	10	5	5	NUM
cuesj-1122	305	11	,	,	PUNCT
cuesj-1122	305	12	pp	pp	ADJ
cuesj-1122	305	13	.	.	PUNCT
cuesj-1122	306	1	998	998	NUM
cuesj-1122	306	2	-	-	SYM
cuesj-1122	306	3	1004	1004	NUM
cuesj-1122	306	4	,	,	PUNCT
cuesj-1122	306	5	2020	2020	NUM
cuesj-1122	306	6	.	.	PUNCT
cuesj-1122	307	1	39	39	NUM
cuesj-1122	307	2	.	.	PUNCT
cuesj-1122	308	1	c.	c.	PROPN
cuesj-1122	308	2	wu	wu	PROPN
cuesj-1122	308	3	,	,	PUNCT
cuesj-1122	308	4	x.	x.	PROPN
cuesj-1122	308	5	chen	chen	PROPN
cuesj-1122	308	6	,	,	PUNCT
cuesj-1122	308	7	y.	y.	PROPN
cuesj-1122	308	8	cai	cai	PROPN
cuesj-1122	308	9	,	,	PUNCT
cuesj-1122	308	10	j.	j.	PROPN
cuesj-1122	308	11	xia	xia	PROPN
cuesj-1122	308	12	,	,	PUNCT
cuesj-1122	308	13	x.	x.	PROPN
cuesj-1122	308	14	zhou	zhou	PROPN
cuesj-1122	308	15	,	,	PUNCT
cuesj-1122	308	16	s.	s.	PROPN
cuesj-1122	308	17	xu	xu	PROPN
cuesj-1122	308	18	,	,	PUNCT
cuesj-1122	308	19	h.	h.	PROPN
cuesj-1122	308	20	huang	huang	PROPN
cuesj-1122	308	21	,	,	PUNCT
cuesj-1122	308	22	l.	l.	PROPN
cuesj-1122	308	23	zhang	zhang	PROPN
cuesj-1122	308	24	,	,	PUNCT
cuesj-1122	308	25	x.	x.	PROPN
cuesj-1122	308	26	zhou	zhou	PROPN
cuesj-1122	308	27	,	,	PUNCT
cuesj-1122	308	28	c.	c.	PROPN
cuesj-1122	308	29	du	du	PROPN
cuesj-1122	308	30	,	,	PUNCT
cuesj-1122	308	31	y.	y.	PROPN
cuesj-1122	308	32	zhang	zhang	PROPN
cuesj-1122	308	33	,	,	PUNCT
cuesj-1122	308	34	j.	j.	PROPN
cuesj-1122	308	35	song	song	PROPN
cuesj-1122	308	36	,	,	PUNCT
cuesj-1122	308	37	s.	s.	PROPN
cuesj-1122	308	38	wang	wang	PROPN
cuesj-1122	308	39	,	,	PUNCT
cuesj-1122	308	40	y.	y.	PROPN
cuesj-1122	308	41	chao	chao	PROPN
cuesj-1122	308	42	,	,	PUNCT
cuesj-1122	308	43	z.	z.	PROPN
cuesj-1122	308	44	yang	yang	PROPN
cuesj-1122	308	45	,	,	PUNCT
cuesj-1122	308	46	j.	j.	PROPN
cuesj-1122	308	47	xu	xu	PROPN
cuesj-1122	308	48	,	,	PUNCT
cuesj-1122	308	49	x.	x.	PROPN
cuesj-1122	308	50	zhou	zhou	PROPN
cuesj-1122	308	51	,	,	PUNCT
cuesj-1122	308	52	d.	d.	PROPN
cuesj-1122	308	53	chen	chen	PROPN
cuesj-1122	308	54	,	,	PUNCT
cuesj-1122	308	55	w.	w.	PROPN
cuesj-1122	308	56	xiong	xiong	PROPN
cuesj-1122	308	57	,	,	PUNCT
cuesj-1122	308	58	l.	l.	PROPN
cuesj-1122	308	59	xu	xu	PROPN
cuesj-1122	308	60	,	,	PUNCT
cuesj-1122	308	61	f.	f.	PROPN
cuesj-1122	308	62	zhou	zhou	PROPN
cuesj-1122	308	63	,	,	PUNCT
cuesj-1122	308	64	j.	j.	PROPN
cuesj-1122	308	65	jiang	jiang	PROPN
cuesj-1122	308	66	,	,	PUNCT
cuesj-1122	308	67	c.	c.	PROPN
cuesj-1122	308	68	bai	bai	PROPN
cuesj-1122	308	69	,	,	PUNCT
cuesj-1122	308	70	j.	j.	PROPN
cuesj-1122	308	71	zheng	zheng	PROPN
cuesj-1122	308	72	and	and	CCONJ
cuesj-1122	308	73	y.	y.	PROPN
cuesj-1122	308	74	song	song	PROPN
cuesj-1122	308	75	.	.	PUNCT
cuesj-1122	309	1	risk	risk	NOUN
cuesj-1122	309	2	factors	factor	NOUN
cuesj-1122	309	3	associated	associate	VERB
cuesj-1122	309	4	with	with	ADP
cuesj-1122	309	5	acute	acute	ADJ
cuesj-1122	309	6	respiratory	respiratory	ADJ
cuesj-1122	309	7	distress	distress	NOUN
cuesj-1122	309	8	syndrome	syndrome	NOUN
cuesj-1122	309	9	and	and	CCONJ
cuesj-1122	309	10	death	death	NOUN
cuesj-1122	309	11	in	in	ADP
cuesj-1122	309	12	patients	patient	NOUN
cuesj-1122	309	13	with	with	ADP
cuesj-1122	309	14	coronavirus	coronavirus	NOUN
cuesj-1122	309	15	disease	disease	NOUN
cuesj-1122	309	16	2019	2019	NUM
cuesj-1122	309	17	pneumonia	pneumonia	NOUN
cuesj-1122	309	18	in	in	ADP
cuesj-1122	309	19	wuhan	wuhan	PROPN
cuesj-1122	309	20	,	,	PUNCT
cuesj-1122	309	21	china	china	PROPN
cuesj-1122	309	22	.	.	PUNCT
cuesj-1122	310	1	jama	jama	PROPN
cuesj-1122	310	2	internal	internal	ADJ
cuesj-1122	310	3	medicine	medicine	NOUN
cuesj-1122	310	4	,	,	PUNCT
cuesj-1122	310	5	vol	vol	NOUN
cuesj-1122	310	6	.	.	PROPN
cuesj-1122	310	7	180	180	NUM
cuesj-1122	310	8	,	,	PUNCT
cuesj-1122	310	9	no	no	INTJ
cuesj-1122	310	10	.	.	NOUN
cuesj-1122	310	11	7	7	NUM
cuesj-1122	310	12	,	,	PUNCT
cuesj-1122	310	13	pp	pp	ADJ
cuesj-1122	310	14	.	.	PUNCT
cuesj-1122	311	1	934	934	NUM
cuesj-1122	311	2	-	-	SYM
cuesj-1122	311	3	943	943	NUM
cuesj-1122	311	4	,	,	PUNCT
cuesj-1122	311	5	2020	2020	NUM
cuesj-1122	311	6	.	.	PUNCT
cuesj-1122	312	1	40	40	NUM
cuesj-1122	312	2	.	.	PUNCT
cuesj-1122	312	3	i.	i.	PROPN
cuesj-1122	312	4	garrido	garrido	PROPN
cuesj-1122	312	5	,	,	PUNCT
cuesj-1122	312	6	r.	r.	PROPN
cuesj-1122	312	7	liberal	liberal	PROPN
cuesj-1122	312	8	and	and	CCONJ
cuesj-1122	312	9	g.	g.	PROPN
cuesj-1122	312	10	macedo	macedo	PROPN
cuesj-1122	312	11	.	.	PROPN
cuesj-1122	313	1	review	review	PROPN
cuesj-1122	313	2	article	article	NOUN
cuesj-1122	313	3	:	:	PUNCT
cuesj-1122	313	4	covid-19	covid-19	PROPN
cuesj-1122	313	5	and	and	CCONJ
cuesj-1122	313	6	liver	liver	NOUN
cuesj-1122	313	7	disease	disease	NOUN
cuesj-1122	313	8	-	-	PUNCT
cuesj-1122	313	9	what	what	PRON
cuesj-1122	313	10	we	we	PRON
cuesj-1122	313	11	know	know	VERB
cuesj-1122	313	12	on	on	ADP
cuesj-1122	313	13	1st	1st	PROPN
cuesj-1122	313	14	may	may	AUX
cuesj-1122	313	15	2020	2020	NUM
cuesj-1122	313	16	.	.	PUNCT
cuesj-1122	314	1	alimentary	alimentary	ADJ
cuesj-1122	314	2	pharmacology	pharmacology	NOUN
cuesj-1122	314	3	and	and	CCONJ
cuesj-1122	314	4	therapeutics	therapeutic	NOUN
cuesj-1122	314	5	,	,	PUNCT
cuesj-1122	314	6	vol	vol	NOUN
cuesj-1122	314	7	.	.	PROPN
cuesj-1122	314	8	52	52	NUM
cuesj-1122	314	9	,	,	PUNCT
cuesj-1122	314	10	no	no	INTJ
cuesj-1122	314	11	.	.	NOUN
cuesj-1122	314	12	2	2	NUM
cuesj-1122	314	13	,	,	PUNCT
cuesj-1122	314	14	pp	pp	ADJ
cuesj-1122	314	15	.	.	PUNCT
cuesj-1122	315	1	267	267	NUM
cuesj-1122	315	2	-	-	SYM
cuesj-1122	315	3	275	275	NUM
cuesj-1122	315	4	,	,	PUNCT
cuesj-1122	315	5	2020	2020	NUM
cuesj-1122	315	6	.	.	PUNCT
cuesj-1122	316	1	41	41	NUM
cuesj-1122	316	2	.	.	PUNCT
cuesj-1122	317	1	s.	s.	PROPN
cuesj-1122	317	2	piano	piano	PROPN
cuesj-1122	317	3	,	,	PUNCT
cuesj-1122	317	4	a.	a.	PROPN
cuesj-1122	317	5	dalbeni	dalbeni	PROPN
cuesj-1122	317	6	,	,	PUNCT
cuesj-1122	317	7	e.	e.	PROPN
cuesj-1122	317	8	vettore	vettore	PROPN
cuesj-1122	317	9	,	,	PUNCT
cuesj-1122	317	10	d.	d.	PROPN
cuesj-1122	317	11	benfaremo	benfaremo	NOUN
cuesj-1122	317	12	,	,	PUNCT
cuesj-1122	317	13	m.	m.	NOUN
cuesj-1122	317	14	mattioli	mattioli	PROPN
cuesj-1122	317	15	,	,	PUNCT
cuesj-1122	317	16	c.	c.	PROPN
cuesj-1122	317	17	g.	g.	PROPN
cuesj-1122	317	18	gambino	gambino	PROPN
cuesj-1122	317	19	,	,	PUNCT
cuesj-1122	317	20	v.	v.	ADP
cuesj-1122	317	21	framba	framba	PROPN
cuesj-1122	317	22	,	,	PUNCT
cuesj-1122	317	23	l.	l.	PROPN
cuesj-1122	317	24	cerruti	cerruti	PROPN
cuesj-1122	317	25	,	,	PUNCT
cuesj-1122	317	26	a.	a.	NOUN
cuesj-1122	317	27	mantovani	mantovani	PROPN
cuesj-1122	317	28	,	,	PUNCT
cuesj-1122	317	29	a.	a.	NOUN
cuesj-1122	317	30	martini	martini	PROPN
cuesj-1122	317	31	,	,	PUNCT
cuesj-1122	317	32	m.	m.	NOUN
cuesj-1122	317	33	m.	m.	NOUN
cuesj-1122	317	34	luchetti	luchetti	PROPN
cuesj-1122	317	35	,	,	PUNCT
cuesj-1122	317	36	r.	r.	PROPN
cuesj-1122	317	37	serra	serra	PROPN
cuesj-1122	317	38	,	,	PUNCT
cuesj-1122	317	39	a.	a.	NOUN
cuesj-1122	317	40	cattelan	cattelan	PROPN
cuesj-1122	317	41	and	and	CCONJ
cuesj-1122	317	42	r.	r.	PROPN
cuesj-1122	317	43	vettor	vettor	PROPN
cuesj-1122	317	44	,	,	PUNCT
cuesj-1122	317	45	p.	p.	NOUN
cuesj-1122	317	46	angeli	angeli	PROPN
cuesj-1122	317	47	and	and	CCONJ
cuesj-1122	317	48	covid	covid	ADJ
cuesj-1122	317	49	-	-	PUNCT
cuesj-1122	317	50	liver	liver	NOUN
cuesj-1122	317	51	study	study	NOUN
cuesj-1122	317	52	group	group	NOUN
cuesj-1122	317	53	.	.	PUNCT
cuesj-1122	318	1	abnormal	abnormal	ADJ
cuesj-1122	318	2	liver	liver	NOUN
cuesj-1122	318	3	function	function	NOUN
cuesj-1122	318	4	tests	test	NOUN
cuesj-1122	318	5	predict	predict	VERB
cuesj-1122	318	6	transfer	transfer	NOUN
cuesj-1122	318	7	to	to	ADP
cuesj-1122	318	8	intensive	intensive	ADJ
cuesj-1122	318	9	care	care	NOUN
cuesj-1122	318	10	unit	unit	NOUN
cuesj-1122	318	11	and	and	CCONJ
cuesj-1122	318	12	death	death	NOUN
cuesj-1122	318	13	in	in	ADP
cuesj-1122	318	14	covid-19	covid-19	PROPN
cuesj-1122	318	15	.	.	PUNCT
cuesj-1122	318	16	liver	liver	PROPN
cuesj-1122	318	17	international	international	ADJ
cuesj-1122	318	18	,	,	PUNCT
cuesj-1122	318	19	vol	vol	NOUN
cuesj-1122	318	20	.	.	PROPN
cuesj-1122	318	21	40	40	NUM
cuesj-1122	318	22	,	,	PUNCT
cuesj-1122	318	23	no	no	INTJ
cuesj-1122	318	24	.	.	NOUN
cuesj-1122	318	25	10	10	NUM
cuesj-1122	318	26	,	,	PUNCT
cuesj-1122	318	27	pp	pp	ADJ
cuesj-1122	318	28	.	.	PUNCT
cuesj-1122	318	29	2394	2394	NUM
cuesj-1122	318	30	-	-	SYM
cuesj-1122	318	31	2406	2406	NUM
cuesj-1122	318	32	,	,	PUNCT
cuesj-1122	318	33	2020	2020	NUM
cuesj-1122	318	34	.	.	PUNCT
cuesj-1122	319	1	42	42	NUM
cuesj-1122	319	2	.	.	PUNCT
cuesj-1122	319	3	m.	m.	PROPN
cuesj-1122	319	4	aziz	aziz	PROPN
cuesj-1122	319	5	,	,	PUNCT
cuesj-1122	319	6	r.	r.	PROPN
cuesj-1122	319	7	fatima	fatima	PROPN
cuesj-1122	319	8	,	,	PUNCT
cuesj-1122	319	9	w.	w.	PROPN
cuesj-1122	319	10	lee	lee	PROPN
cuesj-1122	319	11	-	-	PUNCT
cuesj-1122	319	12	smith	smith	PROPN
cuesj-1122	319	13	and	and	CCONJ
cuesj-1122	319	14	r.	r.	PROPN
cuesj-1122	319	15	assaly	assaly	PROPN
cuesj-1122	319	16	.	.	PUNCT
cuesj-1122	320	1	the	the	DET
cuesj-1122	320	2	association	association	NOUN
cuesj-1122	320	3	of	of	ADP
cuesj-1122	320	4	low	low	ADJ
cuesj-1122	320	5	serum	serum	NOUN
cuesj-1122	320	6	albumin	albumin	ADJ
cuesj-1122	320	7	level	level	NOUN
cuesj-1122	320	8	with	with	ADP
cuesj-1122	320	9	severe	severe	ADJ
cuesj-1122	320	10	covid-19	covid-19	PROPN
cuesj-1122	320	11	:	:	PUNCT
cuesj-1122	320	12	a	a	DET
cuesj-1122	320	13	systematic	systematic	ADJ
cuesj-1122	320	14	review	review	NOUN
cuesj-1122	320	15	and	and	CCONJ
cuesj-1122	320	16	meta	meta	ADJ
cuesj-1122	320	17	-	-	PUNCT
cuesj-1122	320	18	analysis	analysis	NOUN
cuesj-1122	320	19	.	.	PUNCT
cuesj-1122	321	1	critical	critical	ADJ
cuesj-1122	321	2	care	care	NOUN
cuesj-1122	321	3	,	,	PUNCT
cuesj-1122	321	4	vol	vol	NOUN
cuesj-1122	321	5	.	.	PROPN
cuesj-1122	321	6	24	24	NUM
cuesj-1122	321	7	,	,	PUNCT
cuesj-1122	321	8	p.	p.	NOUN
cuesj-1122	321	9	225	225	NUM
cuesj-1122	321	10	,	,	PUNCT
cuesj-1122	321	11	2020	2020	NUM
cuesj-1122	321	12	.	.	PUNCT
cuesj-1122	322	1	43	43	NUM
cuesj-1122	322	2	.	.	PUNCT
cuesj-1122	322	3	m.	m.	NOUN
cuesj-1122	322	4	s.	s.	PROPN
cuesj-1122	322	5	petimani	petimani	PROPN
cuesj-1122	322	6	,	,	PUNCT
cuesj-1122	322	7	p.	p.	NOUN
cuesj-1122	322	8	adake	adake	NOUN
cuesj-1122	322	9	,	,	PUNCT
cuesj-1122	322	10	p.	p.	NOUN
cuesj-1122	322	11	h	h	PROPN
cuesj-1122	322	12	and	and	CCONJ
cuesj-1122	322	13	d.	d.	PROPN
cuesj-1122	322	14	kaladharan	kaladharan	PROPN
cuesj-1122	322	15	.	.	PUNCT
cuesj-1122	323	1	comparison	comparison	NOUN
cuesj-1122	323	2	of	of	ADP
cuesj-1122	323	3	biochemical	biochemical	ADJ
cuesj-1122	323	4	and	and	CCONJ
cuesj-1122	323	5	hematological	hematological	ADJ
cuesj-1122	323	6	parameters	parameter	NOUN
cuesj-1122	323	7	among	among	ADP
cuesj-1122	323	8	covid-19	covid-19	PROPN
cuesj-1122	323	9	patients	patient	NOUN
cuesj-1122	323	10	with	with	ADP
cuesj-1122	323	11	and	and	CCONJ
cuesj-1122	323	12	without	without	ADP
cuesj-1122	323	13	vaccination	vaccination	NOUN
cuesj-1122	323	14	in	in	ADP
cuesj-1122	323	15	a	a	DET
cuesj-1122	323	16	tertiary	tertiary	ADJ
cuesj-1122	323	17	care	care	NOUN
cuesj-1122	323	18	hospital	hospital	NOUN
cuesj-1122	323	19	:	:	PUNCT
cuesj-1122	323	20	a	a	DET
cuesj-1122	323	21	retrospective	retrospective	NOUN
cuesj-1122	323	22	.	.	PUNCT
cuesj-1122	324	1	pharmaceutical	pharmaceutical	NOUN
cuesj-1122	324	2	and	and	CCONJ
cuesj-1122	324	3	biomedical	biomedical	ADJ
cuesj-1122	324	4	research	research	NOUN
cuesj-1122	324	5	,	,	PUNCT
cuesj-1122	324	6	vol	vol	NOUN
cuesj-1122	324	7	.	.	PROPN
cuesj-1122	324	8	9	9	NUM
cuesj-1122	324	9	,	,	PUNCT
cuesj-1122	324	10	no	no	INTJ
cuesj-1122	324	11	.	.	NOUN
cuesj-1122	324	12	1	1	NUM
cuesj-1122	324	13	,	,	PUNCT
cuesj-1122	324	14	pp	pp	ADJ
cuesj-1122	324	15	.	.	PUNCT
cuesj-1122	325	1	45	45	NUM
cuesj-1122	325	2	-	-	SYM
cuesj-1122	325	3	52	52	NUM
cuesj-1122	325	4	,	,	PUNCT
cuesj-1122	325	5	2023	2023	NUM
cuesj-1122	325	6	.	.	PUNCT
cuesj-1122	326	1	44	44	NUM
cuesj-1122	326	2	.	.	PUNCT
cuesj-1122	327	1	y.	y.	PROPN
cuesj-1122	327	2	e.	e.	PROPN
cuesj-1122	327	3	ozdemir	ozdemir	PROPN
cuesj-1122	327	4	,	,	PUNCT
cuesj-1122	327	5	m.	m.	NOUN
cuesj-1122	327	6	s.	s.	PROPN
cuesj-1122	327	7	tarhan	tarhan	PROPN
cuesj-1122	327	8	,	,	PUNCT
cuesj-1122	327	9	b.	b.	PROPN
cuesj-1122	327	10	kizilçay	kizilçay	PROPN
cuesj-1122	327	11	,	,	PUNCT
cuesj-1122	327	12	m.	m.	NOUN
cuesj-1122	327	13	sönmezişik	sönmezişik	PROPN
cuesj-1122	327	14	,	,	PUNCT
cuesj-1122	327	15	e.	e.	PROPN
cuesj-1122	327	16	canbolat	canbolat	PROPN
cuesj-1122	327	17	ünlü	ünlü	PROPN
cuesj-1122	327	18	,	,	PUNCT
cuesj-1122	327	19	d.	d.	PROPN
cuesj-1122	327	20	borçak	borçak	PROPN
cuesj-1122	327	21	,	,	PUNCT
cuesj-1122	327	22	s.	s.	PROPN
cuesj-1122	327	23	sürme	sürme	PROPN
cuesj-1122	327	24	,	,	PUNCT
cuesj-1122	327	25	m.	m.	NOUN
cuesj-1122	327	26	ş	ş	PROPN
cuesj-1122	327	27	.	.	PUNCT
cuesj-1122	328	1	özdemir	özdemir	NOUN
cuesj-1122	328	2	,	,	PUNCT
cuesj-1122	328	3	o.	o.	PROPN
cuesj-1122	328	4	f.	f.	PROPN
cuesj-1122	328	5	bayramlar	bayramlar	PROPN
cuesj-1122	328	6	,	,	PUNCT
cuesj-1122	328	7	z.	z.	PROPN
cuesj-1122	328	8	yeşilbağ	yeşilbağ	PROPN
cuesj-1122	328	9	,	,	PUNCT
cuesj-1122	328	10	s.	s.	PROPN
cuesj-1122	328	11	şenoğlu	şenoğlu	PROPN
cuesj-1122	328	12	,	,	PUNCT
cuesj-1122	328	13	h.	h.	PROPN
cuesj-1122	328	14	gedik	gedik	PROPN
cuesj-1122	328	15	and	and	CCONJ
cuesj-1122	328	16	k.	k.	PROPN
cuesj-1122	328	17	k.	k.	PROPN
cuesj-1122	328	18	yaşar	yaşar	PROPN
cuesj-1122	328	19	.	.	PUNCT
cuesj-1122	329	1	comparison	comparison	NOUN
cuesj-1122	329	2	of	of	ADP
cuesj-1122	329	3	clinical	clinical	ADJ
cuesj-1122	329	4	outcomes	outcome	NOUN
cuesj-1122	329	5	of	of	ADP
cuesj-1122	329	6	coronavac	coronavac	NOUN
cuesj-1122	329	7	vaccinated	vaccinated	ADJ
cuesj-1122	329	8	and	and	CCONJ
cuesj-1122	329	9	unvaccinated	unvaccinate	VERB
cuesj-1122	329	10	older	old	ADJ
cuesj-1122	329	11	adults	adult	NOUN
cuesj-1122	329	12	with	with	ADP
cuesj-1122	329	13	hospitalized	hospitalize	VERB
cuesj-1122	329	14	covid-19	covid-19	PROPN
cuesj-1122	329	15	.	.	PUNCT
cuesj-1122	330	1	turkish	turkish	ADJ
cuesj-1122	330	2	journal	journal	NOUN
cuesj-1122	330	3	of	of	ADP
cuesj-1122	330	4	geriatrics	geriatrics	PROPN
cuesj-1122	330	5	/	/	SYM
cuesj-1122	330	6	türk	türk	PROPN
cuesj-1122	330	7	geriatri	geriatri	PROPN
cuesj-1122	330	8	dergisi	dergisi	PROPN
cuesj-1122	330	9	,	,	PUNCT
cuesj-1122	330	10	vol	vol	NOUN
cuesj-1122	330	11	.	.	PROPN
cuesj-1122	330	12	25	25	NUM
cuesj-1122	330	13	,	,	PUNCT
cuesj-1122	330	14	no	no	INTJ
cuesj-1122	330	15	.	.	NOUN
cuesj-1122	330	16	4	4	NUM
cuesj-1122	330	17	,	,	PUNCT
cuesj-1122	330	18	pp	pp	ADJ
cuesj-1122	330	19	.	.	PUNCT
cuesj-1122	331	1	622	622	NUM
cuesj-1122	331	2	-	-	SYM
cuesj-1122	331	3	631	631	NUM
cuesj-1122	331	4	,	,	PUNCT
cuesj-1122	331	5	2022	2022	NUM
cuesj-1122	331	6	.	.	PUNCT
cuesj-1122	332	1	45	45	NUM
cuesj-1122	332	2	.	.	PUNCT
cuesj-1122	332	3	d.	d.	PROPN
cuesj-1122	332	4	ferrari	ferrari	PROPN
cuesj-1122	332	5	,	,	PUNCT
cuesj-1122	332	6	a.	a.	PROPN
cuesj-1122	332	7	motta	motta	PROPN
cuesj-1122	332	8	,	,	PUNCT
cuesj-1122	332	9	m.	m.	NOUN
cuesj-1122	332	10	strollo	strollo	PROPN
cuesj-1122	332	11	,	,	PUNCT
cuesj-1122	332	12	g.	g.	PROPN
cuesj-1122	332	13	banfi	banfi	PROPN
cuesj-1122	332	14	and	and	CCONJ
cuesj-1122	332	15	m.	m.	NOUN
cuesj-1122	332	16	locatelli	locatelli	PROPN
cuesj-1122	332	17	.	.	PUNCT
cuesj-1122	333	1	routine	routine	ADJ
cuesj-1122	333	2	blood	blood	NOUN
cuesj-1122	333	3	tests	test	NOUN
cuesj-1122	333	4	as	as	ADP
cuesj-1122	333	5	a	a	DET
cuesj-1122	333	6	potential	potential	ADJ
cuesj-1122	333	7	diagnostic	diagnostic	ADJ
cuesj-1122	333	8	tool	tool	NOUN
cuesj-1122	333	9	for	for	ADP
cuesj-1122	333	10	covid-19	covid-19	PROPN
cuesj-1122	333	11	.	.	PUNCT
cuesj-1122	334	1	clinical	clinical	ADJ
cuesj-1122	334	2	chemistry	chemistry	NOUN
cuesj-1122	334	3	and	and	CCONJ
cuesj-1122	334	4	laboratory	laboratory	NOUN
cuesj-1122	334	5	medicine	medicine	NOUN
cuesj-1122	334	6	,	,	PUNCT
cuesj-1122	334	7	vol	vol	NOUN
cuesj-1122	334	8	.	.	PROPN
cuesj-1122	335	1	58	58	NUM
cuesj-1122	335	2	,	,	PUNCT
cuesj-1122	335	3	no	no	INTJ
cuesj-1122	335	4	.	.	NOUN
cuesj-1122	335	5	7	7	NUM
cuesj-1122	335	6	,	,	PUNCT
cuesj-1122	335	7	pp	pp	ADJ
cuesj-1122	335	8	.	.	PUNCT
cuesj-1122	336	1	1095	1095	NUM
cuesj-1122	336	2	-	-	SYM
cuesj-1122	336	3	1099	1099	NUM
cuesj-1122	336	4	,	,	PUNCT
cuesj-1122	336	5	2020	2020	NUM
cuesj-1122	336	6	.	.	PUNCT
cuesj-1122	337	1	46	46	NUM
cuesj-1122	337	2	.	.	PUNCT
cuesj-1122	338	1	w.	w.	PROPN
cuesj-1122	338	2	luo	luo	PROPN
cuesj-1122	338	3	,	,	PUNCT
cuesj-1122	338	4	y.	y.	PROPN
cuesj-1122	338	5	lin	lin	PROPN
cuesj-1122	338	6	,	,	PUNCT
cuesj-1122	338	7	x.	x.	NOUN
cuesj-1122	338	8	yao	yao	PROPN
cuesj-1122	338	9	,	,	PUNCT
cuesj-1122	338	10	y.	y.	PROPN
cuesj-1122	338	11	shi	shi	PROPN
cuesj-1122	338	12	,	,	PUNCT
cuesj-1122	338	13	f.	f.	PROPN
cuesj-1122	338	14	lu	lu	PROPN
cuesj-1122	338	15	,	,	PUNCT
cuesj-1122	338	16	z.	z.	PROPN
cuesj-1122	338	17	wang	wang	PROPN
cuesj-1122	338	18	and	and	CCONJ
cuesj-1122	338	19	d.	d.	PROPN
cuesj-1122	338	20	wu	wu	PROPN
cuesj-1122	338	21	.	.	PUNCT
cuesj-1122	339	1	clinical	clinical	ADJ
cuesj-1122	339	2	findings	finding	NOUN
cuesj-1122	339	3	of	of	ADP
cuesj-1122	339	4	35	35	NUM
cuesj-1122	339	5	cases	case	NOUN
cuesj-1122	339	6	with	with	ADP
cuesj-1122	339	7	novel	novel	ADJ
cuesj-1122	339	8	coronavirus	coronavirus	NOUN
cuesj-1122	339	9	pneumonia	pneumonia	NOUN
cuesj-1122	339	10	outside	outside	ADP
cuesj-1122	339	11	of	of	ADP
cuesj-1122	339	12	wuhan	wuhan	PROPN
cuesj-1122	339	13	.	.	PUNCT
cuesj-1122	340	1	research	research	PROPN
cuesj-1122	340	2	square	square	PROPN
cuesj-1122	341	1	[	[	X
cuesj-1122	341	2	preprint	preprint	NOUN
cuesj-1122	341	3	]	]	X
cuesj-1122	341	4	,	,	PUNCT
cuesj-1122	341	5	2020	2020	NUM
cuesj-1122	341	6	.	.	PUNCT
cuesj-1122	342	1	47	47	NUM
cuesj-1122	342	2	.	.	PUNCT
cuesj-1122	343	1	p.	p.	NOUN
cuesj-1122	343	2	malik	malik	PROPN
cuesj-1122	343	3	,	,	PUNCT
cuesj-1122	343	4	u.	u.	PROPN
cuesj-1122	343	5	patel	patel	PROPN
cuesj-1122	343	6	,	,	PUNCT
cuesj-1122	343	7	d.	d.	PROPN
cuesj-1122	343	8	mehta	mehta	PROPN
cuesj-1122	343	9	,	,	PUNCT
cuesj-1122	343	10	n.	n.	PROPN
cuesj-1122	343	11	patel	patel	PROPN
cuesj-1122	343	12	,	,	PUNCT
cuesj-1122	343	13	r.	r.	PROPN
cuesj-1122	343	14	kelkar	kelkar	PROPN
cuesj-1122	343	15	,	,	PUNCT
cuesj-1122	343	16	m.	m.	NOUN
cuesj-1122	343	17	akrmah	akrmah	PROPN
cuesj-1122	343	18	and	and	CCONJ
cuesj-1122	343	19	j.	j.	PROPN
cuesj-1122	343	20	l.	l.	PROPN
cuesj-1122	343	21	gabrilove	gabrilove	PROPN
cuesj-1122	343	22	,	,	PUNCT
cuesj-1122	343	23	h.	h.	PROPN
cuesj-1122	343	24	sacks	sacks	PROPN
cuesj-1122	343	25	.	.	PUNCT
cuesj-1122	344	1	biomarkers	biomarker	NOUN
cuesj-1122	344	2	and	and	CCONJ
cuesj-1122	344	3	outcomes	outcome	NOUN
cuesj-1122	344	4	of	of	ADP
cuesj-1122	344	5	covid-19	covid-19	PROPN
cuesj-1122	344	6	hospitalisations	hospitalisation	NOUN
cuesj-1122	344	7	:	:	PUNCT
cuesj-1122	344	8	systematic	systematic	ADJ
cuesj-1122	344	9	review	review	NOUN
cuesj-1122	344	10	and	and	CCONJ
cuesj-1122	344	11	meta	meta	ADJ
cuesj-1122	344	12	-	-	PUNCT
cuesj-1122	344	13	analysis	analysis	NOUN
cuesj-1122	344	14	.	.	PUNCT
cuesj-1122	345	1	bmj	bmj	PROPN
cuesj-1122	345	2	evidence	evidence	NOUN
cuesj-1122	345	3	-	-	PUNCT
cuesj-1122	345	4	based	base	VERB
cuesj-1122	345	5	medicine	medicine	NOUN
cuesj-1122	345	6	,	,	PUNCT
cuesj-1122	345	7	vol	vol	NOUN
cuesj-1122	345	8	.	.	PROPN
cuesj-1122	345	9	26	26	NUM
cuesj-1122	345	10	,	,	PUNCT
cuesj-1122	345	11	no	no	INTJ
cuesj-1122	345	12	.	.	NOUN
cuesj-1122	345	13	3	3	NUM
cuesj-1122	345	14	,	,	PUNCT
cuesj-1122	345	15	pp	pp	ADJ
cuesj-1122	345	16	.	.	PUNCT
cuesj-1122	346	1	107	107	NUM
cuesj-1122	346	2	-	-	SYM
cuesj-1122	346	3	108	108	NUM
cuesj-1122	346	4	,	,	PUNCT
cuesj-1122	346	5	2021	2021	NUM
cuesj-1122	346	6	.	.	PUNCT
cuesj-1122	347	1	48	48	NUM
cuesj-1122	347	2	.	.	PUNCT
cuesj-1122	348	1	p.	p.	NOUN
cuesj-1122	348	2	pinar	pinar	PROPN
cuesj-1122	348	3	deniz	deniz	PROPN
cuesj-1122	348	4	,	,	PUNCT
cuesj-1122	348	5	i̇.	i̇.	PROPN
cuesj-1122	348	6	hanta	hanta	NOUN
cuesj-1122	348	7	,	,	PUNCT
cuesj-1122	348	8	p.	p.	PROPN
cuesj-1122	348	9	duru	duru	PROPN
cuesj-1122	348	10	çetinkaya	çetinkaya	PROPN
cuesj-1122	348	11	,	,	PUNCT
cuesj-1122	348	12	o.	o.	PROPN
cuesj-1122	348	13	altınöz	altınöz	PROPN
cuesj-1122	348	14	,	,	PUNCT
cuesj-1122	348	15	y.	y.	PROPN
cuesj-1122	348	16	tasova	tasova	PROPN
cuesj-1122	348	17	and	and	CCONJ
cuesj-1122	348	18	b.	b.	PROPN
cuesj-1122	348	19	mete	mete	PROPN
cuesj-1122	348	20	.	.	PUNCT
cuesj-1122	349	1	the	the	DET
cuesj-1122	349	2	effect	effect	NOUN
cuesj-1122	349	3	of	of	ADP
cuesj-1122	349	4	vaccination	vaccination	NOUN
cuesj-1122	349	5	on	on	ADP
cuesj-1122	349	6	biochemical	biochemical	ADJ
cuesj-1122	349	7	and	and	CCONJ
cuesj-1122	349	8	inflammatory	inflammatory	ADJ
cuesj-1122	349	9	markers	marker	NOUN
cuesj-1122	349	10	in	in	ADP
cuesj-1122	349	11	hospitalized	hospitalize	VERB
cuesj-1122	349	12	covid-19	covid-19	PROPN
cuesj-1122	349	13	patients	patient	NOUN
cuesj-1122	349	14	.	.	PUNCT
cuesj-1122	350	1	kafkas	kafkas	ADJ
cuesj-1122	350	2	journal	journal	PROPN
cuesj-1122	350	3	of	of	ADP
cuesj-1122	350	4	medical	medical	ADJ
cuesj-1122	350	5	sciences	science	NOUN
cuesj-1122	350	6	,	,	PUNCT
cuesj-1122	350	7	vol	vol	NOUN
cuesj-1122	350	8	.	.	PROPN
cuesj-1122	350	9	13	13	NUM
cuesj-1122	350	10	,	,	PUNCT
cuesj-1122	350	11	no	no	INTJ
cuesj-1122	350	12	.	.	NOUN
cuesj-1122	350	13	2	2	NUM
cuesj-1122	350	14	,	,	PUNCT
cuesj-1122	350	15	pp	pp	ADJ
cuesj-1122	350	16	.	.	PUNCT
cuesj-1122	351	1	155	155	NUM
cuesj-1122	351	2	-	-	SYM
cuesj-1122	351	3	159	159	NUM
cuesj-1122	351	4	,	,	PUNCT
cuesj-1122	351	5	2023	2023	NUM
cuesj-1122	351	6	.	.	PUNCT
cuesj-1122	352	1	49	49	NUM
cuesj-1122	352	2	.	.	PUNCT
cuesj-1122	353	1	h.	h.	PROPN
cuesj-1122	353	2	n.	n.	PROPN
cuesj-1122	353	3	jasim	jasim	PROPN
cuesj-1122	353	4	and	and	CCONJ
cuesj-1122	353	5	i.	i.	PROPN
cuesj-1122	353	6	j.	j.	PROPN
cuesj-1122	353	7	nasser	nasser	PROPN
cuesj-1122	353	8	.	.	PUNCT
cuesj-1122	354	1	comparative	comparative	ADJ
cuesj-1122	354	2	study	study	NOUN
cuesj-1122	354	3	of	of	ADP
cuesj-1122	354	4	vaccinated	vaccinated	ADJ
cuesj-1122	354	5	and	and	CCONJ
cuesj-1122	354	6	non	non	ADJ
cuesj-1122	354	7	-	-	ADJ
cuesj-1122	354	8	vaccinated	vaccinated	ADJ
cuesj-1122	354	9	patients	patient	NOUN
cuesj-1122	354	10	of	of	ADP
cuesj-1122	354	11	covid19	covid19	NOUN
cuesj-1122	354	12	in	in	ADP
cuesj-1122	354	13	inflammatory	inflammatory	ADJ
cuesj-1122	354	14	markers	marker	NOUN
cuesj-1122	354	15	in	in	ADP
cuesj-1122	354	16	diyala	diyala	PROPN
cuesj-1122	354	17	governorate	governorate	PROPN
cuesj-1122	354	18	.	.	PUNCT
cuesj-1122	355	1	revis	revis	PROPN
cuesj-1122	355	2	bionatura	bionatura	PROPN
cuesj-1122	355	3	,	,	PUNCT
cuesj-1122	355	4	vol	vol	NOUN
cuesj-1122	355	5	.	.	PROPN
cuesj-1122	355	6	8	8	NUM
cuesj-1122	355	7	,	,	PUNCT
cuesj-1122	355	8	p.	p.	NOUN
cuesj-1122	355	9	51	51	NUM
cuesj-1122	355	10	,	,	PUNCT
cuesj-1122	355	11	2023	2023	NUM
cuesj-1122	355	12	.	.	PUNCT
cuesj-1122	356	1	50	50	NUM
cuesj-1122	356	2	.	.	PUNCT
cuesj-1122	356	3	l.	l.	PROPN
cuesj-1122	356	4	anghel	anghel	PROPN
cuesj-1122	356	5	,	,	PUNCT
cuesj-1122	356	6	c.	c.	PROPN
cuesj-1122	356	7	manole	manole	PROPN
cuesj-1122	356	8	,	,	PUNCT
cuesj-1122	356	9	a.	a.	NOUN
cuesj-1122	356	10	nechita	nechita	PROPN
cuesj-1122	356	11	,	,	PUNCT
cuesj-1122	356	12	a.	a.	PROPN
cuesj-1122	356	13	l.	l.	PROPN
cuesj-1122	356	14	tatu	tatu	PROPN
cuesj-1122	356	15	,	,	PUNCT
cuesj-1122	356	16	b.	b.	PROPN
cuesj-1122	356	17	i.	i.	PROPN
cuesj-1122	356	18	ștefănescu	ștefănescu	PROPN
cuesj-1122	356	19	,	,	PUNCT
cuesj-1122	356	20	l.	l.	PROPN
cuesj-1122	356	21	nechita	nechita	PROPN
cuesj-1122	356	22	,	,	PUNCT
cuesj-1122	356	23	c.	c.	PROPN
cuesj-1122	356	24	bușilă	bușilă	PROPN
cuesj-1122	356	25	,	,	PUNCT
cuesj-1122	356	26	p.	p.	PROPN
cuesj-1122	356	27	zainea	zainea	PROPN
cuesj-1122	356	28	,	,	PUNCT
cuesj-1122	356	29	l.	l.	PROPN
cuesj-1122	356	30	baroiu	baroiu	PROPN
cuesj-1122	356	31	and	and	CCONJ
cuesj-1122	356	32	c.	c.	PROPN
cuesj-1122	356	33	l.	l.	PROPN
cuesj-1122	356	34	mușat	mușat	PROPN
cuesj-1122	356	35	.	.	PUNCT
cuesj-1122	356	36	calcium	calcium	NOUN
cuesj-1122	356	37	,	,	PUNCT
cuesj-1122	356	38	phosphorus	phosphorus	NOUN
cuesj-1122	356	39	and	and	CCONJ
cuesj-1122	356	40	magnesium	magnesium	NOUN
cuesj-1122	356	41	abnormalities	abnormality	NOUN
cuesj-1122	356	42	associated	associate	VERB
cuesj-1122	356	43	with	with	ADP
cuesj-1122	356	44	ahmed	ahmed	PROPN
cuesj-1122	356	45	,	,	PUNCT
cuesj-1122	356	46	et	et	PROPN
cuesj-1122	356	47	al	al	PROPN
cuesj-1122	356	48	.	.	PUNCT
cuesj-1122	356	49	:	:	PUNCT
cuesj-1122	356	50	comparison	comparison	NOUN
cuesj-1122	356	51	of	of	ADP
cuesj-1122	356	52	biochemical	biochemical	ADJ
cuesj-1122	356	53	parameters	parameter	NOUN
cuesj-1122	356	54	in	in	ADP
cuesj-1122	356	55	vaccinated	vaccinated	ADJ
cuesj-1122	356	56	57	57	NUM
cuesj-1122	356	57	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1122	356	58	cuesj	cuesj	NOUN
cuesj-1122	356	59	2024	2024	NUM
cuesj-1122	356	60	,	,	PUNCT
cuesj-1122	356	61	8	8	NUM
cuesj-1122	356	62	(	(	PUNCT
cuesj-1122	356	63	1	1	NUM
cuesj-1122	356	64	):	):	PUNCT
cuesj-1122	356	65	46	46	NUM
cuesj-1122	356	66	-	-	SYM
cuesj-1122	356	67	57	57	NUM
cuesj-1122	356	68	covid-19	covid-19	PROPN
cuesj-1122	356	69	infection	infection	NOUN
cuesj-1122	356	70	,	,	PUNCT
cuesj-1122	356	71	and	and	CCONJ
cuesj-1122	356	72	beyond	beyond	ADP
cuesj-1122	356	73	.	.	PUNCT
cuesj-1122	357	1	biomedicines	biomedicine	NOUN
cuesj-1122	357	2	,	,	PUNCT
cuesj-1122	357	3	vol	vol	NOUN
cuesj-1122	357	4	.	.	PROPN
cuesj-1122	357	5	11	11	NUM
cuesj-1122	357	6	,	,	PUNCT
cuesj-1122	357	7	p.	p.	NOUN
cuesj-1122	357	8	2362	2362	NUM
cuesj-1122	357	9	,	,	PUNCT
cuesj-1122	357	10	2023	2023	NUM
cuesj-1122	357	11	.	.	PUNCT
cuesj-1122	358	1	51	51	NUM
cuesj-1122	358	2	.	.	PUNCT
cuesj-1122	358	3	f.	f.	PROPN
cuesj-1122	358	4	cappellini	cappellini	PROPN
cuesj-1122	358	5	,	,	PUNCT
cuesj-1122	358	6	r.	r.	PROPN
cuesj-1122	358	7	brivio	brivio	NOUN
cuesj-1122	358	8	,	,	PUNCT
cuesj-1122	358	9	m.	m.	NOUN
cuesj-1122	358	10	casati	casati	PROPN
cuesj-1122	358	11	,	,	PUNCT
cuesj-1122	358	12	a.	a.	NOUN
cuesj-1122	358	13	cavallero	cavallero	NOUN
cuesj-1122	358	14	,	,	PUNCT
cuesj-1122	358	15	e.	e.	PROPN
cuesj-1122	358	16	contro	contro	PROPN
cuesj-1122	358	17	and	and	CCONJ
cuesj-1122	358	18	p.	p.	NOUN
cuesj-1122	358	19	brambilla	brambilla	NOUN
cuesj-1122	358	20	.	.	PUNCT
cuesj-1122	359	1	low	low	ADJ
cuesj-1122	359	2	levels	level	NOUN
cuesj-1122	359	3	of	of	ADP
cuesj-1122	359	4	total	total	ADJ
cuesj-1122	359	5	and	and	CCONJ
cuesj-1122	359	6	ionized	ionized	ADJ
cuesj-1122	359	7	calcium	calcium	NOUN
cuesj-1122	359	8	in	in	ADP
cuesj-1122	359	9	blood	blood	NOUN
cuesj-1122	359	10	of	of	ADP
cuesj-1122	359	11	covid-19	covid-19	PROPN
cuesj-1122	359	12	patients	patient	NOUN
cuesj-1122	359	13	.	.	PUNCT
cuesj-1122	360	1	clinical	clinical	ADJ
cuesj-1122	360	2	chemistry	chemistry	NOUN
cuesj-1122	360	3	and	and	CCONJ
cuesj-1122	360	4	laboratory	laboratory	NOUN
cuesj-1122	360	5	medicine	medicine	NOUN
cuesj-1122	360	6	,	,	PUNCT
cuesj-1122	360	7	vol	vol	NOUN
cuesj-1122	360	8	.	.	PROPN
cuesj-1122	361	1	58	58	NUM
cuesj-1122	361	2	,	,	PUNCT
cuesj-1122	361	3	no	no	INTJ
cuesj-1122	361	4	.	.	NOUN
cuesj-1122	361	5	9	9	NUM
cuesj-1122	361	6	,	,	PUNCT
cuesj-1122	361	7	pp	pp	ADJ
cuesj-1122	361	8	.	.	PUNCT
cuesj-1122	362	1	e171	e171	PROPN
cuesj-1122	362	2	-	-	PUNCT
cuesj-1122	362	3	e173	e173	PROPN
cuesj-1122	362	4	,	,	PUNCT
cuesj-1122	362	5	2020	2020	NUM
cuesj-1122	362	6	.	.	PUNCT
cuesj-1122	363	1	52	52	NUM
cuesj-1122	363	2	.	.	PUNCT
cuesj-1122	363	3	a.	a.	PROPN
cuesj-1122	363	4	s.	s.	PROPN
cuesj-1122	363	5	elham	elham	PROPN
cuesj-1122	363	6	,	,	PUNCT
cuesj-1122	363	7	k.	k.	PROPN
cuesj-1122	363	8	azam	azam	PROPN
cuesj-1122	363	9	,	,	PUNCT
cuesj-1122	363	10	j.	j.	PROPN
cuesj-1122	363	11	azam	azam	PROPN
cuesj-1122	363	12	,	,	PUNCT
cuesj-1122	363	13	l.	l.	PROPN
cuesj-1122	363	14	mostafa	mostafa	PROPN
cuesj-1122	363	15	,	,	PUNCT
cuesj-1122	363	16	b.	b.	PROPN
cuesj-1122	363	17	nasrin	nasrin	PROPN
cuesj-1122	363	18	and	and	CCONJ
cuesj-1122	363	19	n.	n.	PROPN
cuesj-1122	363	20	marzieh	marzieh	PROPN
cuesj-1122	363	21	.	.	PUNCT
cuesj-1122	364	1	serum	serum	PROPN
cuesj-1122	364	2	vitamin	vitamin	PROPN
cuesj-1122	364	3	d	d	NOUN
cuesj-1122	364	4	,	,	PUNCT
cuesj-1122	364	5	calcium	calcium	NOUN
cuesj-1122	364	6	,	,	PUNCT
cuesj-1122	364	7	and	and	CCONJ
cuesj-1122	364	8	zinc	zinc	NOUN
cuesj-1122	364	9	levels	level	NOUN
cuesj-1122	364	10	in	in	ADP
cuesj-1122	364	11	patients	patient	NOUN
cuesj-1122	364	12	with	with	ADP
cuesj-1122	364	13	covid-19	covid-19	PROPN
cuesj-1122	364	14	.	.	PUNCT
cuesj-1122	365	1	clinical	clinical	PROPN
cuesj-1122	365	2	nutrition	nutrition	PROPN
cuesj-1122	365	3	espen	espen	PROPN
cuesj-1122	365	4	,	,	PUNCT
cuesj-1122	365	5	vol	vol	NOUN
cuesj-1122	365	6	.	.	PROPN
cuesj-1122	365	7	43	43	NUM
cuesj-1122	365	8	,	,	PUNCT
cuesj-1122	365	9	pp	pp	ADJ
cuesj-1122	365	10	.	.	PUNCT
cuesj-1122	366	1	276	276	NUM
cuesj-1122	366	2	-	-	SYM
cuesj-1122	366	3	282	282	NUM
cuesj-1122	366	4	,	,	PUNCT
cuesj-1122	366	5	2021	2021	NUM
cuesj-1122	366	6	.	.	PUNCT
cuesj-1122	367	1	53	53	NUM
cuesj-1122	367	2	.	.	PUNCT
cuesj-1122	368	1	j.	j.	PROPN
cuesj-1122	368	2	bajpai	bajpai	PROPN
cuesj-1122	368	3	,	,	PUNCT
cuesj-1122	368	4	s.	s.	PROPN
cuesj-1122	368	5	kant	kant	PROPN
cuesj-1122	368	6	,	,	PUNCT
cuesj-1122	368	7	a.	a.	PROPN
cuesj-1122	368	8	verma	verma	PROPN
cuesj-1122	368	9	,	,	PUNCT
cuesj-1122	368	10	a.	a.	PROPN
cuesj-1122	368	11	k.	k.	PROPN
cuesj-1122	368	12	patwa	patwa	PROPN
cuesj-1122	368	13	,	,	PUNCT
cuesj-1122	368	14	v.	v.	ADP
cuesj-1122	368	15	atam	atam	PROPN
cuesj-1122	368	16	,	,	PUNCT
cuesj-1122	368	17	s.	s.	PROPN
cuesj-1122	368	18	c.	c.	PROPN
cuesj-1122	368	19	chaudhary	chaudhary	PROPN
cuesj-1122	368	20	and	and	CCONJ
cuesj-1122	368	21	a.	a.	PROPN
cuesj-1122	368	22	pandey	pandey	PROPN
cuesj-1122	368	23	.	.	PUNCT
cuesj-1122	369	1	the	the	DET
cuesj-1122	369	2	severity	severity	NOUN
cuesj-1122	369	3	of	of	ADP
cuesj-1122	369	4	covid	covid	PROPN
cuesj-1122	369	5	19	19	NUM
cuesj-1122	369	6	pneumonia	pneumonia	NOUN
cuesj-1122	369	7	in	in	ADP
cuesj-1122	369	8	vaccinated	vaccinate	VERB
cuesj-1122	369	9	vs.	vs.	ADP
cuesj-1122	369	10	non	non	ADJ
cuesj-1122	369	11	-	-	ADJ
cuesj-1122	369	12	vaccinated	vaccinated	ADJ
cuesj-1122	369	13	patients	patient	NOUN
cuesj-1122	369	14	in	in	ADP
cuesj-1122	369	15	the	the	DET
cuesj-1122	369	16	second	second	ADJ
cuesj-1122	369	17	wave	wave	NOUN
cuesj-1122	369	18	:	:	PUNCT
cuesj-1122	369	19	an	an	DET
cuesj-1122	369	20	experience	experience	NOUN
cuesj-1122	369	21	from	from	ADP
cuesj-1122	369	22	a	a	DET
cuesj-1122	369	23	tertiary	tertiary	ADJ
cuesj-1122	369	24	care	care	NOUN
cuesj-1122	369	25	center	center	NOUN
cuesj-1122	369	26	in	in	ADP
cuesj-1122	369	27	india	india	PROPN
cuesj-1122	369	28	.	.	PUNCT
cuesj-1122	370	1	cureus	cureus	PROPN
cuesj-1122	370	2	,	,	PUNCT
cuesj-1122	370	3	vol	vol	NOUN
cuesj-1122	370	4	.	.	PROPN
cuesj-1122	370	5	14	14	NUM
cuesj-1122	370	6	,	,	PUNCT
cuesj-1122	370	7	no	no	INTJ
cuesj-1122	370	8	.	.	NOUN
cuesj-1122	370	9	5	5	NUM
cuesj-1122	370	10	,	,	PUNCT
cuesj-1122	370	11	p.	p.	NOUN
cuesj-1122	370	12	e25378	e25378	NOUN
cuesj-1122	370	13	,	,	PUNCT
cuesj-1122	370	14	2022	2022	NUM
cuesj-1122	370	15	.	.	PUNCT
cuesj-1122	371	1	54	54	NUM
cuesj-1122	371	2	.	.	PUNCT
cuesj-1122	371	3	m.	m.	NOUN
cuesj-1122	371	4	fakhrolmobasheri	fakhrolmobasheri	PROPN
cuesj-1122	371	5	,	,	PUNCT
cuesj-1122	371	6	m.	m.	NOUN
cuesj-1122	371	7	vakhshoori	vakhshoori	PROPN
cuesj-1122	371	8	,	,	PUNCT
cuesj-1122	371	9	m.	m.	NOUN
cuesj-1122	371	10	heidarpour	heidarpour	PROPN
cuesj-1122	371	11	,	,	PUNCT
cuesj-1122	371	12	a.	a.	NOUN
cuesj-1122	371	13	najimi	najimi	PROPN
cuesj-1122	371	14	,	,	PUNCT
cuesj-1122	371	15	a.	a.	NOUN
cuesj-1122	371	16	m.	m.	NOUN
cuesj-1122	371	17	mozafari	mozafari	PROPN
cuesj-1122	371	18	and	and	CCONJ
cuesj-1122	371	19	h.	h.	PROPN
cuesj-1122	371	20	rezvanian	rezvanian	PROPN
cuesj-1122	371	21	.	.	PUNCT
cuesj-1122	372	1	hypophosphatemia	hypophosphatemia	NOUN
cuesj-1122	372	2	in	in	ADP
cuesj-1122	372	3	coronavirus	coronavirus	NOUN
cuesj-1122	372	4	disease	disease	NOUN
cuesj-1122	372	5	2019	2019	NUM
cuesj-1122	372	6	(	(	PUNCT
cuesj-1122	372	7	covid-19	covid-19	PROPN
cuesj-1122	372	8	)	)	PUNCT
cuesj-1122	372	9	,	,	PUNCT
cuesj-1122	372	10	complications	complication	NOUN
cuesj-1122	372	11	,	,	PUNCT
cuesj-1122	372	12	and	and	CCONJ
cuesj-1122	372	13	considerations	consideration	NOUN
cuesj-1122	372	14	:	:	PUNCT
cuesj-1122	372	15	a	a	DET
cuesj-1122	372	16	systematic	systematic	ADJ
cuesj-1122	372	17	review	review	NOUN
cuesj-1122	372	18	.	.	PUNCT
cuesj-1122	372	19	biomed	biome	VERB
cuesj-1122	372	20	research	research	NOUN
cuesj-1122	372	21	international	international	ADJ
cuesj-1122	372	22	,	,	PUNCT
cuesj-1122	372	23	vol	vol	NOUN
cuesj-1122	372	24	.	.	NOUN
cuesj-1122	372	25	2022	2022	NUM
cuesj-1122	372	26	,	,	PUNCT
cuesj-1122	372	27	p.	p.	NOUN
cuesj-1122	372	28	1468786	1468786	NUM
cuesj-1122	372	29	,	,	PUNCT
cuesj-1122	372	30	2022	2022	NUM
cuesj-1122	372	31	.	.	PUNCT
cuesj-1122	373	1	55	55	NUM
cuesj-1122	373	2	.	.	PUNCT
cuesj-1122	373	3	m.	m.	NOUN
cuesj-1122	373	4	hadavi	hadavi	PROPN
cuesj-1122	373	5	,	,	PUNCT
cuesj-1122	373	6	f.	f.	PROPN
cuesj-1122	373	7	taghinezhad	taghinezhad	PROPN
cuesj-1122	373	8	,	,	PUNCT
cuesj-1122	373	9	e.	e.	PROPN
cuesj-1122	373	10	shafiei	shafiei	PROPN
cuesj-1122	373	11	,	,	PUNCT
cuesj-1122	373	12	s.	s.	PROPN
cuesj-1122	373	13	h.	h.	PROPN
cuesj-1122	373	14	babakr	babakr	PROPN
cuesj-1122	373	15	,	,	PUNCT
cuesj-1122	373	16	s.	s.	PROPN
cuesj-1122	373	17	bastaminejad	bastaminejad	PROPN
cuesj-1122	373	18	,	,	PUNCT
cuesj-1122	373	19	m.	m.	NOUN
cuesj-1122	373	20	kaffashian	kaffashian	PROPN
cuesj-1122	373	21	,	,	PUNCT
cuesj-1122	373	22	i.	i.	PROPN
cuesj-1122	373	23	ahmadi	ahmadi	PROPN
cuesj-1122	373	24	and	and	CCONJ
cuesj-1122	373	25	a.	a.	NOUN
cuesj-1122	373	26	mozafari	mozafari	PROPN
cuesj-1122	373	27	.	.	PUNCT
cuesj-1122	374	1	hypo	hypo	ADJ
cuesj-1122	374	2	-	-	PUNCT
cuesj-1122	374	3	and	and	CCONJ
cuesj-1122	374	4	hyperphosphatemia	hyperphosphatemia	NOUN
cuesj-1122	374	5	at	at	ADP
cuesj-1122	374	6	admission	admission	NOUN
cuesj-1122	374	7	as	as	ADP
cuesj-1122	374	8	independent	independent	ADJ
cuesj-1122	374	9	factors	factor	NOUN
cuesj-1122	374	10	of	of	ADP
cuesj-1122	374	11	mortality	mortality	NOUN
cuesj-1122	374	12	of	of	ADP
cuesj-1122	374	13	covid-19	covid-19	PROPN
cuesj-1122	374	14	patients	patient	NOUN
cuesj-1122	374	15	:	:	PUNCT
cuesj-1122	374	16	findings	finding	NOUN
cuesj-1122	374	17	from	from	ADP
cuesj-1122	374	18	a	a	DET
cuesj-1122	374	19	retrospective	retrospective	ADJ
cuesj-1122	374	20	cohort	cohort	NOUN
cuesj-1122	374	21	study	study	NOUN
cuesj-1122	374	22	.	.	PUNCT
cuesj-1122	375	1	international	international	ADJ
cuesj-1122	375	2	journal	journal	PROPN
cuesj-1122	375	3	of	of	ADP
cuesj-1122	375	4	endocrinology	endocrinology	NOUN
cuesj-1122	375	5	and	and	CCONJ
cuesj-1122	375	6	metabolism	metabolism	NOUN
cuesj-1122	375	7	,	,	PUNCT
cuesj-1122	375	8	vol	vol	NOUN
cuesj-1122	375	9	.	.	PROPN
cuesj-1122	375	10	20	20	NUM
cuesj-1122	375	11	,	,	PUNCT
cuesj-1122	375	12	no	no	INTJ
cuesj-1122	375	13	.	.	NOUN
cuesj-1122	375	14	3	3	NUM
cuesj-1122	375	15	,	,	PUNCT
cuesj-1122	375	16	p.	p.	NOUN
cuesj-1122	375	17	e126386	e126386	NOUN
cuesj-1122	375	18	,	,	PUNCT
cuesj-1122	375	19	2022	2022	NUM
cuesj-1122	375	20	.	.	PUNCT
cuesj-1122	376	1	56	56	NUM
cuesj-1122	376	2	.	.	PUNCT
cuesj-1122	376	3	w.	w.	PROPN
cuesj-1122	376	4	wang	wang	PROPN
cuesj-1122	376	5	,	,	PUNCT
cuesj-1122	376	6	x.	x.	PROPN
cuesj-1122	376	7	su	su	PROPN
cuesj-1122	376	8	,	,	PUNCT
cuesj-1122	376	9	y.	y.	PROPN
cuesj-1122	376	10	ding	ding	PROPN
cuesj-1122	376	11	,	,	PUNCT
cuesj-1122	376	12	w.	w.	PROPN
cuesj-1122	376	13	fan	fan	PROPN
cuesj-1122	376	14	,	,	PUNCT
cuesj-1122	376	15	w.	w.	PROPN
cuesj-1122	376	16	zhou	zhou	PROPN
cuesj-1122	376	17	,	,	PUNCT
cuesj-1122	376	18	j.	j.	PROPN
cuesj-1122	376	19	su	su	PROPN
cuesj-1122	376	20	,	,	PUNCT
cuesj-1122	376	21	z.	z.	PROPN
cuesj-1122	376	22	chen	chen	PROPN
cuesj-1122	376	23	,	,	PUNCT
cuesj-1122	376	24	h.	h.	PROPN
cuesj-1122	376	25	zhao	zhao	PROPN
cuesj-1122	376	26	,	,	PUNCT
cuesj-1122	376	27	k.	k.	PROPN
cuesj-1122	376	28	xu	xu	PROPN
cuesj-1122	376	29	,	,	PUNCT
cuesj-1122	376	30	q.	q.	PROPN
cuesj-1122	376	31	ni	ni	PROPN
cuesj-1122	376	32	,	,	PUNCT
cuesj-1122	376	33	x.	x.	PROPN
cuesj-1122	376	34	xu	xu	PROPN
cuesj-1122	376	35	,	,	PUNCT
cuesj-1122	376	36	y.	y.	PROPN
cuesj-1122	376	37	qiu	qiu	PROPN
cuesj-1122	376	38	and	and	CCONJ
cuesj-1122	376	39	l.	l.	PROPN
cuesj-1122	376	40	teng	teng	PROPN
cuesj-1122	376	41	.	.	PUNCT
cuesj-1122	377	1	thyroid	thyroid	PROPN
cuesj-1122	377	2	function	function	VERB
cuesj-1122	377	3	abnormalities	abnormality	NOUN
cuesj-1122	377	4	in	in	ADP
cuesj-1122	377	5	covid-19	covid-19	PROPN
cuesj-1122	377	6	patients	patient	NOUN
cuesj-1122	377	7	.	.	PUNCT
cuesj-1122	378	1	front	front	ADJ
cuesj-1122	378	2	endocrinol	endocrinol	NOUN
cuesj-1122	378	3	(	(	PUNCT
cuesj-1122	378	4	lausanne	lausanne	PROPN
cuesj-1122	378	5	)	)	PUNCT
cuesj-1122	378	6	,	,	PUNCT
cuesj-1122	378	7	vol	vol	NOUN
cuesj-1122	378	8	.	.	PROPN
cuesj-1122	378	9	11	11	NUM
cuesj-1122	378	10	,	,	PUNCT
cuesj-1122	378	11	p.	p.	NOUN
cuesj-1122	378	12	623792	623792	NUM
cuesj-1122	378	13	,	,	PUNCT
cuesj-1122	378	14	2020	2020	NUM
cuesj-1122	378	15	.	.	PUNCT
cuesj-1122	379	1	57	57	NUM
cuesj-1122	379	2	.	.	PUNCT
cuesj-1122	379	3	b.	b.	PROPN
cuesj-1122	379	4	khoo	khoo	PROPN
cuesj-1122	379	5	,	,	PUNCT
cuesj-1122	379	6	t.	t.	PROPN
cuesj-1122	379	7	tan	tan	PROPN
cuesj-1122	379	8	,	,	PUNCT
cuesj-1122	379	9	s.	s.	PROPN
cuesj-1122	379	10	a.	a.	PROPN
cuesj-1122	379	11	clarke	clarke	PROPN
cuesj-1122	379	12	,	,	PUNCT
cuesj-1122	379	13	e.	e.	PROPN
cuesj-1122	379	14	g.	g.	PROPN
cuesj-1122	379	15	mills	mills	PROPN
cuesj-1122	379	16	,	,	PUNCT
cuesj-1122	379	17	b.	b.	PROPN
cuesj-1122	379	18	patel	patel	PROPN
cuesj-1122	379	19	,	,	PUNCT
cuesj-1122	379	20	m.	m.	PROPN
cuesj-1122	379	21	modi	modi	PROPN
cuesj-1122	379	22	,	,	PUNCT
cuesj-1122	379	23	m.	m.	NOUN
cuesj-1122	379	24	phylactou	phylactou	NOUN
cuesj-1122	379	25	,	,	PUNCT
cuesj-1122	379	26	p.	p.	PROPN
cuesj-1122	379	27	c.	c.	PROPN
cuesj-1122	379	28	eng	eng	PROPN
cuesj-1122	379	29	,	,	PUNCT
cuesj-1122	379	30	l.	l.	PROPN
cuesj-1122	379	31	thurston	thurston	PROPN
cuesj-1122	379	32	,	,	PUNCT
cuesj-1122	379	33	e.	e.	PROPN
cuesj-1122	379	34	c	c	PROPN
cuesj-1122	379	35	alexander	alexander	PROPN
cuesj-1122	379	36	,	,	PUNCT
cuesj-1122	379	37	k.	k.	PROPN
cuesj-1122	379	38	meeran	meeran	PROPN
cuesj-1122	379	39	,	,	PUNCT
cuesj-1122	379	40	a.	a.	NOUN
cuesj-1122	379	41	n.	n.	PROPN
cuesj-1122	379	42	comninos	comninos	PROPN
cuesj-1122	379	43	,	,	PUNCT
cuesj-1122	379	44	a.	a.	NOUN
cuesj-1122	379	45	abbara	abbara	PROPN
cuesj-1122	379	46	and	and	CCONJ
cuesj-1122	379	47	w.	w.	PROPN
cuesj-1122	379	48	s	s	VERB
cuesj-1122	380	1	dhillo	dhillo	PROPN
cuesj-1122	380	2	.	.	PUNCT
cuesj-1122	380	3	thyroid	thyroid	NOUN
cuesj-1122	380	4	function	function	VERB
cuesj-1122	380	5	before	before	ADV
cuesj-1122	380	6	,	,	PUNCT
cuesj-1122	380	7	during	during	ADP
cuesj-1122	380	8	,	,	PUNCT
cuesj-1122	380	9	and	and	CCONJ
cuesj-1122	380	10	after	after	ADP
cuesj-1122	380	11	covid-19	covid-19	PROPN
cuesj-1122	380	12	.	.	PUNCT
cuesj-1122	381	1	the	the	DET
cuesj-1122	381	2	journal	journal	NOUN
cuesj-1122	381	3	of	of	ADP
cuesj-1122	381	4	clinical	clinical	ADJ
cuesj-1122	381	5	endocrinology	endocrinology	NOUN
cuesj-1122	381	6	and	and	CCONJ
cuesj-1122	381	7	metabolism	metabolism	NOUN
cuesj-1122	381	8	,	,	PUNCT
cuesj-1122	381	9	vol	vol	NOUN
cuesj-1122	381	10	.	.	PROPN
cuesj-1122	381	11	106	106	NUM
cuesj-1122	381	12	,	,	PUNCT
cuesj-1122	381	13	no	no	INTJ
cuesj-1122	381	14	.	.	NOUN
cuesj-1122	381	15	2	2	NUM
cuesj-1122	381	16	,	,	PUNCT
cuesj-1122	381	17	pp	pp	ADJ
cuesj-1122	381	18	.	.	PUNCT
cuesj-1122	382	1	e803	e803	PROPN
cuesj-1122	382	2	-	-	PUNCT
cuesj-1122	382	3	e811	e811	PROPN
cuesj-1122	382	4	,	,	PUNCT
cuesj-1122	382	5	2021	2021	NUM
cuesj-1122	382	6	.	.	PUNCT
cuesj-1122	383	1	58	58	NUM
cuesj-1122	383	2	.	.	PUNCT
cuesj-1122	384	1	m.	m.	PROPN
cuesj-1122	384	2	chen	chen	PROPN
cuesj-1122	384	3	,	,	PUNCT
cuesj-1122	384	4	w.	w.	PROPN
cuesj-1122	384	5	zhou	zhou	PROPN
cuesj-1122	384	6	and	and	CCONJ
cuesj-1122	384	7	w.	w.	PROPN
cuesj-1122	384	8	xu	xu	PROPN
cuesj-1122	384	9	.	.	PUNCT
cuesj-1122	385	1	thyroid	thyroid	PROPN
cuesj-1122	385	2	function	function	VERB
cuesj-1122	385	3	analysis	analysis	NOUN
cuesj-1122	385	4	in	in	ADP
cuesj-1122	385	5	50	50	NUM
cuesj-1122	385	6	patients	patient	NOUN
cuesj-1122	385	7	with	with	ADP
cuesj-1122	385	8	covid-19	covid-19	PROPN
cuesj-1122	385	9	:	:	PUNCT
cuesj-1122	385	10	a	a	DET
cuesj-1122	385	11	retrospective	retrospective	ADJ
cuesj-1122	385	12	study	study	NOUN
cuesj-1122	385	13	.	.	PUNCT
cuesj-1122	386	1	thyroid	thyroid	NOUN
cuesj-1122	386	2	,	,	PUNCT
cuesj-1122	386	3	vol	vol	NOUN
cuesj-1122	386	4	.	.	PROPN
cuesj-1122	387	1	31	31	NUM
cuesj-1122	387	2	,	,	PUNCT
cuesj-1122	387	3	no	no	INTJ
cuesj-1122	387	4	.	.	NOUN
cuesj-1122	387	5	1	1	NUM
cuesj-1122	387	6	,	,	PUNCT
cuesj-1122	387	7	pp	pp	ADJ
cuesj-1122	387	8	.	.	PUNCT
cuesj-1122	388	1	8	8	NUM
cuesj-1122	388	2	-	-	SYM
cuesj-1122	388	3	11	11	NUM
cuesj-1122	388	4	,	,	PUNCT
cuesj-1122	388	5	2021	2021	NUM
cuesj-1122	388	6	.	.	PUNCT
cuesj-1122	389	1	59	59	NUM
cuesj-1122	389	2	.	.	PUNCT
cuesj-1122	389	3	r.	r.	PROPN
cuesj-1122	389	4	ma	ma	PROPN
cuesj-1122	389	5	,	,	PUNCT
cuesj-1122	389	6	s.	s.	PROPN
cuesj-1122	389	7	morshed	morshe	VERB
cuesj-1122	389	8	,	,	PUNCT
cuesj-1122	389	9	r.	r.	PROPN
cuesj-1122	389	10	latif	latif	PROPN
cuesj-1122	389	11	,	,	PUNCT
cuesj-1122	389	12	m.	m.	NOUN
cuesj-1122	389	13	zaidi	zaidi	PROPN
cuesj-1122	389	14	and	and	CCONJ
cuesj-1122	389	15	t.	t.	PROPN
cuesj-1122	389	16	f.	f.	PROPN
cuesj-1122	389	17	davies	davies	PROPN
cuesj-1122	389	18	.	.	PUNCT
cuesj-1122	390	1	the	the	DET
cuesj-1122	390	2	influence	influence	NOUN
cuesj-1122	390	3	of	of	ADP
cuesj-1122	390	4	thyroid	thyroid	NOUN
cuesj-1122	390	5	-	-	PUNCT
cuesj-1122	390	6	stimulating	stimulate	VERB
cuesj-1122	390	7	hormone	hormone	NOUN
cuesj-1122	390	8	and	and	CCONJ
cuesj-1122	390	9	thyroid	thyroid	NOUN
cuesj-1122	390	10	-	-	PUNCT
cuesj-1122	390	11	stimulating	stimulate	VERB
cuesj-1122	390	12	hormone	hormone	NOUN
cuesj-1122	390	13	receptor	receptor	NOUN
cuesj-1122	390	14	antibodies	antibodie	VERB
cuesj-1122	390	15	on	on	ADP
cuesj-1122	390	16	osteoclastogenesis	osteoclastogenesis	NOUN
cuesj-1122	390	17	.	.	PUNCT
cuesj-1122	391	1	thyroid	thyroid	NOUN
cuesj-1122	391	2	,	,	PUNCT
cuesj-1122	391	3	vol	vol	NOUN
cuesj-1122	391	4	.	.	PROPN
cuesj-1122	391	5	21	21	NUM
cuesj-1122	391	6	,	,	PUNCT
cuesj-1122	391	7	no	no	INTJ
cuesj-1122	391	8	.	.	NOUN
cuesj-1122	391	9	8	8	NUM
cuesj-1122	391	10	,	,	PUNCT
cuesj-1122	391	11	pp	pp	ADJ
cuesj-1122	391	12	.	.	PUNCT
cuesj-1122	391	13	897	897	NUM
cuesj-1122	391	14	-	-	SYM
cuesj-1122	391	15	906	906	NUM
cuesj-1122	391	16	,	,	PUNCT
cuesj-1122	391	17	2011	2011	NUM
cuesj-1122	391	18	.	.	PUNCT
cuesj-1122	392	1	60	60	NUM
cuesj-1122	392	2	.	.	PUNCT
cuesj-1122	393	1	t.	t.	PROPN
cuesj-1122	393	2	m.	m.	PROPN
cuesj-1122	393	3	galliford	galliford	PROPN
cuesj-1122	393	4	,	,	PUNCT
cuesj-1122	393	5	e.	e.	PROPN
cuesj-1122	393	6	murphy	murphy	PROPN
cuesj-1122	393	7	,	,	PUNCT
cuesj-1122	393	8	a.	a.	PROPN
cuesj-1122	393	9	j.	j.	PROPN
cuesj-1122	393	10	williams	williams	PROPN
cuesj-1122	393	11	,	,	PUNCT
cuesj-1122	393	12	j.	j.	PROPN
cuesj-1122	393	13	h.	h.	PROPN
cuesj-1122	393	14	d.	d.	PROPN
cuesj-1122	393	15	bassett	bassett	PROPN
cuesj-1122	393	16	and	and	CCONJ
cuesj-1122	393	17	g.	g.	PROPN
cuesj-1122	393	18	r.	r.	PROPN
cuesj-1122	393	19	williams	williams	PROPN
cuesj-1122	393	20	.	.	PUNCT
cuesj-1122	394	1	effects	effect	NOUN
cuesj-1122	394	2	of	of	ADP
cuesj-1122	394	3	thyroid	thyroid	NOUN
cuesj-1122	394	4	status	status	NOUN
cuesj-1122	394	5	on	on	ADP
cuesj-1122	394	6	bone	bone	NOUN
cuesj-1122	394	7	metabolism	metabolism	NOUN
cuesj-1122	394	8	:	:	PUNCT
cuesj-1122	394	9	a	a	DET
cuesj-1122	394	10	primary	primary	ADJ
cuesj-1122	394	11	role	role	NOUN
cuesj-1122	394	12	for	for	ADP
cuesj-1122	394	13	thyroid	thyroid	NOUN
cuesj-1122	394	14	stimulating	stimulate	VERB
cuesj-1122	394	15	hormone	hormone	NOUN
cuesj-1122	394	16	or	or	CCONJ
cuesj-1122	394	17	thyroid	thyroid	NOUN
cuesj-1122	394	18	hormone	hormone	NOUN
cuesj-1122	394	19	?	?	PUNCT
cuesj-1122	395	1	minerva	minerva	PROPN
cuesj-1122	395	2	endocrinologica	endocrinologica	PROPN
cuesj-1122	395	3	,	,	PUNCT
cuesj-1122	395	4	vol	vol	NOUN
cuesj-1122	395	5	.	.	PROPN
cuesj-1122	395	6	30	30	NUM
cuesj-1122	395	7	,	,	PUNCT
cuesj-1122	395	8	no	no	INTJ
cuesj-1122	395	9	.	.	NOUN
cuesj-1122	395	10	4	4	NUM
cuesj-1122	395	11	,	,	PUNCT
cuesj-1122	395	12	pp	pp	ADJ
cuesj-1122	395	13	.	.	PUNCT
cuesj-1122	396	1	237	237	NUM
cuesj-1122	396	2	-	-	SYM
cuesj-1122	396	3	246	246	NUM
cuesj-1122	396	4	,	,	PUNCT
cuesj-1122	396	5	2005	2005	NUM
cuesj-1122	396	6	.	.	PUNCT
cuesj-1122	397	1	[	[	X
cuesj-1122	397	2	in	in	ADP
cuesj-1122	397	3	english	english	PROPN
cuesj-1122	397	4	]	]	PUNCT
cuesj-1122	397	5	61	61	NUM
cuesj-1122	397	6	.	.	PUNCT
cuesj-1122	397	7	f.	f.	PROPN
cuesj-1122	397	8	kreier	kreier	PROPN
cuesj-1122	397	9	.	.	PUNCT
cuesj-1122	398	1	long	long	ADJ
cuesj-1122	398	2	-	-	PUNCT
cuesj-1122	398	3	covid	covid	PROPN
cuesj-1122	398	4	symptoms	symptom	NOUN
cuesj-1122	398	5	less	less	ADV
cuesj-1122	398	6	likely	likely	ADJ
cuesj-1122	398	7	in	in	ADP
cuesj-1122	398	8	vaccinated	vaccinated	ADJ
cuesj-1122	398	9	people	people	NOUN
cuesj-1122	398	10	,	,	PUNCT
cuesj-1122	398	11	israeli	israeli	ADJ
cuesj-1122	398	12	data	datum	NOUN
cuesj-1122	398	13	say	say	VERB
cuesj-1122	398	14	.	.	PUNCT
cuesj-1122	399	1	nature	nature	NOUN
cuesj-1122	399	2	,	,	PUNCT
cuesj-1122	399	3	epub	epub	NOUN
cuesj-1122	399	4	ahead	ahead	ADV
cuesj-1122	399	5	of	of	ADP
cuesj-1122	399	6	print	print	NOUN
cuesj-1122	399	7	,	,	PUNCT
cuesj-1122	399	8	2022	2022	NUM
cuesj-1122	399	9	.	.	PUNCT
cuesj-1122	400	1	https://doi	https://doi	PROPN
cuesj-1122	400	2	.	.	PUNCT
cuesj-1122	400	3	org/10.1038	org/10.1038	PROPN
cuesj-1122	400	4	/	/	SYM
cuesj-1122	400	5	d41586	d41586	PROPN
cuesj-1122	400	6	-	-	PUNCT
cuesj-1122	400	7	022	022	NUM
cuesj-1122	400	8	-	-	PUNCT
cuesj-1122	400	9	00177	00177	NUM
cuesj-1122	400	10	-	-	SYM
cuesj-1122	400	11	5	5	NUM
cuesj-1122	400	12	62	62	NUM
cuesj-1122	400	13	.	.	PUNCT
cuesj-1122	401	1	e.	e.	PROPN
cuesj-1122	401	2	j.	j.	PROPN
cuesj-1122	401	3	haas	haas	PROPN
cuesj-1122	401	4	,	,	PUNCT
cuesj-1122	401	5	f.	f.	PROPN
cuesj-1122	401	6	j.	j.	PROPN
cuesj-1122	401	7	angulo	angulo	PROPN
cuesj-1122	401	8	,	,	PUNCT
cuesj-1122	401	9	j.	j.	PROPN
cuesj-1122	401	10	m.	m.	PROPN
cuesj-1122	401	11	mclaughlin	mclaughlin	PROPN
cuesj-1122	401	12	,	,	PUNCT
cuesj-1122	401	13	e.	e.	PROPN
cuesj-1122	401	14	anis	anis	PROPN
cuesj-1122	401	15	,	,	PUNCT
cuesj-1122	401	16	s.	s.	PROPN
cuesj-1122	401	17	r.	r.	PROPN
cuesj-1122	401	18	singer	singer	PROPN
cuesj-1122	401	19	,	,	PUNCT
cuesj-1122	401	20	f.	f.	PROPN
cuesj-1122	401	21	khan	khan	PROPN
cuesj-1122	401	22	,	,	PUNCT
cuesj-1122	401	23	n.	n.	PROPN
cuesj-1122	401	24	brooks	brooks	PROPN
cuesj-1122	401	25	,	,	PUNCT
cuesj-1122	401	26	m.	m.	NOUN
cuesj-1122	401	27	smaja	smaja	PROPN
cuesj-1122	401	28	,	,	PUNCT
cuesj-1122	401	29	g.	g.	PROPN
cuesj-1122	401	30	mircus	mircus	PROPN
cuesj-1122	401	31	,	,	PUNCT
cuesj-1122	401	32	k.	k.	PROPN
cuesj-1122	401	33	pan	pan	PROPN
cuesj-1122	401	34	,	,	PUNCT
cuesj-1122	401	35	j.	j.	PROPN
cuesj-1122	401	36	southern	southern	PROPN
cuesj-1122	401	37	,	,	PUNCT
cuesj-1122	401	38	d.	d.	PROPN
cuesj-1122	401	39	l.	l.	PROPN
cuesj-1122	401	40	swerdlow	swerdlow	PROPN
cuesj-1122	401	41	and	and	CCONJ
cuesj-1122	401	42	l.	l.	PROPN
cuesj-1122	401	43	jodar	jodar	PROPN
cuesj-1122	401	44	,	,	PUNCT
cuesj-1122	401	45	y.	y.	PROPN
cuesj-1122	401	46	levy	levy	PROPN
cuesj-1122	401	47	,	,	PUNCT
cuesj-1122	401	48	s.	s.	PROPN
cuesj-1122	401	49	alroy-preis.impact	alroy-preis.impact	PROPN
cuesj-1122	401	50	and	and	CCONJ
cuesj-1122	401	51	effectiveness	effectiveness	NOUN
cuesj-1122	401	52	of	of	ADP
cuesj-1122	401	53	mrna	mrna	PROPN
cuesj-1122	401	54	bnt162b2	bnt162b2	PROPN
cuesj-1122	401	55	vaccine	vaccine	NOUN
cuesj-1122	401	56	against	against	ADP
cuesj-1122	401	57	sars	sar	NOUN
cuesj-1122	401	58	-	-	PUNCT
cuesj-1122	401	59	cov-2	cov-2	PART
cuesj-1122	401	60	infections	infection	NOUN
cuesj-1122	401	61	and	and	CCONJ
cuesj-1122	401	62	covid-19	covid-19	PROPN
cuesj-1122	401	63	cases	case	NOUN
cuesj-1122	401	64	,	,	PUNCT
cuesj-1122	401	65	hospitalisations	hospitalisation	NOUN
cuesj-1122	401	66	,	,	PUNCT
cuesj-1122	401	67	and	and	CCONJ
cuesj-1122	401	68	deaths	death	NOUN
cuesj-1122	401	69	following	follow	VERB
cuesj-1122	401	70	a	a	DET
cuesj-1122	401	71	nationwide	nationwide	ADJ
cuesj-1122	401	72	vaccination	vaccination	NOUN
cuesj-1122	401	73	campaign	campaign	NOUN
cuesj-1122	401	74	in	in	ADP
cuesj-1122	401	75	israel	israel	PROPN
cuesj-1122	401	76	:	:	PUNCT
cuesj-1122	401	77	an	an	DET
cuesj-1122	401	78	observational	observational	ADJ
cuesj-1122	401	79	study	study	NOUN
cuesj-1122	401	80	using	use	VERB
cuesj-1122	401	81	national	national	ADJ
cuesj-1122	401	82	surveillance	surveillance	NOUN
cuesj-1122	401	83	data	datum	NOUN
cuesj-1122	401	84	.	.	PUNCT
cuesj-1122	402	1	the	the	DET
cuesj-1122	402	2	lancet	lancet	PROPN
cuesj-1122	402	3	,	,	PUNCT
cuesj-1122	402	4	vol	vol	NOUN
cuesj-1122	402	5	.	.	PROPN
cuesj-1122	402	6	397	397	NUM
cuesj-1122	402	7	,	,	PUNCT
cuesj-1122	402	8	no	no	NOUN
cuesj-1122	402	9	.	.	NOUN
cuesj-1122	402	10	10287	10287	NUM
cuesj-1122	402	11	,	,	PUNCT
cuesj-1122	402	12	pp	pp	ADJ
cuesj-1122	402	13	.	.	PUNCT
cuesj-1122	403	1	1819	1819	NUM
cuesj-1122	403	2	-	-	SYM
cuesj-1122	403	3	1829	1829	NUM
cuesj-1122	403	4	,	,	PUNCT
cuesj-1122	403	5	2021	2021	NUM
cuesj-1122	403	6	.	.	PUNCT